
<html lang="en"     class="pb-page"  data-request-id="272bd65a-e465-472e-937b-5a9a15b982a5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00551;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization" /></meta><meta name="dc.Creator" content="Haichan  Niu" /></meta><meta name="dc.Creator" content="Tracy E.  Strecker" /></meta><meta name="dc.Creator" content="Jeni L.  Gerberich" /></meta><meta name="dc.Creator" content="James W.  Campbell, III" /></meta><meta name="dc.Creator" content="Debabrata  Saha" /></meta><meta name="dc.Creator" content="Deboprosad  Mondal" /></meta><meta name="dc.Creator" content="Ernest  Hamel" /></meta><meta name="dc.Creator" content="David J.  Chaplin" /></meta><meta name="dc.Creator" content="Ralph P.  Mason" /></meta><meta name="dc.Creator" content="Mary Lynn  Trawick" /></meta><meta name="dc.Creator" content="Kevin G.  Pinney" /></meta><meta name="dc.Description" content="A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretast..." /></meta><meta name="Description" content="A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretast..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 6, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00551" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00551" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00551" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00551" /></link>
        
    
    

<title>Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00551" /></meta><meta property="og:title" content="Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0012.jpeg" /></meta><meta property="og:description" content="A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretastatin A-4 (CA4). Our previous studies with benzocycloalkenyl and heteroaromatic ring systems yielded promising inhibitors with dihydronaphthalene and benzosuberene analogues featuring phenolic (KGP03 and KGP18) and aniline (KGP05 and KGP156) congeners emerging as lead agents. These molecules demonstrated dual mechanism of action, functioning both as potent vascular disrupting agents (VDAs) and as highly cytotoxic anticancer agents. A further series of analogues was designed to extend functional group diversity and investigate regioisomeric tolerance. Ten new molecules were effective inhibitors of tubulin polymerization (IC50 &lt; 5 μM) with seven of these exhibiting highly potent activity comparable to CA4, KGP18, and KGP03. For one of the most effective agents, dose-dependent vascular shutdown was demonstrated using dynamic bioluminescence imaging in a human prostate tumor xenograft growing in a rat." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00551"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00551">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00551&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00551&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00551&amp;href=/doi/10.1021/acs.jmedchem.9b00551" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5594-5615</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00518" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00561" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Haichan Niu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haichan Niu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haichan++Niu">Haichan Niu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tracy E. Strecker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tracy E. Strecker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tracy+E.++Strecker">Tracy E. Strecker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeni L. Gerberich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeni L. Gerberich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeni+L.++Gerberich">Jeni L. Gerberich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James W. Campbell III</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James W. Campbell, III</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Campbell%2C++III">James W. Campbell, III</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Debabrata Saha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debabrata Saha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology Oncology, Division of Molecular Radiation Biology, The University of Texas Southwestern Medical Center, 2201 Inwood Road, Dallas, Texas 75390-9187, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debabrata++Saha">Debabrata Saha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deboprosad Mondal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deboprosad Mondal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deboprosad++Mondal">Deboprosad Mondal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ernest Hamel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ernest Hamel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland 21702, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ernest++Hamel">Ernest Hamel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David J. Chaplin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Chaplin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</div><div class="loa-info-affiliations-info">Mateon Therapeutics, Inc., 701 Gateway Boulevard, Suite 210, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Chaplin">David J. Chaplin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ralph P. Mason</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ralph P. Mason</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ralph+P.++Mason">Ralph P. Mason</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mary Lynn Trawick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mary Lynn Trawick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Lynn++Trawick">Mary Lynn Trawick</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kevin G. Pinney</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin G. Pinney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +1-254-710-4117. Fax: +1-254-710-4272. E-mail: <a href="/cdn-cgi/l/email-protection#2b604e5d4245747b4245454e526b494a52474459054e4f5e"><span class="__cf_email__" data-cfemail="d398b6a5babd8c83babdbdb6aa93b1b2aabfbca1fdb6b7a6">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+G.++Pinney">Kevin G. Pinney</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1262-8631" title="Orcid link">http://orcid.org/0000-0003-1262-8631</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00551&amp;href=/doi/10.1021%2Facs.jmedchem.9b00551" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5594–5615</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 6, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 March 2019</li><li><span class="item_label"><b>Published</b> online</span>6 May 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00551" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00551</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5594%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHaichan%2BNiu%252C%2BTracy%2BE.%2BStrecker%252C%2BJeni%2BL.%2BGerberich%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D11%26contentID%3Dacs.jmedchem.9b00551%26title%3DStructure%2BGuided%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2BBenzosuberene%2BAnalogues%2Bas%2BInhibitors%2Bof%2BTubulin%2BPolymerization%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5615%26publicationDate%3DJune%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00551"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1590</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00551" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Haichan&quot;,&quot;last_name&quot;:&quot;Niu&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;E. Strecker&quot;},{&quot;first_name&quot;:&quot;Jeni&quot;,&quot;last_name&quot;:&quot;L. Gerberich&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Campbell&quot;},{&quot;first_name&quot;:&quot;Debabrata&quot;,&quot;last_name&quot;:&quot;Saha&quot;},{&quot;first_name&quot;:&quot;Deboprosad&quot;,&quot;last_name&quot;:&quot;Mondal&quot;},{&quot;first_name&quot;:&quot;Ernest&quot;,&quot;last_name&quot;:&quot;Hamel&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Chaplin&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;P. Mason&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Lynn Trawick&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;G. Pinney&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5594-5615&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00551&quot;},&quot;abstract&quot;:&quot;A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretastatin A-4 (CA4). Our previous studies with benzocycloalkenyl and heteroaromatic ring systems yielded promising inhibitors with dihydronaphthalene and benzosuberene analogues featuring phenolic (KGP03 and KGP18) and aniline (KGP05 and KGP156) congeners emerging as lead agents. These molecules demonstrated dual mechanism of action, functioning both as potent vascular disrupting agents (VDAs) and as highly cytotoxic anticancer agents. A further series of analogues was designed to extend functional group diversity and investigate regioisomeric tolerance. Ten new molecules were effective inhibitors of tubulin polymerization (IC50 &lt; 5 μM) with seven of these exhibiting highly potent activity comparable to CA4, KGP18, and KGP03. For one of the most effective agents, dose-dependent vascular shutdown was demonstrated using dy&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00551&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00551" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00551&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00551" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00551&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00551" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00551&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00551&amp;href=/doi/10.1021/acs.jmedchem.9b00551" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00551" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00551" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00551%26sid%3Dliteratum%253Aachs%26pmid%3D31059248%26genre%3Darticle%26aulast%3DNiu%26date%3D2019%26atitle%3DStructure%2BGuided%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2BBenzosuberene%2BAnalogues%2Bas%2BInhibitors%2Bof%2BTubulin%2BPolymerization%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D11%26spage%3D5594%26epage%3D5615%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292232" title="Polymerization">Polymerization</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/jmcmar.2019.62.issue-11/20190613/jmcmar.2019.62.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretastatin A-4 (CA4). Our previous studies with benzocycloalkenyl and heteroaromatic ring systems yielded promising inhibitors with dihydronaphthalene and benzosuberene analogues featuring phenolic (KGP03 and KGP18) and aniline (KGP05 and KGP156) congeners emerging as lead agents. These molecules demonstrated dual mechanism of action, functioning both as potent vascular disrupting agents (VDAs) and as highly cytotoxic anticancer agents. A further series of analogues was designed to extend functional group diversity and investigate regioisomeric tolerance. Ten new molecules were effective inhibitors of tubulin polymerization (IC<sub>50</sub> < 5 μM) with seven of these exhibiting highly potent activity comparable to CA4, KGP18, and KGP03. For one of the most effective agents, dose-dependent vascular shutdown was demonstrated using dynamic bioluminescence imaging in a human prostate tumor xenograft growing in a rat.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Solid tumors require a functional vasculature to supply oxygen and nutrients to their cells when they exceed 1 mm<sup>3</sup> in size.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Unlike normal vasculature, the tumor-associated vascular network tends to expand irregularly, incorporating fragile and chaotic bulges and blind ends.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> The primitive character and inherent fragility of tumor-associated vasculature, along with the seminal observations by Denekamp and co-workers that blocking established tumor-associated blood flow leads to tumor regression in mice, positioned tumor-associated vasculature as a promising target for cancer therapy.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> Two categories of small-molecule, vascular-targeted therapies have been developed: angiogenesis inhibiting agents (AIAs) that inhibit neovascularization in developing tumors and, separately, vascular disrupting agents (VDAs) that irreversibly damage established tumor-associated vasculature.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9−13)</a> The two major subdivisions of VDAs include biologics and small-molecule anticancer agents. The majority of small-molecule VDAs function as inhibitors of tubulin polymerization, which destabilize the tubulin-microtubule protein system by binding to the colchicine site on β-tubulin in close proximity to the α,β-tubulin heterodimer interface. The endothelial cells lining microvessels undergo rapid cytoskeletal disruption, manifested by morphological changes (flat to round) in response to inhibition of their tubulin-microtubule protein system cytoskeleton triggered by VDA binding to the colchicine site. This rapid endothelial cell cytoskeletal rearrangement leads to irreversible damage to the tumor-associated vasculature, culminating in tumor necrosis.<a onclick="showRef(event, 'ref4 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref4 ref14 ref15 ref16 ref17">(4,14−17)</a></div><div class="NLM_p">The natural products colchicine, combretastatin A-4 (CA4), and combretastatin A-1 (CA1), along with the synthetic analogue phenstatin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), are potent colchicine site inhibitors of tubulin polymerization that function as promising VDAs.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24">(18−24)</a> These molecules have provided structural inspiration and guidance for the design, synthesis, and biological evaluation of many second-generation (and beyond) molecules in a worldwide effort to identify a small-molecule colchicine site agent with the necessary efficacy coupled with safety to be utilized as a cancer therapeutic in humans. To date, no small-molecule therapeutic agent that interacts with the colchicine site and functions as either an antiproliferative agent or a VDA (or demonstrates a dual mechanism of action) has reached FDA approval. Structural similarities between these natural products include a trimethoxyphenyl ring, a separate hydroxylated <i>p</i>-methoxyaryl moiety, and a bridging functionality connecting the two rings with a comparable centroid-to-centroid distance. Our long-standing program focused on molecular recognition for the colchicine site has led to the discovery of promising synthetic analogues and derivatives,<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25−28)</a> including stilbenoid,<a onclick="showRef(event, 'ref14 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref14 ref29 ref30 ref31">(14,29−31)</a> benzo[<i>b</i>]thiophene,<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> benzofuran,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> dihydronaphthalene,<a onclick="showRef(event, 'ref8 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref8 ref35 ref36">(8,35,36)</a> benzosuberene,<a onclick="showRef(event, 'ref8 ref25 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref35 ref36 ref37 ref38">(8,25,35−38)</a> and indole-based<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> molecules (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Numerous other studies have investigated a myriad of structural and functional group modifications to the A-ring, the B-ring, and the ethylene bridge of combretastatin A-4, the results of which are conveyed in extensive publications (too numerous to cite herein) and summarized in various review articles, yet none are comprehensive.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49">(40−49)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative small-molecule inhibitors of tubulin polymerization: colchicine,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> combretastatins (CA4, CA1),<a onclick="showRef(event, 'ref15 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref23">(15,23)</a> phenstatin, dihydronaphthalene analogues (KGP03, KGP05),<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> benzosuberene analogues (KGP18, KGP156),<a onclick="showRef(event, 'ref8 ref25 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref37 ref38">(8,25,37,38)</a> indole analogue (OXi8006),<a onclick="showRef(event, 'ref39 ref50'); return false;" href="javascript:void(0);" class="ref ref39 ref50">(39,50)</a> and benzo[<i>b</i>]furan analogue (BNC105).<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Two benzosuberene-based analogues (referred to as KGP18<a onclick="showRef(event, 'ref8 ref25 ref37'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref37">(8,25,37)</a> and its amino congener KGP156<a onclick="showRef(event, 'ref35 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref38">(35,38)</a>) emerged from our previous studies as molecules with high relevance as potential preclinical candidates due, in part, to their potent inhibition of tubulin polymerization, pronounced cytotoxicity against human cancer cell lines, and promising activity as VDAs.<a onclick="showRef(event, 'ref8 ref25 ref38'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref38">(8,25,38)</a></div><div class="NLM_p">Studies by us and others have investigated a variety of functional group modifications on both the fused and pendant aryl rings of tubulin-binding benzosuberene and dihydronaphthalene molecular frameworks (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref8 ref25 ref35 ref36 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref35 ref36 ref54 ref55">(8,25,35,36,54,55)</a> In particular, Maderna and co-workers contributed efficient methodology toward the benzosuberene structural motif and presented a number of important B-ring modified benzosuberene analogues (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) along with an evaluation of their biological potency and their drugability characteristics.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Interestingly, a benzosuberene B-ring diene analogue was identified as one of the most potent cytotoxic agents among their synthesized series of 11 members,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and this same molecule (Maderna compound, listed as <b>68</b> herein) was obtained during our synthetic campaign as an unexpected product. It is also noteworthy that a new class of benzodiazepines has been reported as inhibitors of tubulin polymerization.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected KGP18 derivatives as inhibitors of tubulin polymerization with modifications at the C-4 position of the A ring and the C-6, 7, 8 positions of the B ring.<a onclick="showRef(event, 'ref25 ref57'); return false;" href="javascript:void(0);" class="ref ref25 ref57">(25,57)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein we designed, synthesized, and biologically evaluated a series of structurally varied analogues using KGP18 and KGP05 as lead compounds and further adopted our methodology to investigate functional group modifications on the A-ring (C-4 position) and the B-ring (C-6, 7, 8, 9 positions), along with regiochemical translocation of the pendant aryl ring (C-ring) in regard to their influence on inhibition of tubulin polymerization and cytotoxicity against several human cancer cell lines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Molecular Design and Synthesis</h3><div class="NLM_p">Eighteen benzosuberene and dihydronaphthalene analogues (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) were prepared by chemical synthesis and evaluated for their cytotoxicity against selected human cancer cell lines and their ability to inhibit tubulin polymerization. Structural modifications included (1) functional group (R) modifications on the fused aryl ring including the installation of alcohol, aldehyde, nitrile, and ester groups along with ether linkages to facilitate extension of the polar alcohol moiety away from the fused six–seven ring system; (2) R<sub>2</sub> and R<sub>3</sub> incorporation at the olefinic and allylic positions of the seven-membered ring introduced -Br, -OH, and -NHAc groups; (3) modification (R<sub>4</sub> position) of the fused aliphatic ring adjacent to the tertiary alcohol site, and (4) olefination and pendant trimethoxyphenyl ring regiochemistry on the fused nonaromatic ring. The synthesis of analogues <b>3</b>, <b>6</b>, <b>8</b>, <b>11</b>, <b>13</b>, <b>15</b> was initiated from a common intermediate ketone <b>1</b> that was readily available utilizing our previous methodolgy.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Treatment of benzosuberone <b>1</b> with trimethoxyphenyllithium (prepared from the corresponding bromide) generated tertiary alcohol <b>2</b>, which was subsequently converted to diol <b>3</b> upon removal of the phenolic TBS protecting group. Separately, tertiary alcohol <b>2</b> was converted to its corresponding benzosuberene <b>4,</b> which underwent treatment with a series of oxidants (<i>m-</i>CPBA, NBS, OsO<sub>4</sub>) to facilitate epoxidation followed by ring opening and oxidation, bromination, and Upjohn dihydroxylation.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Following the removal of protecting groups, target compounds <b>6</b>, <b>13</b>, and <b>15</b> were obtained. Similarly, reaction of 4-methylbenzosuberene <b>12</b> (prepared by us previously<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>) with NBS/AIBN afforded vinyl bromide <b>13</b>. Lead compound <b>7</b> (referred to as KGP18), also available through this methodology, was directly converted to its corresponding ether analogues <b>8</b> and <b>11</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref25 ref61'); return false;" href="javascript:void(0);" class="ref ref25 ref61">(25,61)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Benzosuberene and Benzosuberane Intermediates and Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compilation of synthesized benzosuberene, benzosuberane, benzosuberone, and dihydronaphthalene analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lead compounds benzosuberene <b>16</b> (referred to as KGP156) and its corresponding dihydronaphthalene analogue <b>17</b> (referred to as KGP05), which were readily available from our previous synthetic studies, were subjected to a Sandmeyer radical-nucleophilic aromatic substitution protocol to generate nitrile analogues <b>18</b> and <b>19</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref35 ref38 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref35 ref38 ref62 ref63">(35,38,62,63)</a> The benzosuberene aldehyde analogue <b>20</b> was obtained after subsequent reduction of the nitrile analogue (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Nitrile- and Aldehyde-Substituted R Position Analogues <b>18</b>–<b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As part of a larger program focused on the use of potently cytotoxic benzosuberene and dihydronaphthalene analogues as payloads in antibody–drug conjugates (ADCs) and as prodrugs targeted for selective release in regions of profound tumor hypoxia, we were intrigued by the possibility of replacing the heteroatom [oxygen (phenol) or nitrogen (aniline)] at the 4-position with a short carbon chain terminating with a primary alcohol (or amino) moiety, thus maintaining its hydrogen-bond donor nature and serving as a viable position for future attachment of various linkers. Accordingly, methylation of phenolic bromoaldehyde <b>21</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) followed by Wittig olefination and subsequent hydrogenation (under Ph<sub>2</sub>S mediation to maintain the arylbromine group) afforded methyl ester <b>24</b>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Benzosuberone <b>25</b> was obtained through an intramolecular Friedel–Crafts annulation facilitated by Eaton’s reagent (7.7 wt % P<sub>2</sub>O<sub>5</sub> in CH<sub>3</sub>SO<sub>3</sub>H), and subsequent treatment of compounds <b>25</b> with trimethoxyphenyllithium, followed by reaction workup under acidic conditions, generated benzosuberene intermediate <b>26</b>.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> We have previously evaluated corresponding fluorine and chlorine benzosuberene analogues.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Halogen–lithium exchange, followed by reaction with ethyl chloroformate, afforded ethyl ester <b>27</b>, which was reduced (LiAlH<sub>4</sub>) to generate benzylic alcohol <b>28</b>. Notably, while it proved possible to obtain analogue <b>28</b> directly from intermediate <b>26</b>, the isolated yield was quite low (≤8%) under these conditions, which was likely due, in part, to the low solubility of paraformaldehyde at low temperature in THF and its low reactivity as a polymer (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Ester Analogue <b>27</b> and Primary Alcohol Analogue <b>28</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Secondary allylic alcohol <b>37</b> and its corresponding <i>N</i>-acetyl congener <b>49</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) were prepared to investigate structure–activity relationship correlations associated with heteroatom incorporation on the conformationally flexible fused seven-membered ring. Appropriate aldehyde chain elongations were facilitated by Meldrum’s acid (toward <b>37</b>) and Wittig-ylide methodology (toward <b>49</b>), and subsequent functional group transformations (including installation of carboxylic acid moieties obtained under saponification conditions) afforded protected alcohol <b>34</b> and <i>N</i>-acetamide <b>45</b>, separately. Lewis acid mediated cyclization to obtain the benzosuberone molecular core was achieved by treatment of the requisite acyl chloride with either tin tetrachloride (to obtain ketone <b>35</b>) or Eaton’s reagent (to obtain ketone <b>46</b>). In each case, the pendant ring was installed through reaction with 3,4,5-trimethoxyphenyllithium. The secondary alcohol moiety (target compound <b>37</b>) was revealed (by deprotection) prior to the organolithium step, while the phenolic moiety (target compound <b>49</b>) was revealed after the organolithium reaction (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref8 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref8 ref67 ref68 ref69">(8,67−69)</a> Both compounds <b>36</b> and <b>37</b> undergo elimination first (allylic alcohol), then demethylation if treated with a Lewis acid such as AlCl<sub>3</sub> or BCl<sub>3</sub>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Allylic Alcohol Analogue <b>37</b> and Allylic <i>N</i>-Acetamide Analogue <b>49</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Translocation of the trimethoxyphenyl group (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) was achieved by initial cyclization (Eaton’s reagent) of carboxylic acid <b>54</b> with concomitant elimination to afford α,β-unsaturated ketone <b>55</b>. With the α,β-unsaturated ketone in hand, 1,2- and 1,4-addition reactions were conducted using the appropriate aryllithium and Gilman reagents to provide tertiary alcohol analogue <b>56 (</b>with unsaturated seven-membered ring to maintain rigidity), and separately the Michael adduct, trimethoxy pendant phenyl ring shifted analogue <b>57</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of α-Unsaturated Tertiary Alcohol Analogue <b>56</b> and Pendant Ring Shifted Analogue <b>57</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the course of an investigation centered on variability in phenolic moiety protecting groups for a subset of benzosuberene analogues, we were surprised by the formation of diene <b>67</b>, obtained upon 1,2-addition of trimethoxyphenyllithium to ketone <b>66</b>, followed by reaction workup. In this case, the secondary alcohol demonstrated a propensity to undergo elimination even under mild acidic or basic conditions such as TBAF deprotection or BCl<sub>3</sub> cleavage at lowered temperature. We attempted various combinations of 4-position (phenolic moiety on the fused aryl ring) and allylic alcohol protecting group strategies, which eventually led to the unanticipated formation of diene <b>68</b>. It is important to note that this diene (<b>68</b>) was previously obtained by Maderna and co-workers.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Having this compound in hand and noting its exceptional biological activity (inhibition of tubulin polymerization and cytotoxicity against human cancer cell lines, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> motivated us to prepare the corresponding water-soluble phosphate prodrug disodium salt <b>69</b> to facilitate in vivo studies in a mouse model of prostate cancer to evaluate the efficacy of this compound as a VDA, as evidenced by bioluminescence imaging (BLI) (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).<a onclick="showRef(event, 'ref8 ref25 ref57 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref57 ref68 ref69">(8,25,57,68,69)</a></div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Benzosuberdiene <b>68</b> and Phosphate Salt <b>69</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Tubulin Polymerization, Percent Inhibition of Colchicine Binding, and Cytotoxicity of the Benzosuberene and Dihydronaphthalene Analogues<a class="ref internalNav" href="#t1fn8" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">GI<sub>50</sub> (μM) SRB assay<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">inhibition of tubulin polymerization, IC<sub>50</sub> ± SD (μM)</th><th class="colsep0 rowsep0" align="center">% inhibition of colchicine binding ± SD</th><th class="colsep0 rowsep0" align="center">SK-OV-3</th><th class="colsep0 rowsep0" align="center">NCI-H460</th><th class="colsep0 rowsep0" align="center">DU-145</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CA4</td><td class="colsep0 rowsep0" align="left">1.0<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">84 ± 3 (1 μM), 98 ± 0.007 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.00455</td><td class="colsep0 rowsep0" align="left">0.00223<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.00327<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CA4P</td><td class="colsep0 rowsep0" align="left">>40<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.00119</td><td class="colsep0 rowsep0" align="left">0.00194<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.00323<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KGP18</td><td class="colsep0 rowsep0" align="left">0.85 ± 0.02<a class="ref internalNav" href="#t1fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">73 ± 5 (1 μM), 95 ± 0.5 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0000543<a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">0.0000418<a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">0.0000249<a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KGP03</td><td class="colsep0 rowsep0" align="left">0.5<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">90 ± 2 (1 μM), 98 ± 0.3 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0029<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.0032<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.00040<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doxorubicin</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.0789</td><td class="colsep0 rowsep0" align="left">0.123</td><td class="colsep0 rowsep0" align="left">0.134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">paclitaxel</td><td class="colsep0 rowsep0" align="left">NR</td><td class="colsep0 rowsep0" align="left">NR</td><td class="colsep0 rowsep0" align="left">0.00134</td><td class="colsep0 rowsep0" align="left">0.00176</td><td class="colsep0 rowsep0" align="left">0.00147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.394</td><td class="colsep0 rowsep0" align="left">0.173</td><td class="colsep0 rowsep0" align="left">0.0330</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">72 ± 2 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0314</td><td class="colsep0 rowsep0" align="left">0.0476</td><td class="colsep0 rowsep0" align="left">0.141</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">6.52</td><td class="colsep0 rowsep0" align="left">1.90</td><td class="colsep0 rowsep0" align="left">5.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">3.22</td><td class="colsep0 rowsep0" align="left">0.855</td><td class="colsep0 rowsep0" align="left">3.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.39 ± 0.06</td><td class="colsep0 rowsep0" align="left">88 ± 1 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0221</td><td class="colsep0 rowsep0" align="left">0.0353</td><td class="colsep0 rowsep0" align="left">0.0362</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">4.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">35 ± 5 (1 μM)</td><td class="colsep0 rowsep0" align="left">0.312</td><td class="colsep0 rowsep0" align="left">0.449</td><td class="colsep0 rowsep0" align="left">0.423</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0 (5 μM)</td><td class="colsep0 rowsep0" align="left">3.03</td><td class="colsep0 rowsep0" align="left">3.86</td><td class="colsep0 rowsep0" align="left">4.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">62 ± 0.7 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0648</td><td class="colsep0 rowsep0" align="left">0.434</td><td class="colsep0 rowsep0" align="left">0.860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.37 ± 0.08</td><td class="colsep0 rowsep0" align="left">73 ± 0.6 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0384</td><td class="colsep0 rowsep0" align="left">0.0605</td><td class="colsep0 rowsep0" align="left">0.0252</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3.2 ± 0.08</td><td class="colsep0 rowsep0" align="left">61 ± 3 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0572</td><td class="colsep0 rowsep0" align="left">0.0847</td><td class="colsep0 rowsep0" align="left">0.0402</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">1.0 ± 0.07</td><td class="colsep0 rowsep0" align="left">47 ± 1 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.299</td><td class="colsep0 rowsep0" align="left">0.353</td><td class="colsep0 rowsep0" align="left">0.631</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">0.63 ± 0.03</td><td class="colsep0 rowsep0" align="left">76 ± 2 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0403</td><td class="colsep0 rowsep0" align="left">0.0628</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">3.8 ± 0.5</td><td class="colsep0 rowsep0" align="left">28 ± 4 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.263</td><td class="colsep0 rowsep0" align="left">0.432</td><td class="colsep0 rowsep0" align="left">0.439</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.6 (5 μM)</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.334</td><td class="colsep0 rowsep0" align="left">1.20<a class="ref internalNav" href="#t1fn7" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0 (5 μM)</td><td class="colsep0 rowsep0" align="left">27.2</td><td class="colsep0 rowsep0" align="left">70.5</td><td class="colsep0 rowsep0" align="left">26.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0 (5 μM)</td><td class="colsep0 rowsep0" align="left">5.77</td><td class="colsep0 rowsep0" align="left">2.00</td><td class="colsep0 rowsep0" align="left">4.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">0.48 ± 0.08</td><td class="colsep0 rowsep0" align="left">68 ± 1 (0.5 μM), 95 ± 0.8 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.00690</td><td class="colsep0 rowsep0" align="left">0.0581</td><td class="colsep0 rowsep0" align="left">0.0976</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">16 ± 0.7</td><td class="colsep0 rowsep0" align="left">45 ± 2 (5 μM)</td><td class="colsep0 rowsep0" align="left">0.0153</td><td class="colsep0 rowsep0" align="left">0.0291</td><td class="colsep0 rowsep0" align="left">0.0239</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn8"><div class="footnote" id="t1fn8"><sup><sup>a</sup></sup><p class="last">ND = not determined. NR = not relevant (paclitaxel enhances microtubule assembly),</p></div><div class="footnote" id="t1fn1"><sup><sup>b</sup></sup><p class="last">Average of <i>n</i> ≥ 3 independent determinations (unless otherwise noted).</p></div><div class="footnote" id="t1fn2"><sup><sup>c</sup></sup><p class="last">Data from refs <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and <a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a>.</p></div><div class="footnote" id="t1fn3"><sup><sup>d</sup></sup><p class="last">For additional data, see ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>.</p></div><div class="footnote" id="t1fn4"><sup><sup>e</sup></sup><p class="last">For additional data, see ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>.</p></div><div class="footnote" id="t1fn5"><sup><sup>f</sup></sup><p class="last">For additional data, see ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>.</p></div><div class="footnote" id="t1fn6"><sup><sup>g</sup></sup><p class="last">For additional data, see refs <a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and <a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a>.</p></div><div class="footnote" id="t1fn7"><sup><sup>h</sup></sup><p class="last">Average of <i>n</i> = 2 independent determinations (of duplicates).</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biological Evaluation</h3><div class="NLM_p">Each of the 18 compounds (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) was evaluated for its cytotoxicity against human cancer cell lines [SK-OV-3 (ovarian), NCI-H460 (lung), DU-145 (prostate)] and for the ability to inhibit tubulin polymerization (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Ten of the evaluated molecules were identified as strong inhibitors of tubulin assembly (IC<sub>50</sub> < 5 μM, cell-free assay), while seven of the ten were highly active (IC<sub>50</sub> ≤ 1.2 μM). CA4 (IC<sub>50</sub> ≈ 1 μM) and KGP18 (compound <b>7</b>, IC<sub>50</sub> ≈ 0.85 μM) were utilized as comparative compounds. Three of the benzosuberene and dihydronaphthalene analogues (compounds <b>13</b>, <b>19</b>), along with the Maderna compound (<b>68</b>), were more potent against tubulin in comparison to our dihydronaphthalene lead compound KGP03 (IC<sub>50</sub> ≤ 0.5 μM). Excellent IC<sub>50</sub> values for inhibition of tubulin polymerization were retained upon alteration of the 4-position phenolic moiety into nitrile, ethyl ester, and CH<sub>2</sub>OH groups (<b>18</b>, <b>19</b>, <b>27</b>, <b>28</b>), along with modifications to the double bond on the seven-member ring that included replacement with ketone and tertiary alcohol groups, substitution with a bromine group, and increased unsaturation (<b>6</b>, <b>13</b>, <b>68</b>). Extension of the alkyl chain (at position 4) through an ether linkage that terminated with a polar alcohol group (compound <b>11</b>) and separately a methoxy moiety (compound <b>8</b>) resulted in loss of inhibitory activity. Incorporation of a hydrogen bond donor at the allylic position on the seven-member ring (compounds <b>37</b> and <b>49</b>) and substituted saturation of the double bond (compounds <b>3</b> and <b>15</b>) both reduced inhibition of tubulin polymerization. The lack of tubulin activity observed with compound <b>56</b> was unanticipated, since semirigidity of the seven-membered ring was maintained through a double bond one carbon removed from the stereogenic center, and its parent benzosuberene analogue (dimethoxy group on the fused aryl ring) demonstrated a moderate degree of inhibition of tubulin polymerization (IC<sub>50</sub> = 3.1 μM) reported in our previous study.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The lack of activity of compound <b>57</b> in regard to inhibition of tubulin polymerization suggested that the trimethoxy pendant aryl ring situated at the benzylic position on the fused-ring system was closely correlated to biological efficacy (at least in regard to inhibition of tubulin polymerization). While we have previously described similar pendant ring shifts in related benzosuberene analogues, this β-position substitution with a trimethoxy aryl ring has not been previously investigated.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p last">Among the 18 benzosuberene and dihydronaphthalene analogues investigated in this study (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), the most cytotoxic agents were compounds <b>6</b>, <b>13</b>, <b>18</b>, <b>19</b>, <b>28</b>, <b>68</b> (GI<sub>50</sub> = 0.0314, 0.0221, 0.0648, 0.0384, 0.0403, and 0.00690 μM, respectively, against the SK-OV-3 ovarian cancer cell line, for example). Judiciously selected structural modifications to the 4-, 8-, and 9-positions in the parent benzosuberene scaffold accounted for the majority of the highly potent analogues evaluated in this study. While the strong cytotoxicity of this subset of molecules is encouraging, it is noteworthy that all molecules proved less cytotoxic than the lead benzosuberene KGP18 and less cytotoxic (with the partial exception of the Maderna compound <b>68</b>) than the natural product CA4, despite demonstrating similar inhibition of tubulin polymerization (cell free assay). These observations provided an important extension to the known SAR considerations regarding structural modifications to KGP18. As anticipated (and similarly observed for combretastatin A-4 phosphate),<a onclick="showRef(event, 'ref15 ref71'); return false;" href="javascript:void(0);" class="ref ref15 ref71">(15,71)</a> the benzosuberene phosphate prodrug salt <b>69</b> was inactive as an inhibitor of tubulin polymerization in this cell-free assay, presumably due to the lack of phosphatase enzymes necessary to cleave the prodrug to its parent phenolic (biologically active) agent. Prodrug <b>69</b> was an active cytotoxic agent since nonspecific phosphatase activity is present in these cancer cell-based cytotoxicity assays.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Assessment of Vascular Damage</h3><div class="NLM_p">Ultimately, VDAs will be used in vivo, and thus it is crucial to understand both efficacy of vascular disruption and potential off-target toxicity in vivo. As a preliminary investigation, the extent of vascular damage was assessed in a human prostate tumor line in rats treated with the water-soluble prodrug salt <b>69</b> compared to CA4P as control. Many imaging methods have been developed to assess vascular disruption noninvasively in vivo.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> We favor dynamic bioluminescence imaging (BLI) for initial validation of VDA activity since it provides a fast, noninvasive, and easy method and allows comparison of repeat or sequential investigations. BLI does require the use of cells transfected to express luciferase (luc), but these are commonly available and we have used this approach extensively,<a onclick="showRef(event, 'ref11 ref25 ref39 ref53 ref75'); return false;" href="javascript:void(0);" class="ref ref11 ref25 ref39 ref53 ref75">(11,25,39,53,75)</a> as have others.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> We used the human prostate cancer PC3 line in which the tumor suppressor protein DAB2IP had been knocked down and luciferase introduced.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> BLI requires administration of luciferin substrate, which readily crosses membranes and is carried throughout the vasculature. The measurement of light emission dynamics is related to vascular delivery of the luciferin substrate, and thus it provides a measure of vascular patency.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Disruption of tumor vasculature blocks delivery of the substrate and consequently results in a quantifiable decrease in bioluminescent signal. The extent of vascular shutdown was evaluated using ip doses of 10 and 40 or 80 mg/kg of <b>69</b> and compared to a dose of 30 mg/kg of CA4P, which had been shown previously to cause extensive vascular shutdown in rats at this dose.<a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79−81)</a> It should also be noted that the lead benzosuberene KGP18 and the dihydronaphthalene KGP03 (both as their corresponding water-soluble phosphate prodrug salts (KGP265 and KGP04, respectively), along with other structurally modified benzosuberene analogues, demonstrated vascular shutdown (as evidenced by similar BLI imaging studies or color Doppler ultrasound).<a onclick="showRef(event, 'ref25 ref37 ref75'); return false;" href="javascript:void(0);" class="ref ref25 ref37 ref75">(25,37,75)</a></div><div class="NLM_p">Prodrug <b>69</b> administered at 10 mg/kg resulted in minimal change in light emission. A subsequent dose of 40 mg/kg <b>69</b> resulted in substantially diminished light emission (signal reduction 95%; <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) but with substantial recovery by 24 h. When CA4P (30 mg/kg) was administered 4 days later, it caused a very similar effect in terms of extent and longevity of diminished BLI signal as a surrogate for vascular shutdown. Similar activity was observed when a treatment naive rat was given 40 mg/kg <b>69</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) with substantial recovery at 24 h. At 48 h the rats appeared healthy and the signal increased marginally. A dose of 80 mg/kg was also well tolerated, but this higher dose did not show additional vascular disruption.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. BLI assessment of vascular response to VDA. (Left) Heat maps overlaid on photographs of male Copenhagen rat with subcutaneous PC3-DAB2IP-luc human prostate tumor xenograft showing light emission about 20 min after administration of <span class="smallcaps smallerCapital">d</span>-luciferin (120 mg/kg) at various times with respect to VDA administration ip. (Right) Corresponding dynamic light emission curves acquired over about 30 min following luciferin administration. Blue shows baseline, red about 4 h after VDA, and green at 24 h. (A) 10 mg/kg compound <b>69</b> indicating no vascular perturbation but increased signal at 24 h consistent with rapid tumor growth. (B) 6 h later 40 mg/kg compound <b>69</b> was administered to the same rat generating about 95% reduced signal at 4 h, consistent with substantial vascular shutdown and showing substantial recovery by 24 h. (C) Four days later 30 mg/kg CA4P was administered to this rat, eliciting BLI response similar to the BLI response shown in (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Relative light emission following administration of VDAs. (A) Relative signal intensity is shown about 20 min after administration of <span class="smallcaps smallerCapital">d</span>-luciferin subcutaneously in the foreback neck region of a rat with a subcutaneous PC3-DAB2IP-luc prostate tumor xenograft in the thigh: (top) baseline (no prior drug); (center) 4 h after 40 mg/kg <b>69</b>; (bottom) 24 h after <b>69</b>. (B) Corresponding light emission dynamic curve at baseline (blue), 4 h after <b>69</b> (red), and 24 h after <b>69</b> (green). (C) Normalized BLI signal at various times for the rat in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> receiving <b>69</b> sequentially at 10 mg/kg (black), 40 mg/kg (red), and 30 mg/kg CA4P (green), together with the treatment naive rat in (A), (B) receiving 40 mg/kg <b>69</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">These studies have expanded our SAR knowledge regarding the impact of structural modifications to lead benzosuberene and dihydronaphthalene analogues on inhibition of tubulin polymerization and cytotoxicity against human cancer cell lines. Among this group of 17 new molecules [along with the Maderna compound (<b>68</b>), accessed (in this study) through separate synthesis] emerged several promising analogues (compounds <b>6</b>, <b>13</b>, <b>18</b>, <b>19</b>, <b>28</b>, <b>68</b>) that elicited inhibition (IC<sub>50</sub>) of tubulin assembly (cell free assay) greater than or comparable to that of the lead natural product CA4 and our lead benzosuberene analogues KGP18 and KGP156. These compounds demonstrated potent cytotoxicity (GI<sub>50</sub>) against SK-OV-3 (ovarian), NCI-H460 (lung), and DU-145 (prostate) cells typically in the low to mid nM range. Preliminary investigation of water-soluble benzosuberene phosphate prodrug salt <b>69</b> at 40 mg/kg in vivo revealed vascular disruption in a PC3-DAB2IP-luc human prostate tumor xenograft based on BLI (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), which was similar to that obtained with CA4P.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry. General Materials and Methods</h3><div class="NLM_p">Tetrahydrofuran (THF), carbon tetrachloride, dichloromethane, methanol, dimethylformamide (DMF), and acetonitrile were used in their anhydrous forms. Reactions were performed under nitrogen gas. Thin-layer chromatography (TLC) plates (precoated glass plates with silica gel 60 F254, 0.25 mm thickness) were used to monitor reactions. Purification of intermediates and products was carried out with a Biotage Isolera flash purification system using silica gel (200–400 mesh, 60 Å) or RP-18 prepacked columns, or manually in glass columns. Intermediates and products synthesized were characterized on the basis of their <sup>1</sup>H NMR (500 or 600 MHz) and <sup>13</sup>C NMR (125 or 150 MHz) spectroscopic data using a Varian VNMRS 500 MHz, or Bruker DPX 600 MHz instrument. Spectra were recorded in CDCl<sub>3,</sub> D<sub>2</sub>O, (CD<sub>3</sub>)<sub>2</sub>CO, or CD<sub>3</sub>OD. All chemicals shifts are expressed in ppm (δ), and peak patterns are reported as broad (br), singlet (s), doublet (d), triplet (t), quartet (q), pentet (p), sextet (sext), septet (sept), double doublet (dd), double double doublet (ddd), and multiplet (m).</div><div class="NLM_p last">Purity of the final compounds was further analyzed at 25 °C using an Agilent 1200 HPLC system with a diode-array detector (λ = 190–400 nm), a Zorbax XDB-C18 HPLC column (4.6 mm × 150 mm, 5 μm), and a Zorbax reliance cartridge guard-column. Method: solvent A, acetonitrile, solvent B, H<sub>2</sub>O; gradient, 10% A/90% B to 100% A/0% B over 0 to 40 min; post-time 10 min; flow rate 1.0 mL/min; injection volume 20 μL; monitored at wavelengths of 210, 230, 254, 280, and 320 nm. Purity of target molecules (with reported biological data) was ≥95% (as determined by HPLC at one or more scanned wavelengths) with the exception of compound <b>27</b> (94.3% at 254 nm). Mass spectrometry was carried out under positive or negative ESI (electrospray ionization) using a Thermo Scientific LTQ Orbitrap Discovery instrument.</div></div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-methoxy-5-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-ol (<b>2</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h3><div class="NLM_p last">To an oven-dried flask, THF (10 mL) and 3,4,5-trimethoxyphenyl bromide (0.89 g, 3.6 mmol) were added, and the solution was cooled to −78 °C. <i>n</i>-BuLi (1.44 mL, 3.60 mmol) was added dropwise to the reaction mixture, which was then stirred at −78 °C for 1 h. TBS-protected ketone (<b>1</b>) (0.77 g, 2.4 mmol) in THF (5 mL) was then added slowly to the flask, and the reaction mixture was stirred while warming from −78 °C to room temperature over 12 h. The reaction mixture was quenched with water and extracted with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 2% A/98% B (1 CV), 2% A/98% B → 20% A/80% B (10 CV), 20% A/80% B (2 CV); flow rate 50 mL/min; monitored at 254 and 280 nm] to afford tertiary alcohol <b>2</b> (1.05 g, 2.15 mmol, 89%) as a clear oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.15 (1H, d, <i>J</i> = 9 Hz), 6.69 (1H, d, <i>J</i> = 9 Hz), 6.50 (2H, s), 3.84 (3H, s), 3.80 (3H, s), 3.75 (6H, s), 3.29 (1H, m), 2.56 (1H, m), 2.26 (1H, m), 2.12 (2H, m), 1.90 (1H, m), 1.75 (2H, m), 0.99 (9H, s), 0.17 (3H, s), 0.15 (3H, s). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 153.1, 149.4, 142.0, 141.9, 138.7, 137.3, 132.9, 119.8, 108.0, 104.4, 80.2, 61.0, 56.2, 54.8, 41.4, 27.1, 26.4, 26.2, 25.5, 19.1, −3.8, −4.0.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Methoxy-5-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulene-1,5-diol (<b>3</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h3><div class="NLM_p last">TBS-protected tertiary alcohol <b>2</b> (0.41 g, 0.84 mmol) was dissolved in THF (6 mL), TBAF (1.01 mL, 1 M in THF, 1.01 mmol) was added, and the reaction mixture was stirred at room temperature for 4 h. The solution was washed with water and extracted with EtOAc (3 × 20 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 10 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 3% A/97% B (1 CV), 3% A/97% B → 30% A/70% B (10 CV), 30% A/70% B (2 CV); flow rate 12 mL/min, monitored at 254 and 280 nm] to afford phenol (0.11 g, 0.29 mmol, 35%) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.04 (1H, d, <i>J</i> = 9 Hz), 6.70 (1H, d, <i>J</i> = 9 Hz), 6.52 (2H, s), 5.79 (1H, s), 3.91 (3H, s), 3.84 (3H, s), 3.76 (6H, s), 3.23 (1H, m), 2.56 (1H, m), 2.35 (1H, m), 2.11 (1H, m), 1.92 (1H, m), 1,75 (2H, m), 1.47 (1H, m). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 153.1, 145.6, 142.7, 141.9, 139.4, 137.3, 127.2, 118.2, 107.3, 104.4, 80.2, 61.0, 56.3, 56.0, 41.5, 26.8, 26.3, 24.7. HRMS: obsvd 397.1623 [M + Na<sup>+</sup>], calcd for C<sub>21</sub>H<sub>26</sub>O<sub>6</sub>Na, 397.1622. HPLC: 16.33 min.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>tert</i>-Butyl((3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-4-yl)oxy)dimethylsilane (<b>4</b>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h3><div class="NLM_p last">TBS-protected tertiary alcohol <b>2</b> (0.64 g, 1.3 mmol) was dissolved in acetic acid (10 mL), and the reaction mixture was stirred at room temperature for 6 h. The unreacted acetic acid was removed under reduced pressure. The resulting reaction mixture was washed with water and extracted with EtOAc (3 × 30 mL). The combined organic extracts were washed with brine, dried over sodium sulfate, evaporated under reduced pressure, and purified by flash chromatography using a prepacked 25 g silica column [solvent A of EtOAc, solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 50% A/50% B (10 CV), 50% A/50% B (2 CV); flow rate 25 mL/min; monitored at 254 and 280 nm] to afford a clear oil that solidified as a colorless solid of TBS-protected benzosuberene analogue <b>4</b> (0.41 g, 0.87 mmol, 66%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 6.68 (1H, d, <i>J</i> = 8.5 Hz), 6.61 (1H, d, <i>J</i> = 8.5 Hz), 6.48 (2H, s), 6.32 (1H, t, <i>J</i> = 7 Hz), 3.85 (3H, s), 3.81 (3H, s), 3.79 (6H, s), 2.76 (2H, t, <i>J</i> = 7 Hz), 2.10 (2H, m), 1.95 (2H, m), 1.04 (9H, s), 0.23 (6H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 152.9, 148.8, 143.2, 141.6, 138.8, 137.3, 133.9, 133.4, 127.0, 122.5, 108.5, 105.3, 61.0, 56.2, 54.8, 34.1, 26.3, 25.7, 24.4, 19.2, −3.7.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-(<i>tert</i>-Butyldimethylsilyl)oxy)-5-hydroxy-2-methoxy-5-(3,4,5-trimethoxyphenyl)-5,7,8,9-tetrahydro-6<i>H</i>-benzo[7]annulen-6-one (<b>5</b>)</h3><div class="NLM_p last">To a solution of TBS-protected benzosuberene <b>4</b> (0.51 g, 1.1 mmol) dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added <i>m-</i>CPBA (0.36 g, 2.1 mmol) at −5 °C, and the reaction mixture was stirred for 2 h, then at room temperature for 12 h. The solution was washed with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, saturated NaHCO<sub>3</sub>, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organic layers were dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford tertiary alcohol <b>5</b> (0.256 g, 0.51 mmol, 47%) as a yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.26 (1H, d, <i>J</i> = 9 Hz), 6.76 (1H, d, <i>J</i> = 9 Hz), 6.42 (2H, s), 5.01 (1H, s), 3.83 (3H, s), 3.81 (3H, s), 3.75 (6H, s), 3.10 (2H, m), 2.82 (1H, m), 2.70 (1H, m), 1.98 (1H, m), 1.76 (1H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 211.1, 153.4, 150.2, 142.1, 138.0, 137.5, 131.4, 131.1, 127.8, 109.1, 105.2, 85.6, 61.0, 56.3, 54.8, 39.7, 26.2, 25.8, 24.2, 19.1, −3.7, −3.9.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1,5-Dihydroxy-2-methoxy-5-(3,4,5-trimethoxyphenyl)-5,7,8,9-tetrahydro-6<i>H</i>-benzo[7]annulen-6-one (<b>6</b>)</h3><div class="NLM_p last">TBS-protected benzosuberane <b>5</b> (0.17 g, 0.33 mmol) was dissolved in THF (10 mL). TBAF (0.33 mL, 1 M, 0.33 mmol) was added, and the reaction mixture was stirred for 1 h at 0 °C. A brine (30 mL) solution was added, and the reaction mixture was extracted with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate, filtered, evaporated under reduced pressure, and purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford phenol <b>6</b> (123 mg, 0.320 mmol, 96%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.17 (1H, d, <i>J</i> = 8.4 Hz), 6.77 (1H, d, <i>J</i> = 9 Hz), 6.43 (2H, s), 5.88 (1H, s), 5.00 (1H, s), 3.90 (3H, s), 3.82 (3H, s), 3.74 (6H, s), 3.08 (2H, m), 2.84 (1H, m), 2.68 (1H, m), 1.99 (1H, m), 1.83 (1H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 211.0, 153.3, 146.4, 142.8, 138.0, 137.2, 131.6, 125.7, 120.2, 108.4, 105.2, 85.5, 60.9, 56.3, 56.0, 39.4, 25.4, 23.3. HRMS: obsvd 411.1414 [M + Na<sup>+</sup>]. Calcd for C<sub>21</sub>H<sub>24</sub>O<sub>7</sub>Na: 411.1414. HPLC: 15.75 min.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-Methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-4-ol (<b>7</b>)</h3><div class="NLM_p last">TBS-protected benzosuberene <b>4</b> (0.41 g, 0.87 mmol) was dissolved in THF (10 mL). TBAF (1.13 mL, 1.13 mmol) was added, and the reaction mixture was stirred at room temperature for 1 h. The solution was washed with water and extracted with EtOAc (3 × 20 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 10 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 3% A/97% B (1 CV), 3% A/97% B → 30% A/70% B (10 CV), 30% A/70% B (2 CV); flow rate 12 mL/min; monitored at 254 and 280 nm] to afford phenol <b>7</b> (0.25 g, 0.70 mmol, 81%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 6.71 (1H, d, <i>J</i> = 9 Hz), 6.56 (1H, d, <i>J</i> = 9 Hz), 6.50 (2H, s), 6.34 (1H, t, <i>J</i> = 7.5 Hz), 5.74 (1H, s), 3.91 (3H, s), 3.86 (3H, s), 3.80 (6H, s), 2.76 (2H, t, <i>J</i> = 7 Hz), 2.14 (2H, m), 1.97 (2H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 152.9, 145.2, 142.9, 142.4, 138.6, 134.4, 127.9, 127.4, 121.0, 110.1, 107.8, 105.4, 61.1, 56.3, 56.1, 33.7, 25.9, 23.7.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-Methoxy-4-(2-(2-methoxyethoxy)ethoxy)-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulene (<b>8</b>)</h3><div class="NLM_p last">Phenol <b>7</b> (0.11 g, 0.31 mmol) was dissolved in DMF (6 mL), and K<sub>2</sub>CO<sub>3</sub> (0.12 g, 0.86 mmol) was added. The solution was stirred at room temperature for 20 min. 1-Bromo-2-(2-methoxyethoxy)ethane in 90% purity (0.07 mL, 0.5 mmol) was added, and the reaction mixture was stirred at room temperature for 15 h, followed by an additional 3 h of stirring at 150 °C. The solution was washed with water and extracted with EtOAc (3 × 40 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 10 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 3% A/97% B (1 CV), 3% A/97% B → 30% A/70% B (20 CV), 30% A/70% B (2 CV); flow rate 12 mL/min; monitored at 254 and 280 nm] to afford ether <b>8</b> (25 mg, 0.06 mmol, 18%) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.74 (2H, m), 6.48 (2H, s), 6.32 (1H, t, <i>J</i> = 7.5 Hz), 4.18 (2H, t, <i>J</i> = 5 Hz), 3.87 (2H, t, <i>J</i> = 5.5 Hz), 3.85 (6H, s), 3.79 (6H, s), 3.76 (2H, m), 3.60 (2H, m), 3.40 (3H, s), 2.78 (2H, t, <i>J</i> = 6.5 Hz), 2.13 (2H, m), 1.93 (2H, m). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.9, 151.5, 145.1, 142.9, 138.5, 137.4, 136.1, 133.8, 127.3, 125.3, 109.3, 105.3, 72.8, 72.2, 70.78, 70.77, 61.0, 59.2, 56.2, 55.7, 34.5, 25.7, 24.2. HRMS: obsvd 481.2198 [M + Na<sup>+</sup>]. Calcd for C<sub>26</sub>H<sub>34</sub>O<sub>7</sub>Na: 481.2197. HPLC: 21.65 min.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> ((8-Bromo-3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-4-yl)oxy)(<i>tert</i>-butyl)dimethylsilane (<b>9</b>)</h3><div class="NLM_p last">To a solution of TBS-protected benzosuberene (102 mg, 0.22 mmol) in CCl<sub>4</sub> (30 mL) were added NBS (46 mg, 0.26 mmol) and AIBN (3.6 mg, 0.02 mmol). The solution was heated at reflux for 2 h, followed by the addition of water (20 mL) and extraction with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organic phase was dried over sodium sulfate, filtered, and the solvent was removed under reduced pressure. The crude product was obtained as a yellow oil and taken to the next step directly without any further purification.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-methoxy-5-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulene-5,6-diol (<b>10</b>)</h3><div class="NLM_p last">To a solution of TBS-protected benzosuberene <b>4</b> (1.00 g, 2.12 mmol) in acetone/water (35 mL/15 mL) were added OsO<sub>4</sub> (270 mg, 1.06 mmol) and <i>N</i>-methylmorpholine <i>N</i>-oxide (0.66 mL, 4.8 M, 3.2 mmol) at room temperature, and the reaction mixture was stirred for 12 h. A saturated sodium hydrosulfite (20 mL) solution was added, and the reaction mixture was extracted with EtOAc (5 × 20 mL). The combined organic extracts were washed with brine, dried over sodium sulfate, filtered, evaporated under reduced pressure, and purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford diol <b>10</b> (0.35 mg, 0.69 mmol, 33%) as an orange oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.30 (1H, d, <i>J</i> = 8.4 Hz), 6.74 (1H, d, <i>J</i> = 9 Hz), 6.47 (2H, s), 4.51 (1H, s, b), 3.81 (3H, s), 3.80 (3H, s), 3.72 (6H, s), 3.42 (1H, m), 3.33 (1H, s), 2.15 (1H, m), 1.96 (2H, m), 1.83 (1H, m), 1.62 (1H, m), 1.51 (1H, m), 0.98 (9H, s), 0.15 (6H, d, <i>J</i> = 3.6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 153.1, 149.8, 142.0, 138.8, 137.7, 133.1, 132.7, 122.3, 108.5, 105.0, 83.1, 76.5, 60.9, 56.2, 54.7, 32.7, 26.2, 25.9, 21.3, 19.0, −3.9, −4.0.</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-((3-Methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-4-yl)oxy)ethan-1-ol (<b>11</b>)</h3><div class="NLM_p last">Phenol <b>7</b> (0.14 g, 0.39 mmol) was dissolved in DMF (3 mL), then ethylene carbonate (70 mg, 0.79 mmol) and tetrabutyl ammonium bromide (0.13 g, 0.39 mmol) were added together. The solution was stirred and heated at reflux for 24 h. The reaction mixture was diluted with brine, extracted with EtOAc (3 × 10 mL), and the combined organic layers were dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 25 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 25 mL/min; monitored at 254 and 280 nm] to afford alcohol <b>11</b> (0.11 g, 0.27 mmol, 68%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.76 (2H, m), 6.47 (2H, s), 6.33 (1H, t, <i>J</i> = 7.5 Hz), 4.12 (2H, m), 3.89 (2H, m), 3.88 (3H, s), 3.84 (3H, s), 3.79 (6H, s), 2.75 (2H, t, <i>J</i> = 7 Hz), 2.15 (2H, m), 1.95 (2H, m). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.9, 151.1, 145.0, 142.8, 138.3, 137.4, 136.1, 134.2, 127.3, 125.7, 109.2, 105.3, 76.1, 62.2, 61.0, 56.2, 55.8, 34.6, 25.6, 24.6. HRMS: obsvd 423.1780 [M + Na<sup>+</sup>]. Calcd for C<sub>23</sub>H<sub>28</sub>O<sub>6</sub>Na: 423.1778. HPLC: 13.77 min.</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 8-Bromo-3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-4-ol (<b>13</b>)</h3><div class="NLM_p last">Brominated benzosuberene <b>9</b> (0.12 g, 0.22 mmol, crude) was dissolved in THF (20 mL), and TBAF (0.22 mL, 1 M, 0.22 mmol) was added to the solution at 0 °C. The reaction mixture was stirred for 1 h, washed with brine (20 mL), and extracted with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate, filtered, and evaporated under reduced pressure. The resulting material was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford brominated phenol <b>13</b> (97 mg, 0.22 mmol, 100% over two steps) as a white crystalline solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.63 (1H, d, <i>J</i> = 8.4 Hz), 6.45 (2H, s), 6.41 (1H, d, <i>J</i> = 8.4 Hz), 5.74 (1H, s), 3.88 (3H, s), 3.87 (3H, s), 3.80 (6H, s), 2.88 (2H, t, <i>J</i> = 7.2 Hz), 2.58 (2H, t, <i>J</i> = 7.2 Hz), 2.26 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.7, 145.5, 142.5, 140.8, 137.9, 137.3, 135.3, 126.4, 121.5, 121.1, 108.0, 107.5, 61.0, 56.3, 56.1, 38.5, 32.5, 23.2. HRMS: obsvd 457.0621 [M + Na<sup>+</sup>]. Calcd for C<sub>21</sub>H<sub>23</sub>BrO<sub>5</sub>Na: 457.0621. HPLC: 17.54 min.</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 8-Bromo-3-methoxy-4-methyl-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulene (<b>14</b>)</h3><div class="NLM_p last">KGP391 <b>12 (</b>68 mg, 0.19 mmol) was dissolved in CCl<sub>4</sub> (20 mL), and NBS (37 mg, 0.21 mmol) and AIBN (3.1 mg, 0.02 mmol) were added carefully (avoiding shaking or metal spatula since AIBN can be explosive). The reaction mixture was refluxed and stirred for 2 h. The solution was washed with water and extracted by CH<sub>2</sub>Cl<sub>2</sub>; the organic phase was further washed by brine and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 10 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 6% A/94% B (1 CV), 6% A/94% B → 70% A/30% B (10 CV), 70% A/30% B (2 CV); flow rate 12 mL/min; monitored at 254 and 280 nm] to afford brominated benzosuberene analogue <b>14</b> (66 mg, 0.15 mmol, 80%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.70 (1H, d, <i>J</i> = 7 Hz), 6.62 (1H, d, <i>J</i> = 7 Hz), 6.47 (2H, s), 3.88 (3H, s), 3.81 (9H, s), 2.81 (2H, m), 2.53 (2H, m), 2.26 (3H, s), 2.24 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 156.8, 152.7, 141.4, 140.2, 138.0, 137.2, 134.2, 127.6, 123.5, 120.5, 107.7, 107.4, 61.0, 56.3, 55.6, 38.3, 33.0, 27.5, 11.9. HRMS: obsvd 457.0808 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>25</sub>BrO<sub>4</sub>Na: 455.0828. HPLC: 25.38 min.</div></div><div id="sec5_1_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Methoxy-5-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulene-1,5,6-triol (<b>15</b>)</h3><div class="NLM_p last">To a solution of TBS-protected phenol <b>10</b> (0.35 g, 0.69 mmol) in THF (20 mL) was added TBAF (0.76 mL, 1 M in THF, 0.76 mmol) at 0 °C. The reaction mixture was stirred for 1 h, subsequently washed with brine (30 mL), and extracted with EtOAc (3 × 30 mL). The resultant organic phase was dried over sodium sulfate, filtered, evaporated under reduced pressure, and purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 100% A/0% B (10 CV), 100% A/0% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford diol phenol <b>15</b> (138 mg, 0.35 mmol, 51%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.24 (1H, d, <i>J</i> = 8.4 Hz), 6.78 (1H, d, <i>J</i> = 8.4 Hz), 6.51 (2H, s), 5.82 (1H, s), 4.56 (1H, m), 3.93 (3H, s), 3.83 (3H, s), 3.75 (6H, s), 3.37 (1H, m), 3.21 (1H, s), 2.24 (1H, m), 2.05 (1H, m), 1.96 (1H, m), 1.69 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 153.3, 146.1, 142.8, 138.6, 137.9, 133.8, 127.0, 120.6, 107.9, 105.2, 83.3, 76.8, 61.0, 56.3, 56.0, 32.7, 25.1, 21.2. HRMS: obsvd 413.1571 [M + Na<sup>+</sup>]. Calcd for C<sub>21</sub>H<sub>26</sub>O<sub>7</sub>Na: 413.1571. HPLC: 13.71 min.</div></div><div id="sec5_1_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-Methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulene-4-carbonitrile (<b>18</b>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></h3><div class="NLM_p last">To KGP156 (0.10 g, 0.28 mmol) in a 2 M HCl/CH<sub>3</sub>OH solution (5 mL/5 mL) was added NaNO<sub>2</sub> (77.7 mg, 1.12 mmol) at 0 °C, and the mixture was stirred for 1 h. CuCN was added (50.4 mg, 0.56 mmol), and the reaction mixture was heated at 60 °C for 2 h. Na<sub>2</sub>CO<sub>3</sub> and NaCN were added (50 mg of each), and the reaction mixture was stirred for 12 h at room temperature. A saturated FeCl<sub>3</sub> solution (50 mL) was added to quench the reaction, and the reaction mixture was extracted with EtOAc (3 × 30 mL). The combined organic phase was washed with brine and a saturated NaHCO<sub>3</sub> solution, then dried over sodium sulfate and evaporated under reduced pressure. The crude reaction was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford nitrile <b>18</b> (41 mg, 0.11 mmol, 40%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.20 (1H, d, <i>J</i> = 8.4 Hz), 6.80 (1H, d, <i>J</i> = 8.4 Hz), 6.43 (1H, t, <i>J</i> = 7.8 Hz), 6.42 (2H, s), 3.94 (3H, s), 3.86 (3H, s), 3.80 (6H, s), 2.90 (2H, t, <i>J</i> = 7.2 Hz), 2.26 (2H, m), 1.94 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 160.7, 153.1, 147.5, 141.6, 137.6, 137.5, 134.9, 133.4, 128.7, 116.1, 108.5, 105.0, 101.7, 61.1, 56.3, 56.2, 34.8, 25.7, 25.4. HRMS: obsvd 388.1521 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>23</sub>NO<sub>4</sub>Na: 388.1519. HPLC: 20.75 min.</div></div><div id="sec5_1_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Methoxy-5-(3,4,5-trimethoxyphenyl)-7,8-dihydronaphthalene-1-carbonitrile (<b>19</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h3><div class="NLM_p last">KGP05 (48.6 mg, 0.14 mmol) was dissolved in 2 M HCl/CH<sub>3</sub>OH (2 mL/2 mL). The solution was cooled to 0 °C, NaNO<sub>2</sub> (39.2 mg, 0.56 mmol) was added, and the resultant reaction mixture was stirred at 0 °C for 1 h. The reaction mixture was heated at 60 °C for 2 h before the addition of CuCN (25.5 mg, 0.28 mmol). After the reaction mixture was cooled to room temperature, Na<sub>2</sub>CO<sub>3</sub> and NaCN were added to adjust the pH to 10 and provide additional nitrile ions to facilitate improvement of the yield, followed by an additional 12 h of stirring. FeCl<sub>3</sub> was added to quench the reaction, followed by extraction with EtOAc (3 × 20 mL). The combined organic phase was washed with brine and a saturated NaHCO<sub>3</sub> solution, dried over sodium sulfate, and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford nitrile <b>19</b> (17 mg, 0.046 mmol, 32%) as a white foam. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.20 (1H, d, <i>J</i> = 8.4 Hz), 6.69 (1H, d, <i>J</i> = 9 Hz), 6.50 (2H, s), 6.03 (1H, t, <i>J</i> = 4.8 Hz), 3.91 (3H, s), 3.88 (3H, s), 3.84 (6H, s), 3.06 (2H, t, <i>J</i> = 7.8 Hz), 2.43 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 160.3, 153.3, 142.9, 138.5, 137.6, 135.8, 130.8, 128.8, 126.1, 115.6, 108.3, 105.8, 101.6, 61.1, 56.3, 56.2, 26.8, 22.7. HRMS: obsvd 374.1363 [M + Na<sup>+</sup>]. Calcd for C<sub>21</sub>H<sub>21</sub>NO<sub>4</sub>Na: 374.1363. HPLC: 20.92 min.</div></div><div id="sec5_1_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-Methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulene-4-carbaldehyde (<b>20</b>)</h3><div class="NLM_p last">To a solution of nitrile <b>18</b> (48 mg, 0.13 mmol) in toluene (15 mL) was added DIBAL-H (0.16 mL, 1 M, 0.16 mmol) at 0 °C, and the resultant solution was stirred for 12 h while warming to room temperature. 1 M HCl (100 mL) was added to the reaction mixture, which was stirred for 30 min at room temperature while the solution color turned to yellow. EtOAc (3 × 50 mL) was used to extract the organic compound. The combined organic phase was dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford aldehyde <b>20</b> (37.8 mg, 0.10 mmol, 78%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 10.68 (1H, s), 7.18 (1H, d, <i>J</i> = 7.2 Hz), 6.82 (1H, d, <i>J</i> = 8.4 Hz), 6.47 (2H, s), 6.43 (1H, t, <i>J</i> = 7.8 Hz), 3.92 (3H, s), 3.86 (3H, s), 3.81 (6H, s), 2.99 (2H, m), 2.27 (2H, m), 1.91 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 193.3, 161.8, 153.2, 145.2, 141.9, 138.2, 137.6, 135.5, 134.7, 128.8, 123.7, 108.7, 105.3, 61.1, 56.3, 55.9, 31.7, 25.7, 22.8. HRMS: obsvd 391.1519 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>24</sub>O<sub>5</sub>Na: 391.1516. HPLC: 22.39 min.</div></div><div id="sec5_1_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Bromo-3-methoxybenzaldehyde (<b>22</b>)</h3><div class="NLM_p last">To a solution of 2-bromo-3-hydroxybenzaldehyde <b>21</b> (2.50 g, 12.4 mmol) in DMF (50 mL) were added CH<sub>3</sub>I (1.01 mL, 16.2 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.35 g, 13.7 mmol). The reaction mixture was stirred at room temperature for 3 h. The solvent was removed under reduced pressure, and the residue was washed with water (50 mL) and extracted with EtOAc (3 × 50 mL). The organic phases were combined and concentrated without further purification to afford 2-bromo-3-methoxybenzaldehyde <b>22</b> (2.67 g, 12.4 mmol, 100%) as a brown solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 10.44 (1H, s), 7.52 (1H, d, <i>J</i> = 7.8 Hz), 7.38 (1H, t, <i>J</i> = 7.8 Hz), 7.13 (1H, d, <i>J</i> = 8.4 Hz), 3.96 (3H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 192.4, 156.4, 134.9, 128.5, 121.6, 117.3, 117.1, 56.8.</div></div><div id="sec5_1_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-(2-Bromo-3-methoxyphenyl)pent-4-enoic Acid (<b>23</b>)</h3><div class="NLM_p last">To dissolved 3-(carboxypropyl)triphenylphosphonium bromide (5.33 g, 12.4 mmol) in THF (250 mL) was added potassium <i>tert-</i>butoxide (3.08 g, 27.3 mmol), and the reaction mixture was stirred at room temperature for 1 h. 2-Bromo-3-methoxybenzaldehyde <b>22</b> (2.67 g, 16.2 mmol) was added, and the reaction mixture was stirred at room temperature for 12 h. The THF was removed under reduced pressure, and the resulting material was quenched and acidified with 2 M HCl (30 mL) and extracted with EtOAc (3 × 50 mL). The combined organic phase was dried over sodium sulfate, filtered, and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford carboxylic acid <b>23</b> (1.74 g, 6.10 mmol, 49%) as a white solid. NMR characterization was performed after the next step.</div></div><div id="sec5_1_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl 5-(2-Bromo-3-methoxyphenyl)pentanoate (<b>24</b>)</h3><div class="NLM_p last">To dissolved carboxylic acid <b>23</b> (0.69 g, 2.42 mmol) in CH<sub>3</sub>OH (30 mL) were added 10% palladium on carbon (0.26 g), Ph<sub>2</sub>S (40 μL, 0.24 mmol), and two balloons with hydrogen gas. After stirring for 24 h, the mixture was filtered through Celite, and the Celite was washed with EtOAc (3 × 50 mL). The combined organic phase (CH<sub>3</sub>OH and EtOAc) was evaporated under reduced pressure. The residue was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford saturated ester <b>24</b> (0.48 g, 1.6 mmol, 66%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.54 (1H, t, <i>J</i> = 7.8 Hz), 7.19 (1H, d, <i>J</i> = 8.4 Hz), 7.10 (1H, d, <i>J</i> = 7.8 Hz), 4.24 (3H, s), 4.02 (3H, s), 3.14 (2H, m), 2.72 (2H, m), 2.07 (2H, m), 2.02 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 174.2, 156.1, 143.3, 127.8, 122.5, 113.9, 109.5, 56.4, 51.6, 36.1, 34.0, 29.4, 24.8.</div></div><div id="sec5_1_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-Bromo-2-methoxy-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>25</b>)</h3><div class="NLM_p last">To ester <b>24</b> (0.48 g, 1.6 mmol) was added Eaton’s reagent (8.5 mL), and the mixture was stirred at room temperature for 12 h. The reaction mixture was then poured over ice and neutralized with sodium carbonate. The aqueous layer was extracted with EtOAc (3 × 40 mL). The combined organic phase was dried over sodium sulfate, evaporated under reduced pressure, and purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford benzosuberone <b>25</b> (0.20 g, 0.74 mmol, 47%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.63 (1H, d, <i>J</i> = 8.4 Hz), 6.82 (1H, d, <i>J</i> = 8.4 Hz), 3.94 (3H, s), 3.17 (2H, m), 2.69 (2H, m), 1.85 (2H, m), 1.75 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 205.2, 159.0, 142.1, 133.7, 129.1, 114.1, 109.4, 56.6, 40.5, 31.2, 23.9, 20.7.</div></div><div id="sec5_1_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Bromo-3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulene (<b>26</b>)</h3><div class="NLM_p last">To an oven-dried flask, THF (20 mL) and 3,4,5-trimethoxyphenyl bromide (1.12 g, 4.53 mmol) were added, and the solution was cooled to −78 °C. <i>n</i>-Buli (1.81 mL, 2.5 M, 4.52 mmol) was slowly added to the reaction mixture, which was then stirred at −78 °C for 45 min. Benzosuberone <b>25</b> (0.61 g, 2.3 mmol) was then added to the flask dropwise, and the reaction mixture was stirred while warming from −78 °C to room temperature over 12 h. The reaction was quenched with excess HCl (2 M, 50 mL) and stirred for 30 min at room temperature. The reaction mixture was washed with water and extracted with EtOAc (3 × 40 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 20% A/80% B (10 CV), 20% A/80% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford brominated benzosuberene <b>26</b> (0.46 g, 1.1 mmol, 49%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.97 (1H, d, <i>J</i> = 8.4 Hz), 6.75 (1H, d, <i>J</i> = 8.4 Hz), 6.48 (2H, s), 6.37 (1H, t, <i>J</i> = 7.8 Hz), 3.92 (3H, s), 3.86 (3H, s), 3.81 (6H, s), 2.95 (2H, t, <i>J</i> = 7.2 Hz), 2.17 (2H, m), 1.92 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 154.9, 153.1, 143.0, 142.8, 138.0, 137.6, 134.4, 129.1, 127.8, 113.4, 109.1, 105.3, 61.0, 56.4, 56.3, 33.8, 31.9, 25.4.</div></div><div id="sec5_1_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Ethyl 3-Methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulene-4-carboxylate (<b>27</b>)</h3><div class="NLM_p last">To a solution of brominated benzosuberene <b>26</b> (0.15 g, 0.36 mmol) in THF (20 mL) was added <i>n</i>-BuLi (0.34 mL, 1.6 M, 0.54 mmol) dropwise at −78 °C. The reaction mixture was stirred at −78 °C for 30 min, followed by the addition of ethyl chlorofomate (61.5 μL, 0.64 mmol). The reaction mixture was stirred while warming from −78 °C to room temperature over 12 h. The reaction mixture was washed with water and extracted with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford benzosuberene ester <b>27</b> (51.8 mg, 0.13 mmol, 35%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.03 (1H, d, <i>J</i> = 8.4 Hz), 6.76 (1H, d, <i>J</i> = 9 Hz), 6.47 (2H, s), 6.37 (1H, t, <i>J</i> = 7.8 Hz), 4.43 (2H, q, <i>J</i> = 7.2 Hz), 3.85 (3H, s), 3.84 (3H, s), 3.79 (6H, s), 2.56 (2H, t, <i>J</i> = 6.6 Hz), 2.17 (2H, m), 1.96 (2H, m), 1.41 (3H, t, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 168.8, 155.2, 153.0, 142.3, 140.2, 138.1, 137.5, 133.2, 131.6, 127.7, 123.4, 108.6, 105.2, 61.4, 61.0, 56.3, 55.9, 34.9, 29.6, 25.3, 14.4. HRMS: obsvd 435.1778 [M + Na<sup>+</sup>]. Calcd for C<sub>24</sub>H<sub>28</sub>O<sub>6</sub>Na: 435.1778. HPLC: 22.42 min.</div></div><div id="sec5_1_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (3-Methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-4-yl)methanol (<b>28</b>)</h3><div class="NLM_p last">Ester <b>27</b> (0.12 g, 0.28 mmol) was dissolved in THF (10 mL), and the solution was cooled to 0 °C. LiAlH<sub>4</sub> (77 μL, 4 M in ether, 0.31 mmol) was added to the solution dropwise, and the reaction mixture was stirred while warming to room temperature for 1 h. The reaction mixture was washed with water and extracted with EtOAc (3 × 20 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford benzyl alcohol <b>28</b> (54.3 mg, 0.15 mmol, 52%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.97 (1H, d, <i>J</i> = 9 Hz), 6.75 (1H, d, <i>J</i> = 9 Hz), 6.50 (2H, s), 6.35 (1H, t, <i>J</i> = 7.8 Hz), 4.87 (2H, s), 3.89 (3H, s), 3.86 (3H, s), 3.81 (6H, s), 2.79 (2H, t, <i>J</i> = 7.2 Hz), 2.16 (2H, p, <i>J</i> = 7.2 Hz), 1.92 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 157.1, 153.1, 143.3, 142.4, 138.5, 137.5, 133.8, 130.2, 127.1, 126.0, 107.9, 105.4, 61.1, 57.7, 56.3, 55.7, 35.3, 27.6, 25.4. HRMS: obsvd 393.1672 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>26</sub>O<sub>5</sub>Na: 393.1672. HPLC: 19.09 min.</div></div><div id="sec5_1_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(2,3-Dimethoxyphenyl)propanoic Acid (<b>30</b>)</h3><div class="NLM_p last">To cinnamic acid <b>29</b> (5.0 g, 24 mmol) were added methanol (50 mL) and 10% Pd/C (0.8 g). Two hydrogen balloons were installed through the rubber septum, and the reaction mixture was stirred at room temperature for 4 h. The reaction mixture was filtered through Celite, and the Celite was washed with EtOAc (3 × 50 mL). The organic solvents (CH<sub>3</sub>OH and EtOAc) were evaporated under reduced pressure to afford carboxylic acid <b>30</b> (5.0 g, 24 mmol, quantitative) as a white solid. No further purification was needed. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.98 (1H, t, <i>J</i> = 7.8 Hz), 6.78 (2H, m), 3.86 (3H, s), 3.84 (3H, s), 2.95 (2H, t, <i>J</i> = 7.8 Hz), 2.66 (2H, t, <i>J</i> = 7.8 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 178.9, 152.8, 147.2, 134.1, 124.1, 121.8, 110.9, 60.7, 55.8, 34.8, 25.4.</div></div><div id="sec5_1_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Methyl 5-(2,3-Dimethoxyphenyl)-3-oxopentanoate (<b>31</b>)</h3><div class="NLM_p last">To dissolved carboxylic acid <b>30</b> (5.05 g, 24.0 mmol) in dichloromethane (96 mL) were added oxalyl chloride (4.12 mL, 47.2 mmol) and a catalytic amount of DMF (0.15 mL). The reaction mixture was stirred at room temperature for 1 h, at which time an additional catalytic amount of DMF (0.15 mL) was added, and the reaction mixture was stirred for 1 h at room temperature. The solvent and unreacted oxalyl chloride were removed under reduced pressure to afford acyl chloride as a yellow crystalline solid, which was redissolved in dichloromethane (50 mL) and cooled to 0 °C. Meldrum’s acid (3.47 g, 24.1 mmol) and pyridine (4.33 mL, 53.8 mmol) were added, and the reaction mixture was stirred for 30 min at 0 °C, then 1 h at room temperature. The mixture was diluted with dichloromethane (50 mL) and washed with 2 M HCl (20 mL), followed by brine (30 mL). The organic layer was dried over sodium sulfate and concentrated in vacuo. The residue was dissolved in CH<sub>3</sub>OH (50 mL) and heated at reflux for 3 h. The solvent was removed under reduced pressure. The crude product was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 40 mL/min; monitored at 254 and 280 nm] to afford the ester <b>31</b> (3.57 g, 13.4 mmol, 56%) as a pale yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.96 (1H, t, <i>J</i> = 7.8 Hz), 6.77 (1H, d, <i>J</i> = 9 Hz), 6.74 (1H, d, <i>J</i> = 7.8 Hz), 3.84 (3H, s), 3.81 (3H, s), 3.71 (3H, s), 3.44 (2H, s), 2.89 (2H, m), 2.83 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 202.1, 167.6, 152.7, 147.0, 134.2, 124.0, 121.8, 110.6, 60.5, 55.6, 52.3, 49.0, 43.6, 24.2.</div></div><div id="sec5_1_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Methyl 5-(2,3-Dimethoxyphenyl)-3-hydroxypentanoate (<b>32</b>)</h3><div class="NLM_p last">To a well-stirred solution of ketone <b>31</b> (0.50 g, 1.9 mmol) in CH<sub>3</sub>OH (8 mL) at 0 °C, sodium borohydride (24 mg, 0.63 mmol) was added in one aliquot. The reaction mixture was initially stirred at 0 °C for 1 h and then stirred at room temperature for another 1 h. The solvent was removed under reduced pressure. The residue was washed with water (10 mL) and extracted with diethyl ether (3 × 10 mL). The combined organic phase was dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (3 CV), 7% A/93% B → 60% A/40% B (10 CV), 60% A/40% B (1 CV); flow rate 40 mL/min; monitored at 254 and 280 nm] to afford alcohol <b>32</b> (0.40 g, 1.5 mmol, 79%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.98 (1H, t, 7.8 Hz), 6.78 (2H, m), 3.97 (1H, m), 3.85 (3H, s), 3.82 (3H, s), 3.69 (3H, s), 2.76 (2H, t, <i>J</i> = 7.8 Hz), 2.48 (2H, m), 1.78 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 173.3, 152.8, 147.2, 135.4, 124.2, 122.1, 110.5, 67.2, 60.8, 55.8, 51.8, 41.4, 37.6, 25.9.</div></div><div id="sec5_1_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Methyl 3-((<i>tert</i>-Butyldiphenylsilyl)oxy)-5-(2,3-dimethoxyphenyl)pentanoate (<b>33</b>)</h3><div class="NLM_p last">To a solution of alcohol <b>32</b> (0.38 g, 0.14 mmol) and imidazole (0.16 g, 2.3 mmol) in DMF (2.6 mL) at room temperature was added TBDPSCl (0.55 mL, 2.1 mmol) in one aliquot. The reaction mixture was stirred for 12 h, diluted with brine (10 mL), and extracted with Et<sub>2</sub>O (3 × 10 mL). The organic extracts were combined and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 25 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 30% A/70% B (10 CV), 30% A/70% B (2 CV); flow rate 75 mL/min; monitored at 254 and 280 nm] to afford ester <b>33</b> (0.35 g, 0.69 mmol, 49%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.72 (3H, m), 7.67 (1H, m), 7.38 (6H, m), 6.91 (1H, t, <i>J</i> = 7.8 Hz), 6.73 (1H, d, <i>J</i> = 9.6 Hz), 6.55 (1H, d, <i>J</i> = 9 Hz), 4.29 (1H, m), 3.83 (3H, s), 3.71 (3H, s), 3.54 (3H, s), 2.58 (4H, m), 1.76 (2H, m), 1.06 (9H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 172.0, 152.8, 147.1, 136.1, 136.0, 135.9, 135.3, 134.9, 134.2, 134.1, 129.8, 129.7, 127.9, 127.7, 127.6, 123.9, 121.8, 110.2, 70.5, 60.7, 55.8, 51.5, 41.9, 38.2, 27.1, 26.7, 25.4.</div></div><div id="sec5_1_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-((<i>tert</i>-Butyldiphenylsilyl)oxy)-5-(2,3-dimethoxyphenyl)pentanoic Acid (<b>34</b>)</h3><div class="NLM_p last">To a solution of ester <b>33</b> (0.67 g, 1.3 mmol) in CH<sub>3</sub>OH/THF (2.2 mL/1.1 mL) at 0 °C was added 2.5 M NaOH (1.76 mL). The reaction mixture was stirred for 1 h at 0 °C and then 13 h at room temperature, acidified by 2 M HCl (10 mL), and extracted with Et<sub>2</sub>O (3 × 10 mL). The organic extracts were combined and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 25 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 30% A/70% B (10 CV), 30% A/70% B (2 CV); flow rate 75 mL/min; monitored at 254 and 280 nm] to afford carboxylic acid <b>34</b> (0.26 g, 0.53 mmol, 40%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67 (4H, m), 7.41 (6H, m), 6.89 (1H, t, <i>J</i> = 8.4 Hz), 6.72 (1H, d, <i>J</i> = 8.4 Hz), 6.52 (1H, m), 4.20 (1H, m), 3.83 (3H, s), 3.69 (3H, s), 2.50 (4H, m), 1.80 (2H, m), 1.06 (9H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.6, 146.94, 146.93, 135.9, 135.8, 129.9, 129.8, 129.77, 127.7, 127.6, 123.81, 123.80, 121.6, 110.2, 70.2, 60.5, 55.6, 40.8, 37.6, 26.9, 25.3, 19.3.</div></div><div id="sec5_1_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 7-((<i>tert</i>-Butyldiphenylsilyl)oxy)-1,2-dimethoxy-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>35</b>)</h3><div class="NLM_p last">To a solution of carboxylic acid <b>34</b> (5.37g, 10.9 mmol) in dichloromethane (40 mL) were added oxalyl chloride (4.5 mL, 52 mmol) and 3 drops of DMF as catalyst at room temperature. The resultant reaction mixture was stirred for 2 h at 0 °C. The solvent and unreacted oxalyl chloride were removed under reduced pressure. The residue acyl chloride was dissolved in dichloromethane (50 mL). The solution was cooled to −10 °C, at which point SnCl<sub>4</sub> (3.63 mL, 1 M in CH<sub>2</sub>Cl<sub>2</sub>, 3.63 mmol) was added, followed by stirring at −10 °C for 30 min. The reaction was quenched with cold water and extracted with EtOAc (3 × 50 mL). The organic extracts were combined and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 75 mL/min; monitored at 254 and 280 nm] to afford cyclized ketone <b>35</b> (2.80 g, 5.90 mmol, 54%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.63 (4H, m), 7.56 (1H, d, <i>J</i> = 8.4 Hz), 7.39 (6H, m), 6.81 (1H, d, <i>J</i> = 9 Hz), 6.29 (1H, m), 3.90 (3H, s), 3.78 (3H, s), 3.17 (1H, m), 3.03 (2H, m), 2.88 (1H, m), 1.98 (1H, m), 1.84 (1H, m), 1.03 (9H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 199.5, 155.8, 146.2, 137.9, 136.0, 135.9, 134.1, 133.9, 133.1, 129.9, 129.8, 127.81, 127.77, 125.7, 109.6, 68.3, 60.9, 55.9, 50.4, 36.2, 27.0, 21.3, 19.3.</div></div><div id="sec5_1_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 7-Hydroxy-1,2-dimethoxy-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>36</b>)</h3><div class="NLM_p last">To a solution of ketone <b>35</b> (0.73 g, 1.5 mmol) in THF (10 mL) was added TBAF (3.1 mL 1 M in THF, 3.1 mmol), and the reaction mixture was stirred for 30 min at 0 °C and 16 h at room temperature. The reaction was quenched with brine (10 mL) and extracted with EtOAc (3 × 20 mL). The organic extracts were combined and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 20% A/80% B (10 CV), 20% A/80% B (2 CV); flow rate 75 mL/min; monitored at 254 and 280 nm] to afford alcohol <b>36</b> (0.16 g, 0.66 mmol, 49%) as a yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.60 (1H, d, <i>J</i> = 8.4 Hz), 6.84 (1H, d, <i>J</i> = 8.4 Hz), 4.33 (1H, m), 3.91 (3H, s), 3.80 (3H, s), 3.08 (3H, m), 2.99 (1H, m), 1.89 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 199.3, 156.0, 146.3, 137.7, 132.6, 125.8, 109.8, 67.3, 60.9, 56.0, 50.3, 35.8, 21.4.</div></div><div id="sec5_1_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3,4-Dimethoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5<i>H</i>-benzo[7]annulen-7-ol (<b>37</b>)</h3><div class="NLM_p last">To a solution of 3,4,5-trimethoxyphenyl bromide (0.49 g, 2.0 mmol) in THF (20 mL) at −78 °C was added <i>n</i>-BuLi (1.85 mL, 1.6 M in hexanes, 2.98 mmol), and the reaction mixture was stirred for 1 h. Benzosuberone <b>36</b> (0.16 g, 0.66 mmol) in THF (5 mL) was added slowly. The reaction mixture was stirred at 0 °C for 20 h. 2 M HCl (20 mL) was added, and the mixture was extracted with EtOAc (4 × 20 mL). The combined organic phase was further washed with brine and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 25 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 80% A/20% B (10 CV), 80% A/20% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford alcohol <b>37</b> (0.10 g, 0.26 mmol, 39%) as a brown solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.75 (2H, m), 6.51 (2H, s), 6.28 (1H, d, <i>J</i> = 4.8 Hz), 4.18 (1H, m), 3.877 (3H, s), 3.875 (3H, s), 3.86 (3H, s), 3.80 (6H, s), 3.16 (1H, m), 2.53 (1H, m), 2.43 (1H, m), 2.15 (1H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 153.1, 152.0, 146.1, 139.4, 137.8, 137.4, 135.7, 132.9, 131.5, 125.5, 109.6, 105.5, 70.0, 61.4, 61.1, 56.3, 55.8, 43.2, 22.4. HRMS: obsvd 409.1621 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>26</sub>O<sub>6</sub>Na: 409.1622. HPLC: 16.79 min.</div></div><div id="sec5_1_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methoxybenzaldehyde (<b>39</b>)</h3><div class="NLM_p last">To a well-stirred solution of 2-hydroxy-3-methoxybenzaldehyde <b>38</b> (0.50 g, 3.3 mmol) in dichloromethane (30 mL) were added TBSCl (0.74 g, 4.9 mmol), DMAP (0.12 g, 0.99 mmol), and Et<sub>3</sub>N (0.69 mL, 4.9 mmol). The reaction mixture was stirred for 12 h at room temperature, at which point brine (50 mL) was added, and the reaction mixture was extracted with dichloromethane (3 × 40 mL). The organic extracts were combined and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 75 mL/min; monitored at 254 and 280 nm] to afford protected aldehyde <b>39</b> (0.50 g, 1.86 mmol, 57%) as a pale yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 10.51 (1H, s), 7.36 (1H, d, <i>J</i> = 7.8 Hz), 7.03 (1H, d, <i>J</i> = 7.8 Hz), 6.94 (1H, t, <i>J</i> = 8.4 Hz), 3.81 (3H, s), 0.99 (9H, s), 0.20 (6H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 190.4, 150.8, 149.2, 127.9, 121.2, 119.1, 117.0, 55.2, 26.0, 19.0, 4.1.</div></div><div id="sec5_1_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Ethyl 5-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methoxyphenyl)-3-oxopent-4-enoate (<b>40</b>)</h3><div class="NLM_p last">To dissolved ethyl 3-oxo-4-(triphenylphophoranylidene)butanoate (3.22 g, 8.26 mmol) in THF (20 mL) was added protected aldehyde <b>39</b> (2.2 g, 8.3 mmol), and the reaction mixture was heated at reflux and stirred for 17 h. The solvent was removed under reduced pressure, and the residue was taken up as a slurry and purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford ester <b>40</b> (2.50 g, 6.59 mmol, 80%) as an off-white solid. NMR characterization was conducted after the next step.</div></div><div id="sec5_1_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Ethyl 5-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methoxyphenyl)-3-oxopentanoate (<b>41</b>)</h3><div class="NLM_p last">To dissolved ester <b>40</b> (2.50 g, 6.59 mmol) in methanol (60 mL) was added 10% palladium on carbon (0.54 g), and hydrogen gas was introduced with a balloon. The reaction mixture was stirred at room temperature for 12 h and filtered through Celite, and the Celite was washed with EtOAc (3 × 40 mL). The combined organic phase (CH<sub>3</sub>OH and EtOAc) was evaporated under reduced pressure. The resulting organic material was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford saturated ester <b>41</b> (1.15 g, 3.02 mmol, 46%) as a light yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.81(1H, m), 6.71 (1H, d, <i>J</i> = 7.8 Hz), 4.16 (2H, q, <i>J</i> = 7.2 Hz), 3.76 (3H, s), 3.39 (2H, s), 2.90 (2H, m), 2.83 (2H, m), 1.25 (3H, t, <i>J</i> = 7.2 Hz), 0.98 (9H, s), 0.18 (6H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 202.3, 167.2, 150.0, 142.8, 131.8, 121.9, 121.0, 109.7, 61.4, 54.8, 49.4, 43.2, 26.2, 24.8, 18.9, 14.2, −3.7.</div></div><div id="sec5_1_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Ethyl (<i>Z</i>)-3-Amino-5-(2-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pent-2-enoate (<b>42</b>)</h3><div class="NLM_p last">To keto ester <b>41</b> (1.10 g, 2.89 mmol) dissolved in methanol (15 mL) was added dry ammonium acetate (1.11 g, 14.5 mmol). The reaction mixture was stirred at 35 °C for 16 h. The methanol was removed under vacuum, and the residue was suspended in EtOAc (30 mL) and filtered. The filtrate was washed with EtOAc (4 × 20 mL). The combined organic layer was dried over sodium sulfate and concentrated under reduced pressure to afford amine <b>42</b> (1.02 g, 2.69 mmol, 93%) as pale yellow crystals. No further purification was performed. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.82 (1H, m), 6.72 (2H, m), 4.58 (1H, s), 4.11 (2H, m), 3.78 (3H, s), 2.87 (2H, m), 2.40 (2H, m), 1.26 (3H, t, <i>J</i> = 7.2 Hz), 1.00 (9H, s), 0.19 (6H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 170.7, 163.6, 150.0, 142.8, 131.8, 122.0, 121.1, 109.8, 83.5, 58.7, 54.8, 36.7, 29.3, 26.3, 19.0, 14.7, −3.6.</div></div><div id="sec5_1_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Ethyl (<i>Z</i>)-3-Acetamido-5-(2-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pent-2-enoate (<b>43</b>)</h3><div class="NLM_p last">To amine <b>42</b> (4.02 g, 10.6 mmol) dissolved in THF (50 mL) were added pyridine (1.71 mL, 21.2 mmol) and acetic anhydride (6.00 mL, 63.6 mmol). The reaction mixture was stirred for 48 h under reflux. The THF was removed under vacuum, and the residue was dissolved in EtOAc (50 mL) and washed with water (50 mL), 2 M HCl (20 mL), saturated NaHCO<sub>3</sub> (50 mL), and brine (50 mL). The combined organic layer was dried over sodium sulfate and concentrated under reduced pressure. The resulting organic material was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford <i>N</i>-acetamide <b>43</b> (2.17 g, 5.15 mmol, 49%) as a yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.80 (2H, m), 6.70 (1H, m), 4.90 (1H, s), 4.14 (2H, m), 3.76 (3H, s), 3.00 (2H, m), 2.86 (2H, m), 2.15 (3H, s), 1.26 (3H, m), 0.98 (9H, s), 0.17 (6H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 169.3, 168.3, 158.2, 149.8, 142.7, 132.0, 122.2, 120.9, 109.5, 96.2, 59.8, 54.7, 34.5, 28.7, 26.2, 25.3, 18.9, 14.3, −3.8.</div></div><div id="sec5_1_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Ethyl 3-Acetamido-5-(2-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pentanoate (<b>44</b>)</h3><div class="NLM_p last">Unsaturated <i>N</i>-acetamide <b>43</b> (2.17 g, 5.15 mmol) was dissolved in CH<sub>3</sub>OH (30 mL). Palladium (10%) on carbon (0.53 g) and a hydrogen gas balloon were introduced, and the solution was stirred at room temperature for 60 h and filtered through Celite. The Celite was washed with EtOAc (3 × 50 mL). The combined organic phase (CH<sub>3</sub>OH and EtOAc) was evaporated under reduced pressure. The resulting organic material was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 50% A/50% B (10 CV), 50% A/50% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford saturated <i>N</i>-acetamide <b>44</b> (0.96 g, 2.3 mmol, 44%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.83 (1H, t, <i>J</i> = 7.8 Hz), 6.71 (2H, m), 6.03 (1H, d, <i>J</i> = 9 Hz), 4.29 (1H, m), 4.11 (2H, q, <i>J</i> = 7.2 Hz), 3.77 (3H, s), 2.74 (1H, m), 2.62 (1H, m), 2.59 (1H, m), 2.51 (1H, m), 1.96 (3H, s), 1.82 (2H, m), 1.24 (3H, t, <i>J</i> = 7.2 Hz), 1.00 (9H, s), 0.17 (6H, d, <i>J</i> = 10.8 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 172.1, 169.6, 150.0, 142.7, 132.7, 121.9, 121.0, 109.4, 60.7, 54.8, 46.3, 38.8, 34.3, 27.6, 26.3, 23.7, 19.0, 14.3, −3.6, −3.7.</div></div><div id="sec5_1_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-Acetamido-5-(2-hydroxy-3-methoxyphenyl)pentanoic Acid (<b>45</b>)</h3><div class="NLM_p last">To dissolved unsaturated ester <b>44</b> (0.96 g, 2.3 mmol) in methanol (5 mL) was added 1 M KOH (7.48 mL). The reaction was stirred from 0 °C to room temperature over 3 h. The methanol was removed under vacuum, and 2 M HCl (5 mL) was added to the residue, which was then extracted with EtOAc (3 × 20 mL). The combined organic phase was evaporated under reduced pressure. The resulting organic material was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 100% A/0% B (35 CV), 100% A/0% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford carboxylic acid <b>45</b> (0.38 g, 1.8 mmol, 58%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.74 (3H, m), 6.34 (1H, d, <i>J</i> = 9 Hz), 4.25 (1H, m), 3.85 (3H, s), 2.64 (4H, m), 1.97 (3H, s), 1.91 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 175.6, 171.0, 146.6, 143.5, 127.3, 122.5, 119.8, 108.9, 56.2, 46.7, 38.9, 34.1, 26.8, 23.5.</div></div><div id="sec5_1_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(1-Hydroxy-2-methoxy-5-oxo-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)acetamide (<b>46</b>)</h3><div class="NLM_p last">Carboxylic acid <b>45</b> (0.70 g, 2.5 mmol) was dissolved in Eaton’s reagent (14 mL), and the reaction mixture was stirred at room temperature for 12 h. Ice was added to the reaction mixture, which generated a significant amount of heat. A saturated sodium carbonate solution was added until neutral pH was achieved. The mixture was extracted with dichloromethane (4 × 30 mL). The organic phase was further washed by brine and dried over sodium sulfate, filtered, and concentrated under reduced pressure and purified by flash chromatography using a prepacked 50 g silica column [solvent A of CH<sub>3</sub>OH; solvent B of CH<sub>2</sub>Cl<sub>2</sub>; gradient 1% A/99% B (1 CV), 1% A/99% B → 10% A/90% B (10 CV), 10% A/90% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford cyclized ketone <b>46</b> (0.37 g, 1.4 mmol, 57%) as a yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.34 (1H, d, <i>J</i> = 8.4 Hz), 6.79 (1H, d, <i>J</i> = 9 Hz), 5.91 (1H, s), 4.48 (1H, m), 3.94 (3H, s), 3.23 (1H, m), 3.13 (1H, m), 2.83 (2H, m), 2.73 (1H, m), 2.44 (1H, m), 1.96 (3H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 201.1, 169.6, 149.3, 142.9, 133.1, 129.0, 121.1, 108.2, 56.3, 47.0, 45.7, 32.9, 23.6, 22.6.</div></div><div id="sec5_1_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(1-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-methoxy-5-oxo-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)acetamide (<b>47</b>)</h3><div class="NLM_p last">To a solution of cyclized ketone <b>46</b> (0.37 g, 1.4 mmol) in dichloromethane (20 mL) at room temperature were added TBSCl (0.32 g, 2.1 mmol), DMAP (52 mg, 0.42 mmol), and trimethylamine (0.30 mL, 2.1 mmol), and the resultant reaction mixture was stirred for 12 h. The reaction mixture was subsequently washed with brine (30 mL) and extracted with dichloromethane (3 × 40 mL). The combined organic layer was dried over sodium sulfate and concentrated under reduced pressure. The resulting organic material was purified by flash chromatography using a prepacked 50 g silica column [solvent A of CH<sub>3</sub>OH; solvent B of CH<sub>2</sub>Cl<sub>2</sub>; gradient 0% A/100% B (1 CV), 0% A/100% B → 5% A/95% B (10 CV), 5% A/95% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford protected ketone <b>47</b> (0.36 g, 0.95 mmol, 68%) as an off-white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.41 (1H, d, <i>J</i> = 8.4 Hz), 6.78 (1H, d, <i>J</i> = 9 Hz), 5.61 (1H, br), 4.46 (1H, m), 3.84 (3H, s), 3.26 (1H, m), 3.16 (1H, m), 2.80 (2H, m), 2.71 (1H, m), 2.45 (1H, m), 1.96 (3H, s), 1.00 (9H, s), 0.17 (6H, d, <i>J</i> = 14.4 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 201.1, 169.6, 153.4, 142.4, 134.7, 129.0, 122.6, 109.1, 55.1, 46.9, 45.8, 40.0, 33.2, 26.2, 23.6, 19.1, −3.7, −3.8.</div></div><div id="sec5_1_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(1-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-methoxy-5-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)acetamide (<b>48</b>)</h3><div class="NLM_p last">To an oven-dried flask, THF (20 mL) and 3,4,5-trimethoxyphenyl bromide (0.16 g, 0.64 mmol) were added, and the solution was cooled to −78 °C. <i>n-</i>BuLi (1.6 M, 0.59 mL, 0.94 mmol) was added to the reaction mixture slowly, which was then stirred at −78 °C for 45 min. Benzosuberone <b>47</b> (80 mg, 0.21 mmol) was then added dropwise to the flask, and the reaction mixture was stirred while warming from −78 °C to room temperature over 12 h. 2 M HCl (20 mL) was added, and the reaction mixture was stirred for 10 min, then extracted with EtOAc (3 × 50 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 20 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 100% A/0% B (10 CV), 100% A/0% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford cross-coupling product benzosuberene <b>48</b> (63.6 mg, 0.120 mmol, 57%) as a crystalline white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.68 (1H, d, <i>J</i> = 9 Hz), 6.58 (1H, d, <i>J</i> = 8.4 Hz), 6.47 (2H, s), 5.98 (1H, d, <i>J</i> = 6 Hz), 5.54 (1H, d, <i>J</i> = 8.4 Hz, br), 4.39 (1H, m), 3.85 (3H, s), 3.80 (3H, s), 3.79 (9H, s), 3.20–2.46 (4H, m), 1.95 (3H, s), 1.03 (9H, s), 0.25 (3H, s), 0.22 (3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 169.0, 152.8, 149.1, 141.7, 141.5, 137.9, 137.6, 132.7, 132.3, 128.4, 122.9, 108.9, 105.4, 60.9, 56.2, 54.7, 47.8, 41.0, 26.2, 23.6, 22.9, 19.0, −3.6, −3.9.</div></div><div id="sec5_1_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(1-Hydroxy-2-methoxy-5-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-7-yl)acetamide (<b>49</b>)</h3><div class="NLM_p last">Protected benzosuberene <i>N</i>-acetamide <b>48</b> (63.6 mg, 0.12 mmol) was dissolved in THF (2 mL) and cooled to 0 °C. TBAF (0.24 mL, 0.24 mmol) was added, and the reaction mixture was stirred at 0 °C for 2 h. The solution was washed with water and extracted with EtOAc (3 × 20 mL). The combined organic phase was dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by flash chromatography using a prepacked 25 g silica column [solvent A of CH<sub>3</sub>OH; solvent B of CH<sub>2</sub>Cl<sub>2</sub>; gradient 5% A/95% B (1 CV), 10% A/90% B → 10% A/90% B (10 CV), 10% A/90% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford benzosuberene <i>N</i>-acetamide <b>49</b> (22 mg, 0.05 mmol, 44%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.71 (1H, d, <i>J</i> = 9 Hz), 6.54 (1H, d, <i>J</i> = 8.4 Hz), 6.48 (2H, s), 5.98 (1H, d, <i>J</i> = 6 Hz), 5.76 (1H, s), 5.56 (1H, d, <i>J</i> = 9 Hz, br), 4.38 (1H, m), 3.91 (3H, s), 3.86 (3H, s), 3.80 (6H, s), 3.17–2.43 (4H, m), 1.96 (3H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 169.2, 153.0, 145.7, 142.5, 141.4, 137.83, 137.75, 133.3, 128.8, 126.9, 121.5, 108.3, 105.6, 61.1, 56.4, 56.2, 48.1, 40.8, 23.8, 22.3. HRMS: obsvd 436.1730 [M + Na<sup>+</sup>]. Calcd for C<sub>23</sub>H<sub>29</sub>NO<sub>6</sub>Na: 436.1731. HPLC: 9.92 min.</div></div><div id="sec5_1_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Ethyl 5-(2,3-Dimethoxyphenyl)-3-oxopentanoate (<b>52</b>)</h3><div class="NLM_p last">To a solution of 2,3-dimethoxybenzaldehyde <b>50</b> (1.06 g, 6.38 mmol) in THF (50 mL) were added ethyl 3-oxo-4-(triphenylphosphoranylidene)butyrate (3.00 g, 7.65 mmol) and potassium <i>tert</i>-butoxide (1.73 g, 15.3 mmol) at room temperature, and the reaction mixture was stirred for 12 h. The THF was removed under reduced pressure, and the resulting material was quenched with 2 M HCl (20 mL) and extracted with EtOAc (3 × 50 mL). The combined organic layers were evaporated under reduced pressure, and the crude product (<b>51</b>) was dissolved in CH<sub>3</sub>OH (40 mL). To this solution was added 10% palladium on carbon (0.24 g) and balloons with hydrogen gas. The reaction mixture was stirred at room temperature for 12 h, filtered through Celite, and the Celite was washed with EtOAc (3 × 30 mL). The combined organic phase (CH<sub>3</sub>OH and EtOAc) was evaporated under reduced pressure. The resulting organic material was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford saturated ester <b>52</b> (1.45 g, 5.17 mmol, 81%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.97 (1H, t, <i>J</i> = 7.8 Hz), 6.78 (1H, d, <i>J</i> = 9 Hz), 6.75 (1H, d, <i>J</i> = 7.8 Hz), 4.17, (2H, q, <i>J</i> = 7.2 Hz), 3.85 (3H, s), 3.82 (3H, s), 3.43 (2H, s), 2.90 (2H, m), 2.84 (2H, m), 1.26 (3H, t, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 202.4, 167.3, 152.9, 147.2, 134.5, 124.1, 122.0, 110.8, 61.5, 60.7, 55.8, 49.5, 43.8, 24.5, 14.2.</div></div><div id="sec5_1_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Ethyl 5-(2,3-Dimethoxyphenyl)-3-hydroxypentanoate (<b>53</b>)</h3><div class="NLM_p last">To a solution of ketone <b>52</b> (1.45 g, 5.17 mmol) in CH<sub>3</sub>OH (20 mL) at 0 °C was added NaBH<sub>4</sub> (110 mg, 2.91 mmol), and the reaction mixture was stirred for 1 h at 0 °C, then stirred for 3 h at ambient temperature. The CH<sub>3</sub>OH was removed under reduced pressure, and the resulting material was washed with water and extracted with EtOAc (3 × 30 mL). The combined organic phase was concentrated under reduced pressure to afford crude alcohol product <b>53</b> (1.20 g, 4.25 mmol, 82%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.98 (1H, t, <i>J</i> = 7.8 Hz), 6.78 (2H, m), 4.15 (2H, m), 3.97 (1H, m), 3.85 (3H, s), 3.83 (3H, s), 2.76 (2H, m), 2.47 (2H, m), 1.80 (1H, m), 1.72 (1H, m), 1.25 (3H, t, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 173.0, 152.8, 147.2, 135.5, 124.2, 122.1, 110.4, 67.3, 60.8, 55.8, 41.5, 37.6, 25.9, 14.3.</div></div><div id="sec5_1_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 5-(2,3-Dimethoxyphenyl)-3-hydroxypentanoic Acid (<b>54</b>)</h3><div class="NLM_p last">To a solution of ester <b>53</b> in CH<sub>3</sub>OH/THF (8 mL/4 mL) was added a 2.5 M NaOH aqueous solution (6 mL) at 0 °C, and the reaction mixture was stirred for 1 h at 0 °C, then warmed to room temperature over 12 h. The CH<sub>3</sub>OH and THF were removed under reduced pressure, and the resulting material was washed with water and extracted with EtOAc (3 × 30 mL). The combined organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under pressure to afford carboxylic acid <b>54</b> (0.88 g, 3.3 mmol, 77%) as an orange oil (no further purification was needed). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.00 (1H, t, <i>J</i> = 8.4 Hz), 6.78 (2H, dd, <i>J</i> = 6.6 Hz, 6.6 Hz), 3.92 (1H, m), 3.86 (3H, s), 3.84 (3H, s), 2.76 (2H, m), 2.51 (2H, m), 1.82 (1H, m), 1.73 (1H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 176.8, 152.7, 146.9, 134.9, 124.5, 122.2, 110.6, 66.9, 61.0, 55.8, 41.2, 37.6, 25.6.</div></div><div id="sec5_1_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1,2-Dimethoxy-8,9-dihydro-5<i>H</i>-benzo[7]annulen-5-one (<b>55</b>)</h3><div class="NLM_p last">To carboxylic acid <b>54</b> (0.88 g, 3.3 mmol) was added Eaton’s reagent (15.7 mL), and the mixture was stirred at room temperature for 14 h. The mixture was then poured over ice and neutralized with sodium carbonate. The aqueous layer was extracted with EtOAc (3 × 40 mL). The combined organic phase was dried over sodium sulfate, evaporated under reduced pressure, and purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 7% A/93% B (1 CV), 7% A/93% B → 30% A/70% B (10 CV), 30% A/70% B (2 CV); flow rate 50 mL/min; monitored at 254 and 280 nm] to afford unsaturated cyclized ketone <b>55</b> (0.360 g, 1.65 mmol, 50%) as a yellow crystalline solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.55 (1H, d, <i>J</i> = 9 Hz), 6.83 (1H, d, <i>J</i> = 9 Hz), 6.71 (1H, td, <i>J</i> = 4.8 Hz, 12 Hz), 6.23 (1H, td, <i>J</i> = 1.8 Hz, 12 Hz), 3.91 (3H, s), 3.78 (3H, s), 3.16 (2H, m), 2.55 (2H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 193.9, 156.2, 147.0, 145.2, 134.4, 134.3, 132.7, 126.7, 110.0, 61.2, 55.9, 29.6, 25.1.</div></div><div id="sec5_1_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1,2-Dimethoxy-5-(3,4,5-trimethoxyphenyl)-8,9-dihydro-5<i>H</i>-benzo[7]annulen-5-ol (<b>56</b>)</h3><div class="NLM_p last">To an oven-dried flask, THF (30 mL) and 3,4,5-trimethoxyphenyl bromide (0.87 g, 3.5 mmol) were added, and the solution was cooled to −78 °C. <i>n</i>-BuLi (1.41 mL, 2.5 M, 3.52 mmol) was slowly added to the reaction mixture, which was then stirred at −78 °C for 30 min. Unsaturated cyclized ketone <b>55</b> (0.35 g, 1.6 mmol) in THF (5 mL) was then added dropwise to the flask, and the reaction mixture was stirred while warming from −78 °C to room temperature over 12 h. The reaction mixture was washed with 2 M HCl (10 mL) and extracted with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 12% A/88% B (1 CV), 12% A/88% B → 60% A/40% B (10 CV), 60% A/40% B (5 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford tertiary alcohol <b>56</b> (0.457 g, 1.18 mmol, 74%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.54 (1H, d, <i>J</i> = 9 Hz), 6.82 (1H, d, <i>J</i> = 8.4 Hz), 6.59 (2H, s), 6.07 (1H, d, <i>J</i> = 12 Hz), 5.77 (1H, td, <i>J</i> = 1.2 Hz, 12 Hz), 3.90 (3H, s), 3.82 (3H, s), 3.78 (6H, s), 3.75 (3H, s), 3.05 (1H, m), 2.48 (1H, m), 2.43 (1H, m), 2.15 (1H, m). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 153.9, 153.2, 147.5, 145.1, 141.7, 138.3, 137.2, 134.1, 130.8, 121.6, 109.9, 106.0, 78.6, 61.4, 61.1, 56.5, 56.1, 30.0, 23.4. HRMS: obsvd 409.1622 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>26</sub>O<sub>6</sub>Na: 409.1622. HPLC: 17.36 min.</div></div><div id="sec5_1_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1,2-Dimethoxy-7-(3,4,5-trimethoxyphenyl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>57</b>)</h3><div class="NLM_p last">To an oven-dried flask, THF (30 mL) and 3,4,5-trimethoxyphenyl bromide (0.47 g, 1.9 mmol) were added, and the solution was cooled to −78 °C. <i>n-</i>BuLi (0.76 mL, 2.5 M, 1.9 mmol) was slowly added to the reaction mixture, which was stirred at −78 °C for 45 min and then moved to a −10 °C bath. CuI (0.181 g, 0.95 mmol) was added in one aliquot to the flask, and the reaction mixture was stirred at −10 °C for 1 h. Unsaturated ketone <b>55</b> (0.104 g, 0.47 mmol) in THF (10 mL) was then added dropwise to the flask, and the reaction mixture was stirred while warming from −78 °C to room temperature over 7 h. A saturated NH<sub>4</sub>Cl solution and ammonium hydroxide (20 mL/20 mL) were added, followed by stirring for 30 min at room temperature and subsequent extraction with EtOAc (3 × 50 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 110 mL/min; monitored at 254 and 280 nm] to afford Michael addition ketone <b>57</b> (81.7 mg, 0.21 mmol, 44%) as a light white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.56 (1H, d, <i>J</i> = 8.4 Hz), 6.88 (1H, d, <i>J</i> = 9 Hz), 6.41 (2H, s), 3.93 (3H, s), 3.83 (6H, s), 3.824 (3H, s), 3.819 (3H, s), 3.34 (1H, td, <i>J</i> = 4.8 Hz, 15 Hz), 3.09 (1H, m), 3.04 (1H, m), 2.94 (2H, m), 2.16 (1H, m), 1.97 (1H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 203.0, 156.4, 153.4, 146.1, 141.4, 136.6, 135.5, 132.5, 125.7, 110.1, 104.0, 61.3, 61.0, 56.2, 56.0, 47.9, 39.9, 34.6, 23.4. HRMS: obsvd 409.1624 [M + Na<sup>+</sup>]. Calcd for C<sub>22</sub>H<sub>26</sub>O<sub>6</sub>Na: 409.1622. HPLC: 18.77 min.</div></div><div id="sec5_1_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-Isopropoxy-3-methoxybenzaldehyde (<b>58</b>)</h3><div class="NLM_p last">To a solution of 2-hydroxy-3-methoxybenzaldehyde <b>38</b> (5.00 g, 32.9 mmol) in DMF (100 mL) were added K<sub>2</sub>CO<sub>3</sub> (14.97 g, 98.58 mmol) and 2-iodopropane (6.54 mL, 65.7 mmol), and the reaction mixture was stirred at 50 °C for 20 h. The DMF was removed under reduced pressure, and the resulting material was washed with water (100 mL) to remove the excess salt and extracted with EtOAc (3 × 100 mL). The combined organic phase was dried over sodium sulfate and concentrated to afford protected aldehyde <b>58</b> (6.12 g, 31.6 mmol, 96%) as a colorless oil without further purification. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 10.44 (1H, s), 7.41 (1H, d, <i>J</i> = 7.8 Hz), 7.10 (2H, m), 4.62 (1H, m), 3.86 (3H, s), 1.31 (6H, d, <i>J</i> = 6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 191.0, 153.4, 150.7, 131.0, 123.7, 119.0, 118.0, 76.3, 56.1, 22.4.</div></div><div id="sec5_1_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Ethyl 5-(2-Isopropoxy-3-methoxyphenyl)-3-oxopent-4-enoate (<b>59</b>)</h3><div class="NLM_p last">To dissolved ethyl 3-oxo-4-(triphenylphosphoranylidene)butanoate (0.85 g, 2.2 mmol) in THF (50 mL) were added potassium <i>tert</i>-butoxide (0.50 g, 4.4 mmol) and aldehyde <b>58</b> (0.35 g, 1.8 mmol), and the resultant reaction mixture was stirred at room temperature for 12 h. The THF was removed under reduced pressure, and the resulting material was neutralized with 2 M HCl (10 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were evaporated under reduced pressure, and the crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford unsaturated ester <b>59</b> (0.40 g, 1.3 mmol, 72%) as a yellow oil. NMR characterization was conducted after the next step.</div></div><div id="sec5_1_1_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Ethyl 5-(2-Isopropoxy-3-methoxyphenyl)-3-oxopentanoate (<b>60</b>)</h3><div class="NLM_p last">To dissolved unsaturated ester <b>59</b> (0.39 g, 1.3 mmol) in CH<sub>3</sub>OH (20 mL) were added 10% palladium on carbon (0.2 g) and balloons with hydrogen gas. The reaction mixture was stirred at room temperature for 12 h, followed by filtration through Celite, and the Celite was washed with EtOAc (3 × 20 mL). The combined organic phase (CH<sub>3</sub>OH and EtOAc) was evaporated under reduced pressure to afford saturated ester <b>60</b> (0.23 g, 0.73 mmol, 57%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.93 (1H, t, <i>J</i> = 7.8 Hz), 6.75 (2H, m), 4.51 (1H, sept, <i>J</i> = 6 Hz), 4.17 (2H, q, <i>J</i> = 7.2 Hz), 3.81 (3H, s), 3.41 (2H, s), 2.92 (2H, t, <i>J</i> = 7.8 Hz), 2.83 (2H, t, <i>J</i> = 8.4 Hz), 1.25 (6H, d, <i>J</i> = 6 Hz), 1.25 (3H, t, 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 202.5, 167.2, 152.9, 144.9, 135.0, 123.5, 121.9, 110.7, 74.6, 61.4, 55.7, 49.4, 43.6, 25.0, 22.7, 14.2.</div></div><div id="sec5_1_1_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Ethyl 3-Hydroxy-5-(2-isopropoxy-3-methoxyphenyl)pentanoate (<b>61</b>)</h3><div class="NLM_p last">To dissolved ketone <b>60</b> (2.32 g, 7.52 mmol) in CH<sub>3</sub>OH (30 mL) was added NaBH<sub>4</sub> (96 mg, 2.5 mmol) at 0 °C. The reaction was stirred for 1 h and then returned to room temperature for an additional 1 h. The CH<sub>3</sub>OH was removed under reduced pressure, and the residue was washed with water and extracted with EtOAc (3 × 30 mL). The combined organic phase was evaporated under reduced pressure, and the crude reaction product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford alcohol <b>61</b> (1.80 g, 5.80 mmol, 77%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.96 (1H, t, <i>J</i> = 8.4 Hz), 6.77 (1H, d, <i>J</i> = 6.6 Hz), 6.75 (1H, d, <i>J</i> = 7.8 Hz), 4.52 (1H, sept, <i>J</i> = 6.6 Hz), 4.13 (2H, q, <i>J</i> = 7.2 Hz), 3.91 (1H, m), 3.82 (3H, s), 2.82 (1H, m), 2.74 (1H, m), 2.45 (1H, m), 2.44 (1H, m), 1.78 (1H, m), 1.71 (1H, m), 1.28 (3H, t, <i>J</i> = 6.6 Hz), 1.26 (3H, t, <i>J</i> = 6.6 Hz), 1.25 (3H, t, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 172.8, 152.9, 144.8, 136.0, 123.7, 122.1, 110.3, 74.9, 67.1, 60.7, 55.7, 41.6, 37.5, 41.6, 37.5, 26.3, 22.9, 22.6, 14.3.</div></div><div id="sec5_1_1_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Ethyl 3-((<i>tert</i>-Butyldiphenylsilyl)oxy)-5-(2-isopropoxy-3-methoxyphenyl)pentanoate (<b>62</b>)</h3><div class="NLM_p last">To dissolved alcohol <b>61</b> (0.77 g, 2.5 mmol) in DMF (10 mL) were added <i>tert-</i>butyl(chloro)diphenylsilane (TBDPSCl) (0.96 mL, 3.7 mmol) and imidazole (0.280 g, 3.98 mmol) at room temperature, and the solution was stirred for 12 h at room temperature. The DMF was removed under reduced pressure, and the resulting material was washed with brine (50 mL) and extracted with diethyl ether (3 × 30 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford protected alcohol <b>62</b> (0.960 g, 1.75 mmol, 71%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.70 (4H, m), 7.39 (6H, m), 6.87 (1H, t, <i>J</i> = 7.8 Hz), 6.70 (1H, d, <i>J</i> = 8.4 Hz), 6.52 (1H, d, <i>J</i> = 7.8 Hz), 4.41 (1H, m), 4.29 (1H, m), 4.00 (2H, m), 3.80 (3H, s), 2.55 (4H, m), 1.76 (2H, m), 1.19 (6H, m), 1.18 (3H, t, <i>J</i> = 7.2 Hz), 1.08 (9H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 171.6, 152.9, 144.9, 136.5, 136.1, 135.3, 135.0, 134.3, 129.8, 129.7, 127.9, 127.6, 123.3, 121.6, 110.1, 74.4, 70.6, 60.4, 55.8, 42.1, 37.8, 26.7, 25.6, 22.7, 19.5, 19.2, 14.2.</div></div><div id="sec5_1_1_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 3-((<i>tert</i>-Butyldiphenylsilyl)oxy)-5-(2-isopropoxy-3-methoxyphenyl)pentanoic Acid (<b>63</b>)</h3><div class="NLM_p last">To dissolved protected alcohol <b>62</b> (7.80 g, 14.2 mmol) in CH<sub>3</sub>OH/THF (60 mL/30 mL) was added 2.5 M NaOH (20 mL) at 0 °C, and the solution was stirred for 1 h and then stirred at room temperature for 12 h. The organic solvents (CH<sub>3</sub>OH and THF) were removed under reduced pressure, and water (30 mL) was added to the resulting suspension, followed by extraction with diethyl ether (3 × 50 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 60% A/40% B (15 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford carboxylic acid <b>63</b> (3.49 g, 6.70 mmol, 46%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67 (4H, m), 7.39 (6H, m), 6.86 (1H, t, <i>J</i> = 7.8 Hz), 6.70 (1H, d, <i>J</i> = 8.4 Hz), 6.50 (1H, d, <i>J</i> = 7.2 Hz), 4.41 (1H, m), 4.20 (1H, m), 3.79 (3H, s), 2.56 (4H, m), 1.82 (2H, m), 1.19 (6H, t, <i>J</i> = 6 Hz), 1.06 (9H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 175.5, 152.9, 144.8, 136.0, 133.7, 133.6, 129.9, 127.8, 123.4, 121.6, 110.2, 74.5, 70.5, 55.8, 41.2, 37.5, 27.1, 25.7, 22.7, 19.4.</div></div><div id="sec5_1_1_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 7-((<i>tert</i>-Butyldiphenylsilyl)oxy)-1-isopropoxy-2-methoxy-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>64</b>)</h3><div class="NLM_p last">To dissolved carboxylic acid <b>63</b> (3.49 g, 6.70 mmol) in dichloromethane (30 mL) were added oxalyl chloride (2.77 mL, 31.8 mmol) and DMF (0.1 mL) as catalyst at room temperature, and the solution was stirred for 2 h at room temperature. The solvent and unreacted oxalyl chloride were removed under reduced pressure. The yellow acyl chloride was then dissolved in dichloromethane (40 mL) and cooled to −10 °C. To this solution, 1 M SnCl<sub>4</sub> in a dichloromethane solution (7.4 mL, 7.4 mmol) was added, and the reaction mixture was stirred for 30 min at −10 °C. The reaction was quenched by the addition of water, followed by extraction with dichloromethane (3 × 40 mL). The combined organic phase was dried over sodium sulfate and concentrated. The crude product was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford ketone <b>64</b> (2.19 g, 4.50 mmol, 67%) as a pale yellow gel. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.66 (4H, m), 7.54 (1H, d, <i>J</i> = 9.6 Hz), 7.38 (6H, m), 6.79 (1H, d, <i>J</i> = 9 Hz), 4.36 (1H, m), 4.28 (1H, m), 3.86 (3H, s), 3.14 (1H, m), 3.03 (2H, m), 2.88 (1H, m), 1.94 (2H, m), 1.27 (6H, m),1.03 (9H, s). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 199.7, 156.0, 144.1, 138.5, 136.1, 136.0, 135.9, 134.2, 133.9, 133.1, 129.9, 129.8, 127.9, 127.8, 127.7, 125.3, 109.5, 75.2, 68.4, 55.9, 50.4, 36.1, 27.0, 22.7, 22.6, 22.0, 19.3.</div></div><div id="sec5_1_1_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 7-Hydroxy-1-isopropoxy-2-methoxy-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>65</b>)</h3><div class="NLM_p last">Ketone <b>64</b> (2.19 g, 4.50 mmol) was dissolved in THF (20 mL), TBAF (9.00 mL, 9.00 mmol) was added at 0 °C, and the reaction mixture was stirred for 30 min, followed by additional stirring at room temperature for 6 h. Brine (30 mL) was added, and the resultant solution was extracted with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 100 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford alcohol <b>65</b> (0.41 g, 1.7 mmol, 37%) as a yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.57 (1H, d, <i>J</i> = 8.4 Hz), 6.8 (1H, d, <i>J</i> = 8.4 Hz), 4.41 (1H, m), 4.31 (1H, m), 3.88 (3H, s), 3.11 (2H, m), 3.06 (1H, m), 2.99 (1H, m), 2.15 (1H, m), 1.87 (1H, m), 1.29 (6H, m). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ199.6, 156.3, 144.2, 138.4, 132.6, 125.4, 109.7, 75.3, 67.3, 55.9, 50.3, 35.8, 22.7, 22.6, 22.1.</div></div><div id="sec5_1_1_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-Isopropoxy-2-methoxy-7-((trimethylsilyl)oxy)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one (<b>66</b>)</h3><div class="NLM_p last">To a solution of alcohol <b>65</b> (0.35 g, 1.33 mmol) in DMF (20 mL) were added imidazole (0.27 g, 6.4 mmol) and TMSCl (4.26 mmol) at room temperature, and the reaction mixture was stirred for 12 h. The solvent was removed under reduced pressure, and brine (20 mL) was added, followed by extraction with EtOAc (3 × 30 mL). The organic extract was dried over sodium sulfate, filtered, and concentrated under reduced pressure, and the residure was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford TMS protected ketone <b>66</b> (0.19 g, 0.56 mmol, 43%) as a yellow oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.54 (1H, d, <i>J</i> = 10.2 Hz), 6.79 (1H, d, <i>J</i> = 10.8 Hz), 4.39 (1H, m), 4.19 (1H, m), 3.86 (3H, s), 3.22 (1H, m), 2.99 (2H, m), 2.90 (1H, m), 1.91 (2H, m), 1.27 (6H, d, <i>J</i> = 9 Hz), 0.11 (9H, s). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 199.7, 156.1, 144.0, 138.6, 132.6, 125.3, 109.5, 75.1, 67.3, 55.8, 51.0, 36.4, 22.6, 22.5, 21.7.</div></div><div id="sec5_1_1_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-Isopropoxy-3-methoxy-9-(3,4,5-trimethoxyphenyl)-5<i>H</i>-benzo[7]annulene (<b>67</b>)</h3><div class="NLM_p last">To an oven-dried flask, THF (20 mL) and 3,4,5-trimethoxyphenyl bromide (0.21 g, 0.85 mmol) were added, and the solution was cooled to −78 °C. <i>n-</i>BuLi (0.34 mL, 2.5 M, 0.85 mmol) was slowly added to the reaction mixture, which was then stirred at −78 °C for 45 min. Ketone <b>66</b> (0.19 g, 0.56 mmol) was then added dropwise to the flask, and the reaction mixture was stirred (−78 to 0 °C) over 4 h, and then at 0 °C for an additional 1 h. 2 M HCl (20 mL) was added at °C followed by stirring for 10 min and extraction with EtOAc (3 × 30 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 10% A/90% B (1 CV), 10% A/90% B → 40% A/60% B (10 CV), 40% A/60% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford diene <b>67</b> (60 mg, 0.15 mmol, 27%) as a colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.81 (1H, d, <i>J</i> = 8.4 Hz), 6.71 (1H, d, <i>J</i> = 9 Hz), 6.61 (2H, s), 6.60 (1H, d, <i>J</i> = 5.4 Hz), 6.17 (1H, m), 5.87 (1H, m), 4.48 (1H, p, <i>J</i> = 6.6 Hz), 3.91 (3H, s), 3.86 (6H, s), 3.85 (3H, s), 3.26 (2H, m, b), 1.38 (6H, d, <i>J</i> = 6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 153.8, 153.0, 145.6, 142.0, 140.4, 137.5, 134.5, 131.7, 128.5, 126.9, 125.9, 124.8, 109.1, 106.7, 75.0, 61.0, 56.3, 55.8, 26.7, 22.8.</div></div><div id="sec5_1_1_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 3-Methoxy-9-(3,4,5-trimethoxyphenyl)-5<i>H</i>-benzo[7]annulen-4-ol (<b>68</b>)</h3><div class="NLM_p last">Isopropyl protected phenol <b>67</b> (60 mg, 0.15 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), to which BCl<sub>3</sub> (0.17 mL, 1 M, 0.17 mmol) was added, and the reaction mixture was stirred at 0 °C for 1 h. The solution was washed with water and 2 M HCl and extracted with EtOAc (3 × 20 mL). The combined organic phase was dried over sodium sulfate and evaporated under reduced pressure. The crude reaction was purified by flash chromatography using a prepacked 50 g silica column [solvent A of EtOAc; solvent B of hexanes; gradient 5% A/95% B (1 CV), 5% A/95% B → 60% A/40% B (10 CV), 60% A/40% B (2 CV); flow rate 100 mL/min; monitored at 254 and 280 nm] to afford phenol <b>68</b> (40 mg, 0.11 mmol, 75%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.67 (1H, d, <i>J</i> = 8.4 Hz), 6.62 (1H, d, <i>J</i> = 9 Hz), 6.60 (2H, s), 6.59 (1H, d, <i>J</i> = 5.4 Hz), 6.15 (1H, m), 5.94 (1H, m), 3.89 (6H, s), 3.84 (6H, s), 3.23 (2H, m, b). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ153.0, 147.1, 145.5, 140.6, 140.3, 137.5, 132.2, 128.3, 127.0, 126.2, 126.0, 120.1, 107.6, 106.7, 61.1, 56.3, 56.2, 25.7. HRMS: obsvd 377.1361 [M + Na<sup>+</sup>]. Calcd for C<sub>21</sub>H<sub>22</sub>O<sub>5</sub>Na: 377.1359. HPLC: 19.52 min.</div></div><div id="sec5_1_1_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Sodium 3-Methoxy-9-(3,4,5-trimethoxyphenyl)-5<i>H</i>-benzo[7]annulen-4-ylphosphate (<b>69</b>)</h3><div class="NLM_p last">To phenol <b>68</b> (95 mg, 0.27 mmol) dissolved in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) were added POCl<sub>3</sub> (0.11 mL, 1.1 mmol) and pyridine (0.078 mL, 0.97 mmol), and the reaction mixture was stirred from 0 °C to room temperature for 8 h. The CH<sub>2</sub>Cl<sub>2</sub> was removed under reduced pressure, the residue was dissolved in H<sub>2</sub>O/THF (10 mL/5 mL) at room temperature, and the solution was stirred for 1 h. A NaOH solution (0.1 M) was added to the reaction mixture to adjust to pH = 10 at 0 °C, and the solution was stirred at 0 °C for 30 min. Water was removed under reduced pressure. The crude product was purified by flash chromatography using a prepacked 12 g C-18 column [solvent A of acetonitrile; solvent B of water; gradient 0% A/100% B (1 CV), 0% A/100% B → 10% A/90% B (10 CV), 10% A/90% B (2 CV); flow rate 12 mL/min; monitored at 254 and 280 nm] to afford phosphate salt <b>69</b> (65.8 mg, 0.14 mmol, 51%) as a yellow solid. <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 6.65 (2H, s), 6.60 (2H, m), 6.53 (1H, d, <i>J</i> = 6 Hz), 6.10 (1H, m), 5.98 (1H, m), 3.78 (3H, s), 3.72 (3H, s), 3.70 (6H, s), 3.29 (2H, b). <sup>13</sup>C NMR (125 MHz, D<sub>2</sub>O) δ 153.0, 152.1, 144.5, 140.8, 138.4, 136.0, 134.5, 131.1, 129.8, 126.2, 126.1, 124.2, 109.1, 106.7, 60.9, 55.9, 55.7, 26.9. <sup>31</sup>P NMR (200 MHz, D<sub>2</sub>O) δ 0.81. HRMS: obsvd 479.0841 [M + H<sup>+</sup>]. Calcd for C<sub>21</sub>H<sub>22</sub>O<sub>8</sub>Na<sub>2</sub>P<sup>+</sup>: 479.0842. HPLC: 14.22 min</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Confirmation That Target Molecules Are Not PAINS Molecules</h3><div class="NLM_p last">Each of the target molecules and several common motifs were screened using the zinc15 docking algorithm (<a href="http://zinc15.docking.org/patterns/home" class="extLink">http://zinc15.docking.org/patterns/home</a>), which provided confirmation that these benzosuberene-based molecules are not pan assay interference compounds (PAINS). A molecule previously identified as a PAIN molecule (<contrib-group>Capuzzi</contrib-group> ,   <cite><i>J. Chem.
Inf. Model.</i></cite> <span class="NLM_year">2017</span>, <em>57</em>, 417−427) was screened to provide positive confirmation that the algorithm was functioning accurately.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Biology. Cell Lines and Sulforhodamine B (SRB) Assay</h3><div class="NLM_p last">The sulforhodamine B (SRB) assay was used to assess growth inhibition of human cancer cells, as previously described.<a onclick="showRef(event, 'ref29 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref29 ref82 ref83">(29,82,83)</a> DU-145, SK-OV-3, and NCI-H460 cancer cell lines (obtained from ATCC) were maintained in T75 flasks (Corning) using high glucose DMEM supplemented with 10% fetal bovine serum (Gibco)/1% gentamicin sulfate for a maximum of 15 passages. For these experiments, cells were trypsinized, counted, and plated at 7000–8000 cells/well into 96-well plates (Corning) and incubated for 24 h at 37 °C in a humidified incubator in a 5% CO<sub>2</sub> atmosphere. Compounds to be tested were dissolved in DMSO to generate a 10 mg/mL stock solution, and serial dilutions were added in media to the plates. Doxorubicin (Sigma-Aldrich) and paclitaxel (Tokyo Chemical) were used as positive controls. After a 48 h treatment, the cells were fixed with trichloroacetic acid (10% final concentration), washed, dried, stained with SRB dye, washed to remove excess dye, and dried. SRB dye was solubilized, and absorbances were measured at wavelength 540 nm and normalized to values at wavelength 630 nm using an automated Biotek plate reader. A growth inhibition of 50% (GI<sub>50</sub> or the drug concentration causing 50% reduction in the net protein increase) was calculated from the absorbance data.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Colchicine Binding Assay<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></h3><div class="NLM_p last">Inhibition of [<sup>3</sup>H]colchicine binding to tubulin was measured in 0.1 mL reaction mixtures, each containing 1.0 μM tubulin, 5.0 μM [<sup>3</sup>H]colchicine (PerkinElmer), 5% (v/v) dimethyl sulfoxide, compounds at 1.0 or 5.0 μM, as indicated, and components that stabilize the colchicine binding activity of tubulin (1.0 M monosodium glutamate [adjusted to pH 6.6 with HCl in a 2.0 M stock solution], 0.5 mg/mL bovine serum albumin, 0.1 M glucose 1-phosphate, 1.0 mM MgCl<sub>2</sub>, and 1.0 mM GTP). Incubation was for 10 min at 37 °C, when in control reaction mixtures colchicine binding is 40–60% complete. Reactions were stopped with 2.0 mL of ice-cold water, with the reaction mixtures being placed on ice. Each diluted sample was poured onto a stack of two DEAE-cellulose filters (GE Biomedical), followed by three successive 2 mL aliquots of ice-cold water. A reduced vacuum was used to remove excess water from the filters, which were washed three times with 2 mL of water and placed into vials containing 5 mL of Biosafe II scintillation cocktail. Samples were counted 18 h later in a Beckman scintillation counter. Samples with inhibitors were compared to samples with no inhibitor, and percent inhibition was determined, correcting all values for the amount of radiolabel bound to the filters in the absence of tubulin.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Inhibition of Tubulin Polymerization<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></h3><div class="NLM_p last">Tubulin polymerization was evaluated in 0.25 mL reaction mixtures (final volume) containing 1 mg/mL (10 μM) purified bovine brain tubulin, 0.8 M monosodium glutamate (pH 6.6), 4% (v/v) dimethyl sulfoxide, 0.4 mM GTP, and different compound concentrations. All components except GTP were preincubated for 15 min at 30 °C in 0.24 mL. The assay mixtures were cooled to 0 °C, and 10 μL of 0.01 M GTP was added to each sample. Reaction mixtures were transferred to cuvettes held at 0 °C in Beckman DU-7400 and DU-7500 spectrophotometers equipped with electronic temperature controllers. The temperature was increased to 30 °C, over about 30 s, and polymerization was followed turbidimetrically at 350 nm for 20 min. The IC<sub>50</sub> was defined as the compound concentration inhibiting extent of polymerization by 50% after 20 min.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> In Vivo Vascular Disruption</h3><div class="NLM_p last">The human prostate cancer cell line (PC3) was modified by knockdown of a tumor suppressor protein PC3-DAB2IP and further modified by transfection with a firefly luciferase reporter, as described in detail previously.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Male Copenhagen rats (originally from Charles River and bred at UT Southwestern) were inoculated subcutaneously with 5 × 10<sup>5</sup> PC3-DAB2IP-luc cells mixed with 30% Matrigel in the right thigh. These rats were approximately 6 weeks old and weighed between 100–120 g on date of implantation. Tumors were allowed to grow to a diameter of at least 1 cm before treatment commenced. Three rats were treated with VDA prodrug <b>69</b> (25 mg/mL in saline) administered ip. Rat 1 received 10 mg/kg followed by 40 mg/kg 24 h later, and CA4P (30 mg/kg at 20 mg/mL in saline) was administered ip as a control 4 days later. Rat 2 received a single dose of 40 mg/kg of VDA prodrug <b>69</b>, and rat 3 received 80 mg/kg of <b>69</b>. Bioluminescence imaging (BLI) was performed before treatment (baseline), and at 4 and 24 h after treatment using an IVIS Spectrum (PerkinElmer). Briefly, anesthetized rats (breathing oxygen with 3% isoflurane, Henry Schein Inc.) were injected subcutaneously in the foreback neck region with 120 mg/kg <span class="smallcaps smallerCapital">d</span>-luciferin sodium salt (Gold Biotechnology, St. Louis, MO) and imaged over a time course of about 30 min. Fresh luciferin was administered at each time point. The resulting light intensity time curves were analyzed using Living Image software, and light emission was measured for a region of interest encompassing the tumor. All animal procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health as well as the Institutional Animal Care and Use Committee approved protocols (APN 2017-102168) at the University of Texas Southwestern Medical Center.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00551" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00551" class="ext-link">10.1021/acs.jmedchem.9b00551</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (as SMILES) and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_001.xlsx" class="ext-link">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR,<sup>13</sup>C NMR, <sup>31</sup>P NMR, HRMS, HPLC for final target compounds and intermediates (<sup>1</sup>H NMR, <sup>13</sup>C NMR only) associated with this article and a table of biological data including standard deviations (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_001.xlsx">jm9b00551_si_001.xlsx (11.58 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_002.pdf">jm9b00551_si_002.pdf (34.15 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00551" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin G. Pinney</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1262-8631" title="Orcid link">http://orcid.org/0000-0003-1262-8631</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4efc1d2cdcafbf4cdcacac1dde4c6c5ddc8cbd68ac1c0d1"><span class="__cf_email__" data-cfemail="307b5546595e6f60595e5e5549705251495c5f421e555445">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haichan Niu</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy E. Strecker</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeni L. Gerberich</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, The University of Texas Southwestern
Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Campbell</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, The University of Texas Southwestern
Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debabrata Saha</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology Oncology, Division of Molecular Radiation Biology, The University of Texas Southwestern Medical Center, 2201 Inwood Road, Dallas, Texas 75390-9187, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deboprosad Mondal</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ernest Hamel</span> - <span class="hlFld-Affiliation affiliation">Screening
Technologies Branch, Developmental Therapeutics Program, Division
of Cancer Treatment and Diagnosis, National
Cancer Institute, Frederick National Laboratory for Cancer Research,
National Institutes of Health, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Chaplin</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Mateon
Therapeutics, Inc., 701
Gateway Boulevard, Suite 210, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph P. Mason</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, The University of Texas Southwestern
Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Lynn Trawick</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, Baylor University, One Bear Place, No. 97348, Waco, Texas 76798-7348, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A portion of the work presented in this manuscript was funded through Mateon Therapeutics, Inc., and this relationship is properly indicated in the Acknowledgement section. In addition, two of the authors (K.G.P. and D.J.C.) own Mateon stock. We are pleased with this productive and useful collaboration and funding relationship with Mateon, and it is important to note that there is absolutely no actual conflict of interest associated with the science presented in this manuscript.<br /></br><p class="inlineNote">The content of this article is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to the Cancer Prevention and Research Institute of Texas (CPRIT, Grant RP140399 to K.G.P., M.L.T., R.P.M.; Grant RP170696 to K.G.P., M.L.T.; Grant RP140285 to R.P.M.; Grant RP120670-C3 to D.S.), the National Cancer Institute of the National Institutes of Health (Grant 5R01CA140674 to K.G.P., M.L.T., R.P.M.), Mateon Therapeutics, Inc. (grant to K.G.P., M.L.T.), and the University Research Committee (URC) and the Vice Provost for Research at Baylor University (M.L.T.) for financial support of these projects. The authors further acknowledge resources associated with the UT Southwestern Small Animal Imaging Resource (SW-SAIRP), supported in part by the Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant, 1P30CA142543, and the Department of Radiology. The IVIS Spectrum was acquired with the assistance of NIH Shared Instrumentation Grant S10RR024757.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">VDA</td><td class="NLM_def"><p class="first last">vascular disrupting agent</p></td></tr><tr><td class="NLM_term">AIA</td><td class="NLM_def"><p class="first last">angiogenesis inhibiting agent</p></td></tr><tr><td class="NLM_term">TBDPSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldiphenylsilyl chloride</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal growth inhibition</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">bioluminescence imaging</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">not reported</p></td></tr><tr><td class="NLM_term">DEAE</td><td class="NLM_def"><p class="first last">diethylaminoethyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 85 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">Characterizing the Tumor Response to Treatment with Combretastatin A4 Phosphate</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2006.12.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ijrobp.2006.12.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=17448875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVOls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=211-217&issue=1&author=B.+A.+Salmonauthor=D.+W.+Siemann&title=Characterizing+the+Tumor+Response+to+Treatment+with+Combretastatin+A4+Phosphate&doi=10.1016%2Fj.ijrobp.2006.12.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate</span></div><div class="casAuthors">Salmon, Beth A.; Siemann, Dietmar W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">211-217</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: To examine the pathophysiol. impact of treatment with combretastatin A4 phosphate (CA4P) in regions of tumors that ultimately either necrose or survive treatment with this agent.  Methods and Materials: Proliferation, perfusion, vessel d., and expression of vascular endothelial growth factor (VEGF) were analyzed in the KHT tumor model after treatment with CA4P.  Analyses were conducted in the whole tumor and the tumor periphery.  Results: Perfusion in the tumor periphery decreased 4 h after treatment, but returned to baseline 20 h later.  Whole-tumor perfusion also decreased 4 h after treatment, but did not return to baseline.  Vessel d. decreased in the tumor as a whole, but not in the tumor periphery.  No significant effect on the expression of VEGF was obsd., but a decrease in proliferation in the whole tumor and the periphery was noted.  Conclusions: The present study shows that those areas of a tumor that survive treatment with CA4P are affected by CA4P exposure, though only transiently.  The decrease in perfusion could neg. affect therapies utilizing the combination of CA4P and conventional anticancer agents by decreasing drug delivery and tissue oxygenation.  These findings suggest that the timing of CA4P treatments when used in conjunction with conventional anticancer therapies should be considered carefully.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT8IJPWCbvVLVg90H21EOLACvtfcHk0lihXpaF2-mNzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVOls7g%253D&md5=e7af3058df29e33ed6fc008d248962a1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2006.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2006.12.051%26sid%3Dliteratum%253Aachs%26aulast%3DSalmon%26aufirst%3DB.%2BA.%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DCharacterizing%2520the%2520Tumor%2520Response%2520to%2520Treatment%2520with%2520Combretastatin%2520A4%2520Phosphate%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2007%26volume%3D68%26issue%3D1%26spage%3D211%26epage%3D217%26doi%3D10.1016%2Fj.ijrobp.2006.12.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&issue=5&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0liUs1FmE-ryog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26issue%3D5%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">The Unique Characteristics of Tumor Vasculature and Preclinical Evidence for Its Selective Disruption by Tumor-Vascular Disrupting Agents</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2010.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ctrv.2010.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=20570444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFajs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=63-74&issue=1&author=D.+W.+Siemann&title=The+Unique+Characteristics+of+Tumor+Vasculature+and+Preclinical+Evidence+for+Its+Selective+Disruption+by+Tumor-Vascular+Disrupting+Agents&doi=10.1016%2Fj.ctrv.2010.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents</span></div><div class="casAuthors">Siemann, Dietmar W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-74</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The vasculature of solid tumors is fundamentally different from that of normal vasculature and offers a unique target for anti-cancer therapy.  Direct vascular-targeting with Tumor-Vascular Disrupting Agents (Tumor-VDAs) is distinctly different from anti-angiogenic strategies, and offers a complementary approach to std. therapies.  Tumor-VDAs therefore have significant potential when combined with chemotherapy, radiotherapy, and angiogenesis-inhibiting agents.  Preclin. studies with the different Tumor-VDA classes have demonstrated key tumor-selective anti-vascular and anti-tumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKL8nIIVWtVbVg90H21EOLACvtfcHk0liUs1FmE-ryog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFajs7vI&md5=85fe2cb36db459ad473bf53bbcae60af</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2010.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2010.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DThe%2520Unique%2520Characteristics%2520of%2520Tumor%2520Vasculature%2520and%2520Preclinical%2520Evidence%2520for%2520Its%2520Selective%2520Disruption%2520by%2520Tumor-Vascular%2520Disrupting%2520Agents%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2011%26volume%3D37%26issue%3D1%26spage%3D63%26epage%3D74%26doi%3D10.1016%2Fj.ctrv.2010.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanthou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baguley, B. C.</span></span> <span> </span><span class="NLM_article-title">Disrupting Tumour Blood Vessels</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">435</span>, <span class="refDoi"> DOI: 10.1038/nrc1628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fnrc1628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15928673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=423-435&issue=6&author=G.+M.+Tozerauthor=C.+Kanthouauthor=B.+C.+Baguley&title=Disrupting+Tumour+Blood+Vessels&doi=10.1038%2Fnrc1628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting tumor blood vessels</span></div><div class="casAuthors">Tozer, Gillian M.; Kanthou, Chryso; Baguley, Bruce C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-435</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Low-mol.-wt. vascular-disrupting agents (VDAs) cause a pronounced shutdown in blood flow to solid tumors, resulting in extensive tumor-cell necrosis, while they leave the blood flow in normal tissues relatively intact.  The largest group of VDAs is the tubulin-binding combretastatins, several of which are now being tested in clin. trials.  DMXAA (5,6-dimethylxanthenone-4-acetic acid) - one of a structurally distinct group of drugs - is also being tested in clin. trials.  A full understanding of the action of these and other VDAs will provide insights into mechanisms that control tumor blood flow and will be the basis for the development of new therapeutic drugs for targeting the established tumor vasculature for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjdnxmo6H1JrVg90H21EOLACvtfcHk0liUs1FmE-ryog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D&md5=869e9f19ba4b9b82b166b39f089e003b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1628%26sid%3Dliteratum%253Aachs%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26atitle%3DDisrupting%2520Tumour%2520Blood%2520Vessels%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26issue%3D6%26spage%3D423%26epage%3D435%26doi%3D10.1038%2Fnrc1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanthou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span> <span> </span><span class="NLM_article-title">Tumour Targeting by Microtubule-Depolymerizing Vascular Disrupting Agents</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1517/14728222.11.11.1443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1517%2F14728222.11.11.1443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=18028009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1443-1457&issue=11&author=C.+Kanthouauthor=G.+M.+Tozer&title=Tumour+Targeting+by+Microtubule-Depolymerizing+Vascular+Disrupting+Agents&doi=10.1517%2F14728222.11.11.1443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour targeting by microtubule-depolymerising vascular disrupting agents</span></div><div class="casAuthors">Kanthou, Chryso; Tozer, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1443-1457</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Low mol. wt. vascular disrupting agents of the microtubule depolymerising family cause marked and selective disruption of the established tumor blood vessel network, resulting in tumor cell necrosis.  The combretastatins are members of this family and these, together with several other related compds., have undergone extensive preclin. testing and are now in clin. trials for cancer.  Potentially, vascular disrupting agents can also interfere with angiogenesis and constitute a very promising group of novel cancer drugs.  In vitro anal. of their signalling activities points to the endothelial cytoskeleton as being their major target and a key player in the events that culminate in vascular collapse.  As more of these agents progress into the clin. setting, more research in this area is warranted in order to decipher exact mechanisms responsible for vascular disruption and to understand the reasons for drug selectivity for the tumor vasculature.  This information is essential in order to identify new targets within the tumor vasculature and to improve present therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyG45tAky0W7Vg90H21EOLACvtfcHk0ljVQR-nPxpeKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE&md5=08c7e94cddef659fd730c74b86575c55</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1443%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DTumour%2520Targeting%2520by%2520Microtubule-Depolymerizing%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26issue%3D11%26spage%3D1443%26epage%3D1457%26doi%3D10.1517%2F14728222.11.11.1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denekamp, J.</span></span> <span> </span><span class="NLM_article-title">Endothelial Cell Proliferation as a Novel Approach to Targeting Tumour Therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1038/bjc.1982.16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fbjc.1982.16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=7059456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A280%3ADyaL387jsFalsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1982&pages=136-139&issue=1&author=J.+Denekamp&title=Endothelial+Cell+Proliferation+as+a+Novel+Approach+to+Targeting+Tumour+Therapy&doi=10.1038%2Fbjc.1982.16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial cell proliferation as a novel approach to targeting tumour therapy</span></div><div class="casAuthors">Denekamp J</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-9</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4iKdwZjJ3XnthwrmtH4OBfW6udTcc2ea6qohDBRh1n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL387jsFalsQ%253D%253D&md5=7252dcfccc1e956472cd2ac64847b9a8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1982.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1982.16%26sid%3Dliteratum%253Aachs%26aulast%3DDenekamp%26aufirst%3DJ.%26atitle%3DEndothelial%2520Cell%2520Proliferation%2520as%2520a%2520Novel%2520Approach%2520to%2520Targeting%2520Tumour%2520Therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1982%26volume%3D45%26issue%3D1%26spage%3D136%26epage%3D139%26doi%3D10.1038%2Fbjc.1982.16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denekamp, J.</span></span> <span> </span><span class="NLM_article-title">Review Article: Angiogenesis, Neovascular Proliferation and Vascular Pathophysiology as Targets for Cancer Therapy</span>. <i>Br. J. Radiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">783</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1259/0007-1285-66-783-181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1259%2F0007-1285-66-783-181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=7682469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A280%3ADyaK3s3jtVemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1993&pages=181-196&issue=783&author=J.+Denekamp&title=Review+Article%3A+Angiogenesis%2C+Neovascular+Proliferation+and+Vascular+Pathophysiology+as+Targets+for+Cancer+Therapy&doi=10.1259%2F0007-1285-66-783-181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy</span></div><div class="casAuthors">Denekamp J</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of radiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">783</span>),
    <span class="NLM_cas:pages">181-96</span>
        ISSN:<span class="NLM_cas:issn">0007-1285</span>.
    </div><div class="casAbstract">A body of evidence that vascular-mediated damage occurs in murine tumours after many existing forms of anti-tumour therapy is rapidly accumulating (see Gray Conference Proceedings edited by Moore & West, 1991).  Rapid conventional screens of cells in vitro or using leukaemias of lymphomas will not detect this mode of action and such screens will therefore miss effective agents.  A change in the approach to experimental cancer therapy is needed to ensure that this important new avenue is fully investigated.  Solid tumours will need to be studied and the importance of specific tumour cell biochemistry (e.g. on tissue factor procoagulant activity), of endothelial status and the immunocompetence of the host are all likely to be important.  It is a subject of considerable debate at present whether transplanted subcutaneous mouse tumours are adequate models and whether they will reflect the response of spontaneous tumours, or even of transplants into other sites.  Xenografts are not likely to be appropriate if the immuno-suppressed hosts lack the cells needed for the cytokine component of the pathway.  The strategy of design and screening of new agents, for scheduling of existing agents and particularly the sequencing of adjunctive therapies are likely to be completely different for the "direct" tumor cell or "indirect" vascular-mediated approaches.  It may eventually be appropriate to combine vascular manipulation with direct cytotoxicity aimed at malignant cells but the two mechanisms must be recognized as distinct entities and considered separately before attempting to coordinate them.  It is important therefore to identify the "hallmarks" of vascular mediated injury and the means by which this can be distinguished from direct cell kill.  These may be detectable in the tumour response but clues can also be gained from the side effects that are seen in normal tissues both with existing and with novel therapies (Figure 7).  The appeal of vascular-mediated ischaemic therapy is that it is systemic and will have the potential of being effective on any tumour with a newly evoked vascular network, i.e. of about 1 mm in diameter, but it will be even more effective on large tumours than on small.  Thus it should affect both large primary tumours and disseminated small metastases.  The studies with many different anti-cancer agents have illustrated the potential complexity of responses that can appear to cause tumour cell death by collapse or occlusion of the blood supply.  They have also focused attention on features of disparate agents, e.g.  TNF, FAA, PDT, which may share similar pathways.  No single feature of neovasculature can be highlighted as the sole route by which such antivascular therapy should be targeted.  Rapid proliferation of the endothelial cells may prove to be a target, but it also influences differentiation characteristics, so that the immature cells will function abnormally.  The permeability of these poorly formed vessels may lead to extravasation of proteins leading to increase interstitial pressures and by this means to an imbalance between intravascular and extravascular pressures and hence to collapse of the thin-walled vessels.  Changes in systemic blood pressure, cardiac output, viscosity or coagulation and especially a redistribution of regional perfusion would all have differential effects in tumours and normal vessels.  Clearly both vascular patho-physiology and the complexity of endothelial cell function and its imbalance in neovasculature will be important in understanding the mechanism of action of antivascular strategies.  This very challenging boundary between oncology and a number of other medical and biological fields promises to lead to altered attitudes to existing therapies and the discovery of completely new classes of anti-cancer agents.  The next decade should translate into clinical benefit for patients if the progress in this field continues to be as rapid as it has been in the late eighties.  We must now determine what characteristics make one tumour more sensitive than another to agents such as heat, PDT, cytokines and FAA, and learn how to extrapolate from those rodent tumours to the human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-mmKvPwYf_Rjv2lLSLOxFfW6udTcc2ea6qohDBRh1n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3jtVemtA%253D%253D&md5=1d72d08985244fc62268852f50d1e6e3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1259%2F0007-1285-66-783-181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1259%252F0007-1285-66-783-181%26sid%3Dliteratum%253Aachs%26aulast%3DDenekamp%26aufirst%3DJ.%26atitle%3DReview%2520Article%253A%2520Angiogenesis%252C%2520Neovascular%2520Proliferation%2520and%2520Vascular%2520Pathophysiology%2520as%2520Targets%2520for%2520Cancer%2520Therapy%26jtitle%3DBr.%2520J.%2520Radiol.%26date%3D1993%26volume%3D66%26issue%3D783%26spage%3D181%26epage%3D196%26doi%3D10.1259%2F0007-1285-66-783-181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grohmann, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wootton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Dihydronaphthalene and Benzosuberene Analogs of the Combretastatins as Inhibitors of Tubulin Polymerization in Cancer Chemotherapy</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8161</span>– <span class="NLM_lpage">8171</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2008.07.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=18722127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyktbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8161-8171&issue=17&author=M.+Sriramauthor=J.+J.+Hallauthor=N.+C.+Grohmannauthor=T.+E.+Streckerauthor=T.+Woottonauthor=A.+Frankenauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Dihydronaphthalene+and+Benzosuberene+Analogs+of+the+Combretastatins+as+Inhibitors+of+Tubulin+Polymerization+in+Cancer+Chemotherapy&doi=10.1016%2Fj.bmc.2008.07.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy</span></div><div class="casAuthors">Sriram, Madhavi; Hall, John J.; Grohmann, Nathan C.; Strecker, Tracy E.; Wootton, Taylor; Franken, Andreas; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8161-8171</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A novel series of dihydronaphthalene and benzosuberene analogs bearing structural similarity to the combretastatins in terms of 1,2-diarylethene, trimethoxyphenyl, and biaryl functionality has been synthesized.  The compds. have been evaluated in regard to their ability to inhibit tubulin assembly and for their cytotoxicity against selected human cancer cell lines.  From this series of compds., benzosuberene analogs 2 and 4 inhibited tubulin assembly at concns. comparable to that of combretastatin A-4 (CA4) and combretastatin A-1 (CA1).  Furthermore, analog 4 demonstrated remarkable cytotoxicity against the three human cancer cell lines evaluated (for example GI50 = 0.0000032 μM against DU-145 prostate carcinoma).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OycvqOqayrVg90H21EOLACvtfcHk0lhh7IqK-NMY7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyktbnO&md5=a0efe158ffd2427c55f4375d773ff90f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.050%26sid%3Dliteratum%253Aachs%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DGrohmann%26aufirst%3DN.%2BC.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DWootton%26aufirst%3DT.%26aulast%3DFranken%26aufirst%3DA.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Dihydronaphthalene%2520and%2520Benzosuberene%2520Analogs%2520of%2520the%2520Combretastatins%2520as%2520Inhibitors%2520of%2520Tubulin%2520Polymerization%2520in%2520Cancer%2520Chemotherapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D17%26spage%3D8161%26epage%3D8171%26doi%3D10.1016%2Fj.bmc.2008.07.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horsman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busk, M.</span></span> <span> </span><span class="NLM_article-title">Vascular Targeting Therapy: Potential Benefit Depends on Tumor and Host Related Effects</span>. <i>Exp. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=21403608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGjsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=143-148&issue=3&author=M.+R.+Horsmanauthor=A.+B.+Bohnauthor=M.+Busk&title=Vascular+Targeting+Therapy%3A+Potential+Benefit+Depends+on+Tumor+and+Host+Related+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular targeting therapy: potential benefit depends on tumor and host related effects</span></div><div class="casAuthors">Horsman, M. R.; Bohn, A. B.; Busk, M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-148</span>CODEN:
                <span class="NLM_cas:coden">EOXNAQ</span>;
        ISSN:<span class="NLM_cas:issn">1812-9269</span>.
    
            (<span class="NLM_cas:orgname">Morion LLC</span>)
        </div><div class="casAbstract">A review.  The growth and development of most solid tumors require that they form their own functional vascular supply, which they do from the host normal vascular network by the process of angiogenesis.  The significance of this neo-vasculature makes it an excellent target and two forms of vascular targeting agents (VTAs) have evolved; those that inhibit the angiogenesis process (angiogenesis inhibitors, AIs) and those that damage the already established vessels (vascular disrupting agents, VDAs).  Although both AIs and VDAs can have substantial anti-tumor activity, neither induce tumor control, thus for their full clin. potential to be achieved they will need to be combined with more conventional cancer therapies.  Numerous pre-clin. studies have demonstrated the efficacy of combining AIs and VDAs with radio- and chemo-therapy and many of these approaches are now under clin. evaluation.  Although the tumor is the target for VTA therapy the normal host cells play an important role in VTA efficacy.  Host cells such as infiltrating macrophages, neutrophils, mast cells, platelets, endothelial cells, and stromal fibroblasts can all produce the important growth factors that initiate angiogenesis.  Many of these host cells also actively participate in the phys. steps of angiogenesis including destabilization of existing vessels, blood vessel sprouting, endothelial cell migration and proliferation, and vessel stabilization.  There is some evidence that these host cells can also influence VTA treatment, either by helping to normalize tumor vessels when AIs are administered or stimulate tumor angiogenesis after treatment with VDAs.  The host itself also plays a crit. role.  Cancer patients undergoing therapy are normally treated to tolerance, thus the normal tissue side effects actually control the ED given to the tumor.  All VTAs currently in clin. development induce some form of systemic side effects, which range from being rather mild and tolerable to more severe and even life threatening.  For more localized therapies there is also the issue of possible VTA-enhanced local tissue reactions.  A few pre-clin. studies have investigated this with radiation, but failed to show any enhancement of radiation-induced normal tissue damage by VTAs.  Clearly, the therapeutic benefit of VTA treatment will depend on a balance between tumor and host related effects, and in this review we will consider the contribution of each.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWuYMDZtHbAbVg90H21EOLACvtfcHk0lhh7IqK-NMY7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGjsb7M&md5=ccb8cf1e527dccd0f6ecd6ca679ccb1c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorsman%26aufirst%3DM.%2BR.%26aulast%3DBohn%26aufirst%3DA.%2BB.%26aulast%3DBusk%26aufirst%3DM.%26atitle%3DVascular%2520Targeting%2520Therapy%253A%2520Potential%2520Benefit%2520Depends%2520on%2520Tumor%2520and%2520Host%2520Related%2520Effects%26jtitle%3DExp.%2520Oncol.%26date%3D2010%26volume%3D32%26issue%3D3%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dark, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicker, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskens, F. A. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horsman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P. M.</span></span> <span> </span><span class="NLM_article-title">Differentiation and Definition of Vascular-Targeted Therapies</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2, Part I</span>),  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15701823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=416-420&issue=2%2C+Part+I&author=D.+W.+Siemannauthor=M.+C.+Bibbyauthor=G.+G.+Darkauthor=A.+P.+Dickerauthor=F.+A.+L.+M.+Eskensauthor=M.+R.+Horsmanauthor=D.+Marm%C3%A9author=P.+M.+LoRusso&title=Differentiation+and+Definition+of+Vascular-Targeted+Therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation and Definition of Vascular-Targeted Therapies</span></div><div class="casAuthors">Siemann, Dietmar W.; Bibby, Michael C.; Dark, Graham G.; Dicker, Adam P.; Eskens, Ferry A. L. M.; Horsman, Michael R.; Marme, Dieter; LoRusso, Patricia M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">416-420</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The therapeutic potential of targeting the tumor vascular supply is now widely recognized.  Intense research and development activity has resulted in a variety of investigational agents, a no. of which are currently in clin. development.  As these novel agents are quite distinct from the cytotoxic drugs conventionally used in the treatment of solid tumors, it will be particularly important to ensure early differentiation of these vascular-targeted therapies in order to encourage widespread understanding of their potential benefits and application in the clinic.  Two distinct groups of vascular-targeted therapies have evolved: antiangiogenic agents and vascular-disrupting approaches.  These differ in three key respects: their physiol. target, the type or extent of disease that is likely to be susceptible, and the treatment scheduling.  Inhibitors of angiogenesis interfere with new vessel formation and therefore have a preventative action, require chronic administration, and are likely to be of particular benefit in early-stage or asymptomatic metastatic disease.  Vascular-disrupting agents target the established tumor blood vessels, resulting in tumor ischemia and necrosis.  These agents are therefore given acutely, show more immediate effects, and may have particular efficacy against advanced disease.  It is essential that these agents can be readily distinguished from conventional therapies and that an understanding of key differences between the two types of vascular-targeted therapies is fostered.  Here, a simple taxonomy and nomenclature is proposed in anticipation that the therapeutic potential of this novel class can be realized as these approaches advance in clin. settings and a new anticancer strategy becomes available in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIEL4anGTuWbVg90H21EOLACvtfcHk0lhh7IqK-NMY7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWgtro%253D&md5=8a037771f2908fb5729425f7bdc9ae10</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26aulast%3DBibby%26aufirst%3DM.%2BC.%26aulast%3DDark%26aufirst%3DG.%2BG.%26aulast%3DDicker%26aufirst%3DA.%2BP.%26aulast%3DEskens%26aufirst%3DF.%2BA.%2BL.%2BM.%26aulast%3DHorsman%26aufirst%3DM.%2BR.%26aulast%3DMarm%25C3%25A9%26aufirst%3DD.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26atitle%3DDifferentiation%2520and%2520Definition%2520of%2520Vascular-Targeted%2520Therapies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D2%252C%2520Part%2520I%26spage%3D416%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">A Perspective on Vascular Disrupting Agents That Interact with Tubulin: Preclinical Tumor Imaging and Biological Assessment</span>. <i>Integr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1039/c0ib00135j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1039%2Fc0ib00135j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=375-387&issue=4&author=R.+P.+Masonauthor=D.+Zhaoauthor=L.+Liuauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=A+Perspective+on+Vascular+Disrupting+Agents+That+Interact+with+Tubulin%3A+Preclinical+Tumor+Imaging+and+Biological+Assessment&doi=10.1039%2Fc0ib00135j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment</span></div><div class="casAuthors">Mason, Ralph P.; Zhao, Dawen; Liu, Li; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment provides a rich source of potential targets for selective therapeutic intervention with properly designed anticancer agents.  Significant physiol. differences exist between the microvessels that nourish tumors and those that supply healthy tissue.  Selective drug-mediated damage of these tortuous and chaotic microvessels starves a tumor of necessary nutrients and oxygen and eventually leads to massive tumor necrosis.  Vascular targeting strategies in oncol. are divided into two sep. groups: angiogenesis inhibiting agents (AIAs) and vascular disrupting agents (VDAs).  The mechanisms of action between these two classes of compds. are profoundly distinct.  The AIAs inhibit the actual formation of new vessels, while the VDAs damage and/or destroy existing tumor vasculature.  One subset of small-mol. VDAs functions by inhibiting the assembly of tubulin into microtubules, thus causing morphol. changes to the endothelial cells lining the tumor vasculature, triggered by a cascade of cell signaling events.  Ultimately this results in catastrophic damage to the vessels feeding the tumor.  The rapid emergence and subsequent development of the VDA field over the past decade has led to the establishment of a synergistic combination of preclin. state-of-the-art tumor imaging and biol. evaluation strategies that are often indicative of future clin. efficacy for a given VDA.  This review focuses on an integration of the appropriate biochem. and biol. tools necessary to assess (preclinically) new small-mol., tubulin active VDAs for their potential to be clin. effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw2V3dKpQSrLVg90H21EOLACvtfcHk0lgvmRptRcvTfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D&md5=b58788fa8f5cdbc4d3abffff4e7eaca5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2Fc0ib00135j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0ib00135j%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DA%2520Perspective%2520on%2520Vascular%2520Disrupting%2520Agents%2520That%2520Interact%2520with%2520Tubulin%253A%2520Preclinical%2520Tumor%2520Imaging%2520and%2520Biological%2520Assessment%26jtitle%3DIntegr.%2520Biol.%26date%3D2011%26volume%3D3%26issue%3D4%26spage%3D375%26epage%3D387%26doi%3D10.1039%2Fc0ib00135j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, G. J.</span>; <span class="NLM_string-name">Chaplin, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of Vascular Disrupting Agents</span>. In  <i>Vascular Disruptive Agents for the Treatment of Cancer</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">27</span>; <a href="https://doi.org/10.1007/978-1-4419-6609-4_1" class="extLink">https://doi.org/10.1007/978-1-4419-6609-4_1</a>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2F978-1-4419-6609-4_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=1-27&author=G.+J.+Dougherty&author=D.+J.+Chaplin&title=Vascular+Disruptive+Agents+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-6609-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-6609-4_1%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DG.%2BJ.%26atitle%3DDevelopment%2520of%2520Vascular%2520Disrupting%2520Agents%26btitle%3DVascular%2520Disruptive%2520Agents%2520for%2520the%2520Treatment%2520of%2520Cancer%26pub%3DSpringer%26date%3D2010%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">Tumor Vasculature: A Target for Anticancer Therapies</span>. In  <i>Vascular-Targeted Therapies in Oncology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2F0470035439.ch1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=1-8&author=D.+W.+Siemannauthor=D.+W.+Siemann&title=Vascular-Targeted+Therapies+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F0470035439.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470035439.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DTumor%2520Vasculature%253A%2520A%2520Target%2520for%2520Anticancer%2520Therapies%26btitle%3DVascular-Targeted%2520Therapies%2520in%2520Oncology%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26pub%3DWiley%26date%3D2006%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monk, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugabe, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studerus, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvardsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Combretastatin Nitrogen-Containing Derivatives as Inhibitors of Tubulin Assembly and Vascular Disrupting Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3244</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2005.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=16442292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3231-3244&issue=9&author=K.+A.+Monkauthor=R.+Silesauthor=M.+B.+Hadimaniauthor=B.+E.+Mugabeauthor=J.+F.+Ackleyauthor=S.+W.+Studerusauthor=K.+Edvardsenauthor=M.+L.+Trawickauthor=C.+M.+Garnerauthor=M.+R.+Rhodesauthor=G.+R.+Pettitauthor=K.+G.+Pinney&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Combretastatin+Nitrogen-Containing+Derivatives+as+Inhibitors+of+Tubulin+Assembly+and+Vascular+Disrupting+Agents&doi=10.1016%2Fj.bmc.2005.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents</span></div><div class="casAuthors">Monk, Keith A.; Siles, Rogelio; Hadimani, Mallinath B.; Mugabe, Benon E.; Ackley, J. Freeland; Studerus, Scott W.; Edvardsen, Klaus; Trawick, Mary Lynn; Garner, Charles M.; Rhodes, Monte R.; Pettit, George R.; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3231-3244</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of analogs with nitro or serinamide substituents at the C-2'-, C-5'-, or C-6'-position of the combretastatin A-4 (CA4) B-ring was synthesized and evaluated for cytotoxic effects against heart endothelioma cells, blood flow redn. to tumors in SCID mice, and as inhibitors of tubulin polymn.  The synthesis of these analogs typically featured a Wittig reaction between a suitably functionalized arylaldehyde and an arylphosphonium salt followed by sepn. of the resultant E- and Z-isomers.  Several of these nitrogen-modified CA4 derivs. (both amino and nitro) demonstrate significant inhibition of tubulin assembly as well as cytotoxicity and in vivo blood flow redn.  The 2'-aminostilbenoid and 2'-amino-3'-hydroxystilbenoid proved to be the most active in this series.  Both compds. have the potential for further pro-drug modification and development as vascular disrupting agents for treatment of solid tumor cancers and certain ophthalmol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8R_9lmyQOTbVg90H21EOLACvtfcHk0ljku4PyeNmlqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLw%253D&md5=ce4dbfc4af6d73556ac51925b59ce2e2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DMonk%26aufirst%3DK.%2BA.%26aulast%3DSiles%26aufirst%3DR.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DMugabe%26aufirst%3DB.%2BE.%26aulast%3DAckley%26aufirst%3DJ.%2BF.%26aulast%3DStuderus%26aufirst%3DS.%2BW.%26aulast%3DEdvardsen%26aufirst%3DK.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DRhodes%26aufirst%3DM.%2BR.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Combretastatin%2520Nitrogen-Containing%2520Derivatives%2520as%2520Inhibitors%2520of%2520Tubulin%2520Assembly%2520and%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26issue%3D9%26spage%3D3231%26epage%3D3244%26doi%3D10.1016%2Fj.bmc.2005.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, F.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1672</span>, <span class="refDoi"> DOI: 10.1021/jm00010a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00010a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2MXltlyru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1666-1672&issue=10&author=G.+R.+Pettitauthor=S.+B.+Singhauthor=M.+R.+Boydauthor=E.+Hamelauthor=R.+K.+Pettitauthor=J.+M.+Schmidtauthor=F.+Hogan&title=Antineoplastic+Agents.+291.+Isolation+and+Synthesis+of+Combretastatins+A-4%2C+A-5%2C+and+A-6&doi=10.1021%2Fjm00010a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6</span></div><div class="casAuthors">Pettit, George R.; Singh, Sheo Bux; Boyd, Michael R.; Hamel, Ernest; Pettit, Robin K.; Schmidt, Jean M.; Hogan, Fiona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1666-72</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The title compds. (Z)-3,4,5-(MeO)3C6H2CH:CHC6H3(OMe)OH-4,3 (I) and (Z)- and (E)-3,4,5-HO(MeO)2C6H2CH:CHC6H3(OMe)2-3,4 (II) were isolated from Combretum caffrum.  They were also prepd. by Wittig reactions.  I is the most potent cell growth inhibitor of the series.  It is also the most potent inhibitor of colchicine binding to tubulin.  I and II also inhibit the growth of Neisseria gonorrheae, but have no fungicidal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyoXBFl08OLVg90H21EOLACvtfcHk0lhaorrblfd_aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltlyru74%253D&md5=c94f6ec6e373f1fd3eb7ff845b6292e0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00010a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00010a011%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DHogan%26aufirst%3DF.%26atitle%3DAntineoplastic%2520Agents.%2520291.%2520Isolation%2520and%2520Synthesis%2520of%2520Combretastatins%2520A-4%252C%2520A-5%252C%2520and%2520A-6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26issue%3D10%26spage%3D1666%26epage%3D1672%26doi%3D10.1021%2Fjm00010a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGown, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, B. W.</span></span> <span> </span><span class="NLM_article-title">Differential Cytotoxicity of Combretastatins A1 and A4 in Two Daunorubicin-Resistant P388 Cell Lines</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1007/BF02940301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2FBF02940301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=2322992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK3cXktVShtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1990&pages=79-81&issue=1&author=A.+T.+McGownauthor=B.+W.+Fox&title=Differential+Cytotoxicity+of+Combretastatins+A1+and+A4+in+Two+Daunorubicin-Resistant+P388+Cell+Lines&doi=10.1007%2FBF02940301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines</span></div><div class="casAuthors">McGown, Alan T.; Fox, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-81</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">Combretastatin A4 (I), a novel antimitotic agent was effective against two P388 cell lines with acquired resistance to daunorubicin.  In contrast, combretastatin A1 (II) showed a high degree of cross-resistance.  II was also more efficient at increasing intracellular daunorubicin concns. in both resistant cell lines.  Neither agent was capable of altering anthracycline accumulation in the parental (sensitive) cell line.  The cross-resistance to II occurs, at least in part, as a result of the increased affinity of the drug-efflux process operative in these resistant cells for II vs. I.  Hence, I may play a role in the treatment of tumors with acquired resistance to the anthracycline antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUFh8oXVjqDLVg90H21EOLACvtfcHk0lgVRKWcmILVrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVShtr4%253D&md5=df255967c5eaf9991a26b6c4b7ac2e92</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2FBF02940301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02940301%26sid%3Dliteratum%253Aachs%26aulast%3DMcGown%26aufirst%3DA.%2BT.%26aulast%3DFox%26aufirst%3DB.%2BW.%26atitle%3DDifferential%2520Cytotoxicity%2520of%2520Combretastatins%2520A1%2520and%2520A4%2520in%2520Two%2520Daunorubicin-Resistant%2520P388%2520Cell%2520Lines%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1990%26volume%3D26%26issue%3D1%26spage%3D79%26epage%3D81%26doi%3D10.1007%2FBF02940301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, J.-C.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents 460. Synthesis of Combretastatin A-2 Prodrugs</span>. <i>Anti-Cancer Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4–5</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12049477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFyqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=185-193&issue=4%E2%80%935&author=G.+R.+Pettitauthor=B.+R.+Moserauthor=M.+R.+Boydauthor=J.+M.+Schmidtauthor=R.+K.+Pettitauthor=J.-C.+Chapuis&title=Antineoplastic+Agents+460.+Synthesis+of+Combretastatin+A-2+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs</span></div><div class="casAuthors">Pettit, George R.; Moser, Bryan R.; Boyd, Michael R.; Schmidt, Jean M.; Pettit, Robin K.; Chapuis, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4/5</span>),
    <span class="NLM_cas:pages">185-193</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The original synthesis of combretastatin A-2 was modified to provide an efficient scale-up procedure for obtaining this antineoplastic stilbene.  Subsequent conversion to a useful prodrug was accomplished by phosphorylation employing in situ formation of dibenzylchlorophosphite followed by cleavage of the benzyl ester protective groups with bromotrimethylsilane to afford the phosphoric acid intermediate.  The latter was immediately treated with sodium methoxide to complete a practical route to the disodium phosphate prodrug.  The phosphoric acid precursor of disodium phosphate prodrug was employed in a parallel series of reactions to produce a selection of metal and ammonium cation prodrug candidates.  Each of the phosphate salts was evaluated with respect to relative soly. behavior, cancer cell growth inhibition and antimicrobial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorsOFDUAyzzrVg90H21EOLACvtfcHk0lgVRKWcmILVrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFyqtr8%253D&md5=e900c884117ec762ba3f355588ed180f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DMoser%26aufirst%3DB.%2BR.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26aulast%3DChapuis%26aufirst%3DJ.-C.%26atitle%3DAntineoplastic%2520Agents%2520460.%2520Synthesis%2520of%2520Combretastatin%2520A-2%2520Prodrugs%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D2001%26volume%3D16%26issue%3D4%25E2%2580%25935%26spage%3D185%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Kendal, D.</span></span> <span> </span><span class="NLM_article-title">Isolation and Structure of the Strong Cell Growth and Tubulin Inhibitor Combretastatin A-4</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1007/BF01954881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2FBF01954881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=2920809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL1MXktVShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=209-211&issue=2&author=G.%0AR.+Pettitauthor=S.+B.+Singhauthor=E.+Hamelauthor=C.+M.+Linauthor=D.+S.+Albertsauthor=D.+Garcia-Kendal&title=Isolation+and+Structure+of+the+Strong+Cell+Growth+and+Tubulin+Inhibitor+Combretastatin+A-4&doi=10.1007%2FBF01954881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4</span></div><div class="casAuthors">Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; Garcia-Kendall, D.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-11</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">From Combretum caffrum were isolated combretastatin A-4 (I, R1 = R2 = Me, R3 = H), combretastatin A-5 (I, R1 = H, R2 = R3 = Me), and combretastatin A-6 (II, R1 = H and R3 = Me) (the latter as the silyl ether).  The structures of these compds. detd. by spectroscopic methods were confirmed by total syntheses.  Combretastatins A-4, A-5 and A-6 were significantly active against murine L1210 and P388 lymphocytic leukemia cell lines with esp., combretastatin A-4 competing with combretastatin A-1 as the most inhibitor of colchicine binding to tubulin yet described.  Combretastatin A-4 was an inhibitor of tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt_PDOS8sCIrVg90H21EOLACvtfcHk0lgHZFKTRzHIpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVShtbg%253D&md5=5f9cda9322b202960705a92aa1a751ff</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2FBF01954881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01954881%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DAlberts%26aufirst%3DD.%2BS.%26aulast%3DGarcia-Kendal%26aufirst%3DD.%26atitle%3DIsolation%2520and%2520Structure%2520of%2520the%2520Strong%2520Cell%2520Growth%2520and%2520Tubulin%2520Inhibitor%2520Combretastatin%2520A-4%26jtitle%3DExperientia%26date%3D1989%26volume%3D45%26issue%3D2%26spage%3D209%26epage%3D211%26doi%3D10.1007%2FBF01954881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dark, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prise, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span> <span> </span><span class="NLM_article-title">Combretastatin A-4, an Agent That Displays Potent and Selective Toxicity toward Tumor Vasculature</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1829</span>– <span class="NLM_lpage">1834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=9157969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=1829-1834&issue=10&author=G.+G.+Darkauthor=S.+A.+Hillauthor=V.+E.+Priseauthor=G.+M.+Tozerauthor=G.+R.+Pettitauthor=D.+J.+Chaplin&title=Combretastatin+A-4%2C+an+Agent+That+Displays+Potent+and+Selective+Toxicity+toward+Tumor+Vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature</span></div><div class="casAuthors">Dark, Graham G.; Hill, Sally A.; Prise, Vivien E.; Tozer, Gillian M.; Pettit, George R.; Chaplin, Dai J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1834</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Selective induction of vascular damage within tumors represents an emerging approach to cancer treatment.  Histol. studies have shown that several tubulin-binding agents can induce vascular damage within tumors but only at doses approximating the max. tolerated dose, which has limited their clin. applicability.  In this study, we show that the combretastatin A-4 prodrug induces vascular shutdown within tumors at doses less than one-tenth of the max. tolerated dose.  In vitro studies indicate that a short drug exposure results in profound long-term antiproliferative/cytotoxic effects against proliferating endothelial cells but not cells that are quiescent prior to and during drug exposure.  Vascular shutdown, within exptl. and human breast cancer models in vivo following systemic drug administration, was demonstrated with a redn. in functional vascular vol. of 93% at 6 h following drug administration and persisted over the next 12 h, with corresponding histol. consistent with hemorrhagic necrosis resulting from vascular damage.  The actions against tumor vasculature and the broad therapeutic window demonstrate the clin. potential of these drugs and warrant further study to elucidate the mechanisms responsible for the antivascular effects of combretastatin A-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEdUvgSGIqp7Vg90H21EOLACvtfcHk0li245XmeEZcow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D&md5=889e82f6a746aef44c2a28b77135e61f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDark%26aufirst%3DG.%2BG.%26aulast%3DHill%26aufirst%3DS.%2BA.%26aulast%3DPrise%26aufirst%3DV.%2BE.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DCombretastatin%2520A-4%252C%2520an%2520Agent%2520That%2520Displays%2520Potent%2520and%2520Selective%2520Toxicity%2520toward%2520Tumor%2520Vasculature%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26issue%3D10%26spage%3D1829%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdier-Pinard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1688</span>– <span class="NLM_lpage">1695</span>, <span class="refDoi"> DOI: 10.1021/jm970644q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970644q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK1cXisFeitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1688-1695&issue=10&author=G.+R.+Pettitauthor=B.+Tokiauthor=D.+L.+Heraldauthor=P.+Verdier-Pinardauthor=M.+R.+Boydauthor=E.+Hamelauthor=R.+K.+Pettit&title=Antineoplastic+Agents.+379.+Synthesis+of+Phenstatin+Phosphate&doi=10.1021%2Fjm970644q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate</span></div><div class="casAuthors">Pettit, George R.; Toki, Brian; Herald, Delbert L.; Verdier-Pinard, Pascal; Boyd, Michael R.; Hamel, Ernest; Pettit, Robin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1688-1695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship (SAR) study of the South African willow tree (Combretum caffrum) antineoplastic constituent combretastatin A-4 (I; R = OH, R1 = H) directed at maintaining the (Z)-stilbene relationship of the olefin di-Ph substituents led to synthesis of a potent cancer cell growth inhibitor designated phenstatin (II; R2 = OH).  Initially phenstatin silyl ether (II; R2 = OSiMe2CMe3) was unexpectedly obtained by Jacobsen oxidn. of combretastatin A-4 silyl ether (I; R = OSiMe2CMe2, R1 = H), and the parent phenstatin (II; R2 = OH) was later synthesized in quantity.  Phenstatin was converted to the sodium phosphate prodrug [II; R2 = OP(O)(ONa)2] by a dibenzyl phosphite phosphorylation and subsequent hydrogenolysis sequence.  Phenstatin (II; R2 = OH) inhibited growth of the pathogenic bacterium Neisseria gonorrhoeae and was a potent inhibitor of tubulin polymn. and the binding of colchicine to tubulin comparable to combretastatin A-4 (I; R = OH, R1 = H).  Interestingly, the prodrugs were found to have reduced activity in these biochem. assays.  While no significant tubulin activity was obsd. with the phosphorylated deriv. of combretastatin A-4 (I; R = OH, R1 = H), phosphate II [R2 = OP(O)(ONa)2] retained detectable inhibitory effects in both assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz3b1DHVHKBLVg90H21EOLACvtfcHk0lhFz1D-uo0BCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFeitr8%253D&md5=4edd827bb3f81a8bdb912a9fa8178e16</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm970644q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970644q%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DToki%26aufirst%3DB.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DVerdier-Pinard%26aufirst%3DP.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26atitle%3DAntineoplastic%2520Agents.%2520379.%2520Synthesis%2520of%2520Phenstatin%2520Phosphate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D10%26spage%3D1688%26epage%3D1695%26doi%3D10.1021%2Fjm970644q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyland, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyland, M. E.</span></span> <span> </span><span class="NLM_article-title">Studies in Tissue Metabolism: The Action of Colchicine and B. Typhosus Extract</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1937</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1042/bj0310454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1042%2Fbj0310454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=16746357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaA2sXjtlClsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1937&pages=454-460&issue=3&author=E.+Boylandauthor=M.+E.+Boyland&title=Studies+in+Tissue+Metabolism%3A+The+Action+of+Colchicine+and+B.+Typhosus+Extract&doi=10.1042%2Fbj0310454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue metabolism. IX. The action of colchicine and B. typhosus extract</span></div><div class="casAuthors">Boyland, Eric; Boyland, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1937</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">454-60</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">cf. C. A. 30, 3511.1.  Colchicine in nearly toxic doses produced hemorrhage in grafted rat and mice tumors which was accompanied by a reduction in the ascorbic acid content and in the metabolism of the tumors.  A B. typhosus filtrate produced similar effects.  Colchicine also caused a reduction in the ascorbic acid content of the liver and intestine of rats and mice, but did not affect liver metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptf5bT2yvQULVg90H21EOLACvtfcHk0lhFz1D-uo0BCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA2sXjtlClsg%253D%253D&md5=93c59d4f3ce10f2d572d1e40f7c26acf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1042%2Fbj0310454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj0310454%26sid%3Dliteratum%253Aachs%26aulast%3DBoyland%26aufirst%3DE.%26aulast%3DBoyland%26aufirst%3DM.%2BE.%26atitle%3DStudies%2520in%2520Tissue%2520Metabolism%253A%2520The%2520Action%2520of%2520Colchicine%2520and%2520B.%2520Typhosus%2520Extract%26jtitle%3DBiochem.%2520J.%26date%3D1937%26volume%3D31%26issue%3D3%26spage%3D454%26epage%3D460%26doi%3D10.1042%2Fbj0310454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadfield, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGown, A. T.</span></span> <span> </span><span class="NLM_article-title">The Interaction with Tubulin of a Series of Stilbenes Based on Combretastatin A-4</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1038/bjc.1995.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fbjc.1995.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=7710932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2MXmtF2ksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1995&pages=705-711&issue=4&author=J.+A.+Woodsauthor=J.+A.+Hadfieldauthor=G.+R.+Pettitauthor=B.+W.+Foxauthor=A.+T.+McGown&title=The+Interaction+with+Tubulin+of+a+Series+of+Stilbenes+Based+on+Combretastatin+A-4&doi=10.1038%2Fbjc.1995.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction with tubulin of a series of stilbenes based on combretastatin A-4</span></div><div class="casAuthors">Woods, J A.; Hadfield, J A.; Pettit, G R.; Fox, B W.; McGown, A T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">705-11</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">A series of stilbenes, based on combretastatin A-4, were synthesized.  A structure-activity study was carried out to characterize the interaction of these agents with tubulin.  The substitution of small alkyl substituents for the 4'-MeO group of combretastatin A-4 and the loss of the 3'-OH group does not have a major effect on the interaction with tubulin.  Trans-Stilbenes bound tubulin, but did not inhibit microtubule assembly.  An idealized structure for a tubulin-binding agent of this type is proposed.  The antitumor cytotoxicity of the compds. is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNQ1JKdExq0bVg90H21EOLACvtfcHk0lg0-VQ-1rSQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtF2ksLg%253D&md5=b989319706146b1bc0c3bfa35c2ccf07</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1995.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1995.138%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DJ.%2BA.%26aulast%3DHadfield%26aufirst%3DJ.%2BA.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DFox%26aufirst%3DB.%2BW.%26aulast%3DMcGown%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Interaction%2520with%2520Tubulin%2520of%2520a%2520Series%2520of%2520Stilbenes%2520Based%2520on%2520Combretastatin%2520A-4%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1995%26volume%3D71%26issue%3D4%26spage%3D705%26epage%3D711%26doi%3D10.1038%2Fbjc.1995.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niven, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span> <span> </span><span class="NLM_article-title">Isolation, Structure, and Synthesis of Combretastatins A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Derived from Combretum Caffrum</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1021/np50049a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50049a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL2sXltFals7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=119-131&issue=1&author=G.+R.+Pettitauthor=S.+B.+Singhauthor=M.+L.+Nivenauthor=E.+Hamelauthor=J.+M.+Schmidt&title=Isolation%2C+Structure%2C+and+Synthesis+of+Combretastatins+A-1+and+B-1%2C+Potent+New+Inhibitors+of+Microtubule+Assembly%2C+Derived+from+Combretum+Caffrum&doi=10.1021%2Fnp50049a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents.  Part 123.  Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum</span></div><div class="casAuthors">Pettit, George R.; Singh, Sheo Bux; Niven, Margaret L.; Hamel, Ernest; Schmidt, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-31</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">The principal antineoplastic constituent of the South African tree C. caffrum was isolated and designated combretastatin A-1 (I).  The structure of this new cis-stilbene was unequivocally established by x-ray crystal structure detn. and total synthesis.  A Wittig reaction sequence in THF comprised the synthetic key step (92.5% yield) and provided a very favorable 9:1 ratio of the cis-trans isomers.  Selective hydrogenation of I afforded combretastatin B-1 (II), a companion cell growth inhibitory constituent of C. caffrum.  I provided 26-29% life extension at 2.75-11 mg/kg dose levels with ED50 0.99 μg/mL against the murine P-388 lymphocytic leukemia in vivo and in vitro systems.  Both I and II are potent inhibitors of microtubule assembly in vitro and are among the most potent inhibitors of the binding of colchicine to tubulin yet described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrghEgbQcROMLVg90H21EOLACvtfcHk0ljSvZCihyalCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltFals7k%253D&md5=75ee1bd1979d95f667df3fcf1ec14719</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fnp50049a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50049a016%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DNiven%26aufirst%3DM.%2BL.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DIsolation%252C%2520Structure%252C%2520and%2520Synthesis%2520of%2520Combretastatins%2520A-1%2520and%2520B-1%252C%2520Potent%2520New%2520Inhibitors%2520of%2520Microtubule%2520Assembly%252C%2520Derived%2520from%2520Combretum%2520Caffrum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1987%26volume%3D50%26issue%3D1%26spage%3D119%26epage%3D131%26doi%3D10.1021%2Fnp50049a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grealish, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 443. Synthesis of the Cancer Cell Growth Inhibitor Hydroxyphenstatin and Its Sodium Diphosphate Prodrug</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2731</span>– <span class="NLM_lpage">2737</span>, <span class="refDoi"> DOI: 10.1021/jm000045a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000045a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1Grt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2731-2737&issue=14&author=G.+R.+Pettitauthor=M.+P.+Grealishauthor=D.+L.+Heraldauthor=M.+R.+Boydauthor=E.+Hamelauthor=R.+K.+Pettit&title=Antineoplastic+Agents.+443.+Synthesis+of+the+Cancer+Cell+Growth+Inhibitor+Hydroxyphenstatin+and+Its+Sodium+Diphosphate+Prodrug&doi=10.1021%2Fjm000045a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 443. Synthesis of the Cancer Cell Growth Inhibitor Hydroxyphenstatin and Its Sodium Diphosphate Prodrug</span></div><div class="casAuthors">Pettit, George R.; Grealish, Matthew P.; Herald, Delbert L.; Boyd, Michael R.; Hamel, Ernest; Pettit, Robin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2731-2737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship (SAR) study of the South African willow tree (Combretum caffrum) antineoplastic constituent combretastatin A-4 led to the discovery of a potent cancer cell growth inhibitor designated phenstatin.  This benzophenone deriv. of combretastatin A-4 showed remarkable antineoplastic activity, and the benzophenone deriv. of combretastatin A-1 was therefore synthesized.  The benzophenone, designated hydroxyphenstatin (I), was synthesized by coupling of a protected bromobenzene and a benzaldehyde to give the benzhydrol with subsequent oxidn. to the ketone.  Hydroxyphenstatin was converted to the sodium phosphate prodrug by a dibenzyl phosphite phosphorylation and subsequent benzyl cleavage.  While hydroxyphenstatin I was a potent inhibitor of tubulin polymn. with activity comparable to that of combretastatin A-1, the phosphorylated deriv. of I was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1rnEzAIdLk7Vg90H21EOLACvtfcHk0lgt_sHJc6SdhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1Grt7c%253D&md5=4481df66fec835289cb9f20729246c41</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm000045a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000045a%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DGrealish%26aufirst%3DM.%2BP.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26atitle%3DAntineoplastic%2520Agents.%2520443.%2520Synthesis%2520of%2520the%2520Cancer%2520Cell%2520Growth%2520Inhibitor%2520Hydroxyphenstatin%2520and%2520Its%2520Sodium%2520Diphosphate%2520Prodrug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D14%26spage%3D2731%26epage%3D2737%26doi%3D10.1021%2Fjm000045a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herdman, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devkota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Structural Interrogation of Benzosuberene-Based Inhibitors of Tubulin Polymerization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7497</span>– <span class="NLM_lpage">7520</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2015.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=26775540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7497-7520&issue=24&author=C.+A.+Herdmanauthor=L.+Devkotaauthor=C.-M.+Linauthor=H.+Niuauthor=T.+E.+Streckerauthor=R.+Lopezauthor=L.+Liuauthor=C.+S.+Georgeauthor=R.+P.+Tanpureauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Structural+Interrogation+of+Benzosuberene-Based+Inhibitors+of+Tubulin+Polymerization&doi=10.1016%2Fj.bmc.2015.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization</span></div><div class="casAuthors">Herdman, Christine A.; Devkota, Laxman; Lin, Chen-Ming; Niu, Haichan; Strecker, Tracy E.; Lopez, Ramona; Liu, Li; George, Clinton S.; Tanpure, Rajendra P.; Hamel, Ernest; Chaplin, David J.; Mason, Ralph P.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7497-7520</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of 3-methoxy-9-(3',4',5'-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulen-4-ol (a benzosuberene-based analog referred to as KGP18) was originally inspired by the natural products colchicine and combretastatin A-4 (CA4).  The relative structural simplicity and ease of synthesis of KGP18, coupled with its potent biol. activity as an inhibitor of tubulin polymn. and its cytotoxicity (in vitro) against human cancer cell lines, has resulted in studies focused on new analog design and synthesis.  The goal was to probe the relationship of structure to function in this class of anticancer agents.  A series of twenty-two new benzosuberene-based analogs of KGP18 was designed and synthesized.  These compds. vary in their methoxylation pattern and sep. incorporate trifluoromethyl groups around the pendant aryl ring for the evaluation of the effect of functional group modifications on the fused six-membered arom. ring.  In addn., the 8,9-satd. congener of KGP18 has been synthesized to assess the necessity of unsatn. at the carbon atom bearing the pendant aryl ring.  Six of the mols. from this benzosuberene-series of compds. were active (IC50 < 5 μM) as inhibitors of tubulin polymn. while four analogs were comparable (IC50 approx. 1 μM) in their tubulin inhibitory activity to CA4 and KGP18.  The potency of a bis-trifluoromethyl analog I and the unsatd. KGP18 deriv. II as inhibitors of tubulin assembly along with their moderate cytotoxicity suggested the potential utility of these compds. as vascular disrupting agents (VDAs) to selectively target microvessels feeding tumors.  Accordingly, water-sol. and DMSO-sol. phosphate prodrug salts of each were synthesized for preliminary in vivo studies to assess their potential efficacy as VDAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHMYiacQz2erVg90H21EOLACvtfcHk0lhVOxuPojlncQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsbvO&md5=adf22a9f30ec679efc0641324bade909</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DHerdman%26aufirst%3DC.%2BA.%26aulast%3DDevkota%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DNiu%26aufirst%3DH.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeorge%26aufirst%3DC.%2BS.%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DStructural%2520Interrogation%2520of%2520Benzosuberene-Based%2520Inhibitors%2520of%2520Tubulin%2520Polymerization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D24%26spage%3D7497%26epage%3D7520%26doi%3D10.1016%2Fj.bmc.2015.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkrider, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Application of the McMurry Coupling Reaction in the Synthesis of Tri- and Tetra-Arylethylene Analogues as Potential Cancer Chemotherapeutic Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6993</span>– <span class="NLM_lpage">7001</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2009.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=19733085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFamsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6993-7001&issue=19&author=R.+P.+Tanpureauthor=A.+R.+Harkriderauthor=T.+E.+Streckerauthor=E.+Hamelauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Application+of+the+McMurry+Coupling+Reaction+in+the+Synthesis+of+Tri-+and+Tetra-Arylethylene+Analogues+as+Potential+Cancer+Chemotherapeutic+Agents&doi=10.1016%2Fj.bmc.2009.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents</span></div><div class="casAuthors">Tanpure, Rajendra P.; Harkrider, Amanda R.; Strecker, Tracy E.; Hamel, Ernest; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6993-7001</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structural redesign of selected non-steroidal estrogen receptor binding compds. has previously been successful in the discovery of new inhibitors of tubulin assembly.  Accordingly, tetra-substituted alkene analogs (21-30) were designed based in part on combinations of the structural and electronic components of tamoxifen and combretastatin A-4 (CA4).  The McMurry coupling reaction was used as the key synthetic step in the prepn. of these tri- and tetra-arylethylene analogs.  The structural assignment of E, Z isomers was detd. on the basis of 2D-NOESY expts.  The ability of these compds. to inhibit tubulin polymn. and cell growth in selected human cancer cell lines was evaluated.  Although the compds. were found to be less potent than CA4, these analogs significantly advance the known structure-activity relationship assocd. with the colchicine binding site on β-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHVM9sLR3RQbVg90H21EOLACvtfcHk0ljfE2-KNBfCVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFamsbjL&md5=047bacdf31fdc03d43a230351bf4577f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DHarkrider%26aufirst%3DA.%2BR.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DApplication%2520of%2520the%2520McMurry%2520Coupling%2520Reaction%2520in%2520the%2520Synthesis%2520of%2520Tri-%2520and%2520Tetra-Arylethylene%2520Analogues%2520as%2520Potential%2520Cancer%2520Chemotherapeutic%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D19%26spage%3D6993%26epage%3D7001%26doi%3D10.1016%2Fj.bmc.2009.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelinek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span> <span> </span><span class="NLM_article-title">The Discovery and Development of the Combretastatins</span>. <i>Anticancer Agents Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1201/b11185-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1201%2Fb11185-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=27-63&author=K.+G.+Pinneyauthor=G.+R.+Pettitauthor=M.+L.+Trawickauthor=C.+Jelinekauthor=D.+J.+Chaplin&title=The+Discovery+and+Development+of+the+Combretastatins&doi=10.1201%2Fb11185-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1201%2Fb11185-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1201%252Fb11185-4%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DJelinek%26aufirst%3DC.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Discovery%2520and%2520Development%2520of%2520the%2520Combretastatins%26jtitle%3DAnticancer%2520Agents%2520Nat.%2520Prod.%26date%3D2011%26spage%3D27%26epage%3D63%26doi%3D10.1201%2Fb11185-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of the Colchicine Binding Site as a Design Paradigm for the Discovery and Development of Vascular Disrupting Agents</span>. In  <i>Vascular-Targeted Therapies in Oncology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">121</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2F0470035439.ch6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=95-121&author=K.+G.+Pinneyauthor=D.+W.+Siemann&title=Vascular-Targeted+Therapies+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F0470035439.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470035439.ch6%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DMolecular%2520Recognition%2520of%2520the%2520Colchicine%2520Binding%2520Site%2520as%2520a%2520Design%2520Paradigm%2520for%2520the%2520Discovery%2520and%2520Development%2520of%2520Vascular%2520Disrupting%2520Agents%26btitle%3DVascular-Targeted%2520Therapies%2520in%2520Oncology%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26pub%3DWiley%26date%3D2006%26spage%3D95%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugabe, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddneppanavar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvardsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Combretastatin Dinitrogen-Substituted Stilbene Analogues as Tubulin-Binding and Vascular-Disrupting Agents</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1021/np070377j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np070377j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFWkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=313-320&issue=3&author=R.+Silesauthor=J.+F.+Ackleyauthor=M.+B.+Hadimaniauthor=J.+J.+Hallauthor=B.+E.+Mugabeauthor=R.+Guddneppanavarauthor=K.+A.+Monkauthor=J.-C.+Chapuisauthor=G.+R.+Pettitauthor=D.+J.+Chaplinauthor=K.+Edvardsenauthor=M.+L.+Trawickauthor=G.+M.+Garnerauthor=K.+G.+Pinney&title=Combretastatin+Dinitrogen-Substituted+Stilbene+Analogues+as+Tubulin-Binding+and+Vascular-Disrupting+Agents&doi=10.1021%2Fnp070377j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin Dinitrogen-Substituted Stilbene Analogues as Tubulin-Binding and Vascular-Disrupting Agents</span></div><div class="casAuthors">Siles, Rogelio; Ackley, J. Freeland; Hadimani, Mallinath B.; Hall, John J.; Mugabe, Benon E.; Guddneppanavar, Rajsekhar; Monk, Keith A.; Chapuis, Jean-Charles; Pettit, George R.; Chaplin, David J.; Edvardsen, Klaus; Trawick, Mary Lynn; Garner, Charles M.; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-320</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Several stilbenoid compds. having structural similarity to the combretastatin group of natural products and characterized by the incorporation of two N-bearing groups (amine, nitro, serinamide) were prepd. by chem. synthesis and evaluated in terms of biochem. and biol. activity.  The 2',3'-diamino B-ring analog (Z)-2-(2,3-diamino-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)ethene (17) demonstrated remarkable cytotoxicity against selected human cancer cell lines in vitro (av. GI50 = 13.9 nM) and also showed good activity in regard to inhibition of tubulin assembly (IC50 = 2.8 μM).  A single dose (10 mg/kg) of compd. 17 caused a 40% tumor-selective blood flow shutdown in tumor-bearing SCID mice at 24 h, thus suggesting the potential value of this compd. and its corresponding salt formulations as new vascular-disrupting agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu_0PO1vallbVg90H21EOLACvtfcHk0liVxrgn8b9Okg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFWkt7c%253D&md5=e9e37d310f45b58510d633e98278da60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fnp070377j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp070377j%26sid%3Dliteratum%253Aachs%26aulast%3DSiles%26aufirst%3DR.%26aulast%3DAckley%26aufirst%3DJ.%2BF.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DMugabe%26aufirst%3DB.%2BE.%26aulast%3DGuddneppanavar%26aufirst%3DR.%26aulast%3DMonk%26aufirst%3DK.%2BA.%26aulast%3DChapuis%26aufirst%3DJ.-C.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DEdvardsen%26aufirst%3DK.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DGarner%26aufirst%3DG.%2BM.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DCombretastatin%2520Dinitrogen-Substituted%2520Stilbene%2520Analogues%2520as%2520Tubulin-Binding%2520and%2520Vascular-Disrupting%2520Agents%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26issue%3D3%26spage%3D313%26epage%3D320%26doi%3D10.1021%2Fnp070377j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddneppanavar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelinek, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthasery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrell, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMordie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1P</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1021/np800661r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np800661r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=414-421&issue=3&author=A.+Shiraliauthor=M.+Sriramauthor=J.+J.+Hallauthor=B.+L.+Nguyenauthor=R.+Guddneppanavarauthor=M.+B.+Hadimaniauthor=J.+F.+Ackleyauthor=R.+Silesauthor=C.+J.+Jelinekauthor=P.+Arthaseryauthor=R.+C.+Brownauthor=V.+L.+Murrellauthor=A.+McMordieauthor=S.+Sharmaauthor=D.+J.+Chaplinauthor=K.+G.+Pinney&title=Development+of+Synthetic+Methodology+Suitable+for+the+Radiosynthesis+of+Combretastatin+A-1+%28CA1%29+and+Its+Corresponding+Prodrug+CA1P&doi=10.1021%2Fnp800661r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1P</span></div><div class="casAuthors">Shirali, Anupama; Sriram, Madhavi; Hall, John J.; Nguyen, Benson L.; Guddneppanavar, Rajsekhar; Hadimani, Mallinath B.; Ackley, J. Freeland; Siles, Rogelio; Jelinek, Christopher J.; Arthasery, Phyllis; Brown, Rodney C.; Murrell, Victor Leon; McMordie, Austin; Sharma, Suman; Chaplin, David J.; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-421</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Synthetic methodol. has been established suitable for the prepn. of combretastatin A-1 (I) and its corresponding phosphate prodrug salt CA1P in high specific activity radiolabeled form.  Judicious selection of appropriate phenolic protecting groups to distinguish positions on the A-ring from the B-ring of the stilbenoid was paramount for the success of this project.  Methylation of the C-4' phenolic moiety by removal of the tert-butyldimethylsilyl protecting group in the presence of Me iodide was accomplished in excellent yield without significant Z to E isomerization.  This step (carried out with 14C-Me iodide as proof of concept in this study) represents the process in which a 14C radioisotope could be incorporated in an actual radiosynthesis.  I is a natural product isolated from the African bush willow tree (Combretum caffrum) that has important medicinal value due, in part, to its ability to inhibit tubulin assembly.  As a prodrug, CA1P (OXi4503) is in human clin. trials as a vascular disrupting agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL45RoMfF3FLVg90H21EOLACvtfcHk0lgI2r-1EGXZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs7Y%253D&md5=8c7e4ca9616847331ea3af293e06761e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fnp800661r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp800661r%26sid%3Dliteratum%253Aachs%26aulast%3DShirali%26aufirst%3DA.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DGuddneppanavar%26aufirst%3DR.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DAckley%26aufirst%3DJ.%2BF.%26aulast%3DSiles%26aufirst%3DR.%26aulast%3DJelinek%26aufirst%3DC.%2BJ.%26aulast%3DArthasery%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DR.%2BC.%26aulast%3DMurrell%26aufirst%3DV.%2BL.%26aulast%3DMcMordie%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DDevelopment%2520of%2520Synthetic%2520Methodology%2520Suitable%2520for%2520the%2520Radiosynthesis%2520of%2520Combretastatin%2520A-1%2520%2528CA1%2529%2520and%2520Its%2520Corresponding%2520Prodrug%2520CA1P%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2009%26volume%3D72%26issue%3D3%26spage%3D414%26epage%3D421%26doi%3D10.1021%2Fnp800661r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span>; <span class="NLM_string-name">Garner, C. M.,  III</span>; <span class="NLM_string-name">Kane, R. R.</span>; <span class="NLM_string-name">Pinney, K. G.</span>; <span class="NLM_string-name">Prezioso, J. A.</span>; <span class="NLM_string-name">Edvardsen, K.</span></span> <span> </span><span class="NLM_article-title">Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents</span>. <span class="NLM_patent">US7384925B2</span>, June 10, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+J.+Chaplin&author=C.+M.+Garner&author=R.+R.+Kane&author=K.+G.+Pinney&author=J.+A.+Prezioso&author=K.+Edvardsen&title=Functionalized+Stilbene+Derivatives+as+Improved+Vascular+Targeting+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DFunctionalized%2520Stilbene%2520Derivatives%2520as%2520Improved%2520Vascular%2520Targeting%2520Agents%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocharla, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Preparation of New Anti-Tubulin Ligands Through a Dual-Mode, Addition–Elimination Reaction to a Bromo-Substituted α,β-Unsaturated Sulfoxide</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">8811</span>– <span class="NLM_lpage">8815</span>, <span class="refDoi"> DOI: 10.1021/jo0004761</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0004761" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFynu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=8811-8815&issue=25&author=Z.+Chenauthor=V.+P.+Mocharlaauthor=J.+M.+Farmerauthor=G.+R.+Pettitauthor=E.+Hamelauthor=K.+G.+Pinney&title=Preparation+of+New+Anti-Tubulin+Ligands+Through+a+Dual-Mode%2C+Addition%E2%80%93Elimination+Reaction+to+a+Bromo-Substituted+%CE%B1%2C%CE%B2-Unsaturated+Sulfoxide&doi=10.1021%2Fjo0004761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of new anti-tubulin ligands through a dual-mode, addition-elimination reaction to a bromo-substituted α,β-unsaturated sulfoxide</span></div><div class="casAuthors">Chen, Zhi; Mocharla, Vani P.; Farmer, J. Matt; Pettit, George R.; Hamel, Ernest; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8811-8815</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two new anti-tubulin ligands, thiophene I and aryl thioether II, were prepd.  Thus, bromination of 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene followed by S-oxidn., substitution with 3,4,5-(MeO)3C6H3OH, and LiAlH4 redn. gave I in 68% yield.  II was prepd. via addn.-elimination-ring cleavage of thiophene oxide III with cuprate IV.  The crystal structure of II X-oxide was detd. by x-ray diffraction.  I, II, and their S-oxides were tested for anticancer activity and as inhibitors of tubulin polymn.  I was the most cytotoxic against human cell cancer cell lines and is a strong inhibitor of tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXPi7L0aep1rVg90H21EOLACvtfcHk0lgp9GP4eRQIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFynu7s%253D&md5=6b0aedf4f0ce91ef9bd1d1345c267baf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo0004761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0004761%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DFarmer%26aufirst%3DJ.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DPreparation%2520of%2520New%2520Anti-Tubulin%2520Ligands%2520Through%2520a%2520Dual-Mode%252C%2520Addition%25E2%2580%2593Elimination%2520Reaction%2520to%2520a%2520Bromo-Substituted%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Sulfoxide%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26issue%3D25%26spage%3D8811%26epage%3D8815%26doi%3D10.1021%2Fjo0004761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bounds, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingeman, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocharla, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span> <span> </span><span class="NLM_article-title">A New Anti-Tubulin Agent Containing the Benzo[b]Thiophene Ring System</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(99)00143-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2FS0960-894X%2899%2900143-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10328289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVKlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1081-1086&issue=8&author=K.+G.+Pinneyauthor=A.+D.+Boundsauthor=K.+M.+Dingemanauthor=V.+P.+Mocharlaauthor=G.+R.+Pettitauthor=R.+Baiauthor=E.+Hamel&title=A+New+Anti-Tubulin+Agent+Containing+the+Benzo%5Bb%5DThiophene+Ring+System&doi=10.1016%2FS0960-894X%2899%2900143-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A new anti-tubulin agent containing the benzo[b]thiophene ring system</span></div><div class="casAuthors">Pinney, Kevin G.; Bounds, A. Dawn; Dingeman, Koren M.; Mocharla, Vani P.; Pettit, George R.; Bai, Ruoli; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1081-1086</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new type of inhibitor of tubulin polymn. was discovered based on the 3-aroyl-2-arylbenzo[b]thiophene mol. skeleton.  The lead compd. in this series, 3-(3,4,5-Trimethoxybenzoyl)-2-(4-methoxyphenyl)-6-methoxybenzo[b]thiophene, inhibited tubulin polymn., caused an increase in the mitotic index of CA46 Burkitt lymphoma cells, and inhibited the growth of several human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI93GfkpJGXLVg90H21EOLACvtfcHk0lhJG5OY9baqjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVKlsrk%253D&md5=a1705d553e01438738b7a85c450c056e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900143-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900143-2%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DBounds%26aufirst%3DA.%2BD.%26aulast%3DDingeman%26aufirst%3DK.%2BM.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DA%2520New%2520Anti-Tubulin%2520Agent%2520Containing%2520the%2520Benzo%255Bb%255DThiophene%2520Ring%2520System%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26issue%3D8%26spage%3D1081%26epage%3D1086%26doi%3D10.1016%2FS0960-894X%2899%2900143-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K.</span>; <span class="NLM_string-name">Pettit, G.</span>; <span class="NLM_string-name">Mocharla, V.</span>; <span class="NLM_string-name">del Pilar Mejia, M.</span>; <span class="NLM_string-name">Shirali, A.</span></span> <span> </span><span class="NLM_article-title">Anti-Mitotic Agents Which Inhibit Tubulin Polymerization</span>. <span class="NLM_patent">WO/1998/039323</span>, September 12, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=K.+Pinney&author=G.+Pettit&author=V.+Mocharla&author=M.+del+Pilar+Mejia&author=A.+Shirali&title=Anti-Mitotic+Agents+Which+Inhibit+Tubulin+Polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%26atitle%3DAnti-Mitotic%2520Agents%2520Which%2520Inhibit%2520Tubulin%2520Polymerization%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K.</span>; <span class="NLM_string-name">Sriram, M.</span>; <span class="NLM_string-name">George, C.</span>; <span class="NLM_string-name">Tanpure, R.</span></span> <span> </span><span class="NLM_article-title">Efficient Method for Preparing Functionalized Benzosuberenes</span>. <span class="NLM_patent">WO/2012/068284</span>, May 25, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+Pinney&author=M.+Sriram&author=C.+George&author=R.+Tanpure&title=Efficient+Method+for+Preparing+Functionalized+Benzosuberenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%26atitle%3DEfficient%2520Method%2520for%2520Preparing%2520Functionalized%2520Benzosuberenes%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K.</span>; <span class="NLM_string-name">Mocharla, V.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Garner, C.</span>; <span class="NLM_string-name">Ghatak, A.</span>; <span class="NLM_string-name">Hadimani, M.</span>; <span class="NLM_string-name">Kessler, J.</span>; <span class="NLM_string-name">Dorsey, J.</span>; <span class="NLM_string-name">Edvardsen, K.</span>; <span class="NLM_string-name">Chaplin, D.</span>; <span class="NLM_string-name">Prezioso, J.</span>; <span class="NLM_string-name">Ghatak, U.</span></span> <span> </span><span class="NLM_article-title">Tubulin Binding Agents and Corresponding Prodrug Constructs</span>. <span class="NLM_patent">US20040043969A1</span>, March 4, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=K.+Pinney&author=V.+Mocharla&author=Z.+Chen&author=C.+Garner&author=A.+Ghatak&author=M.+Hadimani&author=J.+Kessler&author=J.+Dorsey&author=K.+Edvardsen&author=D.+Chaplin&author=J.+Prezioso&author=U.+Ghatak&title=Tubulin+Binding+Agents+and+Corresponding+Prodrug+Constructs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%26atitle%3DTubulin%2520Binding%2520Agents%2520and%2520Corresponding%2520Prodrug%2520Constructs%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devkota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidmore, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdman, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonough, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Structurally Diverse Benzosuberene Analogues and Their Biological Evaluation as Anti-Cancer Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8019</span>– <span class="NLM_lpage">8032</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2013.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=24183586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12ksLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=8019-8032&issue=24&author=R.%0AP.+Tanpureauthor=C.+S.+Georgeauthor=T.+E.+Streckerauthor=L.+Devkotaauthor=J.+K.+Tidmoreauthor=C.-M.+Linauthor=C.+A.+Herdmanauthor=M.+T.+MacDonoughauthor=M.+Sriramauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+Structurally+Diverse+Benzosuberene+Analogues+and+Their+Biological+Evaluation+as+Anti-Cancer+Agents&doi=10.1016%2Fj.bmc.2013.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents</span></div><div class="casAuthors">Tanpure, Rajendra P.; George, Clinton S.; Strecker, Tracy E.; Devkota, Laxman; Tidmore, Justin K.; Lin, Chen-Ming; Herdman, Christine A.; MacDonough, Matthew T.; Sriram, Madhavi; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8019-8032</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Diversely functionalized, fused aryl-alkyl ring systems hold a prominent position as well-established mol. frameworks for a variety of anti-cancer agents.  The benzosuberene (6,7-fused, also referred to as dihydro-5H-benzo[7]annulene and benzocycloheptene) ring system has emerged as a valuable mol. core component for the development of inhibitors of tubulin assembly, which function as antiproliferative anti-cancer agents and, in certain cases, as vascular disrupting agents (VDAs).  Both a phenolic-based analog, I (R = OH) (known as KGP18) and its corresponding amine-based congener, I (R = NH2) (referred to as KGP156), which demonstrate strong inhibition of tubulin assembly (low micromolar range) and potent cytotoxicity (picomolar range for KGP18 and nanomolar range for KGP156) are noteworthy examples of such benzosuberene-based compds.  In order to extend the structure-activity relationship (SAR) knowledge base related to benzosuberene anti-cancer agents, a series of eleven analogs (including KGP18) were prepd. in which the methoxylation pattern on the pendant aryl ring as well as functional group incorporation on the fused aryl ring were varied.  The synthetic approach to these compds. featured a sequential Wittig olefination, redn., Eaton's reagent-mediated cyclization strategy to achieve the core benzosuberone intermediate, and represented a higher-yielding synthesis of KGP18 (which we prepd. previously through a ring-expansion strategy).  Incorporation of a fluorine or chlorine atom at the 1-position of the fused aryl ring or replacement of one of the methoxy groups with hydrogen (on the pendant aryl ring of KGP18) led to benzosuberene analogs that were both strongly inhibitory against tubulin assembly (IC50 approx. 1.0 μM) and strongly cytotoxic against selected human cancer cell lines, for example, GI50 = 5.47 nM against NCI-H460 cells with fluoro-benzosuberene analog I (R = F).  A water-sol. phosphate prodrug salt of KGP18, I [R = P(O)O2Na2+] (referred to as KGP265) and a water-sol. serinamide salt, II, of KGP156 were also synthesized and evaluated in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphmOTSUYXMPLVg90H21EOLACvtfcHk0lg1AasFrWFluQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12ksLfE&md5=3a22651448245794e07521adb12a4a33</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DGeorge%26aufirst%3DC.%2BS.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DDevkota%26aufirst%3DL.%26aulast%3DTidmore%26aufirst%3DJ.%2BK.%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DHerdman%26aufirst%3DC.%2BA.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520Structurally%2520Diverse%2520Benzosuberene%2520Analogues%2520and%2520Their%2520Biological%2520Evaluation%2520as%2520Anti-Cancer%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D8019%26epage%3D8032%26doi%3D10.1016%2Fj.bmc.2013.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidmore, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton-Sevcik, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable Cytotoxicity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1039/c2md00318j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1039%2Fc2md00318j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23772309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=720-724&issue=6&author=R.+P.+Tanpureauthor=C.+S.+Georgeauthor=M.+Sriramauthor=T.+E.+Streckerauthor=J.+K.+Tidmoreauthor=E.+Hamelauthor=A.+K.+Charlton-Sevcikauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=An+Amino-Benzosuberene+Analogue+That+Inhibits+Tubulin+Assembly+and+Demonstrates+Remarkable+Cytotoxicity&doi=10.1039%2Fc2md00318j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity</span></div><div class="casAuthors">Tanpure, Rajendra P.; George, Clinton S.; Sriram, Madhavi; Strecker, Tracy E.; Tidmore, Justin K.; Hamel, Ernest; Charlton-Sevcik, Amanda K.; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">720-724</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The recent discovery of a small-mol. benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymn. (1-2 μM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivs.  An efficient synthetic route to functionalized benzosuberenes was developed.  This methodol. utilized a Wittig reaction, followed by a selective alkene redn. and ring-closing cyclization to form the core benzosuberone structure.  This synthetic route facilitated the prepn. of a 4-nitro-1-(3',4',5'-trimethoxyphenyl) benzosuberene deriv. and its corresponding 4-amino analog in good yield.  The 4-amino analog was a strong inhibitor of tubulin polymn. (1.2 μM), demonstrated enhanced cytotoxicity against the human cancer cell lines examd. (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concn. dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7itN54t7yMLVg90H21EOLACvtfcHk0lg1AasFrWFluQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyhsbk%253D&md5=84cae4cc4413204616160eda558e51b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2Fc2md00318j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md00318j%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DGeorge%26aufirst%3DC.%2BS.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DTidmore%26aufirst%3DJ.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DCharlton-Sevcik%26aufirst%3DA.%2BK.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DAn%2520Amino-Benzosuberene%2520Analogue%2520That%2520Inhibits%2520Tubulin%2520Assembly%2520and%2520Demonstrates%2520Remarkable%2520Cytotoxicity%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D720%26epage%3D724%26doi%3D10.1039%2Fc2md00318j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonough, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghatak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirali, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a 2-Aryl-3-Aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1021/np400374w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400374w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=1668-1678&issue=9&author=M.+B.+Hadimaniauthor=M.+T.+MacDonoughauthor=A.+Ghatakauthor=T.+E.+Streckerauthor=R.+Lopezauthor=M.+Sriramauthor=B.+L.+Nguyenauthor=J.+J.+Hallauthor=R.+J.+Kesslerauthor=A.+R.+Shiraliauthor=L.+Liuauthor=C.+M.+Garnerauthor=G.+R.+Pettitauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+a+2-Aryl-3-Aroyl+Indole+Salt+%28OXi8007%29+Resembling+Combretastatin+A-4+with+Application+as+a+Vascular+Disrupting+Agent&doi=10.1021%2Fnp400374w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span></div><div class="casAuthors">Hadimani, Mallinath B.; MacDonough, Matthew T.; Ghatak, Anjan; Strecker, Tracy E.; Lopez, Ramona; Sriram, Madhavi; Nguyen, Benson L.; Hall, John J.; Kessler, Raymond J.; Shirali, Anupama R.; Liu, Li; Garner, Charles M.; Pettit, George R.; Hamel, Ernest; Chaplin, David J.; Mason, Ralph P.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1678</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The natural products colchicine and combretastatin A-4 are potent inhibitors of tubulin assembly, and they have inspired the design and synthesis of a large no. of small-mol., potential anticancer agents.  The indole-based mol. scaffold is prominent among these SAR modifications, leading to a rapidly increasing no. of agents.  The water-sol. phosphate prodrug I [R = P(O)(O-Na+)2] (OXi8007) (II) of 2-aryl-3-aroylindole-based phenol I (R = H) (OXi8006) (III) was prepd. by chem. synthesis and found to be strongly cytotoxic against selected human cancer cell lines (GI50 = 36 nM against DU-145 cells, for example).  The free phenol, III (OXi8006), was a strong inhibitor (IC50 = 1.1 μM) of tubulin assembly.  The corresponding phosphate prodrug II (OXi8007) also demonstrated pronounced interference with tumor vasculature in a preliminary in vivo study utilizing a SCID mouse model bearing an orthotopic PC-3 (prostate) tumor as imaged by color Doppler ultrasound.  The combination of these results provides evidence that the indole-based phosphate prodrug II (OXi8007) functions as a vascular disrupting agent that may prove useful for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPuuWz4Lp4LVg90H21EOLACvtfcHk0lg1AasFrWFluQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN&md5=d17de0d4667b5565c5715a956549c456</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fnp400374w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400374w%26sid%3Dliteratum%253Aachs%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DKessler%26aufirst%3DR.%2BJ.%26aulast%3DShirali%26aufirst%3DA.%2BR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520a%25202-Aryl-3-Aroyl%2520Indole%2520Salt%2520%2528OXi8007%2529%2520Resembling%2520Combretastatin%2520A-4%2520with%2520Application%2520as%2520a%2520Vascular%2520Disrupting%2520Agent%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2013%26volume%3D76%26issue%3D9%26spage%3D1668%26epage%3D1678%26doi%3D10.1021%2Fnp400374w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span> <span> </span><span class="NLM_article-title">Antimitotic Natural Products and Their Interactions with Tubulin</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1128(199603)16:2<207::AID-MED4>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=8656780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK28Xit12ku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=207-231&issue=2&author=E.+Hamel&title=Antimitotic+Natural+Products+and+Their+Interactions+with+Tubulin&doi=10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antimitotic natural products and their interactions with tubulin</span></div><div class="casAuthors">Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-31</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 143 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NTtfAB2p0LVg90H21EOLACvtfcHk0livPew-3d4SEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit12ku78%253D&md5=eea5ddcb906ac1250300618fb4bba53b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199603%252916%253A2%253C207%253A%253AAID-MED4%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DAntimitotic%2520Natural%2520Products%2520and%2520Their%2520Interactions%2520with%2520Tubulin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1996%26volume%3D16%26issue%3D2%26spage%3D207%26epage%3D231%26doi%3D10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.2174/1871520616666160219161921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.2174%2F1871520616666160219161921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=26899186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1325-1338&issue=10&author=X.+Wuauthor=Q.+Wangauthor=W.+Li&title=Recent+Advances+in+Heterocyclic+Tubulin+Inhibitors+Targeting+the+Colchicine+Binding+Site&doi=10.2174%2F1871520616666160219161921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site</span></div><div class="casAuthors">Wu, Xiaoxin; Wang, Qinghui; Li, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1325-1338</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Microtubules are involved in many crit. cellular processes including cell division, cell shape maintenance, vesicle transportation and motility regulation.  Disruption of tubulin dynamics is a well-validated cancer drug target with several FDA approved, highly efficacious tubulin inhibitors targeting the taxane or the vinca binding sites.  Despite the tremendous successes for these clin. tubulin inhibitors, their limitations are also apparent, particularly in the development of transporter mediated drug resistance.  While currently there are no FDA approved inhibitors targeting the colchicine binding site in tubulin, extensive preclin. studies have suggested that colchicine binding site inhibitors (CBSIs) have significantly less susceptibility to transporter medicated drug resistance.  The presence of one or more heterocyclic moieties is often crit. for the antiproliferative activities for most of these CBSIs.  This article aims to review the structures and antiproliferative activities of most recently developed heterocyclic CBSIs from 2013 to present.  We focus this review on compds. that are designed based on the CA-4, chalcone and PTOX scaffolds which are well established to interact with the colchicine binding site in tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsh10kAoyRzLVg90H21EOLACvtfcHk0livPew-3d4SEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrfE&md5=7959990391bd432fa2a417cf1309aec4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160219161921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160219161921%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DRecent%2520Advances%2520in%2520Heterocyclic%2520Tubulin%2520Inhibitors%2520Targeting%2520the%2520Colchicine%2520Binding%2520Site%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26issue%3D10%26spage%3D1325%26epage%3D1338%26doi%3D10.2174%2F1871520616666160219161921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirtz, D. A.</span></span> <span> </span><span class="NLM_article-title">Colchicine Site Inhibitors of Microtubule Integrity as Vascular Disrupting Agents</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1002/ddr.20267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fddr.20267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=352-358&issue=6&author=R.+M.+Leeauthor=D.+A.+Gewirtz&title=Colchicine+Site+Inhibitors+of+Microtubule+Integrity+as+Vascular+Disrupting+Agents&doi=10.1002%2Fddr.20267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Colchicine site inhibitors of microtubule integrity as vascular disrupting agents</span></div><div class="casAuthors">Lee, Ray M.; Gewirtz, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">352-358</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Drugs that bind to the colchicine binding site of tubulin and induce tubulin depolymn. hold promise as antitumor drugs through their ability to induce cell cycle arrest and to kill cancer cells through apoptosis and mitotic catastrophe.  However, development of this group of compds. as direct antitumor cytotoxic agents has not proved successful.  Over the last few years, the potential of these compds. to act as selective vascular disrupting agents has been recognized.  Several agents have advanced to phase I and phase II clin. studies, and their capacity to suppress growth of the tumor vasculature has been confirmed.  Toxicity in terms of cardiovascular and thromboembolic events remains a major concern and their therapeutic efficacy as single agents has been disappointing.  Nevertheless, a more comprehensive understanding of tumor compensatory mechanisms and potential combination strategies with anti-angiogenic agents suggest that vascular targeting therapy may be a fruitful direction for the further development of this class of drugs as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA1dFtz8TzprVg90H21EOLACvtfcHk0ljPPOwzEqS-3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2gsg%253D%253D&md5=a56c7b47b1f6695bf30af778d4089ab6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fddr.20267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.20267%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BM.%26aulast%3DGewirtz%26aufirst%3DD.%2BA.%26atitle%3DColchicine%2520Site%2520Inhibitors%2520of%2520Microtubule%2520Integrity%2520as%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2008%26volume%3D69%26issue%3D6%26spage%3D352%26epage%3D358%26doi%3D10.1002%2Fddr.20267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gigant, B.</span>; <span class="NLM_string-name">Cormier, A.</span>; <span class="NLM_string-name">Dorléans, A.</span>; <span class="NLM_string-name">Ravelli, R. B. G.</span>; <span class="NLM_string-name">Knossow, M.</span></span> <span> </span><span class="NLM_article-title">Microtubule-Destabilizing Agents: Structural and Mechanistic Insights from the Interaction of Colchicine and Vinblastine with Tubulin</span>. In  <i>Tubulin-Binding Agents: Synthetic, Structural and Mechanistic Insights</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlomagno, T.</span></span>, Ed.; Topics in Current Chemistry; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2009</span>; pp  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">278</span>, <a href="https://doi.org/10.1007/128_2008_11" class="extLink">https://doi.org/10.1007/128_2008_11</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=259-278&author=B.+Gigant&author=A.+Cormier&author=A.+Dorl%C3%A9ans&author=R.+B.+G.+Ravelli&author=M.+Knossowauthor=T.+Carlomagno&title=Tubulin-Binding+Agents%3A+Synthetic%2C+Structural+and+Mechanistic+Insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGigant%26aufirst%3DB.%26atitle%3DMicrotubule-Destabilizing%2520Agents%253A%2520Structural%2520and%2520Mechanistic%2520Insights%2520from%2520the%2520Interaction%2520of%2520Colchicine%2520and%2520Vinblastine%2520with%2520Tubulin%26btitle%3DTubulin-Binding%2520Agents%253A%2520Synthetic%252C%2520Structural%2520and%2520Mechanistic%2520Insights%26aulast%3DCarlomagno%26aufirst%3DT.%26pub%3DSpringer%26date%3D2009%26spage%3D259%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sackett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podophyllotoxin, L.</span></span> <span> </span><span class="NLM_article-title">Steganacin and Combretastatin: Natural Products That Bind at the Colchicine Site of Tubulin</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(93)90044-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2F0163-7258%2893%2990044-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=8278462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1993&pages=163-228&issue=2&author=D.+Sackettauthor=L.+Podophyllotoxin&title=Steganacin+and+Combretastatin%3A+Natural+Products+That+Bind+at+the+Colchicine+Site+of+Tubulin&doi=10.1016%2F0163-7258%2893%2990044-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Podophyllotoxin, steganacin and combretastatin: Natural products that bind at the colchicine site of tubulin</span></div><div class="casAuthors">Sackett, Dan L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-228</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with >300 refs.  Occurrence and isolation, chem. and biosynthesis, binding to tubulin, inhibition of polymn., analogs and structure-activity relationship and biol. activity of podophyllotoxin, steganacin, and combretastatin are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0uKGl_o7MWbVg90H21EOLACvtfcHk0li3FSPm69_51Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2mtQ%253D%253D&md5=05f0c6d53e4c1d818ad378c4f07e0f1c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2893%2990044-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252893%252990044-E%26sid%3Dliteratum%253Aachs%26aulast%3DSackett%26aufirst%3DD.%26aulast%3DPodophyllotoxin%26aufirst%3DL.%26atitle%3DSteganacin%2520and%2520Combretastatin%253A%2520Natural%2520Products%2520That%2520Bind%2520at%2520the%2520Colchicine%2520Site%2520of%2520Tubulin%26jtitle%3DPharmacol.%2520Ther.%26date%3D1993%26volume%3D59%26issue%3D2%26spage%3D163%26epage%3D228%26doi%3D10.1016%2F0163-7258%2893%2990044-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Structures of a Diverse Set of Colchicine Binding Site Inhibitors in Complex with Tubulin Provide a Rationale for Drug Discovery</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/febs.13555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1111%2Ffebs.13555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=26462166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=102-111&issue=1&author=Y.+Wangauthor=H.+Zhangauthor=B.+Gigantauthor=Y.+Yuauthor=Y.+Wuauthor=X.+Chenauthor=Q.+Laiauthor=Z.+Yangauthor=Q.+Chenauthor=J.+Yang&title=Structures+of+a+Diverse+Set+of+Colchicine+Binding+Site+Inhibitors+in+Complex+with+Tubulin+Provide+a+Rationale+for+Drug+Discovery&doi=10.1111%2Ffebs.13555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery</span></div><div class="casAuthors">Wang, Yuxi; Zhang, Hang; Gigant, Benoit; Yu, Yamei; Wu, Yangping; Chen, Xiangzheng; Lai, Qinhuai; Yang, Zhaoya; Chen, Qiang; Yang, Jinliang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Microtubules are dynamic assemblies of αβ-tubulin heterodimers and have been recognized as highly attractive targets for cancer chemotherapy.  A broad range of agents bind to tubulin and interfere with microtubule assembly.  Despite having a long history of characterization, colchicine binding site inhibitors (CBSIs) have not yet reached the com. phase as anti-cancer drugs to date.  We detd. the structures of tubulin complexed with a set of structurally diverse CBSIs (lexibulin, nocodazole, plinabulin and tivantinib), among which nocodazole and tivantinib are both binary-function inhibitors targeting cancer-related kinases and microtubules simultaneously.  High resoln. structures revealed the detailed interactions between these ligands and tubulin.  Our results showed that the binding modes of the CBSIs were different from previous docking models, highlighting the importance of crystal structure information in structure-based drug design.  A real structure-based pharmacophore was proposed to rationalize key common interactions of the CBSIs at the colchicine domain.  Our studies provide a solid structural basis for developing new anti-cancer agents for the colchicine binding site.  Database : The at. coordinates and structure factors for tubulin complexed with lexibulin, nocodazole, plinabulin and tivantinib have been deposited in the Protein Data Bank under accession codes , , and , resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIAVSS_EsIbVg90H21EOLACvtfcHk0lgppeqLFHL6gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP&md5=d5a17d9a3ac54d8eda44d0543ffa5fbd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13555%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Binding%2520Site%2520Inhibitors%2520in%2520Complex%2520with%2520Tubulin%2520Provide%2520a%2520Rationale%2520for%2520Drug%2520Discovery%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26issue%3D1%26spage%3D102%26epage%3D111%26doi%3D10.1111%2Ffebs.13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1348</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150114163732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.2174%2F0929867322666150114163732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=25620094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1348-1360&issue=11&author=Y.-T.+Jiauthor=Y.-N.+Liuauthor=Z.-P.+Liu&title=Tubulin+Colchicine+Binding+Site+Inhibitors+as+Vascular+Disrupting+Agents+in+Clinical+Developments&doi=10.2174%2F0929867322666150114163732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments</span></div><div class="casAuthors">Ji, Ya-Ting; Liu, Yan-Na; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1348-1360</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor vasculature is an important target in cancer treatment.  Two distinct vasculartargeting therapeutic strategies are applied to attack cancer cells indirectly.  The antiangiogenic approach intervenes in the neovascularization processes and blocks the formation of new blood vessels, while th e antivascular approach targets the established tumor blood vessels, making vascular shutdown and resulting in rapid haemorrhagic necrosis and tumor cell death.  A no. of compds. with diverse structural scaffolds have been designed to target tumor vasculature and they are called vascular disrupting agents (VDAs).  The biol. or ligand-directed VDAs utilize antibodies, peptides or growth factors to deliver toxins or pro-coagulants or proapoptotic affectors to tumor-related blood vessels, while the small-mol. VDAs selectively target tumor blood vessels and have little effects on the normal endothelium.  Among the small-mol. VDAs, the tubulin colchicine binding site inhibitors have been extensively studied and many of them have entered the clin. trials, including CA-4P, CA-1P, AVE8062, OXi4503, CKD-516, BNC105P, ABT-751, CYT- 997, ZD6126, NPI-2358, MN-029 and EPC2407.  This review makes a summary of the small-mol. VDAs in clin. developments and highlights some potential VDA leads or candidates for the treatment of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-aHECQeEv7LVg90H21EOLACvtfcHk0lidms0ViygLAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D&md5=65300d3649e348a5c3c66fbc2dac4f07</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150114163732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150114163732%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DY.-T.%26aulast%3DLiu%26aufirst%3DY.-N.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DTubulin%2520Colchicine%2520Binding%2520Site%2520Inhibitors%2520as%2520Vascular%2520Disrupting%2520Agents%2520in%2520Clinical%2520Developments%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26issue%3D11%26spage%3D1348%26epage%3D1360%26doi%3D10.2174%2F0929867322666150114163732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermone, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharevitz, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gussio, R.</span></span> <span> </span><span class="NLM_article-title">A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6107</span>– <span class="NLM_lpage">6116</span>, <span class="refDoi"> DOI: 10.1021/jm050502t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&issue=19&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+Common+Pharmacophore+for+a+Diverse+Set+of+Colchicine+Site+Inhibitors+Using+a+Structure-Based+Approach&doi=10.1021%2Fjm050502t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0lhPZfHz6QfB8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520Common%2520Pharmacophore%2520for%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Site%2520Inhibitors%2520Using%2520a%2520Structure-Based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D19%26spage%3D6107%26epage%3D6116%26doi%3D10.1021%2Fjm050502t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.2174/138955709789055234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.2174%2F138955709789055234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=19817710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOjsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1174-1190&issue=10&author=J.+Chenauthor=T.+Liuauthor=X.+Dongauthor=Y.+Hu&title=Recent+Development+and+SAR+Analysis+of+Colchicine+Binding+Site+Inhibitors&doi=10.2174%2F138955709789055234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Recent development and SAR analysis of colchicine binding site inhibitors</span></div><div class="casAuthors">Chen, Jing; Liu, Tao; Dong, Xiaowu; Hu, Yongzhou</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1174-1190</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Microtubules are cytoskeletal components that play important roles in a no. of cellular processes.  Colchicine binding site inhibitors (CSIs) is one major class of tubulin polymn. inhibitors, inhibiting microtubule polymn. and blocking cell proliferation at metaphase during mitosis.  Many CSIs were discovered or designed and synthesized as anticancer agents in the past several years and great progress had been made.  Here, we discuss the insights gained so far relevant to the mechanism of CSIs and their common pharmacophore.  The recent development of CSIs with their biol. activity and structure-activity relationship (SAR) are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqehPVBYRYe9bVg90H21EOLACvtfcHk0lijBqwOjqjlvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOjsL%252FP&md5=86d05831ad98872972f2ae17d1ddd85d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F138955709789055234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955709789055234%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DRecent%2520Development%2520and%2520SAR%2520Analysis%2520of%2520Colchicine%2520Binding%2520Site%2520Inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26issue%3D10%26spage%3D1174%26epage%3D1190%26doi%3D10.2174%2F138955709789055234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2943</span>– <span class="NLM_lpage">2971</span>, <span class="refDoi"> DOI: 10.1007/s11095-012-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2Fs11095-012-0828-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=22814904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2943-2971&issue=11&author=Y.+Luauthor=J.+Chenauthor=M.+Xiaoauthor=W.+Liauthor=D.+D.+Miller&title=An+Overview+of+Tubulin+Inhibitors+That+Interact+with+the+Colchicine+Binding+Site&doi=10.1007%2Fs11095-012-0828-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span></div><div class="casAuthors">Lu, Yan; Chen, Jianjun; Xiao, Min; Li, Wei; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2943-2971</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tubulin dynamics is a promising target for new chemotherapeutic agents.  The colchicine binding site is one of the most important pockets for potential tubulin polymn. destabilizers.  Colchicine binding site inhibitors (CBSI) exert their biol. effects by inhibiting tubulin assembly and suppressing microtubule formation.  A large no. of mols. interacting with the colchicine binding site have been designed and synthesized with significant structural diversity.  CBSIs have been modified as to chem. structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers.  CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin.  The present review is a synopsis of compds. that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrFQVgeCbBbVg90H21EOLACvtfcHk0ljlSc6V6BQMxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN&md5=dfe42e8eb1f0ff22b256641aaa8c17ab</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DAn%2520Overview%2520of%2520Tubulin%2520Inhibitors%2520That%2520Interact%2520with%2520the%2520Colchicine%2520Binding%2520Site%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D2943%26epage%3D2971%26doi%3D10.1007%2Fs11095-012-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macdonough, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Indole-Based, Anti-Cancer Agents Inspired by the Vascular Disrupting Agent 2-(3′-Hydroxy-4′-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6831</span>– <span class="NLM_lpage">6843</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2013.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23993969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6831-6843&issue=21&author=M.+T.+Macdonoughauthor=T.+E.+Streckerauthor=E.+Hamelauthor=J.+J.+Hallauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+and+Biological+Evaluation+of+Indole-Based%2C+Anti-Cancer+Agents+Inspired+by+the+Vascular+Disrupting+Agent+2-%283%E2%80%B2-Hydroxy-4%E2%80%B2-methoxyphenyl%29-3-%283%E2%80%B3%2C4%E2%80%B3%2C5%E2%80%B3-trimethoxybenzoyl%29-6-methoxyindole+%28OXi8006%29&doi=10.1016%2Fj.bmc.2013.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3'',4'',5''-trimethoxybenzoyl)-6-methoxyindole (OXi8006)</span></div><div class="casAuthors">MacDonough, Matthew T.; Strecker, Tracy E.; Hamel, Ernest; Hall, John J.; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6831-6843</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of a 2-aryl-3-aroyl indole-based small-mol. inhibitor of tubulin assembly (referred to as OXi8006) inspired the design, synthesis, and biol. evaluation of a series of diversely functionalized analogs.  In the majority of examples, the pendant 2-aryl ring contained a 3-hydroxy-4-methoxy substitution pattern, and the fused aryl ring featured a 6-methoxy group.  Most of the variability was in the 3-aroyl moiety, which was modified to incorporate methoxy (33-36), nitro (25-27), halogen (28-29), trifluoromethyl (30), or trifluoromethoxy (31-32) functionalities.  In two analogs (34 and 36), the methoxy substitution pattern in the fused aryl ring varied, while in another deriv. (35) the phenolic moiety was translocated from the pendant 2-aryl ring to position-7 of the fused aryl ring.  Each of the compds. were evaluated for their cytotoxicity (in vitro) against the SK-OV-3 (ovarian), NCI-H460 (lung), and DU-145 (prostate) human cancer cell lines and for their ability to inhibit tubulin assembly.  Four of the compds. (30, 31, 35, 36) proved to be potent inhibitors of tubulin assembly (IC50 <5 μM), and three of these compds. (31, 35, 36) were strongly cytotoxic against the three cancer cell lines.  The most active compd. (36) in this series, which incorporated a methoxy group at position-7, was comparable in terms of inhibition of tubulin assembly and cytotoxicity to the lead compd. OXi8006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-JO7cUZaeLVg90H21EOLACvtfcHk0lhNrowHULkM-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtbzE&md5=e7ad3c7876f5dc41113c136135f7513c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonough%26aufirst%3DM.%2BT.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Indole-Based%252C%2520Anti-Cancer%2520Agents%2520Inspired%2520by%2520the%2520Vascular%2520Disrupting%2520Agent%25202-%25283%25E2%2580%25B2-Hydroxy-4%25E2%2580%25B2-methoxyphenyl%2529-3-%25283%25E2%2580%25B3%252C4%25E2%2580%25B3%252C5%25E2%2580%25B3-trimethoxybenzoyl%2529-6-methoxyindole%2520%2528OXi8006%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D21%26spage%3D6831%26epage%3D6843%26doi%3D10.1016%2Fj.bmc.2013.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grobelny, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leske, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavranos, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostewicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremmidiotis, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-Hydroxy-6-Methoxy-2-Methyl-3-(3,4,5-Trimethoxybenzoyl)Benzo[b]Furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6014</span>– <span class="NLM_lpage">6027</span>, <span class="refDoi"> DOI: 10.1021/jm200454y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200454y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6014-6027&issue=17&author=B.+L.+Flynnauthor=G.+S.+Gillauthor=D.+W.+Grobelnyauthor=J.+H.+Chaplinauthor=D.+Paulauthor=A.+F.+Leskeauthor=T.+C.+Lavranosauthor=D.+K.+Chalmersauthor=S.+A.+Charmanauthor=E.+Kostewiczauthor=D.+M.+Shacklefordauthor=J.+Morizziauthor=E.+Hamelauthor=M.+K.+Jungauthor=G.+Kremmidiotis&title=Discovery+of+7-Hydroxy-6-Methoxy-2-Methyl-3-%283%2C4%2C5-Trimethoxybenzoyl%29Benzo%5Bb%5DFuran+%28BNC105%29%2C+a+Tubulin+Polymerization+Inhibitor+with+Potent+Antiproliferative+and+Tumor+Vascular+Disrupting+Properties&doi=10.1021%2Fjm200454y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties</span></div><div class="casAuthors">Flynn, Bernard L.; Gill, Gurmit S.; Grobelny, Damian W.; Chaplin, Jason H.; Paul, Dharam; Leske, Annabell F.; Lavranos, Tina C.; Chalmers, David K.; Charman, Susan A.; Kostewicz, Edmund; Shackleford, David M.; Morizzi, Julia; Hamel, Ernest; Jung, M. Katherine; Kremmidiotis, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6014-6027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trimethoxybenzoyl benzofurans such as I [R = H, (NaO)2P:O] were prepd. as analogs of combretastatin A4 for use as antitumor agents and tested for their inhibition of tubulin polymn.  Structure-activity relationships were detd. for the inhibition of tubulin polymn. by benzoyl benzofurans; introduction of a conformation bias and addn. of a hydrogen bond donor improved the activities of the compds.  I (R = H) was found by screening for selectivity against cancer cells and activated endothelial cells over quiescent endothelial cells; its activity against nonresistant and resistant human cancer cell lines and pharmacokinetics in rats were detd.  I [R = (NaO)2P:O] has improved soly., improved ability to disrupt tumor vasculature, and improved tumor growth inhibition over both I (R = H) and combretastatin A-4 disodium phosphate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV_WE1ggYIxLVg90H21EOLACvtfcHk0liXTlBVlLs5aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsb8%253D&md5=7c9a9ea031ebbb02d2c262015ff3df25</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm200454y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200454y%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DB.%2BL.%26aulast%3DGill%26aufirst%3DG.%2BS.%26aulast%3DGrobelny%26aufirst%3DD.%2BW.%26aulast%3DChaplin%26aufirst%3DJ.%2BH.%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DLeske%26aufirst%3DA.%2BF.%26aulast%3DLavranos%26aufirst%3DT.%2BC.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKostewicz%26aufirst%3DE.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DJung%26aufirst%3DM.%2BK.%26aulast%3DKremmidiotis%26aufirst%3DG.%26atitle%3DDiscovery%2520of%25207-Hydroxy-6-Methoxy-2-Methyl-3-%25283%252C4%252C5-Trimethoxybenzoyl%2529Benzo%255Bb%255DFuran%2520%2528BNC105%2529%252C%2520a%2520Tubulin%2520Polymerization%2520Inhibitor%2520with%2520Potent%2520Antiproliferative%2520and%2520Tumor%2520Vascular%2520Disrupting%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D17%26spage%3D6014%26epage%3D6027%26doi%3D10.1021%2Fjm200454y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4621</span>– <span class="NLM_lpage">4628</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-3474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1158%2F0008-5472.CAN-03-3474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15231674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlOrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4621-4628&issue=13&author=C.-C.+Kuoauthor=H.-P.+Hsiehauthor=W.-Y.+Panauthor=C.-P.+Chenauthor=J.-P.+Liouauthor=S.-J.+Leeauthor=Y.-L.+Changauthor=L.-T.+Chenauthor=C.-T.+Chenauthor=J.-Y.+Chang&title=BPR0L075%2C+a+Novel+Synthetic+Indole+Compound+with+Antimitotic+Activity+in+Human+Cancer+Cells%2C+Exerts+Effective+Antitumoral+Activity+in+Vivo&doi=10.1158%2F0008-5472.CAN-03-3474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo</span></div><div class="casAuthors">Kuo, Ching-Chuan; Hsieh, Hsing-Pang; Pan, Wen-Yu; Chen, Ching-Ping; Liou, Jing-Ping; Lee, Shiow-Ju; Chang, Yi-Ling; Chen, Li-Tzong; Chen, Chiung-Tong; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4621-4628</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BPR0L075 is a novel synthetic compd. discovered through research to identify new microtubule inhibitors.  BPR0L075 inhibits tubulin polymn. through binding to the colchicine-binding site of tubulin.  Cytotoxic activity of BPR0L075 in a variety of human tumor cell lines has been ascertained, with IC50 values in single-digit nanomolar ranges.  As detd. by flow cytometry, human cervical carcinoma KB cells are arrested in G2-M phases in a time-dependent manner before cell death occurs.  Terminal deoxynucleotidyl transferase-mediated nick end labeling assay indicates that cell death proceeds through an apoptotic pathway.  Addnl. studies indicate that the effect of BPR0L075 on cell cycle arrest is assocd. with an increase in cyclin B1 levels and a mobility shift of Cdc2 and Cdc25C.  The changes in Cdc2 and Cdc25C coincide with the appearance of phosphoepitopes recognized by a marker of mitosis, MPM-2.  Furthermore, phosphorylated forms of Bcl-2, perturbed mitochondrial membrane potential, and activation of the caspase-3 cascade may be involved in BPR0L075-induced apoptosis.  Notably, several KB-derived multidrug-resistant cell lines overexpressing P-gp170/MDR and MRP are resistant to vincristine, paclitaxel, and colchicine but not to BPR0L075.  Moreover, BPR0L075 shows potent activity against the growth of xenograft tumors of the gastric carcinoma MKN-45, human cervical carcinoma KB, and KB-derived P-gp170/MDR-overexpressing KB-VIN10 cells at i.v. doses of 50 mg/kg in nude mice.  These findings indicate BPR0L075 is a promising anticancer compd. with antimitotic activity that has potential for management of various malignancies, particularly for patients with drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoSqx6pRirD7Vg90H21EOLACvtfcHk0lhFytwr33E4Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlOrsbc%253D&md5=c828eca8875e66dc0780c6a61574828b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-3474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-3474%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DC.-C.%26aulast%3DHsieh%26aufirst%3DH.-P.%26aulast%3DPan%26aufirst%3DW.-Y.%26aulast%3DChen%26aufirst%3DC.-P.%26aulast%3DLiou%26aufirst%3DJ.-P.%26aulast%3DLee%26aufirst%3DS.-J.%26aulast%3DChang%26aufirst%3DY.-L.%26aulast%3DChen%26aufirst%3DL.-T.%26aulast%3DChen%26aufirst%3DC.-T.%26aulast%3DChang%26aufirst%3DJ.-Y.%26atitle%3DBPR0L075%252C%2520a%2520Novel%2520Synthetic%2520Indole%2520Compound%2520with%2520Antimitotic%2520Activity%2520in%2520Human%2520Cancer%2520Cells%252C%2520Exerts%2520Effective%2520Antitumoral%2520Activity%2520in%2520Vivo%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D13%26spage%3D4621%26epage%3D4628%26doi%3D10.1158%2F0008-5472.CAN-03-3474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e43314</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0043314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1371%2Fjournal.pone.0043314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=22937031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OitLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=8&author=L.+Liuauthor=H.+Beckauthor=X.+Wangauthor=H.-P.+Hsiehauthor=R.+P.+Masonauthor=X.+Liu&title=Tubulin-Destabilizing+Agent+BPR0L075+Induces+Vascular-Disruption+in+Human+Breast+Cancer+Mammary+Fat+Pad+Xenografts&doi=10.1371%2Fjournal.pone.0043314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts</span></div><div class="casAuthors">Liu, Li; Beck, Haley; Wang, Xiaolei; Hsieh, Hsing-Pang; Mason, Ralph P.; Liu, Xinli</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43314</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">BPR0L075, 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole, is a tubulin-binding agent that inhibits tubulin polymn. by binding to the colchicine-binding site.  BPR0L075 has shown antimitotic and antiangiogenic activity in vitro.  The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging.  A single dose of BPR0L075 (50 mg/kg, i.p. ) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 h); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate.  A time-dependent redn. of tumor perfusion after BPR0L075 treatment was confirmed by immunohistol. staining of the perfusion marker Hoechst 33342 and tumor vasculature marker CD31.  The vasculature showed distinct recovery within 24 h post therapy.  A single i.p. injection of 50 mg/kg of BPR0L075 initially produced plasma concns. in the micromolar range within 6 h, but subsequent drug distribution and elimination caused BPR0L075 plasma levels to drop rapidly into the nanomolar range within 24 h.  Tests with human umbilical vein endothelial (HUVEC) cells and tumor cells in culture showed that BPR0L075 was cytotoxic to both tumor cells and proliferating endothelial cells, and disrupted pre-established vessels in vitro and ex vivo.  In conclusion, BPR0L075 caused rapid, albeit, temporary tumor vascular shutdown and led to redn. of tumor perfusion in orthotopic human breast cancer xenografts, suggesting that this antimitotic agent may be useful as a vascular-disrupting cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8_uwLYMl_9bVg90H21EOLACvtfcHk0liprtd6Qrgcxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OitLnM&md5=e4a834ac3a0145ae932b2718b8bf8e05</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043314%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHsieh%26aufirst%3DH.-P.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DTubulin-Destabilizing%2520Agent%2520BPR0L075%2520Induces%2520Vascular-Disruption%2520in%2520Human%2520Breast%2520Cancer%2520Mammary%2520Fat%2520Pad%2520Xenografts%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D8%26doi%3D10.1371%2Fjournal.pone.0043314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasolofonjatovo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provot, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wdzieczak-Bakala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desravines, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brion, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alami, M.</span></span> <span> </span><span class="NLM_article-title">Conformationally Restricted Naphthalene Derivatives Type Isocombretastatin A-4 and Isoerianin Analogues: Synthesis, Cytotoxicity and Antitubulin Activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ejmech.2012.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=22449653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlSlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=22-32&author=E.+Rasolofonjatovoauthor=O.+Provotauthor=A.+Hamzeauthor=J.+Rodrigoauthor=J.+Bignonauthor=J.+Wdzieczak-Bakalaauthor=D.+Desravinesauthor=J.+Duboisauthor=J.-D.+Brionauthor=M.+Alami&title=Conformationally+Restricted+Naphthalene+Derivatives+Type+Isocombretastatin+A-4+and+Isoerianin+Analogues%3A+Synthesis%2C+Cytotoxicity+and+Antitubulin+Activity&doi=10.1016%2Fj.ejmech.2012.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity</span></div><div class="casAuthors">Rasolofonjatovo, Evelia; Provot, Olivier; Hamze, Abdallah; Rodrigo, Jordi; Bignon, Jerome; Wdzieczak-Bakala, Joanna; Desravines, Deborah; Dubois, Joelle; Brion, Jean-Daniel; Alami, Mouad</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A novel series of dihydronaphthalene, tetrahydronaphthalene and naphthalene derivs. as restricted analogs of isoCA-4 were designed, synthesized and evaluated for their anticancer properties.  For example, 5-bromo-6-methoxytetralone reacted with 4-methylbenzenesulfonohydrazide to give hydrazide I, which reacted with 3,4,5-trimethoxyiodobenzene to give aryl deriv. II.  High cell growth inhibition against four tumor cell lines was obsd. at a nanomolar level with dihydronaphthalenes III (R1 = R2 = R3 = OMe, R4 = NH2, OH; R1 = R3 = OMe, R2 = H, R4 = OH), tetrahydronaphthalene IV and naphthalene V.  Structure-activity relationships are also considered.  These compds. exhibited a significant inhibitory activity toward tubulin polymn. (IC50 = 2-3 μM), comparable to that of isoCA-4.  The effect of the lead compds. III (R1 = R2 = R3 = OMe, R4 = OH) and IV on the cancer cells tested was assocd. with cell cycle arrest in the G2/M phase.  Docking studies reveal that these compds. showed a binding mode similar to those obsd. with their non-constraint isoCA-4 and isoerianin congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcGLzOhJXnYbVg90H21EOLACvtfcHk0liprtd6Qrgcxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlSlu7c%253D&md5=a9b641ea4bd1369c606683584701ee66</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DRasolofonjatovo%26aufirst%3DE.%26aulast%3DProvot%26aufirst%3DO.%26aulast%3DHamze%26aufirst%3DA.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DBignon%26aufirst%3DJ.%26aulast%3DWdzieczak-Bakala%26aufirst%3DJ.%26aulast%3DDesravines%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DBrion%26aufirst%3DJ.-D.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DConformationally%2520Restricted%2520Naphthalene%2520Derivatives%2520Type%2520Isocombretastatin%2520A-4%2520and%2520Isoerianin%2520Analogues%253A%2520Synthesis%252C%2520Cytotoxicity%2520and%2520Antitubulin%2520Activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D22%26epage%3D32%26doi%3D10.1016%2Fj.ejmech.2012.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasolofonjatovo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provot, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wdzieczak-Bakala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desravines, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brion, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alami, M.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Anticancer Properties of 5-Arylbenzoxepins as Conformationally Restricted Isocombretastatin A-4 Analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ejmech.2012.12.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23353744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslWmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=28-39&author=E.+Rasolofonjatovoauthor=O.+Provotauthor=A.+Hamzeauthor=J.+Rodrigoauthor=J.+Bignonauthor=J.+Wdzieczak-Bakalaauthor=C.+Lenoirauthor=D.+Desravinesauthor=J.+Duboisauthor=J.-D.+Brionauthor=M.+Alami&title=Design%2C+Synthesis+and+Anticancer+Properties+of+5-Arylbenzoxepins+as+Conformationally+Restricted+Isocombretastatin+A-4+Analogs&doi=10.1016%2Fj.ejmech.2012.12.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs</span></div><div class="casAuthors">Rasolofonjatovo, Evelia; Provot, Olivier; Hamze, Abdallah; Rodrigo, Jordi; Bignon, Jerome; Wdzieczak-Bakala, Joanna; Lenoir, Christine; Desravines, Deborah; Dubois, Joelle; Brion, Jean-Daniel; Alami, Mouad</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel benzoxepins was designed and prepd. as rigid-isoCA-4 analogs according to a convergent strategy using the coupling of N-tosylhydrazones with aryl iodides under palladium catalysis.  The most potent compd., having the greatest resemblance to CA-4 and isoCA-4 displayed antiproliferative activity at nanomolar concns. against various cancer cell lines and inhibited tubulin assembly at a micromolar range.  In addn., said benzoxepin led to the arrest of HCT116, K562, H1299 and MDA-MB231 cancer cell lines in the G2/M phase of the cell cycle, and strongly induced apoptosis at low concns.  Docking studies demonstrated that said benzoxepin adopts an orientation similar to that of isoCA-4 at the colchicine binding site on β-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7-_vjI4pOqbVg90H21EOLACvtfcHk0liaxt4sWpnX0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslWmsLk%253D&md5=a83cb8c450092a6e92d972f717d3afe3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DRasolofonjatovo%26aufirst%3DE.%26aulast%3DProvot%26aufirst%3DO.%26aulast%3DHamze%26aufirst%3DA.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DBignon%26aufirst%3DJ.%26aulast%3DWdzieczak-Bakala%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DC.%26aulast%3DDesravines%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DBrion%26aufirst%3DJ.-D.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Anticancer%2520Properties%2520of%25205-Arylbenzoxepins%2520as%2520Conformationally%2520Restricted%2520Isocombretastatin%2520A-4%2520Analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D28%26epage%3D39%26doi%3D10.1016%2Fj.ejmech.2012.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maderna, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3-Methoxy-9-(3,4,5-Trimethoxyphenyl)-6,7-Dihydro-5H-Benzo[7]Annulen-4-Ol, a Potent Antineoplastic Benzosuberene Derivative for Anti-Cancer Chemotherapy</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.10.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.tetlet.2011.10.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOqur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=64-66&issue=1&author=Z.+Chenauthor=C.+J.+O%E2%80%99Donnellauthor=A.+Maderna&title=Synthesis+of+3-Methoxy-9-%283%2C4%2C5-Trimethoxyphenyl%29-6%2C7-Dihydro-5H-Benzo%5B7%5DAnnulen-4-Ol%2C+a+Potent+Antineoplastic+Benzosuberene+Derivative+for+Anti-Cancer+Chemotherapy&doi=10.1016%2Fj.tetlet.2011.10.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulen-4-ol, a potent antineoplastic benzosuberene derivative for anti-cancer chemotherapy</span></div><div class="casAuthors">Chen, Zecheng; O'Donnell, Christopher J.; Maderna, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-66</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Benzosuberene (I) is a tubulin polymn. inhibitor that possesses remarkable potency against a variety of cancer cell lines.  Herein, an efficient synthetic route for I is described featuring a Claisen rearrangement/RCM sequence and a late stage Suzuki coupling as the key steps.  By adopting this strategy, I was synthesized in eight steps in 18% overall yield starting from known compd. II..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCJZMvcDukY7Vg90H21EOLACvtfcHk0lh1yNhlLlVkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOqur3L&md5=2dafe10dc4c48db96cd78a1a1386f7f7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.10.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.10.145%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DMaderna%26aufirst%3DA.%26atitle%3DSynthesis%2520of%25203-Methoxy-9-%25283%252C4%252C5-Trimethoxyphenyl%2529-6%252C7-Dihydro-5H-Benzo%255B7%255DAnnulen-4-Ol%252C%2520a%2520Potent%2520Antineoplastic%2520Benzosuberene%2520Derivative%2520for%2520Anti-Cancer%2520Chemotherapy%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26issue%3D1%26spage%3D64%26epage%3D66%26doi%3D10.1016%2Fj.tetlet.2011.10.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maderna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukuru, S. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenaar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loganzo, F.</span></span> <span> </span><span class="NLM_article-title">New Cytotoxic Benzosuberene Analogs. Synthesis, Molecular Modeling and Biological Evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6688</span>– <span class="NLM_lpage">6694</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmcl.2013.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=24210503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslygtLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6688-6694&issue=24&author=Z.+Chenauthor=A.+Madernaauthor=S.+C.+K.+Sukuruauthor=M.+Wagenaarauthor=C.+J.+O%E2%80%99Donnellauthor=M.-H.+Lamauthor=S.+Mustoauthor=F.+Loganzo&title=New+Cytotoxic+Benzosuberene+Analogs.+Synthesis%2C+Molecular+Modeling+and+Biological+Evaluation&doi=10.1016%2Fj.bmcl.2013.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">New cytotoxic benzosuberene analogs. Synthesis, molecular modeling and biological evaluation</span></div><div class="casAuthors">Chen, Zecheng; Maderna, Andreas; Sukuru, Sai Chetan K.; Wagenaar, Melissa; O'Donnell, Christopher J.; Lam, My-Hanh; Musto, Sylvia; Loganzo, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6688-6694</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this Letter we describe the synthesis and biol. evaluation of new benzosuberene analogs with structural modifications on the B-ring.  The focus was initially to probe the chem. space around the B-ring C-8 position.  This position was readily available for derivatization chem. using our recently developed new synthesis for this compd. class.  Furthermore, we describe two new B-ring analogs, one contg. a diene (I) and the other a cyclic ether group (II).  Both new analogs show excellent potencies in tumor cell proliferation assays.  In addn., we describe mol. modeling studies that provide a binding rationale for ref. compd. III in the colchicine binding site using the known colchicine crystal structure.  We also examine whether the cell based potency data obtained with selected new analogs are supported by modeling results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzvfobg2qzdLVg90H21EOLACvtfcHk0lh1yNhlLlVkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslygtLnK&md5=252f4f0b77829112d7d0c95ee9558875</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSukuru%26aufirst%3DS.%2BC.%2BK.%26aulast%3DWagenaar%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DLam%26aufirst%3DM.-H.%26aulast%3DMusto%26aufirst%3DS.%26aulast%3DLoganzo%26aufirst%3DF.%26atitle%3DNew%2520Cytotoxic%2520Benzosuberene%2520Analogs.%2520Synthesis%252C%2520Molecular%2520Modeling%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6688%26epage%3D6694%26doi%3D10.1016%2Fj.bmcl.2013.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aprile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrigoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torretta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massarotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canonico, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genazzani, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Combretabenzodiazepines: A Novel Class of Anti-Tubulin Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1357</span>, <span class="refDoi"> DOI: 10.1021/jm5016389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5016389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1345-1357&issue=3&author=U.+Galliauthor=C.+Travelliauthor=S.+Aprileauthor=E.+Arrigoniauthor=S.+Torrettaauthor=G.+Grosaauthor=A.+Massarottiauthor=G.+Sorbaauthor=P.+L.+Canonicoauthor=A.+A.+Genazzaniauthor=G.+C.+Tron&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Combretabenzodiazepines%3A+A+Novel+Class+of+Anti-Tubulin+Agents&doi=10.1021%2Fjm5016389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Combretabenzodiazepines: A Novel Class of Anti-Tubulin Agents</span></div><div class="casAuthors">Galli, Ubaldina; Travelli, Cristina; Aprile, Silvio; Arrigoni, Elena; Torretta, Simone; Grosa, Giorgio; Massarotti, Alberto; Sorba, Giovanni; Canonico, Pier Luigi; Genazzani, Armando A.; Tron, Gian Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1345-1357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present manuscript, starting from the 1,4-benzodiazepin-2-one nucleus, a privileged structure in medicinal chem., we have synthesized a novel class of cis-locked combretastatins named combretabenzodiazepines, e.g., I.  They show similar cytotoxic and antitubulin activity compared to combretastatin (II) in neuroblastoma cells, showing a better pharmacokinetic profile.  This class of compds. has therefore the potential for further development as antitubulin agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_iCDQpOw2bVg90H21EOLACvtfcHk0lhI9sfybGthhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVCquw%253D%253D&md5=9de30ca5f71f2fe2553f48c75e1098c1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm5016389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5016389%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DAprile%26aufirst%3DS.%26aulast%3DArrigoni%26aufirst%3DE.%26aulast%3DTorretta%26aufirst%3DS.%26aulast%3DGrosa%26aufirst%3DG.%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Combretabenzodiazepines%253A%2520A%2520Novel%2520Class%2520of%2520Anti-Tubulin%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D3%26spage%3D1345%26epage%3D1357%26doi%3D10.1021%2Fjm5016389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prileschajew, N.</span></span> <span> </span><span class="NLM_article-title">Oxydation Ungesättigter Verbindungen Mittels Organischer Superoxyde</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1909</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">4811</span>– <span class="NLM_lpage">4815</span>, <span class="refDoi"> DOI: 10.1002/cber.190904204100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcber.190904204100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaD28XnvFc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1909&pages=4811-4815&issue=4&author=N.+Prileschajew&title=Oxydation+Unges%C3%A4ttigter+Verbindungen+Mittels+Organischer+Superoxyde&doi=10.1002%2Fcber.190904204100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of unsaturated compounds using organic peroxides</span></div><div class="casAuthors">Prileschajew, Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft</span>
        (<span class="NLM_cas:date">1909</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4811-4815</span>CODEN:
                <span class="NLM_cas:coden">BDCGAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-9496</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Hf7QY-aLk7Vg90H21EOLACvtfcHk0ljSCNkKq3Xk9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaD28XnvFc%253D&md5=33ecf61ff5ad182826bda34fea01103c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fcber.190904204100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.190904204100%26sid%3Dliteratum%253Aachs%26aulast%3DPrileschajew%26aufirst%3DN.%26atitle%3DOxydation%2520Unges%25C3%25A4ttigter%2520Verbindungen%2520Mittels%2520Organischer%2520Superoxyde%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1909%26volume%3D42%26issue%3D4%26spage%3D4811%26epage%3D4815%26doi%3D10.1002%2Fcber.190904204100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanRheenen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. Y.</span></span> <span> </span><span class="NLM_article-title">An Improved Catalytic OsO4 Oxidation of Olefins to Cis-1,2-Glycols Using Tertiary Amine Oxides as the Oxidant</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)78093-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2FS0040-4039%2800%2978093-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1976&pages=1973-1976&issue=23&author=V.+VanRheenenauthor=R.+C.+Kellyauthor=D.+Y.+Cha&title=An+Improved+Catalytic+OsO4+Oxidation+of+Olefins+to+Cis-1%2C2-Glycols+Using+Tertiary+Amine+Oxides+as+the+Oxidant&doi=10.1016%2FS0040-4039%2800%2978093-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2978093-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252978093-2%26sid%3Dliteratum%253Aachs%26aulast%3DVanRheenen%26aufirst%3DV.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DCha%26aufirst%3DD.%2BY.%26atitle%3DAn%2520Improved%2520Catalytic%2520OsO4%2520Oxidation%2520of%2520Olefins%2520to%2520Cis-1%252C2-Glycols%2520Using%2520Tertiary%2520Amine%2520Oxides%2520as%2520the%2520Oxidant%26jtitle%3DTetrahedron%2520Lett.%26date%3D1976%26volume%3D17%26issue%3D23%26spage%3D1973%26epage%3D1976%26doi%3D10.1016%2FS0040-4039%2800%2978093-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustowski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echegoyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokel, G. W.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Switching in Anthraquinone-Substituted Carbon-Pivot Lariat Ethers and Podands: Chain Length Effects in Geometric and Electronic Cooperativity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7553</span>– <span class="NLM_lpage">7560</span>, <span class="refDoi"> DOI: 10.1021/ja00284a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00284a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL2sXjt1Wquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=1986&pages=7553-7560&issue=24&author=D.+A.+Gustowskiauthor=M.+Delgadoauthor=V.+J.+Gattoauthor=L.+Echegoyenauthor=G.+W.+Gokel&title=Electrochemical+Switching+in+Anthraquinone-Substituted+Carbon-Pivot+Lariat+Ethers+and+Podands%3A+Chain+Length+Effects+in+Geometric+and+Electronic+Cooperativity&doi=10.1021%2Fja00284a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical switching in anthraquinone-substituted carbon-pivot lariat ethers and podands:  chain length effects in geometric and electronic cooperativity</span></div><div class="casAuthors">Gustowski, Deborah A.; Delgado, Milagros; Gatto, Vincent J.; Echegoyen, Luis; Gokel, George W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7553-60</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The complex electrochem. behavior, detd. by cyclic voltammetry for 1- and 2-electron time-resolved redox couples for the title 9,10-anthraquinon-1-yl podands I [R = MeO; (OCH2CH2)nMe, n = 2, 3, 5] and II and the C-pivot lariat crownether III in systems contg. 0-1.0 equiv Li+, Na+, or K+, are due to a combination of electronic and steric factors.  I, II, and III are prepd., most often, by nucleophilic arom. substitution of I (R = Cl).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCbtXkIWHvkLVg90H21EOLACvtfcHk0ljYkk00YytgRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXjt1Wquw%253D%253D&md5=c08407be23b6a5a8ee2256982470e7bd</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fja00284a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00284a019%26sid%3Dliteratum%253Aachs%26aulast%3DGustowski%26aufirst%3DD.%2BA.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGatto%26aufirst%3DV.%2BJ.%26aulast%3DEchegoyen%26aufirst%3DL.%26aulast%3DGokel%26aufirst%3DG.%2BW.%26atitle%3DElectrochemical%2520Switching%2520in%2520Anthraquinone-Substituted%2520Carbon-Pivot%2520Lariat%2520Ethers%2520and%2520Podands%253A%2520Chain%2520Length%2520Effects%2520in%2520Geometric%2520and%2520Electronic%2520Cooperativity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1986%26volume%3D108%26issue%3D24%26spage%3D7553%26epage%3D7560%26doi%3D10.1021%2Fja00284a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandmeyer, T.</span></span> <span> </span><span class="NLM_article-title">Ueber Die Ersetzung Der Amidgruppe Durch Chlor in Den Aromatischen Substanzen</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1884</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1633</span>– <span class="NLM_lpage">1635</span>, <span class="refDoi"> DOI: 10.1002/cber.18840170219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcber.18840170219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1884&pages=1633-1635&issue=2&author=T.+Sandmeyer&title=Ueber+Die+Ersetzung+Der+Amidgruppe+Durch+Chlor+in+Den+Aromatischen+Substanzen&doi=10.1002%2Fcber.18840170219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fcber.18840170219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.18840170219%26sid%3Dliteratum%253Aachs%26aulast%3DSandmeyer%26aufirst%3DT.%26atitle%3DUeber%2520Die%2520Ersetzung%2520Der%2520Amidgruppe%2520Durch%2520Chlor%2520in%2520Den%2520Aromatischen%2520Substanzen%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1884%26volume%3D17%26issue%3D2%26spage%3D1633%26epage%3D1635%26doi%3D10.1002%2Fcber.18840170219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandmeyer, T.</span></span> <span> </span><span class="NLM_article-title">Ueber Die Ersetzung Der Amid-gruppe Durch Chlor, Brom Und Cyan in Den Aromatischen Substanzen</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1884</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2650</span>– <span class="NLM_lpage">2653</span>, <span class="refDoi"> DOI: 10.1002/cber.188401702202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcber.188401702202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1884&pages=2650-2653&issue=2&author=T.+Sandmeyer&title=Ueber+Die+Ersetzung+Der+Amid-gruppe+Durch+Chlor%2C+Brom+Und+Cyan+in+Den+Aromatischen+Substanzen&doi=10.1002%2Fcber.188401702202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fcber.188401702202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.188401702202%26sid%3Dliteratum%253Aachs%26aulast%3DSandmeyer%26aufirst%3DT.%26atitle%3DUeber%2520Die%2520Ersetzung%2520Der%2520Amid-gruppe%2520Durch%2520Chlor%252C%2520Brom%2520Und%2520Cyan%2520in%2520Den%2520Aromatischen%2520Substanzen%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1884%26volume%3D17%26issue%3D2%26spage%3D2650%26epage%3D2653%26doi%3D10.1002%2Fcber.188401702202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizusaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Hydrogenation Method Catalyzed by Pd/C Using Diphenylsulfide as a Reasonable Catalyst Poison</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">11925</span>– <span class="NLM_lpage">11932</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.09.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.tet.2006.09.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyqurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=11925-11932&issue=51&author=A.+Moriauthor=T.+Mizusakiauthor=Y.+Miyakawaauthor=E.+Ohashiauthor=T.+Hagaauthor=T.+Maegawaauthor=Y.+Monguchiauthor=H.+Sajiki&title=Chemoselective+Hydrogenation+Method+Catalyzed+by+Pd%2FC+Using+Diphenylsulfide+as+a+Reasonable+Catalyst+Poison&doi=10.1016%2Fj.tet.2006.09.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective hydrogenation method catalyzed by Pd/C using diphenylsulfide as a reasonable catalyst poison</span></div><div class="casAuthors">Mori, Akinori; Mizusaki, Tomoteru; Miyakawa, Yumi; Ohashi, Eri; Haga, Tomoko; Maegawa, Tomohiro; Monguchi, Yasunari; Sajiki, Hironao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">11925-11932</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">While Pd/C is one of the most useful catalysts for hydrogenation, the high catalyst activity of Pd/C causes difficulty in its application to chemoselective hydrogenation between different types of reducible functionalities.  In order to achieve chemoselective hydrogenation using Pd/C, a catalyst poison as a controller of the catalyst activity has been investigated.  It was found that the addn. of Ph2S (diphenylsulfide) to the Pd/C-catalyzed hydrogenation reaction mixt. led to reasonable deactivation of Pd/C.  By the use of the Pd/C-Ph2S catalytic system, olefins, acetylenes, and azides could be selectively reduced in the coexistence of arom. carbonyls, arom. halides, cyano groups, benzyl esters, and N-Cbz (benzyloxycarbonyl) protecting groups.  This method was promising as a general and practical chemoselective hydrogenation process in synthetic org. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgHK6eKLfUBLVg90H21EOLACvtfcHk0ljvE332MKP8Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyqurjK&md5=98517ac70b810b4b90e7c03dd29a2ecc</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.09.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.09.094%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DA.%26aulast%3DMizusaki%26aufirst%3DT.%26aulast%3DMiyakawa%26aufirst%3DY.%26aulast%3DOhashi%26aufirst%3DE.%26aulast%3DHaga%26aufirst%3DT.%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DMonguchi%26aufirst%3DY.%26aulast%3DSajiki%26aufirst%3DH.%26atitle%3DChemoselective%2520Hydrogenation%2520Method%2520Catalyzed%2520by%2520Pd%252FC%2520Using%2520Diphenylsulfide%2520as%2520a%2520Reasonable%2520Catalyst%2520Poison%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26issue%3D51%26spage%3D11925%26epage%3D11932%26doi%3D10.1016%2Fj.tet.2006.09.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span> <span> </span><span class="NLM_article-title">Phosphorus Pentoxide-Methanesulfonic Acid. Convenient Alternative to Polyphosphoric Acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">4071</span>– <span class="NLM_lpage">4073</span>, <span class="refDoi"> DOI: 10.1021/jo00987a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00987a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaE2cXhsVKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=4071-4073&author=P.+E.+Eatonauthor=G.+R.+Carlsonauthor=J.+T.+Lee&title=Phosphorus+Pentoxide-Methanesulfonic+Acid.+Convenient+Alternative+to+Polyphosphoric+Acid&doi=10.1021%2Fjo00987a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorus pentoxide-methanesulfonic acid.  Convenient alternative to polyphosphoric acid</span></div><div class="casAuthors">Eaton, Philip E.; Carlson, Glenn R.; Lee, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4071-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A new reagent composed of a 1:10 mixture by wt. of P2O5 in Me-SO3H is suggested as an attractive alternative to polyphosphoric acid (PPA).  Product yields in the prepn. of cyclopentenones via the intramol. acylation of γ-lactones and in the prepn. of amides via the Beckmann rearrangement compare favorably with the best yields reported for the same transformations done in PPA.  The new reagent is very much more convenient to handle than PPA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLk_l8be2a_rVg90H21EOLACvtfcHk0lhROH09srzHjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhsVKjtw%253D%253D&md5=791196ffff70d569aa58cee82279660c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjo00987a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00987a028%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DP.%2BE.%26aulast%3DCarlson%26aufirst%3DG.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26atitle%3DPhosphorus%2520Pentoxide-Methanesulfonic%2520Acid.%2520Convenient%2520Alternative%2520to%2520Polyphosphoric%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D4071%26epage%3D4073%26doi%3D10.1021%2Fjo00987a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanis, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moya, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, R. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of the Bioactivity of Simplified Analogs of the Seco-Pseudopterosins; Progress Toward Determining a Pharmacophore</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">10649</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2008.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.tet.2008.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cqsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=10649-10663&issue=47&author=V.+M.+Tanisauthor=C.+Moyaauthor=R.+S.+Jacobsauthor=R.+D.+Little&title=Synthesis+and+Evaluation+of+the+Bioactivity+of+Simplified+Analogs+of+the+Seco-Pseudopterosins%3B+Progress+Toward+Determining+a+Pharmacophore&doi=10.1016%2Fj.tet.2008.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of the bioactivity of simplified analogs of the seco-pseudopterosins; progress toward determining a pharmacophore</span></div><div class="casAuthors">Tanis, Virginia M.; Moya, Claudia; Jacobs, R. S.; Little, R. Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10649-10663</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The pseudopterosins are marine natural products that display significant anti-inflammatory and wound healing properties.  We describe the synthesis of six structural analogs of the seco-pseudopterosin-like core that are devoid of all but one of the stereocenters found in the carbocyclic core of the natural products.  Our targets were selected in an attempt to identify the minimal pharmacophore for the pseudopterosins and their seco analogs.  A deliberate effort was made to utilize a conservative synthetic approach based upon the use of well-established reactions, which enabled us to develop routes that proved to be efficient, practical, and easy to implement.  The results of several bioassays, including an assessment of the ability to inhibit phagocytosis and to competitively bind to the adenosine receptor A2A, demonstrate that greatly simplified structural analogs of the pseudopterosins and their seco forms are capable of maintaining several of the important bioactivities that characterize the natural products, and do so with comparable efficacy.  Those systems bearing two rather than one oxygen atom appended directly to the arom. ring are the more effective binding agents.  This observation may provide a significant clue regarding the key structural features of the minimal pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofwZSHGfLNqrVg90H21EOLACvtfcHk0ljRiIXkIWDc8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cqsr7M&md5=1dc03ee84cc66d8db737842770664516</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2008.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2008.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DTanis%26aufirst%3DV.%2BM.%26aulast%3DMoya%26aufirst%3DC.%26aulast%3DJacobs%26aufirst%3DR.%2BS.%26aulast%3DLittle%26aufirst%3DR.%2BD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520the%2520Bioactivity%2520of%2520Simplified%2520Analogs%2520of%2520the%2520Seco-Pseudopterosins%253B%2520Progress%2520Toward%2520Determining%2520a%2520Pharmacophore%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26issue%3D47%26spage%3D10649%26epage%3D10663%26doi%3D10.1016%2Fj.tet.2008.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Xiao, Y.</span>; <span class="NLM_string-name">He, H.</span>; <span class="NLM_string-name">Zheng</span>; ; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">Fast Synthetic Route for 3-Aryl Substituted Propanoic Acid</span>. <span class="NLM_patent">CN 101747171 A</span>, December 17, <span class="NLM_year">2008</span>; WuXi AppTec.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=W.+Lin&author=Q.+Wang&author=Y.+Xiao&author=H.+He&author=+Zheng&author=X.+Chen&author=S.+Chen&title=Fast+Synthetic+Route+for+3-Aryl+Substituted+Propanoic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%26atitle%3DFast%2520Synthetic%2520Route%2520for%25203-Aryl%2520Substituted%2520Propanoic%2520Acid%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirataki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniliuc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">GluN2B-Selective N-Methyl-d-aspartate (NMDA) Receptor Antagonists Derived from 3-Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7]Annulen-7-amines</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcmdc.201300547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=24677663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFajtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=741-751&issue=4&author=A.+Bennerauthor=A.+Bonifaziauthor=C.+Shiratakiauthor=L.+Temmeauthor=D.+Schepmannauthor=W.+Quagliaauthor=O.+Shojiauthor=Y.+Watanabeauthor=C.+Daniliucauthor=B.+W%C3%BCnsch&title=GluN2B-Selective+N-Methyl-d-aspartate+%28NMDA%29+Receptor+Antagonists+Derived+from+3-Benzazepines%3A+Synthesis+and+Pharmacological+Evaluation+of+Benzo%5B7%5DAnnulen-7-amines&doi=10.1002%2Fcmdc.201300547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2B-Selective N-Methyl-D-aspartate (NMDA) Receptor Antagonists Derived from 3-Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7]annulen-7-amines</span></div><div class="casAuthors">Benner, Andre; Bonifazi, Alessandro; Shirataki, Chikako; Temme, Louisa; Schepmann, Dirk; Quaglia, Wilma; Shoji, Osami; Watanabe, Yoshihito; Daniliuc, Constantin; Wuensch, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-751</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Given their high neuroprotective potential, ligands that block GluN2B-contg. N-methyl-D-aspartate (NMDA) receptors by interacting with the ifenprodil binding site located on the GluN2B subunit are of great interest for the treatment of various neuronal disorders.  In this study, a novel class of GluN2B-selective NMDA receptor antagonists with a benzo[7]annulene scaffold was prepd. and pharmacol. evaluated.  A key intermediate, N-(2-methoxy-5-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl)acetamide, was obtained by cyclization of 3-acetamido-5-(3-methoxyphenyl)pentanoic acid.  The final reaction steps comprise hydrolysis of an amide, redn. of a ketone and reductive alkylation, leading to cis- and trans-configured 7-(ω-phenylalkylamino)benzo[7]annulen-5-ol derivs.  High GluN2B affinity was obsd. with cis-configured γ-amino alcs. substituted with a 3-phenylpropyl moiety at the amino group.  Removal of the benzylic hydroxy moiety led to the most potent GluN2B antagonists of this series: 2-methoxy-N-(3-phenylpropyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-amine (Ki=10 nM) and 2-methoxy-N-methyl-N-(3-phenylpropyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-amine (Ki=7.9 nM).  The selectivity over related receptors (phencyclidine binding site of the NMDA receptor, σ1 and σ2 receptors) was recorded.  In a functional assay measuring the cytoprotective activity of the benzo[7]annulenamines, all tested compds. showed potent NMDA receptor antagonistic activity.  Cytotoxicity induced by GluN2A-subunit-contg. NMDA receptors was not inhibited by the new ligands.  The synthesis of the target compds. was achieved by a reaction of 6,7,8,9-tetrahydro-2-methoxy-5H-benzocyclohepten-5-ol with benzenepropanal or benzenebutanal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GFQ04B0qTrVg90H21EOLACvtfcHk0lirjFVoT6ph8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFajtrw%253D&md5=bdb1858368424ee6507869a3c9131fb7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300547%26sid%3Dliteratum%253Aachs%26aulast%3DBenner%26aufirst%3DA.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DShirataki%26aufirst%3DC.%26aulast%3DTemme%26aufirst%3DL.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DShoji%26aufirst%3DO.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DDaniliuc%26aufirst%3DC.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DGluN2B-Selective%2520N-Methyl-d-aspartate%2520%2528NMDA%2529%2520Receptor%2520Antagonists%2520Derived%2520from%25203-Benzazepines%253A%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Benzo%255B7%255DAnnulen-7-amines%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D741%26epage%3D751%26doi%3D10.1002%2Fcmdc.201300547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. J.</span>; <span class="NLM_string-name">Sha, R.</span>; <span class="NLM_string-name">McCormack, E. M.</span>; <span class="NLM_string-name">Hudson, G. J.</span>; <span class="NLM_string-name">White, M.</span>; <span class="NLM_string-name">Stack, G.
D.</span>; <span class="NLM_string-name">Moran, B.
W.</span>; <span class="NLM_string-name">Coogan, A.</span>; <span class="NLM_string-name">Breen, E. C.</span></span> <span> </span><span class="NLM_article-title">Tubulin Binding Agents</span>. <span class="NLM_patent">US20150018566A1</span>, August 27, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+J.+Walsh&author=R.+Sha&author=E.+M.+McCormack&author=G.+J.+Hudson&author=M.+White&author=G.%0AD.+Stack&author=B.%0AW.+Moran&author=A.+Coogan&author=E.+C.+Breen&title=Tubulin+Binding+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DJ.%2BJ.%26atitle%3DTubulin%2520Binding%2520Agents%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, L. A.</span></span> <span> </span><span class="NLM_article-title">The Preparation of Methylcopper and Some Observations on the Decomposition of Organocopper Compounds</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1630</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1021/jo50012a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo50012a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaG2cXmvFyq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1952&pages=1630-1634&issue=12&author=H.+Gilmanauthor=R.+G.+Jonesauthor=L.+A.+Woods&title=The+Preparation+of+Methylcopper+and+Some+Observations+on+the+Decomposition+of+Organocopper+Compounds&doi=10.1021%2Fjo50012a009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Relative reactivities of organometallic compounds. LXXI. The preparation of methylcopper and some observations on the decomposition of organocopper compounds</span></div><div class="casAuthors">Gilman, Henry; Jones, Reuben G.; Woods, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1630-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">cf. C.A. 46, 3974g.  Stirring 0.03 mole MgMe2 and 0.05 mole CuI in ether 3 hrs. at -15° and washing the ppt. with ether give a yellow CuMe which, heated in ether, gives a gas contg. 0.0137 mole C2H6 and 0.0057 mole CuMe.  CuMe when dried and exposed to the air explodes violently and the isolation of large amts. is dangerous.  Adding (1.5 hrs.) 0.028 mole LiMe in 22 cc. ether to 0.025 mole CuCNS in 50 cc. ether at -15° gives a yellow ppt. which changes to reddish brown at 0° and decomp. at 20°, giving a gas contg. 87% C2H6 and 12% CH4.  Adding (1 hr.) 0.05 mole LiMe in 40 cc. ether to 4.77 g. CuI in 50 cc. ether at -15° gives a colorless soln. which gives a strong Michler ketone color test.  Treating 0.005 mole CuCl in 25 cc. ether and 7.63 g. EtBr with 0.07 mole EtMgBr in 45 cc. ether gives 0.059 mole C2H6 and 0.0589 mole C2H4.  Adding (15 min.) 15.7 g. EtBr in 25 cc. ether to 1 g. Mg-Cu alloy (12.75% Cu) in 25 cc. ether with stirring and refluxing the mixt. 0.5 hr. give 0.0312 mole C2H6 and 0.0262 mole C2H4.  Adding 0.72 mole EtMgBr in 50 cc. ether to the reaction mixt. (which contained 0.072 mole EtBr) and refluxing it 6 hrs. give 0.077 mole C2H6 and 0.0665 mole C2H4.  Treating 0.5 g. CuI in 25 cc. ether and 7.9 g. MeI with 0.055 mole MgMe2 in 50 cc. ether and refluxing the mixt. give CuMe which slowly decomp. at 35°, giving 0.0265 mole C2H6 and 0.0057 mole CH4 after 16 hrs.  Refluxing the washed (ether) Cu (obtained from 3.04 g. CuCNS and LiMe) with 7.75 g. MeI in 25 cc. ether 24 hrs. causes no evolution of gas.  Adding 0.054 mole LiMe in 45 cc. ether gives a gas contg. 0.0052 mole C2H6 and 0.005 mole CH4.  Refluxing 0.089 mole EtMgBr in 50 cc. ether with 1.2 g. CuCl2 in 15 cc. ether and 11 g. PhBr 3 hrs. gives 37.8% C2H6 and 60% C2H4.  In a similar expt. with FeCl3 in lieu of CuCl2 47% C2H6 and 58% C2H4 are formed.  Adding (25 min.) 0.055 mole PhLi in 70 cc. ether to 9.5 g. CuI in 75 cc. ether at -12°, stirring the mixt. 10 min. at -5°, then adding (25 min.) 20.7 g. BzCH:CHPh in 75 cc. ether at -5°, stirring the mixt. 0.5 hr. at -5° and 1 hr. at 20°, and decompg. with NH4Cl gives 69.3% β-phenyl-γ-benzoyl-γ-benzhydrylbutyrophenone, m. 178.5-80.5°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtQYzX8vjcV7Vg90H21EOLACvtfcHk0lhsAdLh07JN3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXmvFyq&md5=f33576f7ba7d239697d36a9994eda989</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjo50012a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo50012a009%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DR.%2BG.%26aulast%3DWoods%26aufirst%3DL.%2BA.%26atitle%3DThe%2520Preparation%2520of%2520Methylcopper%2520and%2520Some%2520Observations%2520on%2520the%2520Decomposition%2520of%2520Organocopper%2520Compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1952%26volume%3D17%26issue%3D12%26spage%3D1630%26epage%3D1634%26doi%3D10.1021%2Fjo50012a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezioso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvardsen, K.</span></span> <span> </span><span class="NLM_article-title">Oxi4503, a Novel Vascular Targeting Agent: Effects on Blood Flow and Antitumor Activity in Comparison to Combretastatin A-4 Phosphate</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">2B</span>),  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12820406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlGmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=1433-1440&issue=2B&author=J.+Huaauthor=Y.+Shengauthor=K.+G.+Pinneyauthor=C.+M.+Garnerauthor=R.+R.+Kaneauthor=J.+A.+Preziosoauthor=G.+R.+Pettitauthor=D.+J.+Chaplinauthor=K.+Edvardsen&title=Oxi4503%2C+a+Novel+Vascular+Targeting+Agent%3A+Effects+on+Blood+Flow+and+Antitumor+Activity+in+Comparison+to+Combretastatin+A-4+Phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate</span></div><div class="casAuthors">Hua, Jianyi; Sheng, Yezhou; Pinney, Kevin G.; Garner, Charles M.; Kane, Robert R.; Prezioso, Joseph A.; Pettit, George R.; Chaplin, David J.; Edvardsen, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2B</span>),
    <span class="NLM_cas:pages">1433-1440</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Oxi 4503, which is the diphosphate prodrug of combretastatin A1, is a novel vascular targeting agent from the combretastatin family.  Another member of this family, Combretastatin A-4 phosphate (CA4P), is a well-characterized vascular targeting agent already being evaluated in clin. trials.  The potential for tumor vascular targeting by Oxi 4503 was assessed in a mouse system.  This approach aims to shut down the established tumor vasculature, leading to the development of extensive tumor cell necrosis.  The vascular effects of Oxi 4503 were assessed in the s.c. implanted MDAMB-231 adenocarcinoma and the MHEC5-T hemangioendothelioma in SCID mice and in a range of normal tissues.  Blood flow was measured by i.v. injection of fluorescence beads, while quant. fluorescence microscopy was used to measure the spatial heterogeneity of blood flow in tumor sections.  Oxi 4503 induced the shutdown of tumor blood vessels in a dose-dependent pattern with an ED50 at 3 mg/kg in contrast to 43 mg/kg of CA4P.  Quant. fluorescence microscopy showed that Oxi 4503 increased the spatial heterogeneity in tumor blood flow.  Oxi 4503 affected peripheral tumor regions less than central regions, although this was not as pronounced as seen with CA4P, where only central regions were affected.  The vascular shutdown induced by administration of Oxi 4503 at a dose of 6 mg/kg resulted in extensive cell loss 24 h following treatment, which translated into a significant effect on tumor growth.  Tumor growth was completely repressed at doses above 12.5 mg/kg of Oxi 4503, while doses above 25 mg/kg showed tumor regression and even complete regression in some animals.  These results are promising for the use of Oxi 4503 as a tumor vascular targeting agent.  Moreover the potent antitumor effect when administered as a single agent suggests a different activity profile than CA4P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTUdnkKOQqFbVg90H21EOLACvtfcHk0lhDZiL-0sV6oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlGmtLg%253D&md5=9d77a06bf6355d0738dd7b66bb5cb81d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DY.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DKane%26aufirst%3DR.%2BR.%26aulast%3DPrezioso%26aufirst%3DJ.%2BA.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DEdvardsen%26aufirst%3DK.%26atitle%3DOxi4503%252C%2520a%2520Novel%2520Vascular%2520Targeting%2520Agent%253A%2520Effects%2520on%2520Blood%2520Flow%2520and%2520Antitumor%2520Activity%2520in%2520Comparison%2520to%2520Combretastatin%2520A-4%2520Phosphate%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26issue%3D2B%26spage%3D1433%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benham, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H.</span></span> <span> </span><span class="NLM_article-title">Alkaline Phosphatase Expression in Human Cell Lines Derived from Various Malignancies</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910270510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fijc.2910270510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=6793524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL3MXkt1amtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1981&pages=637-644&issue=5&author=F.+J.+Benhamauthor=J.+Foghauthor=H.+Harris&title=Alkaline+Phosphatase+Expression+in+Human+Cell+Lines+Derived+from+Various+Malignancies&doi=10.1002%2Fijc.2910270510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Alkaline phosphatase expression in human cell lines derived from various malignancies</span></div><div class="casAuthors">Benham, Frances J.; Fogh, Joergen; Harris, Harry</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-44</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The expression of heat-stable placental-type alk. phosphatase (ALP) was studied in 19 unselected human tumor cell lines, known not to be HeLa.  All cell lines showed measurable ALP activity and in 15 of the lines at least low levels of a heat-stable, presumptively placental-type ALP were detected.  In 5 of these lines where the level of this heat-stable activity was sufficient, further investigation (immunol., inhibition, and electrophoretic studies) demonstrated that this ALP was placental-type and different from liver/bone/kidney or intestinal ALPs.  In 10 lines, the heat-stable activity was too low to allow further characterization.  In 4 lines, no heat-stable activity could be detected.  The thermolabile ALP activity in these various lines was liver/bone/kidney in type.  Apparently, the placental ALP locus may be expressed at least at low levels in a much higher proportion of tumors and tumor cell lines than previously reported.  So-called ectopic synthesis of placental ALP in tumor cells may not necessarily be due to derepression of a structural locus which is completely unexpressed in normal adult tissues.  It may represent an enhancement of expression in malignancy or there may be clonal expansion of a particular cell type which normally expresses the alk. phosphatase at a high level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodtIXkg5ovbrVg90H21EOLACvtfcHk0liqvHcrBOQnYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkt1amtbc%253D&md5=e849e79e8058cdc9cff31ce27e66888c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910270510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910270510%26sid%3Dliteratum%253Aachs%26aulast%3DBenham%26aufirst%3DF.%2BJ.%26aulast%3DFogh%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DH.%26atitle%3DAlkaline%2520Phosphatase%2520Expression%2520in%2520Human%2520Cell%2520Lines%2520Derived%2520from%2520Various%2520Malignancies%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1981%26volume%3D27%26issue%3D5%26spage%3D637%26epage%3D644%26doi%3D10.1002%2Fijc.2910270510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaith, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orriss, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdy, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. M.</span></span> <span> </span><span class="NLM_article-title">Tumour-Derived Alkaline Phosphatase Regulates Tumour Growth, Epithelial Plasticity and Disease-Free Survival in Metastatic Prostate Cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/bjc.2016.402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fbjc.2016.402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=28006818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFOiu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=227-236&issue=2&author=S.+R.+Raoauthor=A.+E.+Snaithauthor=D.+Marinoauthor=X.+Chengauthor=S.+T.+Lwinauthor=I.+R.+Orrissauthor=F.+C.+Hamdyauthor=C.+M.+Edwards&title=Tumour-Derived+Alkaline+Phosphatase+Regulates+Tumour+Growth%2C+Epithelial+Plasticity+and+Disease-Free+Survival+in+Metastatic+Prostate+Cancer&doi=10.1038%2Fbjc.2016.402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer</span></div><div class="casAuthors">Rao, S. R.; Snaith, A. E.; Marino, D.; Cheng, X.; Lwin, S. T.; Orriss, I. R.; Hamdy, F. C.; Edwards, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-236</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Recent evidence suggests that bone-related parameters are the main prognostic factors for overall survival in advanced prostate cancer (PCa), with elevated circulating levels of alk. phosphatase (ALP) thought to reflect the dysregulated bone formation accompanying distant metastases.  We have identified that PCa cells express ALPL, the gene that encodes for tissue nonspecific ALP, and hypothesised that tumor-derived ALPL may contribute to disease progression.  Methods: Functional effects of ALPL inhibition were investigated in metastatic PCa cell lines.  ALPL gene expression was analyzed from published PCa data sets, and correlated with disease-free survival and metastasis.  Results: ALPL expression was increased in PCa cells from metastatic sites.  A redn. in tumor-derived ALPL expression or ALP activity increased cell death, mesenchymal-to-epithelial transition and reduced migration.  Alk. phosphatase activity was decreased by the EMT repressor Snail.  In men with PCa, tumor-derived ALPL correlated with EMT markers, and high ALPL expression was assocd. with a significant redn. in disease-free survival.  Conclusions: Our studies reveal the function of tumor-derived ALPL in regulating cell death and epithelial plasticity, and demonstrate a strong assocn. between ALPL expression in PCa cells and metastasis or disease-free survival, thus identifying tumor-derived ALPL as a major contributor to the pathogenesis of PCa progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPuD1njWZ-NbVg90H21EOLACvtfcHk0lg38iCVCjf4Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFOiu7jO&md5=73aea82569d21ce02ea4fa58feb194d0</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2016.402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2016.402%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%2BR.%26aulast%3DSnaith%26aufirst%3DA.%2BE.%26aulast%3DMarino%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLwin%26aufirst%3DS.%2BT.%26aulast%3DOrriss%26aufirst%3DI.%2BR.%26aulast%3DHamdy%26aufirst%3DF.%2BC.%26aulast%3DEdwards%26aufirst%3DC.%2BM.%26atitle%3DTumour-Derived%2520Alkaline%2520Phosphatase%2520Regulates%2520Tumour%2520Growth%252C%2520Epithelial%2520Plasticity%2520and%2520Disease-Free%2520Survival%2520in%2520Metastatic%2520Prostate%2520Cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26issue%3D2%26spage%3D227%26epage%3D236%26doi%3D10.1038%2Fbjc.2016.402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gangjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risinger, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooberry, S. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Discovery of Water Soluble Microtubule Targeting Agents That Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">8116</span>– <span class="NLM_lpage">8128</span>, <span class="refDoi"> DOI: 10.1021/jm101010n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101010n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlens77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8116-8128&issue=22&author=A.+Gangjeeauthor=Y.+Zhaoauthor=L.+Linauthor=S.+Raghavanauthor=E.+G.+Robertsauthor=A.+L.+Risingerauthor=E.+Hamelauthor=S.+L.+Mooberry&title=Synthesis+and+Discovery+of+Water+Soluble+Microtubule+Targeting+Agents+That+Bind+to+the+Colchicine+Site+on+Tubulin+and+Circumvent+Pgp+Mediated+Resistance&doi=10.1021%2Fjm101010n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance</span></div><div class="casAuthors">Gangjee, Aleem; Zhao, Ying; Lin, Lu; Raghavan, Sudhir; Roberts, Elizabeth G.; Risinger, April L.; Hamel, Ernest; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8116-8128</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two classes of mols. were designed and synthesized based on a 6-CH3 cyclopenta[d]pyrimidine scaffold and a pyrrolo[2,3-d]pyrimidine scaffold.  The pyrrolo[2,3-d]pyrimidines were synthesized by reacting Et 2-cyano-4,4-diethoxybutanoate and acetamidine, which in turn was chlorinated and reacted with the appropriate anilines to afford pyrrolopyrimidines I (R = Me, H).  The cyclopenta[d]pyrimidines were obtained from 3-methyladapic acid, followed by reaction with acetamidine to afford the cyclopenta[d]pyrimidine scaffold.  Chlorination and reaction with appropriate anilines afforded cyclopentapyrimidines, II (R = 4-MeO, 3-MeO, 2-MeO, H).  Pyrimidines I (R = Me)(III) and II (R = 4-MeO)(IV) had potent antiproliferative activities in the nanomolar range.  Cyclopentapyrimidine IV is significantly more potent than pyrrolopyrimidine III.  Mechanistic studies showed that III and IV cause loss of cellular microtubules, inhibit the polymn. of purified tubulin, and inhibit colchicine binding.  Modeling studies show interactions of these compds. within the colchicine site.  The identification of these new inhibitors that can also overcome clin. relevant mechanisms of drug resistance provides new scaffolds for colchicine site agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc5L05H-4Yj7Vg90H21EOLACvtfcHk0ljnlDeO0PS4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlens77M&md5=8a0bd50260d069a868762389f24d5399</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm101010n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101010n%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DE.%2BG.%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DSynthesis%2520and%2520Discovery%2520of%2520Water%2520Soluble%2520Microtubule%2520Targeting%2520Agents%2520That%2520Bind%2520to%2520the%2520Colchicine%2520Site%2520on%2520Tubulin%2520and%2520Circumvent%2520Pgp%2520Mediated%2520Resistance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D22%26spage%3D8116%26epage%3D8128%26doi%3D10.1021%2Fjm101010n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocharla, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Dihydronaphthalene Analogues Inspired by Combretastatin A-4 and Their Biological Evaluation as Anticancer Agents</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1649</span>– <span class="NLM_lpage">1662</span>, <span class="refDoi"> DOI: 10.1039/C8MD00322J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1039%2FC8MD00322J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=30429970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1649-1662&issue=10&author=C.+J.+Maguireauthor=Z.+Chenauthor=V.+P.+Mocharlaauthor=M.+Sriramauthor=T.+E.+Streckerauthor=E.+Hamelauthor=H.+Zhouauthor=R.+Lopezauthor=Y.+Wangauthor=R.+P.+Masonauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+Dihydronaphthalene+Analogues+Inspired+by+Combretastatin+A-4+and+Their+Biological+Evaluation+as+Anticancer+Agents&doi=10.1039%2FC8MD00322J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents</span></div><div class="casAuthors">Maguire, Casey J.; Chen, Zhi; Mocharla, Vani P.; Sriram, Madhavi; Strecker, Tracy E.; Hamel, Ernest; Zhou, Heling; Lopez, Ramona; Wang, Yifan; Mason, Ralph P.; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1649-1662</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The natural products colchicine and combretastatin A-4 (CA4) have provided inspiration for the discovery and development of a wide array of derivs. and analogs that inhibit tubulin polymn. through a binding interaction at the colchicine site on β-tubulin.  A water-sol. phosphate prodrug salt of CA4 (referred to as CA4P) has demonstrated the ability to selectively damage tumor-assocd. vasculature and ushered in a new class of developmental anticancer agents known as vascular disrupting agents (VDAs).  Through a long-term program of structure activity relationship (SAR) driven inquiry, we discovered that the dihydronaphthalene mol. scaffold provided access to small-mol. inhibitors of tubulin polymn.  In particular, a dihydronaphthalene analog bearing a pendant trimethoxy aryl ring (referred to as KGP03) and a similar aroyl ring (referred to as KGP413) were potent inhibitors of tubulin polymn. (IC50 = 1.0 and 1.2 μM, resp.) and displayed low nM cytotoxicity against human cancer cell lines.  In order to enhance water-soly. for in vivo evaluation, the corresponding phosphate prodrug salts (KGP04 and KGP152, resp.) were synthesized.  In a preliminary in vivo study in a SCID-BALB/c mouse model bearing the human breast tumor MDA-MB-231-luc, a 99% redn. in signal was obsd. with bioluminescence imaging (BLI) 4 h after IP administration of KGP152 (200 mg kg-1) indicating reduced tumor blood flow.  In a sep. study, disruption of tumor-assocd. blood flow in a Fischer rat bearing an A549-luc human lung tumor was obsd. by color Doppler ultrasound following administration of KGP04 (15 mg kg-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIQ1UFKH-j37Vg90H21EOLACvtfcHk0liqlEI4gu1R-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyktbvM&md5=a3d05e0345a50f5bd5ffb68ada1c827d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1039%2FC8MD00322J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00322J%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520Dihydronaphthalene%2520Analogues%2520Inspired%2520by%2520Combretastatin%2520A-4%2520and%2520Their%2520Biological%2520Evaluation%2520as%2520Anticancer%2520Agents%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26issue%3D10%26spage%3D1649%26epage%3D1662%26doi%3D10.1039%2FC8MD00322J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folaron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshadri, M.</span></span> <span> </span><span class="NLM_article-title">Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas</span>. <i>Mol. Imaging Biol. MIB Off. Publ. Acad. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1007/s11307-016-0963-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2Fs11307-016-0963-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=27160251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A280%3ADC%252BC28bnslektA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=860-869&issue=6&author=M.+Folaronauthor=M.+Seshadri&title=Bioluminescence+and+MR+Imaging+of+the+Safety+and+Efficacy+of+Vascular+Disruption+in+Gliomas&doi=10.1007%2Fs11307-016-0963-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas</span></div><div class="casAuthors">Folaron Margaret; Seshadri Mukund; Folaron Margaret; Seshadri Mukund; Seshadri Mukund</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">860-869</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The goal of the present study was to examine the safety and efficacy of the vascular disrupting agent (VDA) EPC2407 (Crolibulin®) in experimental glioma models using bioluminescence imaging (BLI) and magnetic resonance imaging (MRI).  PROCEDURES:  Experimental imaging studies were performed in subcutaneous human U87 glioma xenografts and orthotopic murine gliomas established by intracranial implantation of luciferase-transfected glioma cells (GL261-luc).  Correlative histopathology and long-term survival analysis was also performed.  RESULTS:  Treatment with EPC2407 decreased tumor perfusion and increased necrosis and tumor doubling times in subcutaneous U87 xenografts.  Dynamic BLI and T1-weighted contrast-enhanced MRI showed reduction in blood flow of intracranial GL261-luc gliomas within a few hours of VDA treatment.  T2-weighted MRI did not show any evidence of hemorrhaging or edema in uninvolved brain tissue of EPC2407-treated animals.  A significant increase in median survival (p < 0.05) was observed in the orthotopic GL261-luc model following VDA treatment compared to untreated controls.  CONCLUSIONS:  We demonstrate, for the first time, the biological activity of EPC2407 in experimental gliomas.  Further investigation into the potential of VDAs in combination with chemoradiation therapy against gliomas is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAs75bsyFrrYHWj6b1v8uTfW6udTcc2eZ8bUXwzMG7SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bnslektA%253D%253D&md5=784ccbe1f1a742b956f4b6e143d385a2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs11307-016-0963-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-016-0963-8%26sid%3Dliteratum%253Aachs%26aulast%3DFolaron%26aufirst%3DM.%26aulast%3DSeshadri%26aufirst%3DM.%26atitle%3DBioluminescence%2520and%2520MR%2520Imaging%2520of%2520the%2520Safety%2520and%2520Efficacy%2520of%2520Vascular%2520Disruption%2520in%2520Gliomas%26jtitle%3DMol.%2520Imaging%2520Biol.%2520MIB%2520Off.%2520Publ.%2520Acad.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D18%26issue%3D6%26spage%3D860%26epage%3D869%26doi%3D10.1007%2Fs11307-016-0963-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tumati, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, D.</span></span> <span> </span><span class="NLM_article-title">Development of a Locally Advanced Orthotopic Prostate Tumor Model in Rats for Assessment of Combined Modality Therapy</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.3892/ijo.2013.1858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.3892%2Fijo.2013.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23525451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=1613-1619&issue=5&author=V.+Tumatiauthor=S.+Mathurauthor=K.+Songauthor=J.-T.+Hsiehauthor=D.+Zhaoauthor=M.+Takahashiauthor=T.+Dobinauthor=L.+Gandeeauthor=T.+D.+Solbergauthor=A.+A.+Habibauthor=D.+Saha&title=Development+of+a+Locally+Advanced+Orthotopic+Prostate+Tumor+Model+in+Rats+for+Assessment+of+Combined+Modality+Therapy&doi=10.3892%2Fijo.2013.1858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy</span></div><div class="casAuthors">Tumati, Vasu; Mathur, Sanjeev; Song, Kwang; Hsieh, Jer-Tsong; Zhao, Dawen; Takahashi, Masaya; Dobin, Timothy; Gandee, Leah; Solberg, Timothy D.; Habib, Amyn A.; Saha, Debabrata</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1613-1619</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biol. agents.  For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3-KD).  These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance.  We report that: (i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; (ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; (iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; (iv) precise measurement of the tumor vol. and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, resp.; and (v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor.  This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGm67pbWnVULVg90H21EOLACvtfcHk0lh0Yts5IEymig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFehsr0%253D&md5=bdc7c4dd6702d0c7ed96180e02371393</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3892%2Fijo.2013.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2013.1858%26sid%3Dliteratum%253Aachs%26aulast%3DTumati%26aufirst%3DV.%26aulast%3DMathur%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DHsieh%26aufirst%3DJ.-T.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DDobin%26aufirst%3DT.%26aulast%3DGandee%26aufirst%3DL.%26aulast%3DSolberg%26aufirst%3DT.%2BD.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DSaha%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520Locally%2520Advanced%2520Orthotopic%2520Prostate%2520Tumor%2520Model%2520in%2520Rats%2520for%2520Assessment%2520of%2520Combined%2520Modality%2520Therapy%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2013%26volume%3D42%26issue%3D5%26spage%3D1613%26epage%3D1619%26doi%3D10.3892%2Fijo.2013.1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span> <span> </span><span class="NLM_article-title">Antivascular Effects of Combretastatin A4 Phosphate in Breast Cancer Xenograft Assessed Using Dynamic Bioluminescence Imaging and Confirmed by MRI</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2445</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.1096/fj.07-103713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1096%2Ffj.07-103713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=18263704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlGntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2445-2451&issue=7&author=D.+Zhaoauthor=E.+Richerauthor=P.+P.+Antichauthor=R.+P.+Mason&title=Antivascular+Effects+of+Combretastatin+A4+Phosphate+in+Breast+Cancer+Xenograft+Assessed+Using+Dynamic+Bioluminescence+Imaging+and+Confirmed+by+MRI&doi=10.1096%2Ffj.07-103713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI</span></div><div class="casAuthors">Zhao, Dawen; Richer, Edmond; Antich, Peter P.; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2445-2451, 10.1096/fj.07-103713</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Bioluminescence imaging (BLI) has found significant use in evaluating long-term cancer therapy in small animals.  We have now tested the feasibility of using BLI to assess acute effects of the vascular disrupting agent combretastatin A4 phosphate (CA4P) on luciferase-expressing MDA-MB-231 human breast tumor cells growing as xenografts in mice.  Following administration of luciferin substrate, there is a rapid increase in light emission reaching a max. after about 6 min, which gradually decreases over the following 20 min.  The kinetics of light emission are highly reproducible; however, following i.p. administration of CA4P (120 mg/kg), the detected light emission was decreased between 50 and 90%, and time to max. was significantly delayed.  Twenty-four hours later, there was some recovery of light emission following further administration of luciferin substrate.  Comparison with dynamic contrast-enhanced MRI based on the paramagnetic contrast agent Omniscan showed comparable changes in the tumors consistent with the previous literature.  Histol. also confirmed shutdown of tumor vascular perfusion.  We believe this finding provides an important novel application for BLI that could have widespread application in screening novel therapeutics expected to cause acute vascular changes in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldcNIzMt3h7Vg90H21EOLACvtfcHk0liU2IUW1wfDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlGntLo%253D&md5=70d3c8e8fb0f1e0db2800e8b8411f70e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1096%2Ffj.07-103713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.07-103713%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DRicher%26aufirst%3DE.%26aulast%3DAntich%26aufirst%3DP.%2BP.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DAntivascular%2520Effects%2520of%2520Combretastatin%2520A4%2520Phosphate%2520in%2520Breast%2520Cancer%2520Xenograft%2520Assessed%2520Using%2520Dynamic%2520Bioluminescence%2520Imaging%2520and%2520Confirmed%2520by%2520MRI%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26issue%3D7%26spage%3D2445%26epage%3D2451%26doi%3D10.1096%2Ffj.07-103713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span> <span> </span><span class="NLM_article-title">Tumor Physiologic Response to Combretastatin A4 Phosphate Assessed by MRI</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">872</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2005.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ijrobp.2005.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15936572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVOnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2005&pages=872-880&issue=3&author=D.+Zhaoauthor=L.+Jiangauthor=E.+W.+Hahnauthor=R.+P.+Mason&title=Tumor+Physiologic+Response+to+Combretastatin+A4+Phosphate+Assessed+by+MRI&doi=10.1016%2Fj.ijrobp.2005.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor physiologic response to combretastatin A4 phosphate assessed by MRI</span></div><div class="casAuthors">Zhao, Dawen; Jiang, Lan; Hahn, Eric W.; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">872-880</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">To evaluate the effect of the vascular targeting agent, combretastatin A4 phosphate, on tumor oxygenation compared with vascular perfusion/permeability. 19F MRI oximetry and dynamic contrast-enhanced (DCE)-MRI were used to monitor tumor oxygenation and perfusion/permeability in syngeneic 13762NF rat breast carcinoma.  A significant drop was found in the mean tumor pO2 (23 to 9 mm Hg, p <0.05) within 90 min after treatment (30 mg/kg of combretastatin A4 phosphate) and a further decrease was obsd. at 2 h (mean 2 mm Hg; p <0.01).  The initial changes in pO2 in the central and peripheral regions were parallel, but by 24 h after treatment, a significant difference was apparent: the pO2 in the periphery had improved significantly, and the center remained hypoxic.  These data are consistent with DCE-MRI, which revealed an ∼70% decrease in perfusion/permeability (initial area under signal-intensity curve) at 2 h (p <0.001).  The initial area under signal-intensity curve recovered fully after 24 h in a thin peripheral region, but not in the tumor center.  The response obsd. by DCE-MRI, indicating vascular shutdown, paralleled the pO2 measurements as expected, but quant. pO2 measurements are potentially important for optimizing the therapeutic combination of vascular targeting agents with radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6XcQDfaGu7Vg90H21EOLACvtfcHk0liwfrDd_C5iVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVOnsb0%253D&md5=3f621dfdc6de6be00f77586c19847cd6</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2005.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2005.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DHahn%26aufirst%3DE.%2BW.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DTumor%2520Physiologic%2520Response%2520to%2520Combretastatin%2520A4%2520Phosphate%2520Assessed%2520by%2520MRI%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2005%26volume%3D62%26issue%3D3%26spage%3D872%26epage%3D880%26doi%3D10.1016%2Fj.ijrobp.2005.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span> <span> </span><span class="NLM_article-title">In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated with Therapeutic Outcome</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2010.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ijrobp.2010.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=21345614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=574-581&issue=2&author=D.+Zhaoauthor=C.-H.+Changauthor=J.+G.+Kimauthor=H.+Liuauthor=R.+P.+Mason&title=In+Vivo+Near-Infrared+Spectroscopy+and+Magnetic+Resonance+Imaging+Monitoring+of+Tumor+Response+to+Combretastatin+A-4-Phosphate+Correlated+with+Therapeutic+Outcome&doi=10.1016%2Fj.ijrobp.2010.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome</span></div><div class="casAuthors">Zhao, Dawen; Chang, Cheng-Hui; Kim, Jae G.; Liu, Hanli; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">574-581</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: To develop a combination treatment consisting of combretastatin A-4-phosphate (CA4P) with radiation based on tumor oxygenation status.  Methods and Materials: In vivo near-IR spectroscopy (NIRS) and diffusion-weighted (DW) magnetic resonance imaging (MRI) were applied to noninvasively monitor changes in tumor blood oxygenation and necrosis induced by CA4P (30 mg/kg) in rat mammary 13762NF adenocarcinoma, and the evidence was used to optimize combinations of CA4P and radiation treatment (a single dose of 5 Gy).  Results: NIRS showed decreasing concns. of tumor vascular oxyHb and total Hb during the first 2 h after CA4P treatment, indicating significant redns. in tumor blood oxygenation and perfusion levels (p < 0.001).  Twenty-four hours later, in response to oxygen inhalation, significant recovery was obsd. in tumor vascular and tissue oxygenation according to NIRS and pimonidazole staining results, resp. (p < 0.05).  DW MRI revealed significantly increased water diffusion in tumors measured by apparent diffusion coeff. at 24 h (p < 0.05), suggesting that CA4P-induced central necrosis.  In concordance with the obsd. tumor oxygen dynamics, we found that treatment efficacy depended on the timing of the combined therapy.  The most significant delay in tumor growth was seen in the group of tumors treated with radiation while the rats breathed oxygen 24 h after CA4P administration.  Conclusions: Noninvasive evaluation of tumor oxygen dynamics allowed us to rationally enhance the response of syngeneic rat breast tumors to combined treatment of CA4P with radiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPUFWrpMkdXbVg90H21EOLACvtfcHk0lh3s7sECS_wyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtrk%253D&md5=a8f81fd671121cbc9cbc62d69f8c9db9</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2010.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2010.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DKim%26aufirst%3DJ.%2BG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DIn%2520Vivo%2520Near-Infrared%2520Spectroscopy%2520and%2520Magnetic%2520Resonance%2520Imaging%2520Monitoring%2520of%2520Tumor%2520Response%2520to%2520Combretastatin%2520A-4-Phosphate%2520Correlated%2520with%2520Therapeutic%2520Outcome%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2011%26volume%3D80%26issue%3D2%26spage%3D574%26epage%3D581%26doi%3D10.1016%2Fj.ijrobp.2010.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galbraith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirling, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhani, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustin, G. J. S.</span></span> <span> </span><span class="NLM_article-title">Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">2831</span>– <span class="NLM_lpage">2842</span>, <span class="refDoi"> DOI: 10.1200/JCO.2003.05.187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1200%2FJCO.2003.05.187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12807936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVKjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2831-2842&issue=15&author=S.+M.+Galbraithauthor=R.+J.+Maxwellauthor=M.+A.+Lodgeauthor=G.+M.+Tozerauthor=J.+Wilsonauthor=N.+J.+Taylorauthor=J.+J.+Stirlingauthor=L.+Senaauthor=A.+R.+Padhaniauthor=G.+J.+S.+Rustin&title=Combretastatin+A4+Phosphate+Has+Tumor+Antivascular+Activity+in+Rat+and+Man+as+Demonstrated+by+Dynamic+Magnetic+Resonance+Imaging&doi=10.1200%2FJCO.2003.05.187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging</span></div><div class="casAuthors">Galbraith, Susan M.; Maxwell, Ross J.; Lodge, Martin A.; Tozer, Gillian M.; Wilson, John; Taylor, N. Jane; Stirling, J. James; Sena, Luiza; Padhani, Anwar R.; Rustin, Gordon J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2831-2842</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Combretastatin A4 phosphate (CA4P) is a novel vascular targeting agent.  Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) studies were performed to examine changes in parameters related to blood flow and vascular permeability in tumor and normal tissue after CA4P treatment.  Materials and Methods: Changes in kinetic DCE-MRI parameters (transfer const. [Ktrans] and area under contrast medium-time curve [AUC]) over 24 h after treatment with CA4P were measured in 18 patients in a phase I trial and compared with those obtained in the rat P22 carcinosarcoma model, using the same imaging technique.  Rats were treated with 30 mg/kg of CA4P; patients received escalating doses from 5 to 114 mg/m2.  Results: A similar pattern and time course of change in tumor and normal tissue parameters was seen in rats and humans.  Rat tumor Ktrans was reduced by 64% 6 h after treatment with CA4P (30 mg/kg).  No significant redns. in kidney or muscle parameters were seen.  Significant redns. were seen in tumor Ktrans in six of 16 patients treated at ≥52 mg/m2, with a significant group mean redn. of 37% and 29% at 4 and 24 h, resp., after treatment.  The mean redn. in tumor initial area under the gadolinium-diethylenetriamine pentaacetic acid concn.-time curve (AUC) was 33% and 18%, resp., at these times.  No redn. was seen in muscle Ktrans or in kidney AUC in group anal. of the clin. data.  Conclusion: CA4P acutely reduces Ktrans in human as well as rat tumors at well-tolerated doses, with no significant changes in kidney or muscle, providing proof of principle that this drug has tumor antivascular activity in rats and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoraIEkX52IMrVg90H21EOLACvtfcHk0lgAZ5XubJ3iOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVKjsb8%253D&md5=e8fd067433d43c93d7b3585b6e77ce2e</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1200%2FJCO.2003.05.187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2003.05.187%26sid%3Dliteratum%253Aachs%26aulast%3DGalbraith%26aufirst%3DS.%2BM.%26aulast%3DMaxwell%26aufirst%3DR.%2BJ.%26aulast%3DLodge%26aufirst%3DM.%2BA.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DN.%2BJ.%26aulast%3DStirling%26aufirst%3DJ.%2BJ.%26aulast%3DSena%26aufirst%3DL.%26aulast%3DPadhani%26aufirst%3DA.%2BR.%26aulast%3DRustin%26aufirst%3DG.%2BJ.%2BS.%26atitle%3DCombretastatin%2520A4%2520Phosphate%2520Has%2520Tumor%2520Antivascular%2520Activity%2520in%2520Rat%2520and%2520Man%2520as%2520Demonstrated%2520by%2520Dynamic%2520Magnetic%2520Resonance%2520Imaging%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26issue%3D15%26spage%3D2831%26epage%3D2842%26doi%3D10.1200%2FJCO.2003.05.187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vichai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirtikara, K.</span></span> <span> </span><span class="NLM_article-title">Sulforhodamine B Colorimetric Assay for Cytotoxicity Screening</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fnprot.2006.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=17406391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1112-1116&issue=3&author=V.+Vichaiauthor=K.+Kirtikara&title=Sulforhodamine+B+Colorimetric+Assay+for+Cytotoxicity+Screening&doi=10.1038%2Fnprot.2006.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforhodamine B colorimetric assay for cytotoxicity screening</span></div><div class="casAuthors">Vichai, Vanicha; Kirtikara, Kanyawim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1112-1116</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The sulforhodamine B (SRB) assay is used for cell d. detn., based on the measurement of cellular protein content.  The method described here was optimized for the toxicity screening of compds. to adherent cells in a 96-well format.  After an incubation period, cell monolayers are fixed with 10% (wt/vol) trichloroacetic acid and stained for 30 min, after which the excess dye is removed by washing repeatedly with 1% (vol/vol) acetic acid.  The protein-bound dye is dissolved in 10 mM Tris base soln. for OD detn. at 510 nm using a microplate reader.  The results are linear over a 20-fold range of cell nos. and the sensitivity is comparable to those of fluorometric methods.  The method not only allows a large no. of samples to be tested within a few days, but also requires only simple equipment and inexpensive reagents.  The SRB assay is therefore an efficient and highly cost-effective method for screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGZ8pao808l7Vg90H21EOLACvtfcHk0lgWzZd27H1BFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O&md5=7173035a1f9eb3f02dd7f1a947bca659</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.179%26sid%3Dliteratum%253Aachs%26aulast%3DVichai%26aufirst%3DV.%26aulast%3DKirtikara%26aufirst%3DK.%26atitle%3DSulforhodamine%2520B%2520Colorimetric%2520Assay%2520for%2520Cytotoxicity%2520Screening%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26issue%3D3%26spage%3D1112%26epage%3D1116%26doi%3D10.1038%2Fnprot.2006.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skehan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistica, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronise, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaigro-Wolff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray-Goodrich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M.</span></span> <span> </span><span class="NLM_article-title">Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1093/jnci/83.11.757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1093%2Fjnci%2F83.11.757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=2041050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1991&pages=757-766&issue=11&author=A.+Monksauthor=D.+Scudieroauthor=P.+Skehanauthor=R.+Shoemakerauthor=K.+Paullauthor=D.+Visticaauthor=C.+Hoseauthor=J.+Langleyauthor=P.+Croniseauthor=A.+Vaigro-Wolffauthor=M.+Gray-Goodrichauthor=H.+Campbellauthor=J.+Mayoauthor=M.+Boyd&title=Feasibility+of+a+High-Flux+Anticancer+Drug+Screen+Using+a+Diverse+Panel+of+Cultured+Human+Tumor+Cell+Lines&doi=10.1093%2Fjnci%2F83.11.757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</span></div><div class="casAuthors">Monks, Anne; Scudiero, Dominic; Skehan, Philip; Shoemaker, Robert; Paull, Kenneth; Vistica, David; Hose, Curtis; Langley, John; Cronise, Paul; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">757-66</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The development and implementation of a pilot-scale, in vitro, anticancer drug screen utilizing a panel of 60 human tumor cell lines organized into subpanels representing leukemia, melanoma, and cancers of the lung, colon, kidney, ovary, and central nervous system is described.  The ultimate goal of this disease-oriented screen is to facilitate the discovery of new compds. with potential cell line-specific and/or subpanel-specific antitumor activity.  In the current screening protocol, each cell line is inoculated onto microtiter plates, then preincubated for 24-28 h.  Subsequently, test agents are added in five 10-fold dilns. and the culture is incubated for an addnl. 48 h.  For each test agent, a dose-response profile is generated.  End-point detns. of the cell viability or cell growth are performed by in situ fixation of cells, followed by staining with a protein-binding dye, sulforhodamine B (SRB).  The SRB binds to the basic amino acids of cellular macromols.; the solubilized stain is measured spectrophotometrically to det. relative cell growth or viability in treated and untreated cells.  Following the pilot screening studies, a screening rate of 400 compds. per wk has been consistently achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2v5P80YUP7Vg90H21EOLACvtfcHk0liAysAyK-Zw0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D&md5=cee33642400d34b01d8f962cb16a9386</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F83.11.757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F83.11.757%26sid%3Dliteratum%253Aachs%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DR.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DHose%26aufirst%3DC.%26aulast%3DLangley%26aufirst%3DJ.%26aulast%3DCronise%26aufirst%3DP.%26aulast%3DVaigro-Wolff%26aufirst%3DA.%26aulast%3DGray-Goodrich%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DH.%26aulast%3DMayo%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%26atitle%3DFeasibility%2520of%2520a%2520High-Flux%2520Anticancer%2520Drug%2520Screen%2520Using%2520a%2520Diverse%2520Panel%2520of%2520Cultured%2520Human%2520Tumor%2520Cell%2520Lines%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D1991%26volume%3D83%26issue%3D11%26spage%3D757%26epage%3D766%26doi%3D10.1093%2Fjnci%2F83.11.757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. M.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the Colchicine-Binding Activity of Tubulin by Organic Acids</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>675</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/0304-4165(81)90231-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2F0304-4165%2881%2990231-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL3MXksFKks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=675&publication_year=1981&pages=226-231&issue=2&author=E.+Hamelauthor=C.+M.+Lin&title=Stabilization+of+the+Colchicine-Binding+Activity+of+Tubulin+by+Organic+Acids&doi=10.1016%2F0304-4165%2881%2990231-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the colchicine-binding activity of tubulin by organic acids</span></div><div class="casAuthors">Hamel, Ernest; Lin, Chii M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">675</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-31</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    </div><div class="casAbstract">A no. of carboxylic acids and org. phosphates were highly effective in stabilizing the colchicine-binding activity of calf brain tubulin.  The most active were glutamate, glutarate, β-aminovalerate, glucose 1-phosphate, glucose 6-phosphate, fructose 1,6-diphosphate, creatine phosphate, and 6-phosphogluconate.  Max. effects occurred at high concns.  Combinations of agents were also examd., and the most effective mixt. for stabilizing tubulin found thus far was the combination of 1.0M glutamate, 100 mM glucose 1-phosphate, 1 mM GTP, and 0.5 mg albumin/mL.  No loss of activity occurred over 48 h at 37° when tubulin was present at 100 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7KAW2P8PRbVg90H21EOLACvtfcHk0lg-0T4jvtK_dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXksFKks7s%253D&md5=a658ea4b7dc66a11024aeda7a99d3aef</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0304-4165%2881%2990231-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-4165%252881%252990231-2%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26atitle%3DStabilization%2520of%2520the%2520Colchicine-Binding%2520Activity%2520of%2520Tubulin%2520by%2520Organic%2520Acids%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D1981%26volume%3D675%26issue%3D2%26spage%3D226%26epage%3D231%26doi%3D10.1016%2F0304-4165%2881%2990231-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Antimitotic Agents by Quantitative Comparisons of Their Effects on the Polymerization of Purified Tubulin</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1385/CBB:38:1:1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1385%2FCBB%3A38%3A1%3A1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12663938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=1-22&issue=1&author=E.+Hamel&title=Evaluation+of+Antimitotic+Agents+by+Quantitative+Comparisons+of+Their+Effects+on+the+Polymerization+of+Purified+Tubulin&doi=10.1385%2FCBB%3A38%3A1%3A1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin</span></div><div class="casAuthors">Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Most antimitotic compds. have highly specific interactions with tubulin, the major protein component of microtubules.  It is, therefore, often desirable to characterize interactions of these agents with tubulin.  In particular, quant. comparisons between new and old ("std.") agents, between different classes of agent, and between structural analogs (e.g., for a structure-activity relationship study) are important.  Because antimitotic drugs have a variety of effects on tubulin and bind at multiple distinct sites on the protein, the tubulin assembly reaction is probably the only universally applicable reaction that can be analyzed.  In my lab., we use the assembly of purified tubulin induced by higher concns. of monosodium glutamate as our basic assay system.  This report presents a detailed description of our current routine assay, including the effects of a variety of reaction components on the reaction.  In addn., the variety of effects that reaction components can have on the quant. results obtained with drugs, using the colchicine site drug combretastatin A-4 as a model compd., is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLvDICXLUiYbVg90H21EOLACvtfcHk0lgdgYcs3sjcig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D&md5=c37c365cc707e237f43feffca64d706b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1385%2FCBB%3A38%3A1%3A1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FCBB%253A38%253A1%253A1%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520Antimitotic%2520Agents%2520by%2520Quantitative%2520Comparisons%2520of%2520Their%2520Effects%2520on%2520the%2520Polymerization%2520of%2520Purified%2520Tubulin%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2003%26volume%3D38%26issue%3D1%26spage%3D1%26epage%3D22%26doi%3D10.1385%2FCBB%3A38%3A1%3A1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Blake A. Winn, Laxman Devkota, Bunnarack Kuch, Matthew T. MacDonough, Tracy E. Strecker, Yifan Wang, Zhe Shi, Jeni L. Gerberich, Deboprosad Mondal, Alejandro J. Ramirez, Ernest Hamel, David J. Chaplin, Peter Davis, Ralph P. Mason, Mary Lynn Trawick, <span class="NLM_string-name hlFld-ContribAuthor">Kevin G. Pinney</span>. </span><span class="cited-content_cbyCitation_article-title">Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (4)
                                     , 937-954. <a href="https://doi.org/10.1021/acs.jnatprod.9b00773" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.9b00773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.9b00773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.9b00773%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DBioreductively%252BActivatable%252BProdrug%252BConjugates%252Bof%252BCombretastatin%252BA-1%252Band%252BCombretastatin%252BA-4%252Bas%252BAnticancer%252BAgents%252BTargeted%252Btoward%252BTumor-Associated%252BHypoxia%26aulast%3DWinn%26aufirst%3DBlake%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13082019%26date%3D20032020%26volume%3D83%26issue%3D4%26spage%3D937%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hairong  Tang</span>, <span class="hlFld-ContribAuthor ">Yuru  Liang</span>, <span class="hlFld-ContribAuthor ">Jiayi  Cheng</span>, <span class="hlFld-ContribAuthor ">Kuiling  Ding</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113531. <a href="https://doi.org/10.1016/j.ejmech.2021.113531" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113531%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252Bchiral%252Bselenium-containing%252B1%25252C4-diarylazetidin-2-ones%252Bwith%252Bpotent%252Bantitumor%252Bactivities%252Bby%252Bdisrupting%252Btubulin%252Bpolymerization%252Band%252Binducing%252Breactive%252Boxygen%252Bspecies%252Bproduction%26aulast%3DTang%26aufirst%3DHairong%26date%3D2021%26volume%3D221%26spage%3D113531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan-Shan  Liao</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Zu-Yu  Mo</span>, <span class="hlFld-ContribAuthor ">Cheng  Hou</span>, <span class="hlFld-ContribAuthor ">Gui-Fa  Su</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Ni(
              ii
              ), Cu(
              ii
              ) and Zn(
              ii
              ) complexes with the 1-trifluoroethoxyl-2,9,10-trimethoxy-7-oxoaporphine ligand simultaneously target microtubules and mitochondria for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (9)
                                     , 2225-2247. <a href="https://doi.org/10.1039/D0QI01463J" title="DOI URL">https://doi.org/10.1039/D0QI01463J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QI01463J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QI01463J%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Frontiers%26atitle%3DNi%252528%252Bii%252B%252529%25252C%252BCu%252528%252Bii%252B%252529%252Band%252BZn%252528%252Bii%252B%252529%252Bcomplexes%252Bwith%252Bthe%252B1-trifluoroethoxyl-2%25252C9%25252C10-trimethoxy-7-oxoaporphine%252Bligand%252Bsimultaneously%252Btarget%252Bmicrotubules%252Band%252Bmitochondria%252Bfor%252Bcancer%252Btherapy%26aulast%3DLiao%26aufirst%3DLan-Shan%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D9%26spage%3D2225%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Devin  O’Kelly</span>, <span class="hlFld-ContribAuthor ">Regan  Schuetze</span>, <span class="hlFld-ContribAuthor ">Graham  Carlson</span>, <span class="hlFld-ContribAuthor ">Heling  Zhou</span>, <span class="hlFld-ContribAuthor ">Mary Lynn  Trawick</span>, <span class="hlFld-ContribAuthor ">Kevin G.  Pinney</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Mason</span>. </span><span class="cited-content_cbyCitation_article-title">Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2551. <a href="https://doi.org/10.3390/molecules26092551" title="DOI URL">https://doi.org/10.3390/molecules26092551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092551%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNon-Invasive%252BEvaluation%252Bof%252BAcute%252BEffects%252Bof%252BTubulin%252BBinding%252BAgents%25253A%252BA%252BReview%252Bof%252BImaging%252BVascular%252BDisruption%252Bin%252BTumors%26aulast%3DLiu%26aufirst%3DLi%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Zhu</span>, <span class="hlFld-ContribAuthor ">Sheng-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Dong  Li</span>, <span class="hlFld-ContribAuthor ">Shu-Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xu  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Song</span>, <span class="hlFld-ContribAuthor ">Ya-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of tubulin polymerization activity detection methods. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>37 </em>, 127698. <a href="https://doi.org/10.1016/j.bmcl.2020.127698" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127698%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProgress%252Bof%252Btubulin%252Bpolymerization%252Bactivity%252Bdetection%252Bmethods%26aulast%3DZhu%26aufirst%3DTing%26date%3D2021%26volume%3D37%26spage%3D127698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie J.  Serkova</span>, <span class="hlFld-ContribAuthor ">Kristine  Glunde</span>, <span class="hlFld-ContribAuthor ">Chad R.  Haney</span>, <span class="hlFld-ContribAuthor ">Mohammed  Farhoud</span>, <span class="hlFld-ContribAuthor ">Alexandra  De Lille</span>, <span class="hlFld-ContribAuthor ">Elizabeth F.  Redente</span>, <span class="hlFld-ContribAuthor ">Dmitri  Simberg</span>, <span class="hlFld-ContribAuthor ">David C.  Westerly</span>, <span class="hlFld-ContribAuthor ">Lynn  Griffin</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Mason</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2021,</strong> <em>81 </em>
                                    (5)
                                     , 1189-1200. <a href="https://doi.org/10.1158/0008-5472.CAN-20-0373" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-0373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-0373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-0373%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DPreclinical%252BApplications%252Bof%252BMulti-Platform%252BImaging%252Bin%252BAnimal%252BModels%252Bof%252BCancer%26aulast%3DSerkova%26aufirst%3DNatalie%2BJ.%26date%3D2021%26date%3D2020%26volume%3D81%26issue%3D5%26spage%3D1189%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Yuelin  Li</span>, <span class="hlFld-ContribAuthor ">Zi  Liu</span>, <span class="hlFld-ContribAuthor ">Zeyu  Wang</span>, <span class="hlFld-ContribAuthor ">Zihan  Liu</span>, <span class="hlFld-ContribAuthor ">Shuai  Man</span>, <span class="hlFld-ContribAuthor ">Yujing  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai  Bao</span>, <span class="hlFld-ContribAuthor ">Yingliang  Wu</span>, <span class="hlFld-ContribAuthor ">Qi  Guan</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Weige  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1
              H
              -tetrazols as novel microtubule destabilizers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 549-560. <a href="https://doi.org/10.1080/14756366.2020.1759582" title="DOI URL">https://doi.org/10.1080/14756366.2020.1759582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1759582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1759582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1-Aryl-5-%2525284-arylpiperazine-1-carbonyl%252529-1%252BH%252B-tetrazols%252Bas%252Bnovel%252Bmicrotubule%252Bdestabilizers%26aulast%3DWang%26aufirst%3DChao%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D549%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weifeng  Ma</span>, <span class="hlFld-ContribAuthor ">Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiansen  Huo</span>, <span class="hlFld-ContribAuthor ">Yufeng  Ma</span>, <span class="hlFld-ContribAuthor ">Yanhong  Li</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Diao</span>, <span class="hlFld-ContribAuthor ">Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Shengquan  Zheng</span>, <span class="hlFld-ContribAuthor ">Mengjin  Hu</span>, <span class="hlFld-ContribAuthor ">Wenwei  You</span>, <span class="hlFld-ContribAuthor ">Peiliang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112847. <a href="https://doi.org/10.1016/j.ejmech.2020.112847" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112847%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Btriazolothiadiazine%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitors%25253A%252BStructure-activity%252Brelationship%25252C%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bstudy%26aulast%3DMa%26aufirst%3DWeifeng%26date%3D2020%26volume%3D208%26spage%3D112847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Yang  Chang</span>, <span class="hlFld-ContribAuthor ">Kai-Xiang  Lai</span>, <span class="hlFld-ContribAuthor ">Yu-Lun  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">In(OTf)
              3
              -catalyzed intramolecular hydroarylation of α-phenylallyl β-ketosulfones – synthesis of sulfonyl 1-benzosuberones and 1-tetralones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (31)
                                     , 18231-18244. <a href="https://doi.org/10.1039/D0RA01962C" title="DOI URL">https://doi.org/10.1039/D0RA01962C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA01962C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA01962C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIn%252528OTf%252529%252B3%252B-catalyzed%252Bintramolecular%252Bhydroarylation%252Bof%252B%2525CE%2525B1-phenylallyl%252B%2525CE%2525B2-ketosulfones%252B%2525E2%252580%252593%252Bsynthesis%252Bof%252Bsulfonyl%252B1-benzosuberones%252Band%252B1-tetralones%26aulast%3DChang%26aufirst%3DMeng-Yang%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D31%26spage%3D18231%26epage%3D18244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eavan C.  McLoughlin</span>, <span class="hlFld-ContribAuthor ">Niamh M.  O’Boyle</span>. </span><span class="cited-content_cbyCitation_article-title">Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (1)
                                     , 8. <a href="https://doi.org/10.3390/ph13010008" title="DOI URL">https://doi.org/10.3390/ph13010008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13010008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13010008%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DColchicine-Binding%252BSite%252BInhibitors%252Bfrom%252BChemistry%252Bto%252BClinic%25253A%252BA%252BReview%26aulast%3DMcLoughlin%26aufirst%3DEavan%2BC.%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D1%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunjiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Bin  Di</span>, <span class="hlFld-ContribAuthor ">Miao-Miao  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (17)
                                     , 3181. <a href="https://doi.org/10.3390/molecules24173181" title="DOI URL">https://doi.org/10.3390/molecules24173181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24173181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24173181%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BPharmacophore%252BDesign%252Band%252BVirtual%252BScreening%252Bfor%252BNovel%252BTubulin%252BInhibitors%252Bwith%252BPotential%252BAnticancer%252BActivity%26aulast%3DZhou%26aufirst%3DYunjiang%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D17%26spage%3D3181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative small-molecule inhibitors of tubulin polymerization: colchicine,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> combretastatins (CA4, CA1),<a onclick="showRef(event, 'ref15 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref23">(15,23)</a> phenstatin, dihydronaphthalene analogues (KGP03, KGP05),<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> benzosuberene analogues (KGP18, KGP156),<a onclick="showRef(event, 'ref8 ref25 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref37 ref38">(8,25,37,38)</a> indole analogue (OXi8006),<a onclick="showRef(event, 'ref39 ref50'); return false;" href="javascript:void(0);" class="ref ref39 ref50">(39,50)</a> and benzo[<i>b</i>]furan analogue (BNC105).<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected KGP18 derivatives as inhibitors of tubulin polymerization with modifications at the C-4 position of the A ring and the C-6, 7, 8 positions of the B ring.<a onclick="showRef(event, 'ref25 ref57'); return false;" href="javascript:void(0);" class="ref ref25 ref57">(25,57)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Benzosuberene and Benzosuberane Intermediates and Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compilation of synthesized benzosuberene, benzosuberane, benzosuberone, and dihydronaphthalene analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Nitrile- and Aldehyde-Substituted R Position Analogues <b>18</b>–<b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Ester Analogue <b>27</b> and Primary Alcohol Analogue <b>28</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Allylic Alcohol Analogue <b>37</b> and Allylic <i>N</i>-Acetamide Analogue <b>49</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of α-Unsaturated Tertiary Alcohol Analogue <b>56</b> and Pendant Ring Shifted Analogue <b>57</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Benzosuberdiene <b>68</b> and Phosphate Salt <b>69</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. BLI assessment of vascular response to VDA. (Left) Heat maps overlaid on photographs of male Copenhagen rat with subcutaneous PC3-DAB2IP-luc human prostate tumor xenograft showing light emission about 20 min after administration of <span class="smallcaps smallerCapital">d</span>-luciferin (120 mg/kg) at various times with respect to VDA administration ip. (Right) Corresponding dynamic light emission curves acquired over about 30 min following luciferin administration. Blue shows baseline, red about 4 h after VDA, and green at 24 h. (A) 10 mg/kg compound <b>69</b> indicating no vascular perturbation but increased signal at 24 h consistent with rapid tumor growth. (B) 6 h later 40 mg/kg compound <b>69</b> was administered to the same rat generating about 95% reduced signal at 4 h, consistent with substantial vascular shutdown and showing substantial recovery by 24 h. (C) Four days later 30 mg/kg CA4P was administered to this rat, eliciting BLI response similar to the BLI response shown in (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/medium/jm-2019-00551k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Relative light emission following administration of VDAs. (A) Relative signal intensity is shown about 20 min after administration of <span class="smallcaps smallerCapital">d</span>-luciferin subcutaneously in the foreback neck region of a rat with a subcutaneous PC3-DAB2IP-luc prostate tumor xenograft in the thigh: (top) baseline (no prior drug); (center) 4 h after 40 mg/kg <b>69</b>; (bottom) 24 h after <b>69</b>. (B) Corresponding light emission dynamic curve at baseline (blue), 4 h after <b>69</b> (red), and 24 h after <b>69</b> (green). (C) Normalized BLI signal at various times for the rat in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> receiving <b>69</b> sequentially at 10 mg/kg (black), 40 mg/kg (red), and 30 mg/kg CA4P (green), together with the treatment naive rat in (A), (B) receiving 40 mg/kg <b>69</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00551/20190607/images/large/jm-2019-00551k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00551&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 85 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">Characterizing the Tumor Response to Treatment with Combretastatin A4 Phosphate</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2006.12.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ijrobp.2006.12.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=17448875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVOls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=211-217&issue=1&author=B.+A.+Salmonauthor=D.+W.+Siemann&title=Characterizing+the+Tumor+Response+to+Treatment+with+Combretastatin+A4+Phosphate&doi=10.1016%2Fj.ijrobp.2006.12.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate</span></div><div class="casAuthors">Salmon, Beth A.; Siemann, Dietmar W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">211-217</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: To examine the pathophysiol. impact of treatment with combretastatin A4 phosphate (CA4P) in regions of tumors that ultimately either necrose or survive treatment with this agent.  Methods and Materials: Proliferation, perfusion, vessel d., and expression of vascular endothelial growth factor (VEGF) were analyzed in the KHT tumor model after treatment with CA4P.  Analyses were conducted in the whole tumor and the tumor periphery.  Results: Perfusion in the tumor periphery decreased 4 h after treatment, but returned to baseline 20 h later.  Whole-tumor perfusion also decreased 4 h after treatment, but did not return to baseline.  Vessel d. decreased in the tumor as a whole, but not in the tumor periphery.  No significant effect on the expression of VEGF was obsd., but a decrease in proliferation in the whole tumor and the periphery was noted.  Conclusions: The present study shows that those areas of a tumor that survive treatment with CA4P are affected by CA4P exposure, though only transiently.  The decrease in perfusion could neg. affect therapies utilizing the combination of CA4P and conventional anticancer agents by decreasing drug delivery and tissue oxygenation.  These findings suggest that the timing of CA4P treatments when used in conjunction with conventional anticancer therapies should be considered carefully.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT8IJPWCbvVLVg90H21EOLACvtfcHk0lj-Y2lH1SRgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVOls7g%253D&md5=e7af3058df29e33ed6fc008d248962a1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2006.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2006.12.051%26sid%3Dliteratum%253Aachs%26aulast%3DSalmon%26aufirst%3DB.%2BA.%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DCharacterizing%2520the%2520Tumor%2520Response%2520to%2520Treatment%2520with%2520Combretastatin%2520A4%2520Phosphate%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2007%26volume%3D68%26issue%3D1%26spage%3D211%26epage%3D217%26doi%3D10.1016%2Fj.ijrobp.2006.12.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&issue=5&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0liASFqM2EtFbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26issue%3D5%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">The Unique Characteristics of Tumor Vasculature and Preclinical Evidence for Its Selective Disruption by Tumor-Vascular Disrupting Agents</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2010.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ctrv.2010.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=20570444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFajs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=63-74&issue=1&author=D.+W.+Siemann&title=The+Unique+Characteristics+of+Tumor+Vasculature+and+Preclinical+Evidence+for+Its+Selective+Disruption+by+Tumor-Vascular+Disrupting+Agents&doi=10.1016%2Fj.ctrv.2010.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents</span></div><div class="casAuthors">Siemann, Dietmar W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-74</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The vasculature of solid tumors is fundamentally different from that of normal vasculature and offers a unique target for anti-cancer therapy.  Direct vascular-targeting with Tumor-Vascular Disrupting Agents (Tumor-VDAs) is distinctly different from anti-angiogenic strategies, and offers a complementary approach to std. therapies.  Tumor-VDAs therefore have significant potential when combined with chemotherapy, radiotherapy, and angiogenesis-inhibiting agents.  Preclin. studies with the different Tumor-VDA classes have demonstrated key tumor-selective anti-vascular and anti-tumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKL8nIIVWtVbVg90H21EOLACvtfcHk0lj3I2_-isxATg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFajs7vI&md5=85fe2cb36db459ad473bf53bbcae60af</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2010.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2010.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DThe%2520Unique%2520Characteristics%2520of%2520Tumor%2520Vasculature%2520and%2520Preclinical%2520Evidence%2520for%2520Its%2520Selective%2520Disruption%2520by%2520Tumor-Vascular%2520Disrupting%2520Agents%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2011%26volume%3D37%26issue%3D1%26spage%3D63%26epage%3D74%26doi%3D10.1016%2Fj.ctrv.2010.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanthou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baguley, B. C.</span></span> <span> </span><span class="NLM_article-title">Disrupting Tumour Blood Vessels</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">435</span>, <span class="refDoi"> DOI: 10.1038/nrc1628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fnrc1628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15928673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=423-435&issue=6&author=G.+M.+Tozerauthor=C.+Kanthouauthor=B.+C.+Baguley&title=Disrupting+Tumour+Blood+Vessels&doi=10.1038%2Fnrc1628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting tumor blood vessels</span></div><div class="casAuthors">Tozer, Gillian M.; Kanthou, Chryso; Baguley, Bruce C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-435</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Low-mol.-wt. vascular-disrupting agents (VDAs) cause a pronounced shutdown in blood flow to solid tumors, resulting in extensive tumor-cell necrosis, while they leave the blood flow in normal tissues relatively intact.  The largest group of VDAs is the tubulin-binding combretastatins, several of which are now being tested in clin. trials.  DMXAA (5,6-dimethylxanthenone-4-acetic acid) - one of a structurally distinct group of drugs - is also being tested in clin. trials.  A full understanding of the action of these and other VDAs will provide insights into mechanisms that control tumor blood flow and will be the basis for the development of new therapeutic drugs for targeting the established tumor vasculature for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjdnxmo6H1JrVg90H21EOLACvtfcHk0lgWZs3ZHnvxqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D&md5=869e9f19ba4b9b82b166b39f089e003b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1628%26sid%3Dliteratum%253Aachs%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26atitle%3DDisrupting%2520Tumour%2520Blood%2520Vessels%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26issue%3D6%26spage%3D423%26epage%3D435%26doi%3D10.1038%2Fnrc1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanthou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span> <span> </span><span class="NLM_article-title">Tumour Targeting by Microtubule-Depolymerizing Vascular Disrupting Agents</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1517/14728222.11.11.1443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1517%2F14728222.11.11.1443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=18028009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1443-1457&issue=11&author=C.+Kanthouauthor=G.+M.+Tozer&title=Tumour+Targeting+by+Microtubule-Depolymerizing+Vascular+Disrupting+Agents&doi=10.1517%2F14728222.11.11.1443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour targeting by microtubule-depolymerising vascular disrupting agents</span></div><div class="casAuthors">Kanthou, Chryso; Tozer, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1443-1457</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Low mol. wt. vascular disrupting agents of the microtubule depolymerising family cause marked and selective disruption of the established tumor blood vessel network, resulting in tumor cell necrosis.  The combretastatins are members of this family and these, together with several other related compds., have undergone extensive preclin. testing and are now in clin. trials for cancer.  Potentially, vascular disrupting agents can also interfere with angiogenesis and constitute a very promising group of novel cancer drugs.  In vitro anal. of their signalling activities points to the endothelial cytoskeleton as being their major target and a key player in the events that culminate in vascular collapse.  As more of these agents progress into the clin. setting, more research in this area is warranted in order to decipher exact mechanisms responsible for vascular disruption and to understand the reasons for drug selectivity for the tumor vasculature.  This information is essential in order to identify new targets within the tumor vasculature and to improve present therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyG45tAky0W7Vg90H21EOLACvtfcHk0lilYTVEF1K-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE&md5=08c7e94cddef659fd730c74b86575c55</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1443%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DTumour%2520Targeting%2520by%2520Microtubule-Depolymerizing%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26issue%3D11%26spage%3D1443%26epage%3D1457%26doi%3D10.1517%2F14728222.11.11.1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denekamp, J.</span></span> <span> </span><span class="NLM_article-title">Endothelial Cell Proliferation as a Novel Approach to Targeting Tumour Therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1038/bjc.1982.16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fbjc.1982.16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=7059456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A280%3ADyaL387jsFalsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1982&pages=136-139&issue=1&author=J.+Denekamp&title=Endothelial+Cell+Proliferation+as+a+Novel+Approach+to+Targeting+Tumour+Therapy&doi=10.1038%2Fbjc.1982.16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial cell proliferation as a novel approach to targeting tumour therapy</span></div><div class="casAuthors">Denekamp J</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-9</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4iKdwZjJ3XnthwrmtH4OBfW6udTcc2eYE5o1B6KJYyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL387jsFalsQ%253D%253D&md5=7252dcfccc1e956472cd2ac64847b9a8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1982.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1982.16%26sid%3Dliteratum%253Aachs%26aulast%3DDenekamp%26aufirst%3DJ.%26atitle%3DEndothelial%2520Cell%2520Proliferation%2520as%2520a%2520Novel%2520Approach%2520to%2520Targeting%2520Tumour%2520Therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1982%26volume%3D45%26issue%3D1%26spage%3D136%26epage%3D139%26doi%3D10.1038%2Fbjc.1982.16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denekamp, J.</span></span> <span> </span><span class="NLM_article-title">Review Article: Angiogenesis, Neovascular Proliferation and Vascular Pathophysiology as Targets for Cancer Therapy</span>. <i>Br. J. Radiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">783</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1259/0007-1285-66-783-181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1259%2F0007-1285-66-783-181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=7682469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A280%3ADyaK3s3jtVemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1993&pages=181-196&issue=783&author=J.+Denekamp&title=Review+Article%3A+Angiogenesis%2C+Neovascular+Proliferation+and+Vascular+Pathophysiology+as+Targets+for+Cancer+Therapy&doi=10.1259%2F0007-1285-66-783-181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy</span></div><div class="casAuthors">Denekamp J</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of radiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">783</span>),
    <span class="NLM_cas:pages">181-96</span>
        ISSN:<span class="NLM_cas:issn">0007-1285</span>.
    </div><div class="casAbstract">A body of evidence that vascular-mediated damage occurs in murine tumours after many existing forms of anti-tumour therapy is rapidly accumulating (see Gray Conference Proceedings edited by Moore & West, 1991).  Rapid conventional screens of cells in vitro or using leukaemias of lymphomas will not detect this mode of action and such screens will therefore miss effective agents.  A change in the approach to experimental cancer therapy is needed to ensure that this important new avenue is fully investigated.  Solid tumours will need to be studied and the importance of specific tumour cell biochemistry (e.g. on tissue factor procoagulant activity), of endothelial status and the immunocompetence of the host are all likely to be important.  It is a subject of considerable debate at present whether transplanted subcutaneous mouse tumours are adequate models and whether they will reflect the response of spontaneous tumours, or even of transplants into other sites.  Xenografts are not likely to be appropriate if the immuno-suppressed hosts lack the cells needed for the cytokine component of the pathway.  The strategy of design and screening of new agents, for scheduling of existing agents and particularly the sequencing of adjunctive therapies are likely to be completely different for the "direct" tumor cell or "indirect" vascular-mediated approaches.  It may eventually be appropriate to combine vascular manipulation with direct cytotoxicity aimed at malignant cells but the two mechanisms must be recognized as distinct entities and considered separately before attempting to coordinate them.  It is important therefore to identify the "hallmarks" of vascular mediated injury and the means by which this can be distinguished from direct cell kill.  These may be detectable in the tumour response but clues can also be gained from the side effects that are seen in normal tissues both with existing and with novel therapies (Figure 7).  The appeal of vascular-mediated ischaemic therapy is that it is systemic and will have the potential of being effective on any tumour with a newly evoked vascular network, i.e. of about 1 mm in diameter, but it will be even more effective on large tumours than on small.  Thus it should affect both large primary tumours and disseminated small metastases.  The studies with many different anti-cancer agents have illustrated the potential complexity of responses that can appear to cause tumour cell death by collapse or occlusion of the blood supply.  They have also focused attention on features of disparate agents, e.g.  TNF, FAA, PDT, which may share similar pathways.  No single feature of neovasculature can be highlighted as the sole route by which such antivascular therapy should be targeted.  Rapid proliferation of the endothelial cells may prove to be a target, but it also influences differentiation characteristics, so that the immature cells will function abnormally.  The permeability of these poorly formed vessels may lead to extravasation of proteins leading to increase interstitial pressures and by this means to an imbalance between intravascular and extravascular pressures and hence to collapse of the thin-walled vessels.  Changes in systemic blood pressure, cardiac output, viscosity or coagulation and especially a redistribution of regional perfusion would all have differential effects in tumours and normal vessels.  Clearly both vascular patho-physiology and the complexity of endothelial cell function and its imbalance in neovasculature will be important in understanding the mechanism of action of antivascular strategies.  This very challenging boundary between oncology and a number of other medical and biological fields promises to lead to altered attitudes to existing therapies and the discovery of completely new classes of anti-cancer agents.  The next decade should translate into clinical benefit for patients if the progress in this field continues to be as rapid as it has been in the late eighties.  We must now determine what characteristics make one tumour more sensitive than another to agents such as heat, PDT, cytokines and FAA, and learn how to extrapolate from those rodent tumours to the human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-mmKvPwYf_Rjv2lLSLOxFfW6udTcc2eYh4ixRD8a3jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3jtVemtA%253D%253D&md5=1d72d08985244fc62268852f50d1e6e3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1259%2F0007-1285-66-783-181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1259%252F0007-1285-66-783-181%26sid%3Dliteratum%253Aachs%26aulast%3DDenekamp%26aufirst%3DJ.%26atitle%3DReview%2520Article%253A%2520Angiogenesis%252C%2520Neovascular%2520Proliferation%2520and%2520Vascular%2520Pathophysiology%2520as%2520Targets%2520for%2520Cancer%2520Therapy%26jtitle%3DBr.%2520J.%2520Radiol.%26date%3D1993%26volume%3D66%26issue%3D783%26spage%3D181%26epage%3D196%26doi%3D10.1259%2F0007-1285-66-783-181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grohmann, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wootton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Dihydronaphthalene and Benzosuberene Analogs of the Combretastatins as Inhibitors of Tubulin Polymerization in Cancer Chemotherapy</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8161</span>– <span class="NLM_lpage">8171</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2008.07.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=18722127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyktbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8161-8171&issue=17&author=M.+Sriramauthor=J.+J.+Hallauthor=N.+C.+Grohmannauthor=T.+E.+Streckerauthor=T.+Woottonauthor=A.+Frankenauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Dihydronaphthalene+and+Benzosuberene+Analogs+of+the+Combretastatins+as+Inhibitors+of+Tubulin+Polymerization+in+Cancer+Chemotherapy&doi=10.1016%2Fj.bmc.2008.07.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy</span></div><div class="casAuthors">Sriram, Madhavi; Hall, John J.; Grohmann, Nathan C.; Strecker, Tracy E.; Wootton, Taylor; Franken, Andreas; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8161-8171</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A novel series of dihydronaphthalene and benzosuberene analogs bearing structural similarity to the combretastatins in terms of 1,2-diarylethene, trimethoxyphenyl, and biaryl functionality has been synthesized.  The compds. have been evaluated in regard to their ability to inhibit tubulin assembly and for their cytotoxicity against selected human cancer cell lines.  From this series of compds., benzosuberene analogs 2 and 4 inhibited tubulin assembly at concns. comparable to that of combretastatin A-4 (CA4) and combretastatin A-1 (CA1).  Furthermore, analog 4 demonstrated remarkable cytotoxicity against the three human cancer cell lines evaluated (for example GI50 = 0.0000032 μM against DU-145 prostate carcinoma).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OycvqOqayrVg90H21EOLACvtfcHk0li9z3reScTd8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyktbnO&md5=a0efe158ffd2427c55f4375d773ff90f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.050%26sid%3Dliteratum%253Aachs%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DGrohmann%26aufirst%3DN.%2BC.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DWootton%26aufirst%3DT.%26aulast%3DFranken%26aufirst%3DA.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Dihydronaphthalene%2520and%2520Benzosuberene%2520Analogs%2520of%2520the%2520Combretastatins%2520as%2520Inhibitors%2520of%2520Tubulin%2520Polymerization%2520in%2520Cancer%2520Chemotherapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D17%26spage%3D8161%26epage%3D8171%26doi%3D10.1016%2Fj.bmc.2008.07.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horsman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busk, M.</span></span> <span> </span><span class="NLM_article-title">Vascular Targeting Therapy: Potential Benefit Depends on Tumor and Host Related Effects</span>. <i>Exp. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=21403608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGjsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=143-148&issue=3&author=M.+R.+Horsmanauthor=A.+B.+Bohnauthor=M.+Busk&title=Vascular+Targeting+Therapy%3A+Potential+Benefit+Depends+on+Tumor+and+Host+Related+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular targeting therapy: potential benefit depends on tumor and host related effects</span></div><div class="casAuthors">Horsman, M. R.; Bohn, A. B.; Busk, M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-148</span>CODEN:
                <span class="NLM_cas:coden">EOXNAQ</span>;
        ISSN:<span class="NLM_cas:issn">1812-9269</span>.
    
            (<span class="NLM_cas:orgname">Morion LLC</span>)
        </div><div class="casAbstract">A review.  The growth and development of most solid tumors require that they form their own functional vascular supply, which they do from the host normal vascular network by the process of angiogenesis.  The significance of this neo-vasculature makes it an excellent target and two forms of vascular targeting agents (VTAs) have evolved; those that inhibit the angiogenesis process (angiogenesis inhibitors, AIs) and those that damage the already established vessels (vascular disrupting agents, VDAs).  Although both AIs and VDAs can have substantial anti-tumor activity, neither induce tumor control, thus for their full clin. potential to be achieved they will need to be combined with more conventional cancer therapies.  Numerous pre-clin. studies have demonstrated the efficacy of combining AIs and VDAs with radio- and chemo-therapy and many of these approaches are now under clin. evaluation.  Although the tumor is the target for VTA therapy the normal host cells play an important role in VTA efficacy.  Host cells such as infiltrating macrophages, neutrophils, mast cells, platelets, endothelial cells, and stromal fibroblasts can all produce the important growth factors that initiate angiogenesis.  Many of these host cells also actively participate in the phys. steps of angiogenesis including destabilization of existing vessels, blood vessel sprouting, endothelial cell migration and proliferation, and vessel stabilization.  There is some evidence that these host cells can also influence VTA treatment, either by helping to normalize tumor vessels when AIs are administered or stimulate tumor angiogenesis after treatment with VDAs.  The host itself also plays a crit. role.  Cancer patients undergoing therapy are normally treated to tolerance, thus the normal tissue side effects actually control the ED given to the tumor.  All VTAs currently in clin. development induce some form of systemic side effects, which range from being rather mild and tolerable to more severe and even life threatening.  For more localized therapies there is also the issue of possible VTA-enhanced local tissue reactions.  A few pre-clin. studies have investigated this with radiation, but failed to show any enhancement of radiation-induced normal tissue damage by VTAs.  Clearly, the therapeutic benefit of VTA treatment will depend on a balance between tumor and host related effects, and in this review we will consider the contribution of each.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWuYMDZtHbAbVg90H21EOLACvtfcHk0liw1LmPHmBuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGjsb7M&md5=ccb8cf1e527dccd0f6ecd6ca679ccb1c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorsman%26aufirst%3DM.%2BR.%26aulast%3DBohn%26aufirst%3DA.%2BB.%26aulast%3DBusk%26aufirst%3DM.%26atitle%3DVascular%2520Targeting%2520Therapy%253A%2520Potential%2520Benefit%2520Depends%2520on%2520Tumor%2520and%2520Host%2520Related%2520Effects%26jtitle%3DExp.%2520Oncol.%26date%3D2010%26volume%3D32%26issue%3D3%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dark, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicker, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskens, F. A. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horsman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P. M.</span></span> <span> </span><span class="NLM_article-title">Differentiation and Definition of Vascular-Targeted Therapies</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2, Part I</span>),  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15701823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=416-420&issue=2%2C+Part+I&author=D.+W.+Siemannauthor=M.+C.+Bibbyauthor=G.+G.+Darkauthor=A.+P.+Dickerauthor=F.+A.+L.+M.+Eskensauthor=M.+R.+Horsmanauthor=D.+Marm%C3%A9author=P.+M.+LoRusso&title=Differentiation+and+Definition+of+Vascular-Targeted+Therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation and Definition of Vascular-Targeted Therapies</span></div><div class="casAuthors">Siemann, Dietmar W.; Bibby, Michael C.; Dark, Graham G.; Dicker, Adam P.; Eskens, Ferry A. L. M.; Horsman, Michael R.; Marme, Dieter; LoRusso, Patricia M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">416-420</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The therapeutic potential of targeting the tumor vascular supply is now widely recognized.  Intense research and development activity has resulted in a variety of investigational agents, a no. of which are currently in clin. development.  As these novel agents are quite distinct from the cytotoxic drugs conventionally used in the treatment of solid tumors, it will be particularly important to ensure early differentiation of these vascular-targeted therapies in order to encourage widespread understanding of their potential benefits and application in the clinic.  Two distinct groups of vascular-targeted therapies have evolved: antiangiogenic agents and vascular-disrupting approaches.  These differ in three key respects: their physiol. target, the type or extent of disease that is likely to be susceptible, and the treatment scheduling.  Inhibitors of angiogenesis interfere with new vessel formation and therefore have a preventative action, require chronic administration, and are likely to be of particular benefit in early-stage or asymptomatic metastatic disease.  Vascular-disrupting agents target the established tumor blood vessels, resulting in tumor ischemia and necrosis.  These agents are therefore given acutely, show more immediate effects, and may have particular efficacy against advanced disease.  It is essential that these agents can be readily distinguished from conventional therapies and that an understanding of key differences between the two types of vascular-targeted therapies is fostered.  Here, a simple taxonomy and nomenclature is proposed in anticipation that the therapeutic potential of this novel class can be realized as these approaches advance in clin. settings and a new anticancer strategy becomes available in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIEL4anGTuWbVg90H21EOLACvtfcHk0liw1LmPHmBuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWgtro%253D&md5=8a037771f2908fb5729425f7bdc9ae10</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26aulast%3DBibby%26aufirst%3DM.%2BC.%26aulast%3DDark%26aufirst%3DG.%2BG.%26aulast%3DDicker%26aufirst%3DA.%2BP.%26aulast%3DEskens%26aufirst%3DF.%2BA.%2BL.%2BM.%26aulast%3DHorsman%26aufirst%3DM.%2BR.%26aulast%3DMarm%25C3%25A9%26aufirst%3DD.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26atitle%3DDifferentiation%2520and%2520Definition%2520of%2520Vascular-Targeted%2520Therapies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D2%252C%2520Part%2520I%26spage%3D416%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">A Perspective on Vascular Disrupting Agents That Interact with Tubulin: Preclinical Tumor Imaging and Biological Assessment</span>. <i>Integr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1039/c0ib00135j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1039%2Fc0ib00135j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=375-387&issue=4&author=R.+P.+Masonauthor=D.+Zhaoauthor=L.+Liuauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=A+Perspective+on+Vascular+Disrupting+Agents+That+Interact+with+Tubulin%3A+Preclinical+Tumor+Imaging+and+Biological+Assessment&doi=10.1039%2Fc0ib00135j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment</span></div><div class="casAuthors">Mason, Ralph P.; Zhao, Dawen; Liu, Li; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment provides a rich source of potential targets for selective therapeutic intervention with properly designed anticancer agents.  Significant physiol. differences exist between the microvessels that nourish tumors and those that supply healthy tissue.  Selective drug-mediated damage of these tortuous and chaotic microvessels starves a tumor of necessary nutrients and oxygen and eventually leads to massive tumor necrosis.  Vascular targeting strategies in oncol. are divided into two sep. groups: angiogenesis inhibiting agents (AIAs) and vascular disrupting agents (VDAs).  The mechanisms of action between these two classes of compds. are profoundly distinct.  The AIAs inhibit the actual formation of new vessels, while the VDAs damage and/or destroy existing tumor vasculature.  One subset of small-mol. VDAs functions by inhibiting the assembly of tubulin into microtubules, thus causing morphol. changes to the endothelial cells lining the tumor vasculature, triggered by a cascade of cell signaling events.  Ultimately this results in catastrophic damage to the vessels feeding the tumor.  The rapid emergence and subsequent development of the VDA field over the past decade has led to the establishment of a synergistic combination of preclin. state-of-the-art tumor imaging and biol. evaluation strategies that are often indicative of future clin. efficacy for a given VDA.  This review focuses on an integration of the appropriate biochem. and biol. tools necessary to assess (preclinically) new small-mol., tubulin active VDAs for their potential to be clin. effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw2V3dKpQSrLVg90H21EOLACvtfcHk0liLNubxCshDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D&md5=b58788fa8f5cdbc4d3abffff4e7eaca5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2Fc0ib00135j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0ib00135j%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DA%2520Perspective%2520on%2520Vascular%2520Disrupting%2520Agents%2520That%2520Interact%2520with%2520Tubulin%253A%2520Preclinical%2520Tumor%2520Imaging%2520and%2520Biological%2520Assessment%26jtitle%3DIntegr.%2520Biol.%26date%3D2011%26volume%3D3%26issue%3D4%26spage%3D375%26epage%3D387%26doi%3D10.1039%2Fc0ib00135j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, G. J.</span>; <span class="NLM_string-name">Chaplin, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of Vascular Disrupting Agents</span>. In  <i>Vascular Disruptive Agents for the Treatment of Cancer</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">27</span>; <a href="https://doi.org/10.1007/978-1-4419-6609-4_1" class="extLink">https://doi.org/10.1007/978-1-4419-6609-4_1</a>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2F978-1-4419-6609-4_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=1-27&author=G.+J.+Dougherty&author=D.+J.+Chaplin&title=Vascular+Disruptive+Agents+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-6609-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-6609-4_1%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DG.%2BJ.%26atitle%3DDevelopment%2520of%2520Vascular%2520Disrupting%2520Agents%26btitle%3DVascular%2520Disruptive%2520Agents%2520for%2520the%2520Treatment%2520of%2520Cancer%26pub%3DSpringer%26date%3D2010%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">Tumor Vasculature: A Target for Anticancer Therapies</span>. In  <i>Vascular-Targeted Therapies in Oncology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2F0470035439.ch1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=1-8&author=D.+W.+Siemannauthor=D.+W.+Siemann&title=Vascular-Targeted+Therapies+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F0470035439.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470035439.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DTumor%2520Vasculature%253A%2520A%2520Target%2520for%2520Anticancer%2520Therapies%26btitle%3DVascular-Targeted%2520Therapies%2520in%2520Oncology%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26pub%3DWiley%26date%3D2006%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monk, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugabe, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studerus, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvardsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Combretastatin Nitrogen-Containing Derivatives as Inhibitors of Tubulin Assembly and Vascular Disrupting Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3244</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2005.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=16442292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3231-3244&issue=9&author=K.+A.+Monkauthor=R.+Silesauthor=M.+B.+Hadimaniauthor=B.+E.+Mugabeauthor=J.+F.+Ackleyauthor=S.+W.+Studerusauthor=K.+Edvardsenauthor=M.+L.+Trawickauthor=C.+M.+Garnerauthor=M.+R.+Rhodesauthor=G.+R.+Pettitauthor=K.+G.+Pinney&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Combretastatin+Nitrogen-Containing+Derivatives+as+Inhibitors+of+Tubulin+Assembly+and+Vascular+Disrupting+Agents&doi=10.1016%2Fj.bmc.2005.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents</span></div><div class="casAuthors">Monk, Keith A.; Siles, Rogelio; Hadimani, Mallinath B.; Mugabe, Benon E.; Ackley, J. Freeland; Studerus, Scott W.; Edvardsen, Klaus; Trawick, Mary Lynn; Garner, Charles M.; Rhodes, Monte R.; Pettit, George R.; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3231-3244</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of analogs with nitro or serinamide substituents at the C-2'-, C-5'-, or C-6'-position of the combretastatin A-4 (CA4) B-ring was synthesized and evaluated for cytotoxic effects against heart endothelioma cells, blood flow redn. to tumors in SCID mice, and as inhibitors of tubulin polymn.  The synthesis of these analogs typically featured a Wittig reaction between a suitably functionalized arylaldehyde and an arylphosphonium salt followed by sepn. of the resultant E- and Z-isomers.  Several of these nitrogen-modified CA4 derivs. (both amino and nitro) demonstrate significant inhibition of tubulin assembly as well as cytotoxicity and in vivo blood flow redn.  The 2'-aminostilbenoid and 2'-amino-3'-hydroxystilbenoid proved to be the most active in this series.  Both compds. have the potential for further pro-drug modification and development as vascular disrupting agents for treatment of solid tumor cancers and certain ophthalmol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8R_9lmyQOTbVg90H21EOLACvtfcHk0liLNubxCshDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLw%253D&md5=ce4dbfc4af6d73556ac51925b59ce2e2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DMonk%26aufirst%3DK.%2BA.%26aulast%3DSiles%26aufirst%3DR.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DMugabe%26aufirst%3DB.%2BE.%26aulast%3DAckley%26aufirst%3DJ.%2BF.%26aulast%3DStuderus%26aufirst%3DS.%2BW.%26aulast%3DEdvardsen%26aufirst%3DK.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DRhodes%26aufirst%3DM.%2BR.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Combretastatin%2520Nitrogen-Containing%2520Derivatives%2520as%2520Inhibitors%2520of%2520Tubulin%2520Assembly%2520and%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26issue%3D9%26spage%3D3231%26epage%3D3244%26doi%3D10.1016%2Fj.bmc.2005.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, F.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1672</span>, <span class="refDoi"> DOI: 10.1021/jm00010a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00010a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2MXltlyru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1666-1672&issue=10&author=G.+R.+Pettitauthor=S.+B.+Singhauthor=M.+R.+Boydauthor=E.+Hamelauthor=R.+K.+Pettitauthor=J.+M.+Schmidtauthor=F.+Hogan&title=Antineoplastic+Agents.+291.+Isolation+and+Synthesis+of+Combretastatins+A-4%2C+A-5%2C+and+A-6&doi=10.1021%2Fjm00010a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6</span></div><div class="casAuthors">Pettit, George R.; Singh, Sheo Bux; Boyd, Michael R.; Hamel, Ernest; Pettit, Robin K.; Schmidt, Jean M.; Hogan, Fiona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1666-72</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The title compds. (Z)-3,4,5-(MeO)3C6H2CH:CHC6H3(OMe)OH-4,3 (I) and (Z)- and (E)-3,4,5-HO(MeO)2C6H2CH:CHC6H3(OMe)2-3,4 (II) were isolated from Combretum caffrum.  They were also prepd. by Wittig reactions.  I is the most potent cell growth inhibitor of the series.  It is also the most potent inhibitor of colchicine binding to tubulin.  I and II also inhibit the growth of Neisseria gonorrheae, but have no fungicidal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyoXBFl08OLVg90H21EOLACvtfcHk0liLuSKqnPMx0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltlyru74%253D&md5=c94f6ec6e373f1fd3eb7ff845b6292e0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00010a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00010a011%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DHogan%26aufirst%3DF.%26atitle%3DAntineoplastic%2520Agents.%2520291.%2520Isolation%2520and%2520Synthesis%2520of%2520Combretastatins%2520A-4%252C%2520A-5%252C%2520and%2520A-6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26issue%3D10%26spage%3D1666%26epage%3D1672%26doi%3D10.1021%2Fjm00010a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGown, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, B. W.</span></span> <span> </span><span class="NLM_article-title">Differential Cytotoxicity of Combretastatins A1 and A4 in Two Daunorubicin-Resistant P388 Cell Lines</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1007/BF02940301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2FBF02940301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=2322992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK3cXktVShtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1990&pages=79-81&issue=1&author=A.+T.+McGownauthor=B.+W.+Fox&title=Differential+Cytotoxicity+of+Combretastatins+A1+and+A4+in+Two+Daunorubicin-Resistant+P388+Cell+Lines&doi=10.1007%2FBF02940301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines</span></div><div class="casAuthors">McGown, Alan T.; Fox, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-81</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">Combretastatin A4 (I), a novel antimitotic agent was effective against two P388 cell lines with acquired resistance to daunorubicin.  In contrast, combretastatin A1 (II) showed a high degree of cross-resistance.  II was also more efficient at increasing intracellular daunorubicin concns. in both resistant cell lines.  Neither agent was capable of altering anthracycline accumulation in the parental (sensitive) cell line.  The cross-resistance to II occurs, at least in part, as a result of the increased affinity of the drug-efflux process operative in these resistant cells for II vs. I.  Hence, I may play a role in the treatment of tumors with acquired resistance to the anthracycline antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUFh8oXVjqDLVg90H21EOLACvtfcHk0liLuSKqnPMx0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVShtr4%253D&md5=df255967c5eaf9991a26b6c4b7ac2e92</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2FBF02940301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02940301%26sid%3Dliteratum%253Aachs%26aulast%3DMcGown%26aufirst%3DA.%2BT.%26aulast%3DFox%26aufirst%3DB.%2BW.%26atitle%3DDifferential%2520Cytotoxicity%2520of%2520Combretastatins%2520A1%2520and%2520A4%2520in%2520Two%2520Daunorubicin-Resistant%2520P388%2520Cell%2520Lines%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1990%26volume%3D26%26issue%3D1%26spage%3D79%26epage%3D81%26doi%3D10.1007%2FBF02940301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, J.-C.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents 460. Synthesis of Combretastatin A-2 Prodrugs</span>. <i>Anti-Cancer Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4–5</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12049477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFyqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=185-193&issue=4%E2%80%935&author=G.+R.+Pettitauthor=B.+R.+Moserauthor=M.+R.+Boydauthor=J.+M.+Schmidtauthor=R.+K.+Pettitauthor=J.-C.+Chapuis&title=Antineoplastic+Agents+460.+Synthesis+of+Combretastatin+A-2+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs</span></div><div class="casAuthors">Pettit, George R.; Moser, Bryan R.; Boyd, Michael R.; Schmidt, Jean M.; Pettit, Robin K.; Chapuis, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4/5</span>),
    <span class="NLM_cas:pages">185-193</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The original synthesis of combretastatin A-2 was modified to provide an efficient scale-up procedure for obtaining this antineoplastic stilbene.  Subsequent conversion to a useful prodrug was accomplished by phosphorylation employing in situ formation of dibenzylchlorophosphite followed by cleavage of the benzyl ester protective groups with bromotrimethylsilane to afford the phosphoric acid intermediate.  The latter was immediately treated with sodium methoxide to complete a practical route to the disodium phosphate prodrug.  The phosphoric acid precursor of disodium phosphate prodrug was employed in a parallel series of reactions to produce a selection of metal and ammonium cation prodrug candidates.  Each of the phosphate salts was evaluated with respect to relative soly. behavior, cancer cell growth inhibition and antimicrobial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorsOFDUAyzzrVg90H21EOLACvtfcHk0liLuSKqnPMx0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFyqtr8%253D&md5=e900c884117ec762ba3f355588ed180f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DMoser%26aufirst%3DB.%2BR.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26aulast%3DChapuis%26aufirst%3DJ.-C.%26atitle%3DAntineoplastic%2520Agents%2520460.%2520Synthesis%2520of%2520Combretastatin%2520A-2%2520Prodrugs%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D2001%26volume%3D16%26issue%3D4%25E2%2580%25935%26spage%3D185%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Kendal, D.</span></span> <span> </span><span class="NLM_article-title">Isolation and Structure of the Strong Cell Growth and Tubulin Inhibitor Combretastatin A-4</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1007/BF01954881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2FBF01954881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=2920809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL1MXktVShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=209-211&issue=2&author=G.%0AR.+Pettitauthor=S.+B.+Singhauthor=E.+Hamelauthor=C.+M.+Linauthor=D.+S.+Albertsauthor=D.+Garcia-Kendal&title=Isolation+and+Structure+of+the+Strong+Cell+Growth+and+Tubulin+Inhibitor+Combretastatin+A-4&doi=10.1007%2FBF01954881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4</span></div><div class="casAuthors">Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; Garcia-Kendall, D.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-11</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">From Combretum caffrum were isolated combretastatin A-4 (I, R1 = R2 = Me, R3 = H), combretastatin A-5 (I, R1 = H, R2 = R3 = Me), and combretastatin A-6 (II, R1 = H and R3 = Me) (the latter as the silyl ether).  The structures of these compds. detd. by spectroscopic methods were confirmed by total syntheses.  Combretastatins A-4, A-5 and A-6 were significantly active against murine L1210 and P388 lymphocytic leukemia cell lines with esp., combretastatin A-4 competing with combretastatin A-1 as the most inhibitor of colchicine binding to tubulin yet described.  Combretastatin A-4 was an inhibitor of tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt_PDOS8sCIrVg90H21EOLACvtfcHk0lj3xDOqDWaIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVShtbg%253D&md5=5f9cda9322b202960705a92aa1a751ff</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2FBF01954881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01954881%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DAlberts%26aufirst%3DD.%2BS.%26aulast%3DGarcia-Kendal%26aufirst%3DD.%26atitle%3DIsolation%2520and%2520Structure%2520of%2520the%2520Strong%2520Cell%2520Growth%2520and%2520Tubulin%2520Inhibitor%2520Combretastatin%2520A-4%26jtitle%3DExperientia%26date%3D1989%26volume%3D45%26issue%3D2%26spage%3D209%26epage%3D211%26doi%3D10.1007%2FBF01954881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dark, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prise, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span> <span> </span><span class="NLM_article-title">Combretastatin A-4, an Agent That Displays Potent and Selective Toxicity toward Tumor Vasculature</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1829</span>– <span class="NLM_lpage">1834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=9157969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=1829-1834&issue=10&author=G.+G.+Darkauthor=S.+A.+Hillauthor=V.+E.+Priseauthor=G.+M.+Tozerauthor=G.+R.+Pettitauthor=D.+J.+Chaplin&title=Combretastatin+A-4%2C+an+Agent+That+Displays+Potent+and+Selective+Toxicity+toward+Tumor+Vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature</span></div><div class="casAuthors">Dark, Graham G.; Hill, Sally A.; Prise, Vivien E.; Tozer, Gillian M.; Pettit, George R.; Chaplin, Dai J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1834</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Selective induction of vascular damage within tumors represents an emerging approach to cancer treatment.  Histol. studies have shown that several tubulin-binding agents can induce vascular damage within tumors but only at doses approximating the max. tolerated dose, which has limited their clin. applicability.  In this study, we show that the combretastatin A-4 prodrug induces vascular shutdown within tumors at doses less than one-tenth of the max. tolerated dose.  In vitro studies indicate that a short drug exposure results in profound long-term antiproliferative/cytotoxic effects against proliferating endothelial cells but not cells that are quiescent prior to and during drug exposure.  Vascular shutdown, within exptl. and human breast cancer models in vivo following systemic drug administration, was demonstrated with a redn. in functional vascular vol. of 93% at 6 h following drug administration and persisted over the next 12 h, with corresponding histol. consistent with hemorrhagic necrosis resulting from vascular damage.  The actions against tumor vasculature and the broad therapeutic window demonstrate the clin. potential of these drugs and warrant further study to elucidate the mechanisms responsible for the antivascular effects of combretastatin A-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEdUvgSGIqp7Vg90H21EOLACvtfcHk0lj3xDOqDWaIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D&md5=889e82f6a746aef44c2a28b77135e61f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDark%26aufirst%3DG.%2BG.%26aulast%3DHill%26aufirst%3DS.%2BA.%26aulast%3DPrise%26aufirst%3DV.%2BE.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DCombretastatin%2520A-4%252C%2520an%2520Agent%2520That%2520Displays%2520Potent%2520and%2520Selective%2520Toxicity%2520toward%2520Tumor%2520Vasculature%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26issue%3D10%26spage%3D1829%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdier-Pinard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1688</span>– <span class="NLM_lpage">1695</span>, <span class="refDoi"> DOI: 10.1021/jm970644q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970644q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK1cXisFeitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1688-1695&issue=10&author=G.+R.+Pettitauthor=B.+Tokiauthor=D.+L.+Heraldauthor=P.+Verdier-Pinardauthor=M.+R.+Boydauthor=E.+Hamelauthor=R.+K.+Pettit&title=Antineoplastic+Agents.+379.+Synthesis+of+Phenstatin+Phosphate&doi=10.1021%2Fjm970644q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate</span></div><div class="casAuthors">Pettit, George R.; Toki, Brian; Herald, Delbert L.; Verdier-Pinard, Pascal; Boyd, Michael R.; Hamel, Ernest; Pettit, Robin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1688-1695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship (SAR) study of the South African willow tree (Combretum caffrum) antineoplastic constituent combretastatin A-4 (I; R = OH, R1 = H) directed at maintaining the (Z)-stilbene relationship of the olefin di-Ph substituents led to synthesis of a potent cancer cell growth inhibitor designated phenstatin (II; R2 = OH).  Initially phenstatin silyl ether (II; R2 = OSiMe2CMe3) was unexpectedly obtained by Jacobsen oxidn. of combretastatin A-4 silyl ether (I; R = OSiMe2CMe2, R1 = H), and the parent phenstatin (II; R2 = OH) was later synthesized in quantity.  Phenstatin was converted to the sodium phosphate prodrug [II; R2 = OP(O)(ONa)2] by a dibenzyl phosphite phosphorylation and subsequent hydrogenolysis sequence.  Phenstatin (II; R2 = OH) inhibited growth of the pathogenic bacterium Neisseria gonorrhoeae and was a potent inhibitor of tubulin polymn. and the binding of colchicine to tubulin comparable to combretastatin A-4 (I; R = OH, R1 = H).  Interestingly, the prodrugs were found to have reduced activity in these biochem. assays.  While no significant tubulin activity was obsd. with the phosphorylated deriv. of combretastatin A-4 (I; R = OH, R1 = H), phosphate II [R2 = OP(O)(ONa)2] retained detectable inhibitory effects in both assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz3b1DHVHKBLVg90H21EOLACvtfcHk0lj3xDOqDWaIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFeitr8%253D&md5=4edd827bb3f81a8bdb912a9fa8178e16</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm970644q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970644q%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DToki%26aufirst%3DB.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DVerdier-Pinard%26aufirst%3DP.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26atitle%3DAntineoplastic%2520Agents.%2520379.%2520Synthesis%2520of%2520Phenstatin%2520Phosphate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D10%26spage%3D1688%26epage%3D1695%26doi%3D10.1021%2Fjm970644q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyland, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyland, M. E.</span></span> <span> </span><span class="NLM_article-title">Studies in Tissue Metabolism: The Action of Colchicine and B. Typhosus Extract</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1937</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1042/bj0310454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1042%2Fbj0310454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=16746357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaA2sXjtlClsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1937&pages=454-460&issue=3&author=E.+Boylandauthor=M.+E.+Boyland&title=Studies+in+Tissue+Metabolism%3A+The+Action+of+Colchicine+and+B.+Typhosus+Extract&doi=10.1042%2Fbj0310454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue metabolism. IX. The action of colchicine and B. typhosus extract</span></div><div class="casAuthors">Boyland, Eric; Boyland, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1937</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">454-60</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">cf. C. A. 30, 3511.1.  Colchicine in nearly toxic doses produced hemorrhage in grafted rat and mice tumors which was accompanied by a reduction in the ascorbic acid content and in the metabolism of the tumors.  A B. typhosus filtrate produced similar effects.  Colchicine also caused a reduction in the ascorbic acid content of the liver and intestine of rats and mice, but did not affect liver metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptf5bT2yvQULVg90H21EOLACvtfcHk0lj3xDOqDWaIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA2sXjtlClsg%253D%253D&md5=93c59d4f3ce10f2d572d1e40f7c26acf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1042%2Fbj0310454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj0310454%26sid%3Dliteratum%253Aachs%26aulast%3DBoyland%26aufirst%3DE.%26aulast%3DBoyland%26aufirst%3DM.%2BE.%26atitle%3DStudies%2520in%2520Tissue%2520Metabolism%253A%2520The%2520Action%2520of%2520Colchicine%2520and%2520B.%2520Typhosus%2520Extract%26jtitle%3DBiochem.%2520J.%26date%3D1937%26volume%3D31%26issue%3D3%26spage%3D454%26epage%3D460%26doi%3D10.1042%2Fbj0310454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadfield, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGown, A. T.</span></span> <span> </span><span class="NLM_article-title">The Interaction with Tubulin of a Series of Stilbenes Based on Combretastatin A-4</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1038/bjc.1995.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fbjc.1995.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=7710932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2MXmtF2ksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1995&pages=705-711&issue=4&author=J.+A.+Woodsauthor=J.+A.+Hadfieldauthor=G.+R.+Pettitauthor=B.+W.+Foxauthor=A.+T.+McGown&title=The+Interaction+with+Tubulin+of+a+Series+of+Stilbenes+Based+on+Combretastatin+A-4&doi=10.1038%2Fbjc.1995.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction with tubulin of a series of stilbenes based on combretastatin A-4</span></div><div class="casAuthors">Woods, J A.; Hadfield, J A.; Pettit, G R.; Fox, B W.; McGown, A T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">705-11</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">A series of stilbenes, based on combretastatin A-4, were synthesized.  A structure-activity study was carried out to characterize the interaction of these agents with tubulin.  The substitution of small alkyl substituents for the 4'-MeO group of combretastatin A-4 and the loss of the 3'-OH group does not have a major effect on the interaction with tubulin.  Trans-Stilbenes bound tubulin, but did not inhibit microtubule assembly.  An idealized structure for a tubulin-binding agent of this type is proposed.  The antitumor cytotoxicity of the compds. is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNQ1JKdExq0bVg90H21EOLACvtfcHk0lgfy41WQqyZHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtF2ksLg%253D&md5=b989319706146b1bc0c3bfa35c2ccf07</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1995.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1995.138%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DJ.%2BA.%26aulast%3DHadfield%26aufirst%3DJ.%2BA.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DFox%26aufirst%3DB.%2BW.%26aulast%3DMcGown%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Interaction%2520with%2520Tubulin%2520of%2520a%2520Series%2520of%2520Stilbenes%2520Based%2520on%2520Combretastatin%2520A-4%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1995%26volume%3D71%26issue%3D4%26spage%3D705%26epage%3D711%26doi%3D10.1038%2Fbjc.1995.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niven, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span> <span> </span><span class="NLM_article-title">Isolation, Structure, and Synthesis of Combretastatins A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Derived from Combretum Caffrum</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1021/np50049a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50049a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL2sXltFals7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=119-131&issue=1&author=G.+R.+Pettitauthor=S.+B.+Singhauthor=M.+L.+Nivenauthor=E.+Hamelauthor=J.+M.+Schmidt&title=Isolation%2C+Structure%2C+and+Synthesis+of+Combretastatins+A-1+and+B-1%2C+Potent+New+Inhibitors+of+Microtubule+Assembly%2C+Derived+from+Combretum+Caffrum&doi=10.1021%2Fnp50049a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents.  Part 123.  Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum</span></div><div class="casAuthors">Pettit, George R.; Singh, Sheo Bux; Niven, Margaret L.; Hamel, Ernest; Schmidt, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-31</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">The principal antineoplastic constituent of the South African tree C. caffrum was isolated and designated combretastatin A-1 (I).  The structure of this new cis-stilbene was unequivocally established by x-ray crystal structure detn. and total synthesis.  A Wittig reaction sequence in THF comprised the synthetic key step (92.5% yield) and provided a very favorable 9:1 ratio of the cis-trans isomers.  Selective hydrogenation of I afforded combretastatin B-1 (II), a companion cell growth inhibitory constituent of C. caffrum.  I provided 26-29% life extension at 2.75-11 mg/kg dose levels with ED50 0.99 μg/mL against the murine P-388 lymphocytic leukemia in vivo and in vitro systems.  Both I and II are potent inhibitors of microtubule assembly in vitro and are among the most potent inhibitors of the binding of colchicine to tubulin yet described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrghEgbQcROMLVg90H21EOLACvtfcHk0lgfy41WQqyZHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltFals7k%253D&md5=75ee1bd1979d95f667df3fcf1ec14719</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fnp50049a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50049a016%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DNiven%26aufirst%3DM.%2BL.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DIsolation%252C%2520Structure%252C%2520and%2520Synthesis%2520of%2520Combretastatins%2520A-1%2520and%2520B-1%252C%2520Potent%2520New%2520Inhibitors%2520of%2520Microtubule%2520Assembly%252C%2520Derived%2520from%2520Combretum%2520Caffrum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1987%26volume%3D50%26issue%3D1%26spage%3D119%26epage%3D131%26doi%3D10.1021%2Fnp50049a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grealish, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, R. K.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic Agents. 443. Synthesis of the Cancer Cell Growth Inhibitor Hydroxyphenstatin and Its Sodium Diphosphate Prodrug</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2731</span>– <span class="NLM_lpage">2737</span>, <span class="refDoi"> DOI: 10.1021/jm000045a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000045a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1Grt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2731-2737&issue=14&author=G.+R.+Pettitauthor=M.+P.+Grealishauthor=D.+L.+Heraldauthor=M.+R.+Boydauthor=E.+Hamelauthor=R.+K.+Pettit&title=Antineoplastic+Agents.+443.+Synthesis+of+the+Cancer+Cell+Growth+Inhibitor+Hydroxyphenstatin+and+Its+Sodium+Diphosphate+Prodrug&doi=10.1021%2Fjm000045a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic Agents. 443. Synthesis of the Cancer Cell Growth Inhibitor Hydroxyphenstatin and Its Sodium Diphosphate Prodrug</span></div><div class="casAuthors">Pettit, George R.; Grealish, Matthew P.; Herald, Delbert L.; Boyd, Michael R.; Hamel, Ernest; Pettit, Robin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2731-2737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship (SAR) study of the South African willow tree (Combretum caffrum) antineoplastic constituent combretastatin A-4 led to the discovery of a potent cancer cell growth inhibitor designated phenstatin.  This benzophenone deriv. of combretastatin A-4 showed remarkable antineoplastic activity, and the benzophenone deriv. of combretastatin A-1 was therefore synthesized.  The benzophenone, designated hydroxyphenstatin (I), was synthesized by coupling of a protected bromobenzene and a benzaldehyde to give the benzhydrol with subsequent oxidn. to the ketone.  Hydroxyphenstatin was converted to the sodium phosphate prodrug by a dibenzyl phosphite phosphorylation and subsequent benzyl cleavage.  While hydroxyphenstatin I was a potent inhibitor of tubulin polymn. with activity comparable to that of combretastatin A-1, the phosphorylated deriv. of I was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1rnEzAIdLk7Vg90H21EOLACvtfcHk0lgfy41WQqyZHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1Grt7c%253D&md5=4481df66fec835289cb9f20729246c41</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm000045a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000045a%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DGrealish%26aufirst%3DM.%2BP.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26atitle%3DAntineoplastic%2520Agents.%2520443.%2520Synthesis%2520of%2520the%2520Cancer%2520Cell%2520Growth%2520Inhibitor%2520Hydroxyphenstatin%2520and%2520Its%2520Sodium%2520Diphosphate%2520Prodrug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D14%26spage%3D2731%26epage%3D2737%26doi%3D10.1021%2Fjm000045a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herdman, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devkota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Structural Interrogation of Benzosuberene-Based Inhibitors of Tubulin Polymerization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7497</span>– <span class="NLM_lpage">7520</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2015.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=26775540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7497-7520&issue=24&author=C.+A.+Herdmanauthor=L.+Devkotaauthor=C.-M.+Linauthor=H.+Niuauthor=T.+E.+Streckerauthor=R.+Lopezauthor=L.+Liuauthor=C.+S.+Georgeauthor=R.+P.+Tanpureauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Structural+Interrogation+of+Benzosuberene-Based+Inhibitors+of+Tubulin+Polymerization&doi=10.1016%2Fj.bmc.2015.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization</span></div><div class="casAuthors">Herdman, Christine A.; Devkota, Laxman; Lin, Chen-Ming; Niu, Haichan; Strecker, Tracy E.; Lopez, Ramona; Liu, Li; George, Clinton S.; Tanpure, Rajendra P.; Hamel, Ernest; Chaplin, David J.; Mason, Ralph P.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7497-7520</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of 3-methoxy-9-(3',4',5'-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulen-4-ol (a benzosuberene-based analog referred to as KGP18) was originally inspired by the natural products colchicine and combretastatin A-4 (CA4).  The relative structural simplicity and ease of synthesis of KGP18, coupled with its potent biol. activity as an inhibitor of tubulin polymn. and its cytotoxicity (in vitro) against human cancer cell lines, has resulted in studies focused on new analog design and synthesis.  The goal was to probe the relationship of structure to function in this class of anticancer agents.  A series of twenty-two new benzosuberene-based analogs of KGP18 was designed and synthesized.  These compds. vary in their methoxylation pattern and sep. incorporate trifluoromethyl groups around the pendant aryl ring for the evaluation of the effect of functional group modifications on the fused six-membered arom. ring.  In addn., the 8,9-satd. congener of KGP18 has been synthesized to assess the necessity of unsatn. at the carbon atom bearing the pendant aryl ring.  Six of the mols. from this benzosuberene-series of compds. were active (IC50 < 5 μM) as inhibitors of tubulin polymn. while four analogs were comparable (IC50 approx. 1 μM) in their tubulin inhibitory activity to CA4 and KGP18.  The potency of a bis-trifluoromethyl analog I and the unsatd. KGP18 deriv. II as inhibitors of tubulin assembly along with their moderate cytotoxicity suggested the potential utility of these compds. as vascular disrupting agents (VDAs) to selectively target microvessels feeding tumors.  Accordingly, water-sol. and DMSO-sol. phosphate prodrug salts of each were synthesized for preliminary in vivo studies to assess their potential efficacy as VDAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHMYiacQz2erVg90H21EOLACvtfcHk0ljsjCcOnD6g8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsbvO&md5=adf22a9f30ec679efc0641324bade909</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DHerdman%26aufirst%3DC.%2BA.%26aulast%3DDevkota%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DNiu%26aufirst%3DH.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeorge%26aufirst%3DC.%2BS.%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DStructural%2520Interrogation%2520of%2520Benzosuberene-Based%2520Inhibitors%2520of%2520Tubulin%2520Polymerization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D24%26spage%3D7497%26epage%3D7520%26doi%3D10.1016%2Fj.bmc.2015.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkrider, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Application of the McMurry Coupling Reaction in the Synthesis of Tri- and Tetra-Arylethylene Analogues as Potential Cancer Chemotherapeutic Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6993</span>– <span class="NLM_lpage">7001</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2009.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=19733085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFamsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6993-7001&issue=19&author=R.+P.+Tanpureauthor=A.+R.+Harkriderauthor=T.+E.+Streckerauthor=E.+Hamelauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Application+of+the+McMurry+Coupling+Reaction+in+the+Synthesis+of+Tri-+and+Tetra-Arylethylene+Analogues+as+Potential+Cancer+Chemotherapeutic+Agents&doi=10.1016%2Fj.bmc.2009.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents</span></div><div class="casAuthors">Tanpure, Rajendra P.; Harkrider, Amanda R.; Strecker, Tracy E.; Hamel, Ernest; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6993-7001</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structural redesign of selected non-steroidal estrogen receptor binding compds. has previously been successful in the discovery of new inhibitors of tubulin assembly.  Accordingly, tetra-substituted alkene analogs (21-30) were designed based in part on combinations of the structural and electronic components of tamoxifen and combretastatin A-4 (CA4).  The McMurry coupling reaction was used as the key synthetic step in the prepn. of these tri- and tetra-arylethylene analogs.  The structural assignment of E, Z isomers was detd. on the basis of 2D-NOESY expts.  The ability of these compds. to inhibit tubulin polymn. and cell growth in selected human cancer cell lines was evaluated.  Although the compds. were found to be less potent than CA4, these analogs significantly advance the known structure-activity relationship assocd. with the colchicine binding site on β-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHVM9sLR3RQbVg90H21EOLACvtfcHk0ljeUopR5tCcRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFamsbjL&md5=047bacdf31fdc03d43a230351bf4577f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DHarkrider%26aufirst%3DA.%2BR.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DApplication%2520of%2520the%2520McMurry%2520Coupling%2520Reaction%2520in%2520the%2520Synthesis%2520of%2520Tri-%2520and%2520Tetra-Arylethylene%2520Analogues%2520as%2520Potential%2520Cancer%2520Chemotherapeutic%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D19%26spage%3D6993%26epage%3D7001%26doi%3D10.1016%2Fj.bmc.2009.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelinek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span> <span> </span><span class="NLM_article-title">The Discovery and Development of the Combretastatins</span>. <i>Anticancer Agents Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1201/b11185-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1201%2Fb11185-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=27-63&author=K.+G.+Pinneyauthor=G.+R.+Pettitauthor=M.+L.+Trawickauthor=C.+Jelinekauthor=D.+J.+Chaplin&title=The+Discovery+and+Development+of+the+Combretastatins&doi=10.1201%2Fb11185-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1201%2Fb11185-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1201%252Fb11185-4%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DJelinek%26aufirst%3DC.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Discovery%2520and%2520Development%2520of%2520the%2520Combretastatins%26jtitle%3DAnticancer%2520Agents%2520Nat.%2520Prod.%26date%3D2011%26spage%3D27%26epage%3D63%26doi%3D10.1201%2Fb11185-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of the Colchicine Binding Site as a Design Paradigm for the Discovery and Development of Vascular Disrupting Agents</span>. In  <i>Vascular-Targeted Therapies in Oncology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">121</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2F0470035439.ch6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=95-121&author=K.+G.+Pinneyauthor=D.+W.+Siemann&title=Vascular-Targeted+Therapies+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F0470035439.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470035439.ch6%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DMolecular%2520Recognition%2520of%2520the%2520Colchicine%2520Binding%2520Site%2520as%2520a%2520Design%2520Paradigm%2520for%2520the%2520Discovery%2520and%2520Development%2520of%2520Vascular%2520Disrupting%2520Agents%26btitle%3DVascular-Targeted%2520Therapies%2520in%2520Oncology%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26pub%3DWiley%26date%3D2006%26spage%3D95%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugabe, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddneppanavar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvardsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Combretastatin Dinitrogen-Substituted Stilbene Analogues as Tubulin-Binding and Vascular-Disrupting Agents</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1021/np070377j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np070377j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFWkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=313-320&issue=3&author=R.+Silesauthor=J.+F.+Ackleyauthor=M.+B.+Hadimaniauthor=J.+J.+Hallauthor=B.+E.+Mugabeauthor=R.+Guddneppanavarauthor=K.+A.+Monkauthor=J.-C.+Chapuisauthor=G.+R.+Pettitauthor=D.+J.+Chaplinauthor=K.+Edvardsenauthor=M.+L.+Trawickauthor=G.+M.+Garnerauthor=K.+G.+Pinney&title=Combretastatin+Dinitrogen-Substituted+Stilbene+Analogues+as+Tubulin-Binding+and+Vascular-Disrupting+Agents&doi=10.1021%2Fnp070377j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin Dinitrogen-Substituted Stilbene Analogues as Tubulin-Binding and Vascular-Disrupting Agents</span></div><div class="casAuthors">Siles, Rogelio; Ackley, J. Freeland; Hadimani, Mallinath B.; Hall, John J.; Mugabe, Benon E.; Guddneppanavar, Rajsekhar; Monk, Keith A.; Chapuis, Jean-Charles; Pettit, George R.; Chaplin, David J.; Edvardsen, Klaus; Trawick, Mary Lynn; Garner, Charles M.; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-320</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Several stilbenoid compds. having structural similarity to the combretastatin group of natural products and characterized by the incorporation of two N-bearing groups (amine, nitro, serinamide) were prepd. by chem. synthesis and evaluated in terms of biochem. and biol. activity.  The 2',3'-diamino B-ring analog (Z)-2-(2,3-diamino-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)ethene (17) demonstrated remarkable cytotoxicity against selected human cancer cell lines in vitro (av. GI50 = 13.9 nM) and also showed good activity in regard to inhibition of tubulin assembly (IC50 = 2.8 μM).  A single dose (10 mg/kg) of compd. 17 caused a 40% tumor-selective blood flow shutdown in tumor-bearing SCID mice at 24 h, thus suggesting the potential value of this compd. and its corresponding salt formulations as new vascular-disrupting agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu_0PO1vallbVg90H21EOLACvtfcHk0liFq2jttacE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFWkt7c%253D&md5=e9e37d310f45b58510d633e98278da60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fnp070377j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp070377j%26sid%3Dliteratum%253Aachs%26aulast%3DSiles%26aufirst%3DR.%26aulast%3DAckley%26aufirst%3DJ.%2BF.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DMugabe%26aufirst%3DB.%2BE.%26aulast%3DGuddneppanavar%26aufirst%3DR.%26aulast%3DMonk%26aufirst%3DK.%2BA.%26aulast%3DChapuis%26aufirst%3DJ.-C.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DEdvardsen%26aufirst%3DK.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DGarner%26aufirst%3DG.%2BM.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DCombretastatin%2520Dinitrogen-Substituted%2520Stilbene%2520Analogues%2520as%2520Tubulin-Binding%2520and%2520Vascular-Disrupting%2520Agents%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26issue%3D3%26spage%3D313%26epage%3D320%26doi%3D10.1021%2Fnp070377j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddneppanavar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelinek, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthasery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrell, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMordie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1P</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1021/np800661r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np800661r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=414-421&issue=3&author=A.+Shiraliauthor=M.+Sriramauthor=J.+J.+Hallauthor=B.+L.+Nguyenauthor=R.+Guddneppanavarauthor=M.+B.+Hadimaniauthor=J.+F.+Ackleyauthor=R.+Silesauthor=C.+J.+Jelinekauthor=P.+Arthaseryauthor=R.+C.+Brownauthor=V.+L.+Murrellauthor=A.+McMordieauthor=S.+Sharmaauthor=D.+J.+Chaplinauthor=K.+G.+Pinney&title=Development+of+Synthetic+Methodology+Suitable+for+the+Radiosynthesis+of+Combretastatin+A-1+%28CA1%29+and+Its+Corresponding+Prodrug+CA1P&doi=10.1021%2Fnp800661r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1P</span></div><div class="casAuthors">Shirali, Anupama; Sriram, Madhavi; Hall, John J.; Nguyen, Benson L.; Guddneppanavar, Rajsekhar; Hadimani, Mallinath B.; Ackley, J. Freeland; Siles, Rogelio; Jelinek, Christopher J.; Arthasery, Phyllis; Brown, Rodney C.; Murrell, Victor Leon; McMordie, Austin; Sharma, Suman; Chaplin, David J.; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-421</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Synthetic methodol. has been established suitable for the prepn. of combretastatin A-1 (I) and its corresponding phosphate prodrug salt CA1P in high specific activity radiolabeled form.  Judicious selection of appropriate phenolic protecting groups to distinguish positions on the A-ring from the B-ring of the stilbenoid was paramount for the success of this project.  Methylation of the C-4' phenolic moiety by removal of the tert-butyldimethylsilyl protecting group in the presence of Me iodide was accomplished in excellent yield without significant Z to E isomerization.  This step (carried out with 14C-Me iodide as proof of concept in this study) represents the process in which a 14C radioisotope could be incorporated in an actual radiosynthesis.  I is a natural product isolated from the African bush willow tree (Combretum caffrum) that has important medicinal value due, in part, to its ability to inhibit tubulin assembly.  As a prodrug, CA1P (OXi4503) is in human clin. trials as a vascular disrupting agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL45RoMfF3FLVg90H21EOLACvtfcHk0lgguIF_3uimLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs7Y%253D&md5=8c7e4ca9616847331ea3af293e06761e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fnp800661r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp800661r%26sid%3Dliteratum%253Aachs%26aulast%3DShirali%26aufirst%3DA.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DGuddneppanavar%26aufirst%3DR.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DAckley%26aufirst%3DJ.%2BF.%26aulast%3DSiles%26aufirst%3DR.%26aulast%3DJelinek%26aufirst%3DC.%2BJ.%26aulast%3DArthasery%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DR.%2BC.%26aulast%3DMurrell%26aufirst%3DV.%2BL.%26aulast%3DMcMordie%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DDevelopment%2520of%2520Synthetic%2520Methodology%2520Suitable%2520for%2520the%2520Radiosynthesis%2520of%2520Combretastatin%2520A-1%2520%2528CA1%2529%2520and%2520Its%2520Corresponding%2520Prodrug%2520CA1P%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2009%26volume%3D72%26issue%3D3%26spage%3D414%26epage%3D421%26doi%3D10.1021%2Fnp800661r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span>; <span class="NLM_string-name">Garner, C. M.,  III</span>; <span class="NLM_string-name">Kane, R. R.</span>; <span class="NLM_string-name">Pinney, K. G.</span>; <span class="NLM_string-name">Prezioso, J. A.</span>; <span class="NLM_string-name">Edvardsen, K.</span></span> <span> </span><span class="NLM_article-title">Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents</span>. <span class="NLM_patent">US7384925B2</span>, June 10, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+J.+Chaplin&author=C.+M.+Garner&author=R.+R.+Kane&author=K.+G.+Pinney&author=J.+A.+Prezioso&author=K.+Edvardsen&title=Functionalized+Stilbene+Derivatives+as+Improved+Vascular+Targeting+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DFunctionalized%2520Stilbene%2520Derivatives%2520as%2520Improved%2520Vascular%2520Targeting%2520Agents%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocharla, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Preparation of New Anti-Tubulin Ligands Through a Dual-Mode, Addition–Elimination Reaction to a Bromo-Substituted α,β-Unsaturated Sulfoxide</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">8811</span>– <span class="NLM_lpage">8815</span>, <span class="refDoi"> DOI: 10.1021/jo0004761</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0004761" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFynu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=8811-8815&issue=25&author=Z.+Chenauthor=V.+P.+Mocharlaauthor=J.+M.+Farmerauthor=G.+R.+Pettitauthor=E.+Hamelauthor=K.+G.+Pinney&title=Preparation+of+New+Anti-Tubulin+Ligands+Through+a+Dual-Mode%2C+Addition%E2%80%93Elimination+Reaction+to+a+Bromo-Substituted+%CE%B1%2C%CE%B2-Unsaturated+Sulfoxide&doi=10.1021%2Fjo0004761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of new anti-tubulin ligands through a dual-mode, addition-elimination reaction to a bromo-substituted α,β-unsaturated sulfoxide</span></div><div class="casAuthors">Chen, Zhi; Mocharla, Vani P.; Farmer, J. Matt; Pettit, George R.; Hamel, Ernest; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8811-8815</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two new anti-tubulin ligands, thiophene I and aryl thioether II, were prepd.  Thus, bromination of 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene followed by S-oxidn., substitution with 3,4,5-(MeO)3C6H3OH, and LiAlH4 redn. gave I in 68% yield.  II was prepd. via addn.-elimination-ring cleavage of thiophene oxide III with cuprate IV.  The crystal structure of II X-oxide was detd. by x-ray diffraction.  I, II, and their S-oxides were tested for anticancer activity and as inhibitors of tubulin polymn.  I was the most cytotoxic against human cell cancer cell lines and is a strong inhibitor of tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXPi7L0aep1rVg90H21EOLACvtfcHk0lh1BQHHOCe_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFynu7s%253D&md5=6b0aedf4f0ce91ef9bd1d1345c267baf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo0004761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0004761%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DFarmer%26aufirst%3DJ.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DPreparation%2520of%2520New%2520Anti-Tubulin%2520Ligands%2520Through%2520a%2520Dual-Mode%252C%2520Addition%25E2%2580%2593Elimination%2520Reaction%2520to%2520a%2520Bromo-Substituted%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Sulfoxide%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26issue%3D25%26spage%3D8811%26epage%3D8815%26doi%3D10.1021%2Fjo0004761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bounds, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingeman, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocharla, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span> <span> </span><span class="NLM_article-title">A New Anti-Tubulin Agent Containing the Benzo[b]Thiophene Ring System</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(99)00143-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2FS0960-894X%2899%2900143-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10328289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVKlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1081-1086&issue=8&author=K.+G.+Pinneyauthor=A.+D.+Boundsauthor=K.+M.+Dingemanauthor=V.+P.+Mocharlaauthor=G.+R.+Pettitauthor=R.+Baiauthor=E.+Hamel&title=A+New+Anti-Tubulin+Agent+Containing+the+Benzo%5Bb%5DThiophene+Ring+System&doi=10.1016%2FS0960-894X%2899%2900143-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A new anti-tubulin agent containing the benzo[b]thiophene ring system</span></div><div class="casAuthors">Pinney, Kevin G.; Bounds, A. Dawn; Dingeman, Koren M.; Mocharla, Vani P.; Pettit, George R.; Bai, Ruoli; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1081-1086</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new type of inhibitor of tubulin polymn. was discovered based on the 3-aroyl-2-arylbenzo[b]thiophene mol. skeleton.  The lead compd. in this series, 3-(3,4,5-Trimethoxybenzoyl)-2-(4-methoxyphenyl)-6-methoxybenzo[b]thiophene, inhibited tubulin polymn., caused an increase in the mitotic index of CA46 Burkitt lymphoma cells, and inhibited the growth of several human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI93GfkpJGXLVg90H21EOLACvtfcHk0lh1BQHHOCe_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVKlsrk%253D&md5=a1705d553e01438738b7a85c450c056e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900143-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900143-2%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DBounds%26aufirst%3DA.%2BD.%26aulast%3DDingeman%26aufirst%3DK.%2BM.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DA%2520New%2520Anti-Tubulin%2520Agent%2520Containing%2520the%2520Benzo%255Bb%255DThiophene%2520Ring%2520System%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26issue%3D8%26spage%3D1081%26epage%3D1086%26doi%3D10.1016%2FS0960-894X%2899%2900143-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K.</span>; <span class="NLM_string-name">Pettit, G.</span>; <span class="NLM_string-name">Mocharla, V.</span>; <span class="NLM_string-name">del Pilar Mejia, M.</span>; <span class="NLM_string-name">Shirali, A.</span></span> <span> </span><span class="NLM_article-title">Anti-Mitotic Agents Which Inhibit Tubulin Polymerization</span>. <span class="NLM_patent">WO/1998/039323</span>, September 12, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=K.+Pinney&author=G.+Pettit&author=V.+Mocharla&author=M.+del+Pilar+Mejia&author=A.+Shirali&title=Anti-Mitotic+Agents+Which+Inhibit+Tubulin+Polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%26atitle%3DAnti-Mitotic%2520Agents%2520Which%2520Inhibit%2520Tubulin%2520Polymerization%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K.</span>; <span class="NLM_string-name">Sriram, M.</span>; <span class="NLM_string-name">George, C.</span>; <span class="NLM_string-name">Tanpure, R.</span></span> <span> </span><span class="NLM_article-title">Efficient Method for Preparing Functionalized Benzosuberenes</span>. <span class="NLM_patent">WO/2012/068284</span>, May 25, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+Pinney&author=M.+Sriram&author=C.+George&author=R.+Tanpure&title=Efficient+Method+for+Preparing+Functionalized+Benzosuberenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%26atitle%3DEfficient%2520Method%2520for%2520Preparing%2520Functionalized%2520Benzosuberenes%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K.</span>; <span class="NLM_string-name">Mocharla, V.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Garner, C.</span>; <span class="NLM_string-name">Ghatak, A.</span>; <span class="NLM_string-name">Hadimani, M.</span>; <span class="NLM_string-name">Kessler, J.</span>; <span class="NLM_string-name">Dorsey, J.</span>; <span class="NLM_string-name">Edvardsen, K.</span>; <span class="NLM_string-name">Chaplin, D.</span>; <span class="NLM_string-name">Prezioso, J.</span>; <span class="NLM_string-name">Ghatak, U.</span></span> <span> </span><span class="NLM_article-title">Tubulin Binding Agents and Corresponding Prodrug Constructs</span>. <span class="NLM_patent">US20040043969A1</span>, March 4, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=K.+Pinney&author=V.+Mocharla&author=Z.+Chen&author=C.+Garner&author=A.+Ghatak&author=M.+Hadimani&author=J.+Kessler&author=J.+Dorsey&author=K.+Edvardsen&author=D.+Chaplin&author=J.+Prezioso&author=U.+Ghatak&title=Tubulin+Binding+Agents+and+Corresponding+Prodrug+Constructs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinney%26aufirst%3DK.%26atitle%3DTubulin%2520Binding%2520Agents%2520and%2520Corresponding%2520Prodrug%2520Constructs%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devkota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidmore, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdman, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonough, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Structurally Diverse Benzosuberene Analogues and Their Biological Evaluation as Anti-Cancer Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8019</span>– <span class="NLM_lpage">8032</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2013.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=24183586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12ksLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=8019-8032&issue=24&author=R.%0AP.+Tanpureauthor=C.+S.+Georgeauthor=T.+E.+Streckerauthor=L.+Devkotaauthor=J.+K.+Tidmoreauthor=C.-M.+Linauthor=C.+A.+Herdmanauthor=M.+T.+MacDonoughauthor=M.+Sriramauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+Structurally+Diverse+Benzosuberene+Analogues+and+Their+Biological+Evaluation+as+Anti-Cancer+Agents&doi=10.1016%2Fj.bmc.2013.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents</span></div><div class="casAuthors">Tanpure, Rajendra P.; George, Clinton S.; Strecker, Tracy E.; Devkota, Laxman; Tidmore, Justin K.; Lin, Chen-Ming; Herdman, Christine A.; MacDonough, Matthew T.; Sriram, Madhavi; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8019-8032</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Diversely functionalized, fused aryl-alkyl ring systems hold a prominent position as well-established mol. frameworks for a variety of anti-cancer agents.  The benzosuberene (6,7-fused, also referred to as dihydro-5H-benzo[7]annulene and benzocycloheptene) ring system has emerged as a valuable mol. core component for the development of inhibitors of tubulin assembly, which function as antiproliferative anti-cancer agents and, in certain cases, as vascular disrupting agents (VDAs).  Both a phenolic-based analog, I (R = OH) (known as KGP18) and its corresponding amine-based congener, I (R = NH2) (referred to as KGP156), which demonstrate strong inhibition of tubulin assembly (low micromolar range) and potent cytotoxicity (picomolar range for KGP18 and nanomolar range for KGP156) are noteworthy examples of such benzosuberene-based compds.  In order to extend the structure-activity relationship (SAR) knowledge base related to benzosuberene anti-cancer agents, a series of eleven analogs (including KGP18) were prepd. in which the methoxylation pattern on the pendant aryl ring as well as functional group incorporation on the fused aryl ring were varied.  The synthetic approach to these compds. featured a sequential Wittig olefination, redn., Eaton's reagent-mediated cyclization strategy to achieve the core benzosuberone intermediate, and represented a higher-yielding synthesis of KGP18 (which we prepd. previously through a ring-expansion strategy).  Incorporation of a fluorine or chlorine atom at the 1-position of the fused aryl ring or replacement of one of the methoxy groups with hydrogen (on the pendant aryl ring of KGP18) led to benzosuberene analogs that were both strongly inhibitory against tubulin assembly (IC50 approx. 1.0 μM) and strongly cytotoxic against selected human cancer cell lines, for example, GI50 = 5.47 nM against NCI-H460 cells with fluoro-benzosuberene analog I (R = F).  A water-sol. phosphate prodrug salt of KGP18, I [R = P(O)O2Na2+] (referred to as KGP265) and a water-sol. serinamide salt, II, of KGP156 were also synthesized and evaluated in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphmOTSUYXMPLVg90H21EOLACvtfcHk0lj_b641lJr4gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12ksLfE&md5=3a22651448245794e07521adb12a4a33</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DGeorge%26aufirst%3DC.%2BS.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DDevkota%26aufirst%3DL.%26aulast%3DTidmore%26aufirst%3DJ.%2BK.%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DHerdman%26aufirst%3DC.%2BA.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520Structurally%2520Diverse%2520Benzosuberene%2520Analogues%2520and%2520Their%2520Biological%2520Evaluation%2520as%2520Anti-Cancer%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D8019%26epage%3D8032%26doi%3D10.1016%2Fj.bmc.2013.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidmore, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton-Sevcik, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable Cytotoxicity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1039/c2md00318j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1039%2Fc2md00318j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23772309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=720-724&issue=6&author=R.+P.+Tanpureauthor=C.+S.+Georgeauthor=M.+Sriramauthor=T.+E.+Streckerauthor=J.+K.+Tidmoreauthor=E.+Hamelauthor=A.+K.+Charlton-Sevcikauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=An+Amino-Benzosuberene+Analogue+That+Inhibits+Tubulin+Assembly+and+Demonstrates+Remarkable+Cytotoxicity&doi=10.1039%2Fc2md00318j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity</span></div><div class="casAuthors">Tanpure, Rajendra P.; George, Clinton S.; Sriram, Madhavi; Strecker, Tracy E.; Tidmore, Justin K.; Hamel, Ernest; Charlton-Sevcik, Amanda K.; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">720-724</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The recent discovery of a small-mol. benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymn. (1-2 μM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivs.  An efficient synthetic route to functionalized benzosuberenes was developed.  This methodol. utilized a Wittig reaction, followed by a selective alkene redn. and ring-closing cyclization to form the core benzosuberone structure.  This synthetic route facilitated the prepn. of a 4-nitro-1-(3',4',5'-trimethoxyphenyl) benzosuberene deriv. and its corresponding 4-amino analog in good yield.  The 4-amino analog was a strong inhibitor of tubulin polymn. (1.2 μM), demonstrated enhanced cytotoxicity against the human cancer cell lines examd. (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concn. dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7itN54t7yMLVg90H21EOLACvtfcHk0lj_b641lJr4gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyhsbk%253D&md5=84cae4cc4413204616160eda558e51b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2Fc2md00318j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md00318j%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DGeorge%26aufirst%3DC.%2BS.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DTidmore%26aufirst%3DJ.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DCharlton-Sevcik%26aufirst%3DA.%2BK.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DAn%2520Amino-Benzosuberene%2520Analogue%2520That%2520Inhibits%2520Tubulin%2520Assembly%2520and%2520Demonstrates%2520Remarkable%2520Cytotoxicity%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D720%26epage%3D724%26doi%3D10.1039%2Fc2md00318j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hadimani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonough, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghatak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirali, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a 2-Aryl-3-Aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1021/np400374w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400374w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=1668-1678&issue=9&author=M.+B.+Hadimaniauthor=M.+T.+MacDonoughauthor=A.+Ghatakauthor=T.+E.+Streckerauthor=R.+Lopezauthor=M.+Sriramauthor=B.+L.+Nguyenauthor=J.+J.+Hallauthor=R.+J.+Kesslerauthor=A.+R.+Shiraliauthor=L.+Liuauthor=C.+M.+Garnerauthor=G.+R.+Pettitauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+a+2-Aryl-3-Aroyl+Indole+Salt+%28OXi8007%29+Resembling+Combretastatin+A-4+with+Application+as+a+Vascular+Disrupting+Agent&doi=10.1021%2Fnp400374w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span></div><div class="casAuthors">Hadimani, Mallinath B.; MacDonough, Matthew T.; Ghatak, Anjan; Strecker, Tracy E.; Lopez, Ramona; Sriram, Madhavi; Nguyen, Benson L.; Hall, John J.; Kessler, Raymond J.; Shirali, Anupama R.; Liu, Li; Garner, Charles M.; Pettit, George R.; Hamel, Ernest; Chaplin, David J.; Mason, Ralph P.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1678</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The natural products colchicine and combretastatin A-4 are potent inhibitors of tubulin assembly, and they have inspired the design and synthesis of a large no. of small-mol., potential anticancer agents.  The indole-based mol. scaffold is prominent among these SAR modifications, leading to a rapidly increasing no. of agents.  The water-sol. phosphate prodrug I [R = P(O)(O-Na+)2] (OXi8007) (II) of 2-aryl-3-aroylindole-based phenol I (R = H) (OXi8006) (III) was prepd. by chem. synthesis and found to be strongly cytotoxic against selected human cancer cell lines (GI50 = 36 nM against DU-145 cells, for example).  The free phenol, III (OXi8006), was a strong inhibitor (IC50 = 1.1 μM) of tubulin assembly.  The corresponding phosphate prodrug II (OXi8007) also demonstrated pronounced interference with tumor vasculature in a preliminary in vivo study utilizing a SCID mouse model bearing an orthotopic PC-3 (prostate) tumor as imaged by color Doppler ultrasound.  The combination of these results provides evidence that the indole-based phosphate prodrug II (OXi8007) functions as a vascular disrupting agent that may prove useful for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPuuWz4Lp4LVg90H21EOLACvtfcHk0lhBR5aAO0QDNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN&md5=d17de0d4667b5565c5715a956549c456</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fnp400374w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400374w%26sid%3Dliteratum%253Aachs%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DKessler%26aufirst%3DR.%2BJ.%26aulast%3DShirali%26aufirst%3DA.%2BR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520a%25202-Aryl-3-Aroyl%2520Indole%2520Salt%2520%2528OXi8007%2529%2520Resembling%2520Combretastatin%2520A-4%2520with%2520Application%2520as%2520a%2520Vascular%2520Disrupting%2520Agent%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2013%26volume%3D76%26issue%3D9%26spage%3D1668%26epage%3D1678%26doi%3D10.1021%2Fnp400374w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span> <span> </span><span class="NLM_article-title">Antimitotic Natural Products and Their Interactions with Tubulin</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1128(199603)16:2<207::AID-MED4>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=8656780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK28Xit12ku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=207-231&issue=2&author=E.+Hamel&title=Antimitotic+Natural+Products+and+Their+Interactions+with+Tubulin&doi=10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antimitotic natural products and their interactions with tubulin</span></div><div class="casAuthors">Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-31</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 143 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NTtfAB2p0LVg90H21EOLACvtfcHk0lhBR5aAO0QDNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit12ku78%253D&md5=eea5ddcb906ac1250300618fb4bba53b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199603%252916%253A2%253C207%253A%253AAID-MED4%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DAntimitotic%2520Natural%2520Products%2520and%2520Their%2520Interactions%2520with%2520Tubulin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1996%26volume%3D16%26issue%3D2%26spage%3D207%26epage%3D231%26doi%3D10.1002%2F%28SICI%291098-1128%28199603%2916%3A2%3C207%3A%3AAID-MED4%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.2174/1871520616666160219161921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.2174%2F1871520616666160219161921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=26899186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1325-1338&issue=10&author=X.+Wuauthor=Q.+Wangauthor=W.+Li&title=Recent+Advances+in+Heterocyclic+Tubulin+Inhibitors+Targeting+the+Colchicine+Binding+Site&doi=10.2174%2F1871520616666160219161921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site</span></div><div class="casAuthors">Wu, Xiaoxin; Wang, Qinghui; Li, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1325-1338</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Microtubules are involved in many crit. cellular processes including cell division, cell shape maintenance, vesicle transportation and motility regulation.  Disruption of tubulin dynamics is a well-validated cancer drug target with several FDA approved, highly efficacious tubulin inhibitors targeting the taxane or the vinca binding sites.  Despite the tremendous successes for these clin. tubulin inhibitors, their limitations are also apparent, particularly in the development of transporter mediated drug resistance.  While currently there are no FDA approved inhibitors targeting the colchicine binding site in tubulin, extensive preclin. studies have suggested that colchicine binding site inhibitors (CBSIs) have significantly less susceptibility to transporter medicated drug resistance.  The presence of one or more heterocyclic moieties is often crit. for the antiproliferative activities for most of these CBSIs.  This article aims to review the structures and antiproliferative activities of most recently developed heterocyclic CBSIs from 2013 to present.  We focus this review on compds. that are designed based on the CA-4, chalcone and PTOX scaffolds which are well established to interact with the colchicine binding site in tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsh10kAoyRzLVg90H21EOLACvtfcHk0lhBR5aAO0QDNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrfE&md5=7959990391bd432fa2a417cf1309aec4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160219161921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160219161921%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DRecent%2520Advances%2520in%2520Heterocyclic%2520Tubulin%2520Inhibitors%2520Targeting%2520the%2520Colchicine%2520Binding%2520Site%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26issue%3D10%26spage%3D1325%26epage%3D1338%26doi%3D10.2174%2F1871520616666160219161921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirtz, D. A.</span></span> <span> </span><span class="NLM_article-title">Colchicine Site Inhibitors of Microtubule Integrity as Vascular Disrupting Agents</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1002/ddr.20267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fddr.20267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=352-358&issue=6&author=R.+M.+Leeauthor=D.+A.+Gewirtz&title=Colchicine+Site+Inhibitors+of+Microtubule+Integrity+as+Vascular+Disrupting+Agents&doi=10.1002%2Fddr.20267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Colchicine site inhibitors of microtubule integrity as vascular disrupting agents</span></div><div class="casAuthors">Lee, Ray M.; Gewirtz, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">352-358</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Drugs that bind to the colchicine binding site of tubulin and induce tubulin depolymn. hold promise as antitumor drugs through their ability to induce cell cycle arrest and to kill cancer cells through apoptosis and mitotic catastrophe.  However, development of this group of compds. as direct antitumor cytotoxic agents has not proved successful.  Over the last few years, the potential of these compds. to act as selective vascular disrupting agents has been recognized.  Several agents have advanced to phase I and phase II clin. studies, and their capacity to suppress growth of the tumor vasculature has been confirmed.  Toxicity in terms of cardiovascular and thromboembolic events remains a major concern and their therapeutic efficacy as single agents has been disappointing.  Nevertheless, a more comprehensive understanding of tumor compensatory mechanisms and potential combination strategies with anti-angiogenic agents suggest that vascular targeting therapy may be a fruitful direction for the further development of this class of drugs as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA1dFtz8TzprVg90H21EOLACvtfcHk0lhBR5aAO0QDNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2gsg%253D%253D&md5=a56c7b47b1f6695bf30af778d4089ab6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fddr.20267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.20267%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BM.%26aulast%3DGewirtz%26aufirst%3DD.%2BA.%26atitle%3DColchicine%2520Site%2520Inhibitors%2520of%2520Microtubule%2520Integrity%2520as%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2008%26volume%3D69%26issue%3D6%26spage%3D352%26epage%3D358%26doi%3D10.1002%2Fddr.20267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gigant, B.</span>; <span class="NLM_string-name">Cormier, A.</span>; <span class="NLM_string-name">Dorléans, A.</span>; <span class="NLM_string-name">Ravelli, R. B. G.</span>; <span class="NLM_string-name">Knossow, M.</span></span> <span> </span><span class="NLM_article-title">Microtubule-Destabilizing Agents: Structural and Mechanistic Insights from the Interaction of Colchicine and Vinblastine with Tubulin</span>. In  <i>Tubulin-Binding Agents: Synthetic, Structural and Mechanistic Insights</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlomagno, T.</span></span>, Ed.; Topics in Current Chemistry; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2009</span>; pp  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">278</span>, <a href="https://doi.org/10.1007/128_2008_11" class="extLink">https://doi.org/10.1007/128_2008_11</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=259-278&author=B.+Gigant&author=A.+Cormier&author=A.+Dorl%C3%A9ans&author=R.+B.+G.+Ravelli&author=M.+Knossowauthor=T.+Carlomagno&title=Tubulin-Binding+Agents%3A+Synthetic%2C+Structural+and+Mechanistic+Insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGigant%26aufirst%3DB.%26atitle%3DMicrotubule-Destabilizing%2520Agents%253A%2520Structural%2520and%2520Mechanistic%2520Insights%2520from%2520the%2520Interaction%2520of%2520Colchicine%2520and%2520Vinblastine%2520with%2520Tubulin%26btitle%3DTubulin-Binding%2520Agents%253A%2520Synthetic%252C%2520Structural%2520and%2520Mechanistic%2520Insights%26aulast%3DCarlomagno%26aufirst%3DT.%26pub%3DSpringer%26date%3D2009%26spage%3D259%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sackett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podophyllotoxin, L.</span></span> <span> </span><span class="NLM_article-title">Steganacin and Combretastatin: Natural Products That Bind at the Colchicine Site of Tubulin</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(93)90044-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2F0163-7258%2893%2990044-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=8278462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1993&pages=163-228&issue=2&author=D.+Sackettauthor=L.+Podophyllotoxin&title=Steganacin+and+Combretastatin%3A+Natural+Products+That+Bind+at+the+Colchicine+Site+of+Tubulin&doi=10.1016%2F0163-7258%2893%2990044-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Podophyllotoxin, steganacin and combretastatin: Natural products that bind at the colchicine site of tubulin</span></div><div class="casAuthors">Sackett, Dan L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-228</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with >300 refs.  Occurrence and isolation, chem. and biosynthesis, binding to tubulin, inhibition of polymn., analogs and structure-activity relationship and biol. activity of podophyllotoxin, steganacin, and combretastatin are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0uKGl_o7MWbVg90H21EOLACvtfcHk0lg1frNOpu7BMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2mtQ%253D%253D&md5=05f0c6d53e4c1d818ad378c4f07e0f1c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2893%2990044-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252893%252990044-E%26sid%3Dliteratum%253Aachs%26aulast%3DSackett%26aufirst%3DD.%26aulast%3DPodophyllotoxin%26aufirst%3DL.%26atitle%3DSteganacin%2520and%2520Combretastatin%253A%2520Natural%2520Products%2520That%2520Bind%2520at%2520the%2520Colchicine%2520Site%2520of%2520Tubulin%26jtitle%3DPharmacol.%2520Ther.%26date%3D1993%26volume%3D59%26issue%3D2%26spage%3D163%26epage%3D228%26doi%3D10.1016%2F0163-7258%2893%2990044-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Structures of a Diverse Set of Colchicine Binding Site Inhibitors in Complex with Tubulin Provide a Rationale for Drug Discovery</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/febs.13555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1111%2Ffebs.13555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=26462166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=102-111&issue=1&author=Y.+Wangauthor=H.+Zhangauthor=B.+Gigantauthor=Y.+Yuauthor=Y.+Wuauthor=X.+Chenauthor=Q.+Laiauthor=Z.+Yangauthor=Q.+Chenauthor=J.+Yang&title=Structures+of+a+Diverse+Set+of+Colchicine+Binding+Site+Inhibitors+in+Complex+with+Tubulin+Provide+a+Rationale+for+Drug+Discovery&doi=10.1111%2Ffebs.13555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery</span></div><div class="casAuthors">Wang, Yuxi; Zhang, Hang; Gigant, Benoit; Yu, Yamei; Wu, Yangping; Chen, Xiangzheng; Lai, Qinhuai; Yang, Zhaoya; Chen, Qiang; Yang, Jinliang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Microtubules are dynamic assemblies of αβ-tubulin heterodimers and have been recognized as highly attractive targets for cancer chemotherapy.  A broad range of agents bind to tubulin and interfere with microtubule assembly.  Despite having a long history of characterization, colchicine binding site inhibitors (CBSIs) have not yet reached the com. phase as anti-cancer drugs to date.  We detd. the structures of tubulin complexed with a set of structurally diverse CBSIs (lexibulin, nocodazole, plinabulin and tivantinib), among which nocodazole and tivantinib are both binary-function inhibitors targeting cancer-related kinases and microtubules simultaneously.  High resoln. structures revealed the detailed interactions between these ligands and tubulin.  Our results showed that the binding modes of the CBSIs were different from previous docking models, highlighting the importance of crystal structure information in structure-based drug design.  A real structure-based pharmacophore was proposed to rationalize key common interactions of the CBSIs at the colchicine domain.  Our studies provide a solid structural basis for developing new anti-cancer agents for the colchicine binding site.  Database : The at. coordinates and structure factors for tubulin complexed with lexibulin, nocodazole, plinabulin and tivantinib have been deposited in the Protein Data Bank under accession codes , , and , resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIAVSS_EsIbVg90H21EOLACvtfcHk0lg1frNOpu7BMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP&md5=d5a17d9a3ac54d8eda44d0543ffa5fbd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13555%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Binding%2520Site%2520Inhibitors%2520in%2520Complex%2520with%2520Tubulin%2520Provide%2520a%2520Rationale%2520for%2520Drug%2520Discovery%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26issue%3D1%26spage%3D102%26epage%3D111%26doi%3D10.1111%2Ffebs.13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1348</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150114163732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.2174%2F0929867322666150114163732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=25620094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1348-1360&issue=11&author=Y.-T.+Jiauthor=Y.-N.+Liuauthor=Z.-P.+Liu&title=Tubulin+Colchicine+Binding+Site+Inhibitors+as+Vascular+Disrupting+Agents+in+Clinical+Developments&doi=10.2174%2F0929867322666150114163732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments</span></div><div class="casAuthors">Ji, Ya-Ting; Liu, Yan-Na; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1348-1360</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor vasculature is an important target in cancer treatment.  Two distinct vasculartargeting therapeutic strategies are applied to attack cancer cells indirectly.  The antiangiogenic approach intervenes in the neovascularization processes and blocks the formation of new blood vessels, while th e antivascular approach targets the established tumor blood vessels, making vascular shutdown and resulting in rapid haemorrhagic necrosis and tumor cell death.  A no. of compds. with diverse structural scaffolds have been designed to target tumor vasculature and they are called vascular disrupting agents (VDAs).  The biol. or ligand-directed VDAs utilize antibodies, peptides or growth factors to deliver toxins or pro-coagulants or proapoptotic affectors to tumor-related blood vessels, while the small-mol. VDAs selectively target tumor blood vessels and have little effects on the normal endothelium.  Among the small-mol. VDAs, the tubulin colchicine binding site inhibitors have been extensively studied and many of them have entered the clin. trials, including CA-4P, CA-1P, AVE8062, OXi4503, CKD-516, BNC105P, ABT-751, CYT- 997, ZD6126, NPI-2358, MN-029 and EPC2407.  This review makes a summary of the small-mol. VDAs in clin. developments and highlights some potential VDA leads or candidates for the treatment of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-aHECQeEv7LVg90H21EOLACvtfcHk0lg1frNOpu7BMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D&md5=65300d3649e348a5c3c66fbc2dac4f07</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150114163732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150114163732%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DY.-T.%26aulast%3DLiu%26aufirst%3DY.-N.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DTubulin%2520Colchicine%2520Binding%2520Site%2520Inhibitors%2520as%2520Vascular%2520Disrupting%2520Agents%2520in%2520Clinical%2520Developments%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26issue%3D11%26spage%3D1348%26epage%3D1360%26doi%3D10.2174%2F0929867322666150114163732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermone, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharevitz, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gussio, R.</span></span> <span> </span><span class="NLM_article-title">A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6107</span>– <span class="NLM_lpage">6116</span>, <span class="refDoi"> DOI: 10.1021/jm050502t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&issue=19&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+Common+Pharmacophore+for+a+Diverse+Set+of+Colchicine+Site+Inhibitors+Using+a+Structure-Based+Approach&doi=10.1021%2Fjm050502t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0lj1PagMOCgxyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520Common%2520Pharmacophore%2520for%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Site%2520Inhibitors%2520Using%2520a%2520Structure-Based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D19%26spage%3D6107%26epage%3D6116%26doi%3D10.1021%2Fjm050502t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.2174/138955709789055234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.2174%2F138955709789055234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=19817710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOjsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1174-1190&issue=10&author=J.+Chenauthor=T.+Liuauthor=X.+Dongauthor=Y.+Hu&title=Recent+Development+and+SAR+Analysis+of+Colchicine+Binding+Site+Inhibitors&doi=10.2174%2F138955709789055234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Recent development and SAR analysis of colchicine binding site inhibitors</span></div><div class="casAuthors">Chen, Jing; Liu, Tao; Dong, Xiaowu; Hu, Yongzhou</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1174-1190</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Microtubules are cytoskeletal components that play important roles in a no. of cellular processes.  Colchicine binding site inhibitors (CSIs) is one major class of tubulin polymn. inhibitors, inhibiting microtubule polymn. and blocking cell proliferation at metaphase during mitosis.  Many CSIs were discovered or designed and synthesized as anticancer agents in the past several years and great progress had been made.  Here, we discuss the insights gained so far relevant to the mechanism of CSIs and their common pharmacophore.  The recent development of CSIs with their biol. activity and structure-activity relationship (SAR) are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqehPVBYRYe9bVg90H21EOLACvtfcHk0ljFlwm-SATlMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOjsL%252FP&md5=86d05831ad98872972f2ae17d1ddd85d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F138955709789055234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955709789055234%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DRecent%2520Development%2520and%2520SAR%2520Analysis%2520of%2520Colchicine%2520Binding%2520Site%2520Inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26issue%3D10%26spage%3D1174%26epage%3D1190%26doi%3D10.2174%2F138955709789055234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2943</span>– <span class="NLM_lpage">2971</span>, <span class="refDoi"> DOI: 10.1007/s11095-012-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2Fs11095-012-0828-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=22814904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2943-2971&issue=11&author=Y.+Luauthor=J.+Chenauthor=M.+Xiaoauthor=W.+Liauthor=D.+D.+Miller&title=An+Overview+of+Tubulin+Inhibitors+That+Interact+with+the+Colchicine+Binding+Site&doi=10.1007%2Fs11095-012-0828-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span></div><div class="casAuthors">Lu, Yan; Chen, Jianjun; Xiao, Min; Li, Wei; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2943-2971</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tubulin dynamics is a promising target for new chemotherapeutic agents.  The colchicine binding site is one of the most important pockets for potential tubulin polymn. destabilizers.  Colchicine binding site inhibitors (CBSI) exert their biol. effects by inhibiting tubulin assembly and suppressing microtubule formation.  A large no. of mols. interacting with the colchicine binding site have been designed and synthesized with significant structural diversity.  CBSIs have been modified as to chem. structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers.  CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin.  The present review is a synopsis of compds. that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrFQVgeCbBbVg90H21EOLACvtfcHk0ljFlwm-SATlMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN&md5=dfe42e8eb1f0ff22b256641aaa8c17ab</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DAn%2520Overview%2520of%2520Tubulin%2520Inhibitors%2520That%2520Interact%2520with%2520the%2520Colchicine%2520Binding%2520Site%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D2943%26epage%3D2971%26doi%3D10.1007%2Fs11095-012-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macdonough, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Indole-Based, Anti-Cancer Agents Inspired by the Vascular Disrupting Agent 2-(3′-Hydroxy-4′-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6831</span>– <span class="NLM_lpage">6843</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmc.2013.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23993969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6831-6843&issue=21&author=M.+T.+Macdonoughauthor=T.+E.+Streckerauthor=E.+Hamelauthor=J.+J.+Hallauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+and+Biological+Evaluation+of+Indole-Based%2C+Anti-Cancer+Agents+Inspired+by+the+Vascular+Disrupting+Agent+2-%283%E2%80%B2-Hydroxy-4%E2%80%B2-methoxyphenyl%29-3-%283%E2%80%B3%2C4%E2%80%B3%2C5%E2%80%B3-trimethoxybenzoyl%29-6-methoxyindole+%28OXi8006%29&doi=10.1016%2Fj.bmc.2013.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3'',4'',5''-trimethoxybenzoyl)-6-methoxyindole (OXi8006)</span></div><div class="casAuthors">MacDonough, Matthew T.; Strecker, Tracy E.; Hamel, Ernest; Hall, John J.; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6831-6843</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of a 2-aryl-3-aroyl indole-based small-mol. inhibitor of tubulin assembly (referred to as OXi8006) inspired the design, synthesis, and biol. evaluation of a series of diversely functionalized analogs.  In the majority of examples, the pendant 2-aryl ring contained a 3-hydroxy-4-methoxy substitution pattern, and the fused aryl ring featured a 6-methoxy group.  Most of the variability was in the 3-aroyl moiety, which was modified to incorporate methoxy (33-36), nitro (25-27), halogen (28-29), trifluoromethyl (30), or trifluoromethoxy (31-32) functionalities.  In two analogs (34 and 36), the methoxy substitution pattern in the fused aryl ring varied, while in another deriv. (35) the phenolic moiety was translocated from the pendant 2-aryl ring to position-7 of the fused aryl ring.  Each of the compds. were evaluated for their cytotoxicity (in vitro) against the SK-OV-3 (ovarian), NCI-H460 (lung), and DU-145 (prostate) human cancer cell lines and for their ability to inhibit tubulin assembly.  Four of the compds. (30, 31, 35, 36) proved to be potent inhibitors of tubulin assembly (IC50 <5 μM), and three of these compds. (31, 35, 36) were strongly cytotoxic against the three cancer cell lines.  The most active compd. (36) in this series, which incorporated a methoxy group at position-7, was comparable in terms of inhibition of tubulin assembly and cytotoxicity to the lead compd. OXi8006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-JO7cUZaeLVg90H21EOLACvtfcHk0ljFlwm-SATlMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtbzE&md5=e7ad3c7876f5dc41113c136135f7513c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonough%26aufirst%3DM.%2BT.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Indole-Based%252C%2520Anti-Cancer%2520Agents%2520Inspired%2520by%2520the%2520Vascular%2520Disrupting%2520Agent%25202-%25283%25E2%2580%25B2-Hydroxy-4%25E2%2580%25B2-methoxyphenyl%2529-3-%25283%25E2%2580%25B3%252C4%25E2%2580%25B3%252C5%25E2%2580%25B3-trimethoxybenzoyl%2529-6-methoxyindole%2520%2528OXi8006%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D21%26spage%3D6831%26epage%3D6843%26doi%3D10.1016%2Fj.bmc.2013.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grobelny, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leske, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavranos, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostewicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremmidiotis, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-Hydroxy-6-Methoxy-2-Methyl-3-(3,4,5-Trimethoxybenzoyl)Benzo[b]Furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6014</span>– <span class="NLM_lpage">6027</span>, <span class="refDoi"> DOI: 10.1021/jm200454y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200454y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6014-6027&issue=17&author=B.+L.+Flynnauthor=G.+S.+Gillauthor=D.+W.+Grobelnyauthor=J.+H.+Chaplinauthor=D.+Paulauthor=A.+F.+Leskeauthor=T.+C.+Lavranosauthor=D.+K.+Chalmersauthor=S.+A.+Charmanauthor=E.+Kostewiczauthor=D.+M.+Shacklefordauthor=J.+Morizziauthor=E.+Hamelauthor=M.+K.+Jungauthor=G.+Kremmidiotis&title=Discovery+of+7-Hydroxy-6-Methoxy-2-Methyl-3-%283%2C4%2C5-Trimethoxybenzoyl%29Benzo%5Bb%5DFuran+%28BNC105%29%2C+a+Tubulin+Polymerization+Inhibitor+with+Potent+Antiproliferative+and+Tumor+Vascular+Disrupting+Properties&doi=10.1021%2Fjm200454y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties</span></div><div class="casAuthors">Flynn, Bernard L.; Gill, Gurmit S.; Grobelny, Damian W.; Chaplin, Jason H.; Paul, Dharam; Leske, Annabell F.; Lavranos, Tina C.; Chalmers, David K.; Charman, Susan A.; Kostewicz, Edmund; Shackleford, David M.; Morizzi, Julia; Hamel, Ernest; Jung, M. Katherine; Kremmidiotis, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6014-6027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trimethoxybenzoyl benzofurans such as I [R = H, (NaO)2P:O] were prepd. as analogs of combretastatin A4 for use as antitumor agents and tested for their inhibition of tubulin polymn.  Structure-activity relationships were detd. for the inhibition of tubulin polymn. by benzoyl benzofurans; introduction of a conformation bias and addn. of a hydrogen bond donor improved the activities of the compds.  I (R = H) was found by screening for selectivity against cancer cells and activated endothelial cells over quiescent endothelial cells; its activity against nonresistant and resistant human cancer cell lines and pharmacokinetics in rats were detd.  I [R = (NaO)2P:O] has improved soly., improved ability to disrupt tumor vasculature, and improved tumor growth inhibition over both I (R = H) and combretastatin A-4 disodium phosphate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV_WE1ggYIxLVg90H21EOLACvtfcHk0lia-yW9MLfttQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsb8%253D&md5=7c9a9ea031ebbb02d2c262015ff3df25</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm200454y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200454y%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DB.%2BL.%26aulast%3DGill%26aufirst%3DG.%2BS.%26aulast%3DGrobelny%26aufirst%3DD.%2BW.%26aulast%3DChaplin%26aufirst%3DJ.%2BH.%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DLeske%26aufirst%3DA.%2BF.%26aulast%3DLavranos%26aufirst%3DT.%2BC.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKostewicz%26aufirst%3DE.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DJung%26aufirst%3DM.%2BK.%26aulast%3DKremmidiotis%26aufirst%3DG.%26atitle%3DDiscovery%2520of%25207-Hydroxy-6-Methoxy-2-Methyl-3-%25283%252C4%252C5-Trimethoxybenzoyl%2529Benzo%255Bb%255DFuran%2520%2528BNC105%2529%252C%2520a%2520Tubulin%2520Polymerization%2520Inhibitor%2520with%2520Potent%2520Antiproliferative%2520and%2520Tumor%2520Vascular%2520Disrupting%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D17%26spage%3D6014%26epage%3D6027%26doi%3D10.1021%2Fjm200454y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4621</span>– <span class="NLM_lpage">4628</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-3474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1158%2F0008-5472.CAN-03-3474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15231674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlOrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4621-4628&issue=13&author=C.-C.+Kuoauthor=H.-P.+Hsiehauthor=W.-Y.+Panauthor=C.-P.+Chenauthor=J.-P.+Liouauthor=S.-J.+Leeauthor=Y.-L.+Changauthor=L.-T.+Chenauthor=C.-T.+Chenauthor=J.-Y.+Chang&title=BPR0L075%2C+a+Novel+Synthetic+Indole+Compound+with+Antimitotic+Activity+in+Human+Cancer+Cells%2C+Exerts+Effective+Antitumoral+Activity+in+Vivo&doi=10.1158%2F0008-5472.CAN-03-3474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo</span></div><div class="casAuthors">Kuo, Ching-Chuan; Hsieh, Hsing-Pang; Pan, Wen-Yu; Chen, Ching-Ping; Liou, Jing-Ping; Lee, Shiow-Ju; Chang, Yi-Ling; Chen, Li-Tzong; Chen, Chiung-Tong; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4621-4628</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BPR0L075 is a novel synthetic compd. discovered through research to identify new microtubule inhibitors.  BPR0L075 inhibits tubulin polymn. through binding to the colchicine-binding site of tubulin.  Cytotoxic activity of BPR0L075 in a variety of human tumor cell lines has been ascertained, with IC50 values in single-digit nanomolar ranges.  As detd. by flow cytometry, human cervical carcinoma KB cells are arrested in G2-M phases in a time-dependent manner before cell death occurs.  Terminal deoxynucleotidyl transferase-mediated nick end labeling assay indicates that cell death proceeds through an apoptotic pathway.  Addnl. studies indicate that the effect of BPR0L075 on cell cycle arrest is assocd. with an increase in cyclin B1 levels and a mobility shift of Cdc2 and Cdc25C.  The changes in Cdc2 and Cdc25C coincide with the appearance of phosphoepitopes recognized by a marker of mitosis, MPM-2.  Furthermore, phosphorylated forms of Bcl-2, perturbed mitochondrial membrane potential, and activation of the caspase-3 cascade may be involved in BPR0L075-induced apoptosis.  Notably, several KB-derived multidrug-resistant cell lines overexpressing P-gp170/MDR and MRP are resistant to vincristine, paclitaxel, and colchicine but not to BPR0L075.  Moreover, BPR0L075 shows potent activity against the growth of xenograft tumors of the gastric carcinoma MKN-45, human cervical carcinoma KB, and KB-derived P-gp170/MDR-overexpressing KB-VIN10 cells at i.v. doses of 50 mg/kg in nude mice.  These findings indicate BPR0L075 is a promising anticancer compd. with antimitotic activity that has potential for management of various malignancies, particularly for patients with drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoSqx6pRirD7Vg90H21EOLACvtfcHk0lia-yW9MLfttQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlOrsbc%253D&md5=c828eca8875e66dc0780c6a61574828b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-3474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-3474%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DC.-C.%26aulast%3DHsieh%26aufirst%3DH.-P.%26aulast%3DPan%26aufirst%3DW.-Y.%26aulast%3DChen%26aufirst%3DC.-P.%26aulast%3DLiou%26aufirst%3DJ.-P.%26aulast%3DLee%26aufirst%3DS.-J.%26aulast%3DChang%26aufirst%3DY.-L.%26aulast%3DChen%26aufirst%3DL.-T.%26aulast%3DChen%26aufirst%3DC.-T.%26aulast%3DChang%26aufirst%3DJ.-Y.%26atitle%3DBPR0L075%252C%2520a%2520Novel%2520Synthetic%2520Indole%2520Compound%2520with%2520Antimitotic%2520Activity%2520in%2520Human%2520Cancer%2520Cells%252C%2520Exerts%2520Effective%2520Antitumoral%2520Activity%2520in%2520Vivo%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D13%26spage%3D4621%26epage%3D4628%26doi%3D10.1158%2F0008-5472.CAN-03-3474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e43314</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0043314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1371%2Fjournal.pone.0043314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=22937031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OitLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=8&author=L.+Liuauthor=H.+Beckauthor=X.+Wangauthor=H.-P.+Hsiehauthor=R.+P.+Masonauthor=X.+Liu&title=Tubulin-Destabilizing+Agent+BPR0L075+Induces+Vascular-Disruption+in+Human+Breast+Cancer+Mammary+Fat+Pad+Xenografts&doi=10.1371%2Fjournal.pone.0043314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts</span></div><div class="casAuthors">Liu, Li; Beck, Haley; Wang, Xiaolei; Hsieh, Hsing-Pang; Mason, Ralph P.; Liu, Xinli</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43314</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">BPR0L075, 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole, is a tubulin-binding agent that inhibits tubulin polymn. by binding to the colchicine-binding site.  BPR0L075 has shown antimitotic and antiangiogenic activity in vitro.  The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging.  A single dose of BPR0L075 (50 mg/kg, i.p. ) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 h); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate.  A time-dependent redn. of tumor perfusion after BPR0L075 treatment was confirmed by immunohistol. staining of the perfusion marker Hoechst 33342 and tumor vasculature marker CD31.  The vasculature showed distinct recovery within 24 h post therapy.  A single i.p. injection of 50 mg/kg of BPR0L075 initially produced plasma concns. in the micromolar range within 6 h, but subsequent drug distribution and elimination caused BPR0L075 plasma levels to drop rapidly into the nanomolar range within 24 h.  Tests with human umbilical vein endothelial (HUVEC) cells and tumor cells in culture showed that BPR0L075 was cytotoxic to both tumor cells and proliferating endothelial cells, and disrupted pre-established vessels in vitro and ex vivo.  In conclusion, BPR0L075 caused rapid, albeit, temporary tumor vascular shutdown and led to redn. of tumor perfusion in orthotopic human breast cancer xenografts, suggesting that this antimitotic agent may be useful as a vascular-disrupting cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8_uwLYMl_9bVg90H21EOLACvtfcHk0li5i08Y-lTgqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OitLnM&md5=e4a834ac3a0145ae932b2718b8bf8e05</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043314%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHsieh%26aufirst%3DH.-P.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DTubulin-Destabilizing%2520Agent%2520BPR0L075%2520Induces%2520Vascular-Disruption%2520in%2520Human%2520Breast%2520Cancer%2520Mammary%2520Fat%2520Pad%2520Xenografts%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D8%26doi%3D10.1371%2Fjournal.pone.0043314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasolofonjatovo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provot, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wdzieczak-Bakala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desravines, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brion, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alami, M.</span></span> <span> </span><span class="NLM_article-title">Conformationally Restricted Naphthalene Derivatives Type Isocombretastatin A-4 and Isoerianin Analogues: Synthesis, Cytotoxicity and Antitubulin Activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ejmech.2012.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=22449653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlSlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=22-32&author=E.+Rasolofonjatovoauthor=O.+Provotauthor=A.+Hamzeauthor=J.+Rodrigoauthor=J.+Bignonauthor=J.+Wdzieczak-Bakalaauthor=D.+Desravinesauthor=J.+Duboisauthor=J.-D.+Brionauthor=M.+Alami&title=Conformationally+Restricted+Naphthalene+Derivatives+Type+Isocombretastatin+A-4+and+Isoerianin+Analogues%3A+Synthesis%2C+Cytotoxicity+and+Antitubulin+Activity&doi=10.1016%2Fj.ejmech.2012.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity</span></div><div class="casAuthors">Rasolofonjatovo, Evelia; Provot, Olivier; Hamze, Abdallah; Rodrigo, Jordi; Bignon, Jerome; Wdzieczak-Bakala, Joanna; Desravines, Deborah; Dubois, Joelle; Brion, Jean-Daniel; Alami, Mouad</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A novel series of dihydronaphthalene, tetrahydronaphthalene and naphthalene derivs. as restricted analogs of isoCA-4 were designed, synthesized and evaluated for their anticancer properties.  For example, 5-bromo-6-methoxytetralone reacted with 4-methylbenzenesulfonohydrazide to give hydrazide I, which reacted with 3,4,5-trimethoxyiodobenzene to give aryl deriv. II.  High cell growth inhibition against four tumor cell lines was obsd. at a nanomolar level with dihydronaphthalenes III (R1 = R2 = R3 = OMe, R4 = NH2, OH; R1 = R3 = OMe, R2 = H, R4 = OH), tetrahydronaphthalene IV and naphthalene V.  Structure-activity relationships are also considered.  These compds. exhibited a significant inhibitory activity toward tubulin polymn. (IC50 = 2-3 μM), comparable to that of isoCA-4.  The effect of the lead compds. III (R1 = R2 = R3 = OMe, R4 = OH) and IV on the cancer cells tested was assocd. with cell cycle arrest in the G2/M phase.  Docking studies reveal that these compds. showed a binding mode similar to those obsd. with their non-constraint isoCA-4 and isoerianin congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcGLzOhJXnYbVg90H21EOLACvtfcHk0li5i08Y-lTgqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlSlu7c%253D&md5=a9b641ea4bd1369c606683584701ee66</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DRasolofonjatovo%26aufirst%3DE.%26aulast%3DProvot%26aufirst%3DO.%26aulast%3DHamze%26aufirst%3DA.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DBignon%26aufirst%3DJ.%26aulast%3DWdzieczak-Bakala%26aufirst%3DJ.%26aulast%3DDesravines%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DBrion%26aufirst%3DJ.-D.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DConformationally%2520Restricted%2520Naphthalene%2520Derivatives%2520Type%2520Isocombretastatin%2520A-4%2520and%2520Isoerianin%2520Analogues%253A%2520Synthesis%252C%2520Cytotoxicity%2520and%2520Antitubulin%2520Activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D22%26epage%3D32%26doi%3D10.1016%2Fj.ejmech.2012.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasolofonjatovo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provot, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wdzieczak-Bakala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desravines, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brion, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alami, M.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Anticancer Properties of 5-Arylbenzoxepins as Conformationally Restricted Isocombretastatin A-4 Analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ejmech.2012.12.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23353744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslWmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=28-39&author=E.+Rasolofonjatovoauthor=O.+Provotauthor=A.+Hamzeauthor=J.+Rodrigoauthor=J.+Bignonauthor=J.+Wdzieczak-Bakalaauthor=C.+Lenoirauthor=D.+Desravinesauthor=J.+Duboisauthor=J.-D.+Brionauthor=M.+Alami&title=Design%2C+Synthesis+and+Anticancer+Properties+of+5-Arylbenzoxepins+as+Conformationally+Restricted+Isocombretastatin+A-4+Analogs&doi=10.1016%2Fj.ejmech.2012.12.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs</span></div><div class="casAuthors">Rasolofonjatovo, Evelia; Provot, Olivier; Hamze, Abdallah; Rodrigo, Jordi; Bignon, Jerome; Wdzieczak-Bakala, Joanna; Lenoir, Christine; Desravines, Deborah; Dubois, Joelle; Brion, Jean-Daniel; Alami, Mouad</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel benzoxepins was designed and prepd. as rigid-isoCA-4 analogs according to a convergent strategy using the coupling of N-tosylhydrazones with aryl iodides under palladium catalysis.  The most potent compd., having the greatest resemblance to CA-4 and isoCA-4 displayed antiproliferative activity at nanomolar concns. against various cancer cell lines and inhibited tubulin assembly at a micromolar range.  In addn., said benzoxepin led to the arrest of HCT116, K562, H1299 and MDA-MB231 cancer cell lines in the G2/M phase of the cell cycle, and strongly induced apoptosis at low concns.  Docking studies demonstrated that said benzoxepin adopts an orientation similar to that of isoCA-4 at the colchicine binding site on β-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7-_vjI4pOqbVg90H21EOLACvtfcHk0li5i08Y-lTgqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslWmsLk%253D&md5=a83cb8c450092a6e92d972f717d3afe3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DRasolofonjatovo%26aufirst%3DE.%26aulast%3DProvot%26aufirst%3DO.%26aulast%3DHamze%26aufirst%3DA.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DBignon%26aufirst%3DJ.%26aulast%3DWdzieczak-Bakala%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DC.%26aulast%3DDesravines%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DBrion%26aufirst%3DJ.-D.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Anticancer%2520Properties%2520of%25205-Arylbenzoxepins%2520as%2520Conformationally%2520Restricted%2520Isocombretastatin%2520A-4%2520Analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D28%26epage%3D39%26doi%3D10.1016%2Fj.ejmech.2012.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maderna, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3-Methoxy-9-(3,4,5-Trimethoxyphenyl)-6,7-Dihydro-5H-Benzo[7]Annulen-4-Ol, a Potent Antineoplastic Benzosuberene Derivative for Anti-Cancer Chemotherapy</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.10.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.tetlet.2011.10.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOqur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=64-66&issue=1&author=Z.+Chenauthor=C.+J.+O%E2%80%99Donnellauthor=A.+Maderna&title=Synthesis+of+3-Methoxy-9-%283%2C4%2C5-Trimethoxyphenyl%29-6%2C7-Dihydro-5H-Benzo%5B7%5DAnnulen-4-Ol%2C+a+Potent+Antineoplastic+Benzosuberene+Derivative+for+Anti-Cancer+Chemotherapy&doi=10.1016%2Fj.tetlet.2011.10.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulen-4-ol, a potent antineoplastic benzosuberene derivative for anti-cancer chemotherapy</span></div><div class="casAuthors">Chen, Zecheng; O'Donnell, Christopher J.; Maderna, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-66</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Benzosuberene (I) is a tubulin polymn. inhibitor that possesses remarkable potency against a variety of cancer cell lines.  Herein, an efficient synthetic route for I is described featuring a Claisen rearrangement/RCM sequence and a late stage Suzuki coupling as the key steps.  By adopting this strategy, I was synthesized in eight steps in 18% overall yield starting from known compd. II..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCJZMvcDukY7Vg90H21EOLACvtfcHk0lgpt90aPQChsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOqur3L&md5=2dafe10dc4c48db96cd78a1a1386f7f7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.10.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.10.145%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DMaderna%26aufirst%3DA.%26atitle%3DSynthesis%2520of%25203-Methoxy-9-%25283%252C4%252C5-Trimethoxyphenyl%2529-6%252C7-Dihydro-5H-Benzo%255B7%255DAnnulen-4-Ol%252C%2520a%2520Potent%2520Antineoplastic%2520Benzosuberene%2520Derivative%2520for%2520Anti-Cancer%2520Chemotherapy%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26issue%3D1%26spage%3D64%26epage%3D66%26doi%3D10.1016%2Fj.tetlet.2011.10.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maderna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukuru, S. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenaar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loganzo, F.</span></span> <span> </span><span class="NLM_article-title">New Cytotoxic Benzosuberene Analogs. Synthesis, Molecular Modeling and Biological Evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6688</span>– <span class="NLM_lpage">6694</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.bmcl.2013.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=24210503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslygtLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6688-6694&issue=24&author=Z.+Chenauthor=A.+Madernaauthor=S.+C.+K.+Sukuruauthor=M.+Wagenaarauthor=C.+J.+O%E2%80%99Donnellauthor=M.-H.+Lamauthor=S.+Mustoauthor=F.+Loganzo&title=New+Cytotoxic+Benzosuberene+Analogs.+Synthesis%2C+Molecular+Modeling+and+Biological+Evaluation&doi=10.1016%2Fj.bmcl.2013.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">New cytotoxic benzosuberene analogs. Synthesis, molecular modeling and biological evaluation</span></div><div class="casAuthors">Chen, Zecheng; Maderna, Andreas; Sukuru, Sai Chetan K.; Wagenaar, Melissa; O'Donnell, Christopher J.; Lam, My-Hanh; Musto, Sylvia; Loganzo, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6688-6694</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this Letter we describe the synthesis and biol. evaluation of new benzosuberene analogs with structural modifications on the B-ring.  The focus was initially to probe the chem. space around the B-ring C-8 position.  This position was readily available for derivatization chem. using our recently developed new synthesis for this compd. class.  Furthermore, we describe two new B-ring analogs, one contg. a diene (I) and the other a cyclic ether group (II).  Both new analogs show excellent potencies in tumor cell proliferation assays.  In addn., we describe mol. modeling studies that provide a binding rationale for ref. compd. III in the colchicine binding site using the known colchicine crystal structure.  We also examine whether the cell based potency data obtained with selected new analogs are supported by modeling results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzvfobg2qzdLVg90H21EOLACvtfcHk0lgpt90aPQChsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslygtLnK&md5=252f4f0b77829112d7d0c95ee9558875</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSukuru%26aufirst%3DS.%2BC.%2BK.%26aulast%3DWagenaar%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DLam%26aufirst%3DM.-H.%26aulast%3DMusto%26aufirst%3DS.%26aulast%3DLoganzo%26aufirst%3DF.%26atitle%3DNew%2520Cytotoxic%2520Benzosuberene%2520Analogs.%2520Synthesis%252C%2520Molecular%2520Modeling%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6688%26epage%3D6694%26doi%3D10.1016%2Fj.bmcl.2013.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aprile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrigoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torretta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massarotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canonico, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genazzani, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Combretabenzodiazepines: A Novel Class of Anti-Tubulin Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1357</span>, <span class="refDoi"> DOI: 10.1021/jm5016389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5016389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1345-1357&issue=3&author=U.+Galliauthor=C.+Travelliauthor=S.+Aprileauthor=E.+Arrigoniauthor=S.+Torrettaauthor=G.+Grosaauthor=A.+Massarottiauthor=G.+Sorbaauthor=P.+L.+Canonicoauthor=A.+A.+Genazzaniauthor=G.+C.+Tron&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Combretabenzodiazepines%3A+A+Novel+Class+of+Anti-Tubulin+Agents&doi=10.1021%2Fjm5016389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Combretabenzodiazepines: A Novel Class of Anti-Tubulin Agents</span></div><div class="casAuthors">Galli, Ubaldina; Travelli, Cristina; Aprile, Silvio; Arrigoni, Elena; Torretta, Simone; Grosa, Giorgio; Massarotti, Alberto; Sorba, Giovanni; Canonico, Pier Luigi; Genazzani, Armando A.; Tron, Gian Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1345-1357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present manuscript, starting from the 1,4-benzodiazepin-2-one nucleus, a privileged structure in medicinal chem., we have synthesized a novel class of cis-locked combretastatins named combretabenzodiazepines, e.g., I.  They show similar cytotoxic and antitubulin activity compared to combretastatin (II) in neuroblastoma cells, showing a better pharmacokinetic profile.  This class of compds. has therefore the potential for further development as antitubulin agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_iCDQpOw2bVg90H21EOLACvtfcHk0lgpt90aPQChsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVCquw%253D%253D&md5=9de30ca5f71f2fe2553f48c75e1098c1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm5016389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5016389%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DTravelli%26aufirst%3DC.%26aulast%3DAprile%26aufirst%3DS.%26aulast%3DArrigoni%26aufirst%3DE.%26aulast%3DTorretta%26aufirst%3DS.%26aulast%3DGrosa%26aufirst%3DG.%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Combretabenzodiazepines%253A%2520A%2520Novel%2520Class%2520of%2520Anti-Tubulin%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D3%26spage%3D1345%26epage%3D1357%26doi%3D10.1021%2Fjm5016389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prileschajew, N.</span></span> <span> </span><span class="NLM_article-title">Oxydation Ungesättigter Verbindungen Mittels Organischer Superoxyde</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1909</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">4811</span>– <span class="NLM_lpage">4815</span>, <span class="refDoi"> DOI: 10.1002/cber.190904204100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcber.190904204100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaD28XnvFc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1909&pages=4811-4815&issue=4&author=N.+Prileschajew&title=Oxydation+Unges%C3%A4ttigter+Verbindungen+Mittels+Organischer+Superoxyde&doi=10.1002%2Fcber.190904204100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of unsaturated compounds using organic peroxides</span></div><div class="casAuthors">Prileschajew, Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft</span>
        (<span class="NLM_cas:date">1909</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4811-4815</span>CODEN:
                <span class="NLM_cas:coden">BDCGAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-9496</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Hf7QY-aLk7Vg90H21EOLACvtfcHk0ljS9odLw2VR1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaD28XnvFc%253D&md5=33ecf61ff5ad182826bda34fea01103c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fcber.190904204100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.190904204100%26sid%3Dliteratum%253Aachs%26aulast%3DPrileschajew%26aufirst%3DN.%26atitle%3DOxydation%2520Unges%25C3%25A4ttigter%2520Verbindungen%2520Mittels%2520Organischer%2520Superoxyde%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1909%26volume%3D42%26issue%3D4%26spage%3D4811%26epage%3D4815%26doi%3D10.1002%2Fcber.190904204100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanRheenen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. Y.</span></span> <span> </span><span class="NLM_article-title">An Improved Catalytic OsO4 Oxidation of Olefins to Cis-1,2-Glycols Using Tertiary Amine Oxides as the Oxidant</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)78093-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2FS0040-4039%2800%2978093-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1976&pages=1973-1976&issue=23&author=V.+VanRheenenauthor=R.+C.+Kellyauthor=D.+Y.+Cha&title=An+Improved+Catalytic+OsO4+Oxidation+of+Olefins+to+Cis-1%2C2-Glycols+Using+Tertiary+Amine+Oxides+as+the+Oxidant&doi=10.1016%2FS0040-4039%2800%2978093-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2978093-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252978093-2%26sid%3Dliteratum%253Aachs%26aulast%3DVanRheenen%26aufirst%3DV.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DCha%26aufirst%3DD.%2BY.%26atitle%3DAn%2520Improved%2520Catalytic%2520OsO4%2520Oxidation%2520of%2520Olefins%2520to%2520Cis-1%252C2-Glycols%2520Using%2520Tertiary%2520Amine%2520Oxides%2520as%2520the%2520Oxidant%26jtitle%3DTetrahedron%2520Lett.%26date%3D1976%26volume%3D17%26issue%3D23%26spage%3D1973%26epage%3D1976%26doi%3D10.1016%2FS0040-4039%2800%2978093-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustowski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echegoyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokel, G. W.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Switching in Anthraquinone-Substituted Carbon-Pivot Lariat Ethers and Podands: Chain Length Effects in Geometric and Electronic Cooperativity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7553</span>– <span class="NLM_lpage">7560</span>, <span class="refDoi"> DOI: 10.1021/ja00284a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00284a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL2sXjt1Wquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=1986&pages=7553-7560&issue=24&author=D.+A.+Gustowskiauthor=M.+Delgadoauthor=V.+J.+Gattoauthor=L.+Echegoyenauthor=G.+W.+Gokel&title=Electrochemical+Switching+in+Anthraquinone-Substituted+Carbon-Pivot+Lariat+Ethers+and+Podands%3A+Chain+Length+Effects+in+Geometric+and+Electronic+Cooperativity&doi=10.1021%2Fja00284a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical switching in anthraquinone-substituted carbon-pivot lariat ethers and podands:  chain length effects in geometric and electronic cooperativity</span></div><div class="casAuthors">Gustowski, Deborah A.; Delgado, Milagros; Gatto, Vincent J.; Echegoyen, Luis; Gokel, George W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7553-60</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The complex electrochem. behavior, detd. by cyclic voltammetry for 1- and 2-electron time-resolved redox couples for the title 9,10-anthraquinon-1-yl podands I [R = MeO; (OCH2CH2)nMe, n = 2, 3, 5] and II and the C-pivot lariat crownether III in systems contg. 0-1.0 equiv Li+, Na+, or K+, are due to a combination of electronic and steric factors.  I, II, and III are prepd., most often, by nucleophilic arom. substitution of I (R = Cl).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCbtXkIWHvkLVg90H21EOLACvtfcHk0ljS9odLw2VR1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXjt1Wquw%253D%253D&md5=c08407be23b6a5a8ee2256982470e7bd</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fja00284a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00284a019%26sid%3Dliteratum%253Aachs%26aulast%3DGustowski%26aufirst%3DD.%2BA.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGatto%26aufirst%3DV.%2BJ.%26aulast%3DEchegoyen%26aufirst%3DL.%26aulast%3DGokel%26aufirst%3DG.%2BW.%26atitle%3DElectrochemical%2520Switching%2520in%2520Anthraquinone-Substituted%2520Carbon-Pivot%2520Lariat%2520Ethers%2520and%2520Podands%253A%2520Chain%2520Length%2520Effects%2520in%2520Geometric%2520and%2520Electronic%2520Cooperativity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1986%26volume%3D108%26issue%3D24%26spage%3D7553%26epage%3D7560%26doi%3D10.1021%2Fja00284a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandmeyer, T.</span></span> <span> </span><span class="NLM_article-title">Ueber Die Ersetzung Der Amidgruppe Durch Chlor in Den Aromatischen Substanzen</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1884</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1633</span>– <span class="NLM_lpage">1635</span>, <span class="refDoi"> DOI: 10.1002/cber.18840170219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcber.18840170219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1884&pages=1633-1635&issue=2&author=T.+Sandmeyer&title=Ueber+Die+Ersetzung+Der+Amidgruppe+Durch+Chlor+in+Den+Aromatischen+Substanzen&doi=10.1002%2Fcber.18840170219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fcber.18840170219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.18840170219%26sid%3Dliteratum%253Aachs%26aulast%3DSandmeyer%26aufirst%3DT.%26atitle%3DUeber%2520Die%2520Ersetzung%2520Der%2520Amidgruppe%2520Durch%2520Chlor%2520in%2520Den%2520Aromatischen%2520Substanzen%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1884%26volume%3D17%26issue%3D2%26spage%3D1633%26epage%3D1635%26doi%3D10.1002%2Fcber.18840170219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandmeyer, T.</span></span> <span> </span><span class="NLM_article-title">Ueber Die Ersetzung Der Amid-gruppe Durch Chlor, Brom Und Cyan in Den Aromatischen Substanzen</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1884</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2650</span>– <span class="NLM_lpage">2653</span>, <span class="refDoi"> DOI: 10.1002/cber.188401702202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcber.188401702202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1884&pages=2650-2653&issue=2&author=T.+Sandmeyer&title=Ueber+Die+Ersetzung+Der+Amid-gruppe+Durch+Chlor%2C+Brom+Und+Cyan+in+Den+Aromatischen+Substanzen&doi=10.1002%2Fcber.188401702202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fcber.188401702202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.188401702202%26sid%3Dliteratum%253Aachs%26aulast%3DSandmeyer%26aufirst%3DT.%26atitle%3DUeber%2520Die%2520Ersetzung%2520Der%2520Amid-gruppe%2520Durch%2520Chlor%252C%2520Brom%2520Und%2520Cyan%2520in%2520Den%2520Aromatischen%2520Substanzen%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1884%26volume%3D17%26issue%3D2%26spage%3D2650%26epage%3D2653%26doi%3D10.1002%2Fcber.188401702202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizusaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Hydrogenation Method Catalyzed by Pd/C Using Diphenylsulfide as a Reasonable Catalyst Poison</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">11925</span>– <span class="NLM_lpage">11932</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.09.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.tet.2006.09.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyqurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=11925-11932&issue=51&author=A.+Moriauthor=T.+Mizusakiauthor=Y.+Miyakawaauthor=E.+Ohashiauthor=T.+Hagaauthor=T.+Maegawaauthor=Y.+Monguchiauthor=H.+Sajiki&title=Chemoselective+Hydrogenation+Method+Catalyzed+by+Pd%2FC+Using+Diphenylsulfide+as+a+Reasonable+Catalyst+Poison&doi=10.1016%2Fj.tet.2006.09.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective hydrogenation method catalyzed by Pd/C using diphenylsulfide as a reasonable catalyst poison</span></div><div class="casAuthors">Mori, Akinori; Mizusaki, Tomoteru; Miyakawa, Yumi; Ohashi, Eri; Haga, Tomoko; Maegawa, Tomohiro; Monguchi, Yasunari; Sajiki, Hironao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">11925-11932</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">While Pd/C is one of the most useful catalysts for hydrogenation, the high catalyst activity of Pd/C causes difficulty in its application to chemoselective hydrogenation between different types of reducible functionalities.  In order to achieve chemoselective hydrogenation using Pd/C, a catalyst poison as a controller of the catalyst activity has been investigated.  It was found that the addn. of Ph2S (diphenylsulfide) to the Pd/C-catalyzed hydrogenation reaction mixt. led to reasonable deactivation of Pd/C.  By the use of the Pd/C-Ph2S catalytic system, olefins, acetylenes, and azides could be selectively reduced in the coexistence of arom. carbonyls, arom. halides, cyano groups, benzyl esters, and N-Cbz (benzyloxycarbonyl) protecting groups.  This method was promising as a general and practical chemoselective hydrogenation process in synthetic org. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgHK6eKLfUBLVg90H21EOLACvtfcHk0lh3fKxQeusJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyqurjK&md5=98517ac70b810b4b90e7c03dd29a2ecc</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.09.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.09.094%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DA.%26aulast%3DMizusaki%26aufirst%3DT.%26aulast%3DMiyakawa%26aufirst%3DY.%26aulast%3DOhashi%26aufirst%3DE.%26aulast%3DHaga%26aufirst%3DT.%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DMonguchi%26aufirst%3DY.%26aulast%3DSajiki%26aufirst%3DH.%26atitle%3DChemoselective%2520Hydrogenation%2520Method%2520Catalyzed%2520by%2520Pd%252FC%2520Using%2520Diphenylsulfide%2520as%2520a%2520Reasonable%2520Catalyst%2520Poison%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26issue%3D51%26spage%3D11925%26epage%3D11932%26doi%3D10.1016%2Fj.tet.2006.09.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span> <span> </span><span class="NLM_article-title">Phosphorus Pentoxide-Methanesulfonic Acid. Convenient Alternative to Polyphosphoric Acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">4071</span>– <span class="NLM_lpage">4073</span>, <span class="refDoi"> DOI: 10.1021/jo00987a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00987a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaE2cXhsVKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=4071-4073&author=P.+E.+Eatonauthor=G.+R.+Carlsonauthor=J.+T.+Lee&title=Phosphorus+Pentoxide-Methanesulfonic+Acid.+Convenient+Alternative+to+Polyphosphoric+Acid&doi=10.1021%2Fjo00987a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorus pentoxide-methanesulfonic acid.  Convenient alternative to polyphosphoric acid</span></div><div class="casAuthors">Eaton, Philip E.; Carlson, Glenn R.; Lee, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4071-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A new reagent composed of a 1:10 mixture by wt. of P2O5 in Me-SO3H is suggested as an attractive alternative to polyphosphoric acid (PPA).  Product yields in the prepn. of cyclopentenones via the intramol. acylation of γ-lactones and in the prepn. of amides via the Beckmann rearrangement compare favorably with the best yields reported for the same transformations done in PPA.  The new reagent is very much more convenient to handle than PPA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLk_l8be2a_rVg90H21EOLACvtfcHk0lh3fKxQeusJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhsVKjtw%253D%253D&md5=791196ffff70d569aa58cee82279660c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjo00987a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00987a028%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DP.%2BE.%26aulast%3DCarlson%26aufirst%3DG.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26atitle%3DPhosphorus%2520Pentoxide-Methanesulfonic%2520Acid.%2520Convenient%2520Alternative%2520to%2520Polyphosphoric%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D4071%26epage%3D4073%26doi%3D10.1021%2Fjo00987a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanis, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moya, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, R. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of the Bioactivity of Simplified Analogs of the Seco-Pseudopterosins; Progress Toward Determining a Pharmacophore</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">10649</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2008.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.tet.2008.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cqsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=10649-10663&issue=47&author=V.+M.+Tanisauthor=C.+Moyaauthor=R.+S.+Jacobsauthor=R.+D.+Little&title=Synthesis+and+Evaluation+of+the+Bioactivity+of+Simplified+Analogs+of+the+Seco-Pseudopterosins%3B+Progress+Toward+Determining+a+Pharmacophore&doi=10.1016%2Fj.tet.2008.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of the bioactivity of simplified analogs of the seco-pseudopterosins; progress toward determining a pharmacophore</span></div><div class="casAuthors">Tanis, Virginia M.; Moya, Claudia; Jacobs, R. S.; Little, R. Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10649-10663</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The pseudopterosins are marine natural products that display significant anti-inflammatory and wound healing properties.  We describe the synthesis of six structural analogs of the seco-pseudopterosin-like core that are devoid of all but one of the stereocenters found in the carbocyclic core of the natural products.  Our targets were selected in an attempt to identify the minimal pharmacophore for the pseudopterosins and their seco analogs.  A deliberate effort was made to utilize a conservative synthetic approach based upon the use of well-established reactions, which enabled us to develop routes that proved to be efficient, practical, and easy to implement.  The results of several bioassays, including an assessment of the ability to inhibit phagocytosis and to competitively bind to the adenosine receptor A2A, demonstrate that greatly simplified structural analogs of the pseudopterosins and their seco forms are capable of maintaining several of the important bioactivities that characterize the natural products, and do so with comparable efficacy.  Those systems bearing two rather than one oxygen atom appended directly to the arom. ring are the more effective binding agents.  This observation may provide a significant clue regarding the key structural features of the minimal pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofwZSHGfLNqrVg90H21EOLACvtfcHk0lh3fKxQeusJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cqsr7M&md5=1dc03ee84cc66d8db737842770664516</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2008.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2008.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DTanis%26aufirst%3DV.%2BM.%26aulast%3DMoya%26aufirst%3DC.%26aulast%3DJacobs%26aufirst%3DR.%2BS.%26aulast%3DLittle%26aufirst%3DR.%2BD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520the%2520Bioactivity%2520of%2520Simplified%2520Analogs%2520of%2520the%2520Seco-Pseudopterosins%253B%2520Progress%2520Toward%2520Determining%2520a%2520Pharmacophore%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26issue%3D47%26spage%3D10649%26epage%3D10663%26doi%3D10.1016%2Fj.tet.2008.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Xiao, Y.</span>; <span class="NLM_string-name">He, H.</span>; <span class="NLM_string-name">Zheng</span>; ; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">Fast Synthetic Route for 3-Aryl Substituted Propanoic Acid</span>. <span class="NLM_patent">CN 101747171 A</span>, December 17, <span class="NLM_year">2008</span>; WuXi AppTec.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=W.+Lin&author=Q.+Wang&author=Y.+Xiao&author=H.+He&author=+Zheng&author=X.+Chen&author=S.+Chen&title=Fast+Synthetic+Route+for+3-Aryl+Substituted+Propanoic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%26atitle%3DFast%2520Synthetic%2520Route%2520for%25203-Aryl%2520Substituted%2520Propanoic%2520Acid%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirataki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniliuc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span> <span> </span><span class="NLM_article-title">GluN2B-Selective N-Methyl-d-aspartate (NMDA) Receptor Antagonists Derived from 3-Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7]Annulen-7-amines</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fcmdc.201300547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=24677663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFajtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=741-751&issue=4&author=A.+Bennerauthor=A.+Bonifaziauthor=C.+Shiratakiauthor=L.+Temmeauthor=D.+Schepmannauthor=W.+Quagliaauthor=O.+Shojiauthor=Y.+Watanabeauthor=C.+Daniliucauthor=B.+W%C3%BCnsch&title=GluN2B-Selective+N-Methyl-d-aspartate+%28NMDA%29+Receptor+Antagonists+Derived+from+3-Benzazepines%3A+Synthesis+and+Pharmacological+Evaluation+of+Benzo%5B7%5DAnnulen-7-amines&doi=10.1002%2Fcmdc.201300547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2B-Selective N-Methyl-D-aspartate (NMDA) Receptor Antagonists Derived from 3-Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7]annulen-7-amines</span></div><div class="casAuthors">Benner, Andre; Bonifazi, Alessandro; Shirataki, Chikako; Temme, Louisa; Schepmann, Dirk; Quaglia, Wilma; Shoji, Osami; Watanabe, Yoshihito; Daniliuc, Constantin; Wuensch, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-751</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Given their high neuroprotective potential, ligands that block GluN2B-contg. N-methyl-D-aspartate (NMDA) receptors by interacting with the ifenprodil binding site located on the GluN2B subunit are of great interest for the treatment of various neuronal disorders.  In this study, a novel class of GluN2B-selective NMDA receptor antagonists with a benzo[7]annulene scaffold was prepd. and pharmacol. evaluated.  A key intermediate, N-(2-methoxy-5-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl)acetamide, was obtained by cyclization of 3-acetamido-5-(3-methoxyphenyl)pentanoic acid.  The final reaction steps comprise hydrolysis of an amide, redn. of a ketone and reductive alkylation, leading to cis- and trans-configured 7-(ω-phenylalkylamino)benzo[7]annulen-5-ol derivs.  High GluN2B affinity was obsd. with cis-configured γ-amino alcs. substituted with a 3-phenylpropyl moiety at the amino group.  Removal of the benzylic hydroxy moiety led to the most potent GluN2B antagonists of this series: 2-methoxy-N-(3-phenylpropyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-amine (Ki=10 nM) and 2-methoxy-N-methyl-N-(3-phenylpropyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-amine (Ki=7.9 nM).  The selectivity over related receptors (phencyclidine binding site of the NMDA receptor, σ1 and σ2 receptors) was recorded.  In a functional assay measuring the cytoprotective activity of the benzo[7]annulenamines, all tested compds. showed potent NMDA receptor antagonistic activity.  Cytotoxicity induced by GluN2A-subunit-contg. NMDA receptors was not inhibited by the new ligands.  The synthesis of the target compds. was achieved by a reaction of 6,7,8,9-tetrahydro-2-methoxy-5H-benzocyclohepten-5-ol with benzenepropanal or benzenebutanal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GFQ04B0qTrVg90H21EOLACvtfcHk0lgICi_hbK_2aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFajtrw%253D&md5=bdb1858368424ee6507869a3c9131fb7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300547%26sid%3Dliteratum%253Aachs%26aulast%3DBenner%26aufirst%3DA.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DShirataki%26aufirst%3DC.%26aulast%3DTemme%26aufirst%3DL.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DQuaglia%26aufirst%3DW.%26aulast%3DShoji%26aufirst%3DO.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DDaniliuc%26aufirst%3DC.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26atitle%3DGluN2B-Selective%2520N-Methyl-d-aspartate%2520%2528NMDA%2529%2520Receptor%2520Antagonists%2520Derived%2520from%25203-Benzazepines%253A%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Benzo%255B7%255DAnnulen-7-amines%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D741%26epage%3D751%26doi%3D10.1002%2Fcmdc.201300547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. J.</span>; <span class="NLM_string-name">Sha, R.</span>; <span class="NLM_string-name">McCormack, E. M.</span>; <span class="NLM_string-name">Hudson, G. J.</span>; <span class="NLM_string-name">White, M.</span>; <span class="NLM_string-name">Stack, G.
D.</span>; <span class="NLM_string-name">Moran, B.
W.</span>; <span class="NLM_string-name">Coogan, A.</span>; <span class="NLM_string-name">Breen, E. C.</span></span> <span> </span><span class="NLM_article-title">Tubulin Binding Agents</span>. <span class="NLM_patent">US20150018566A1</span>, August 27, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+J.+Walsh&author=R.+Sha&author=E.+M.+McCormack&author=G.+J.+Hudson&author=M.+White&author=G.%0AD.+Stack&author=B.%0AW.+Moran&author=A.+Coogan&author=E.+C.+Breen&title=Tubulin+Binding+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DJ.%2BJ.%26atitle%3DTubulin%2520Binding%2520Agents%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, L. A.</span></span> <span> </span><span class="NLM_article-title">The Preparation of Methylcopper and Some Observations on the Decomposition of Organocopper Compounds</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1630</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1021/jo50012a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo50012a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaG2cXmvFyq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1952&pages=1630-1634&issue=12&author=H.+Gilmanauthor=R.+G.+Jonesauthor=L.+A.+Woods&title=The+Preparation+of+Methylcopper+and+Some+Observations+on+the+Decomposition+of+Organocopper+Compounds&doi=10.1021%2Fjo50012a009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Relative reactivities of organometallic compounds. LXXI. The preparation of methylcopper and some observations on the decomposition of organocopper compounds</span></div><div class="casAuthors">Gilman, Henry; Jones, Reuben G.; Woods, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1630-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">cf. C.A. 46, 3974g.  Stirring 0.03 mole MgMe2 and 0.05 mole CuI in ether 3 hrs. at -15° and washing the ppt. with ether give a yellow CuMe which, heated in ether, gives a gas contg. 0.0137 mole C2H6 and 0.0057 mole CuMe.  CuMe when dried and exposed to the air explodes violently and the isolation of large amts. is dangerous.  Adding (1.5 hrs.) 0.028 mole LiMe in 22 cc. ether to 0.025 mole CuCNS in 50 cc. ether at -15° gives a yellow ppt. which changes to reddish brown at 0° and decomp. at 20°, giving a gas contg. 87% C2H6 and 12% CH4.  Adding (1 hr.) 0.05 mole LiMe in 40 cc. ether to 4.77 g. CuI in 50 cc. ether at -15° gives a colorless soln. which gives a strong Michler ketone color test.  Treating 0.005 mole CuCl in 25 cc. ether and 7.63 g. EtBr with 0.07 mole EtMgBr in 45 cc. ether gives 0.059 mole C2H6 and 0.0589 mole C2H4.  Adding (15 min.) 15.7 g. EtBr in 25 cc. ether to 1 g. Mg-Cu alloy (12.75% Cu) in 25 cc. ether with stirring and refluxing the mixt. 0.5 hr. give 0.0312 mole C2H6 and 0.0262 mole C2H4.  Adding 0.72 mole EtMgBr in 50 cc. ether to the reaction mixt. (which contained 0.072 mole EtBr) and refluxing it 6 hrs. give 0.077 mole C2H6 and 0.0665 mole C2H4.  Treating 0.5 g. CuI in 25 cc. ether and 7.9 g. MeI with 0.055 mole MgMe2 in 50 cc. ether and refluxing the mixt. give CuMe which slowly decomp. at 35°, giving 0.0265 mole C2H6 and 0.0057 mole CH4 after 16 hrs.  Refluxing the washed (ether) Cu (obtained from 3.04 g. CuCNS and LiMe) with 7.75 g. MeI in 25 cc. ether 24 hrs. causes no evolution of gas.  Adding 0.054 mole LiMe in 45 cc. ether gives a gas contg. 0.0052 mole C2H6 and 0.005 mole CH4.  Refluxing 0.089 mole EtMgBr in 50 cc. ether with 1.2 g. CuCl2 in 15 cc. ether and 11 g. PhBr 3 hrs. gives 37.8% C2H6 and 60% C2H4.  In a similar expt. with FeCl3 in lieu of CuCl2 47% C2H6 and 58% C2H4 are formed.  Adding (25 min.) 0.055 mole PhLi in 70 cc. ether to 9.5 g. CuI in 75 cc. ether at -12°, stirring the mixt. 10 min. at -5°, then adding (25 min.) 20.7 g. BzCH:CHPh in 75 cc. ether at -5°, stirring the mixt. 0.5 hr. at -5° and 1 hr. at 20°, and decompg. with NH4Cl gives 69.3% β-phenyl-γ-benzoyl-γ-benzhydrylbutyrophenone, m. 178.5-80.5°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtQYzX8vjcV7Vg90H21EOLACvtfcHk0lgICi_hbK_2aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXmvFyq&md5=f33576f7ba7d239697d36a9994eda989</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjo50012a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo50012a009%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DR.%2BG.%26aulast%3DWoods%26aufirst%3DL.%2BA.%26atitle%3DThe%2520Preparation%2520of%2520Methylcopper%2520and%2520Some%2520Observations%2520on%2520the%2520Decomposition%2520of%2520Organocopper%2520Compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1952%26volume%3D17%26issue%3D12%26spage%3D1630%26epage%3D1634%26doi%3D10.1021%2Fjo50012a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezioso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edvardsen, K.</span></span> <span> </span><span class="NLM_article-title">Oxi4503, a Novel Vascular Targeting Agent: Effects on Blood Flow and Antitumor Activity in Comparison to Combretastatin A-4 Phosphate</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">2B</span>),  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12820406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlGmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=1433-1440&issue=2B&author=J.+Huaauthor=Y.+Shengauthor=K.+G.+Pinneyauthor=C.+M.+Garnerauthor=R.+R.+Kaneauthor=J.+A.+Preziosoauthor=G.+R.+Pettitauthor=D.+J.+Chaplinauthor=K.+Edvardsen&title=Oxi4503%2C+a+Novel+Vascular+Targeting+Agent%3A+Effects+on+Blood+Flow+and+Antitumor+Activity+in+Comparison+to+Combretastatin+A-4+Phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate</span></div><div class="casAuthors">Hua, Jianyi; Sheng, Yezhou; Pinney, Kevin G.; Garner, Charles M.; Kane, Robert R.; Prezioso, Joseph A.; Pettit, George R.; Chaplin, David J.; Edvardsen, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2B</span>),
    <span class="NLM_cas:pages">1433-1440</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Oxi 4503, which is the diphosphate prodrug of combretastatin A1, is a novel vascular targeting agent from the combretastatin family.  Another member of this family, Combretastatin A-4 phosphate (CA4P), is a well-characterized vascular targeting agent already being evaluated in clin. trials.  The potential for tumor vascular targeting by Oxi 4503 was assessed in a mouse system.  This approach aims to shut down the established tumor vasculature, leading to the development of extensive tumor cell necrosis.  The vascular effects of Oxi 4503 were assessed in the s.c. implanted MDAMB-231 adenocarcinoma and the MHEC5-T hemangioendothelioma in SCID mice and in a range of normal tissues.  Blood flow was measured by i.v. injection of fluorescence beads, while quant. fluorescence microscopy was used to measure the spatial heterogeneity of blood flow in tumor sections.  Oxi 4503 induced the shutdown of tumor blood vessels in a dose-dependent pattern with an ED50 at 3 mg/kg in contrast to 43 mg/kg of CA4P.  Quant. fluorescence microscopy showed that Oxi 4503 increased the spatial heterogeneity in tumor blood flow.  Oxi 4503 affected peripheral tumor regions less than central regions, although this was not as pronounced as seen with CA4P, where only central regions were affected.  The vascular shutdown induced by administration of Oxi 4503 at a dose of 6 mg/kg resulted in extensive cell loss 24 h following treatment, which translated into a significant effect on tumor growth.  Tumor growth was completely repressed at doses above 12.5 mg/kg of Oxi 4503, while doses above 25 mg/kg showed tumor regression and even complete regression in some animals.  These results are promising for the use of Oxi 4503 as a tumor vascular targeting agent.  Moreover the potent antitumor effect when administered as a single agent suggests a different activity profile than CA4P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTUdnkKOQqFbVg90H21EOLACvtfcHk0lgICi_hbK_2aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlGmtLg%253D&md5=9d77a06bf6355d0738dd7b66bb5cb81d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DY.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DKane%26aufirst%3DR.%2BR.%26aulast%3DPrezioso%26aufirst%3DJ.%2BA.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DEdvardsen%26aufirst%3DK.%26atitle%3DOxi4503%252C%2520a%2520Novel%2520Vascular%2520Targeting%2520Agent%253A%2520Effects%2520on%2520Blood%2520Flow%2520and%2520Antitumor%2520Activity%2520in%2520Comparison%2520to%2520Combretastatin%2520A-4%2520Phosphate%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26issue%3D2B%26spage%3D1433%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benham, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H.</span></span> <span> </span><span class="NLM_article-title">Alkaline Phosphatase Expression in Human Cell Lines Derived from Various Malignancies</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910270510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1002%2Fijc.2910270510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=6793524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL3MXkt1amtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1981&pages=637-644&issue=5&author=F.+J.+Benhamauthor=J.+Foghauthor=H.+Harris&title=Alkaline+Phosphatase+Expression+in+Human+Cell+Lines+Derived+from+Various+Malignancies&doi=10.1002%2Fijc.2910270510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Alkaline phosphatase expression in human cell lines derived from various malignancies</span></div><div class="casAuthors">Benham, Frances J.; Fogh, Joergen; Harris, Harry</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-44</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The expression of heat-stable placental-type alk. phosphatase (ALP) was studied in 19 unselected human tumor cell lines, known not to be HeLa.  All cell lines showed measurable ALP activity and in 15 of the lines at least low levels of a heat-stable, presumptively placental-type ALP were detected.  In 5 of these lines where the level of this heat-stable activity was sufficient, further investigation (immunol., inhibition, and electrophoretic studies) demonstrated that this ALP was placental-type and different from liver/bone/kidney or intestinal ALPs.  In 10 lines, the heat-stable activity was too low to allow further characterization.  In 4 lines, no heat-stable activity could be detected.  The thermolabile ALP activity in these various lines was liver/bone/kidney in type.  Apparently, the placental ALP locus may be expressed at least at low levels in a much higher proportion of tumors and tumor cell lines than previously reported.  So-called ectopic synthesis of placental ALP in tumor cells may not necessarily be due to derepression of a structural locus which is completely unexpressed in normal adult tissues.  It may represent an enhancement of expression in malignancy or there may be clonal expansion of a particular cell type which normally expresses the alk. phosphatase at a high level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodtIXkg5ovbrVg90H21EOLACvtfcHk0liOjHDraIVJNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkt1amtbc%253D&md5=e849e79e8058cdc9cff31ce27e66888c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910270510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910270510%26sid%3Dliteratum%253Aachs%26aulast%3DBenham%26aufirst%3DF.%2BJ.%26aulast%3DFogh%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DH.%26atitle%3DAlkaline%2520Phosphatase%2520Expression%2520in%2520Human%2520Cell%2520Lines%2520Derived%2520from%2520Various%2520Malignancies%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1981%26volume%3D27%26issue%3D5%26spage%3D637%26epage%3D644%26doi%3D10.1002%2Fijc.2910270510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaith, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orriss, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdy, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. M.</span></span> <span> </span><span class="NLM_article-title">Tumour-Derived Alkaline Phosphatase Regulates Tumour Growth, Epithelial Plasticity and Disease-Free Survival in Metastatic Prostate Cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/bjc.2016.402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fbjc.2016.402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=28006818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFOiu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=227-236&issue=2&author=S.+R.+Raoauthor=A.+E.+Snaithauthor=D.+Marinoauthor=X.+Chengauthor=S.+T.+Lwinauthor=I.+R.+Orrissauthor=F.+C.+Hamdyauthor=C.+M.+Edwards&title=Tumour-Derived+Alkaline+Phosphatase+Regulates+Tumour+Growth%2C+Epithelial+Plasticity+and+Disease-Free+Survival+in+Metastatic+Prostate+Cancer&doi=10.1038%2Fbjc.2016.402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer</span></div><div class="casAuthors">Rao, S. R.; Snaith, A. E.; Marino, D.; Cheng, X.; Lwin, S. T.; Orriss, I. R.; Hamdy, F. C.; Edwards, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-236</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Recent evidence suggests that bone-related parameters are the main prognostic factors for overall survival in advanced prostate cancer (PCa), with elevated circulating levels of alk. phosphatase (ALP) thought to reflect the dysregulated bone formation accompanying distant metastases.  We have identified that PCa cells express ALPL, the gene that encodes for tissue nonspecific ALP, and hypothesised that tumor-derived ALPL may contribute to disease progression.  Methods: Functional effects of ALPL inhibition were investigated in metastatic PCa cell lines.  ALPL gene expression was analyzed from published PCa data sets, and correlated with disease-free survival and metastasis.  Results: ALPL expression was increased in PCa cells from metastatic sites.  A redn. in tumor-derived ALPL expression or ALP activity increased cell death, mesenchymal-to-epithelial transition and reduced migration.  Alk. phosphatase activity was decreased by the EMT repressor Snail.  In men with PCa, tumor-derived ALPL correlated with EMT markers, and high ALPL expression was assocd. with a significant redn. in disease-free survival.  Conclusions: Our studies reveal the function of tumor-derived ALPL in regulating cell death and epithelial plasticity, and demonstrate a strong assocn. between ALPL expression in PCa cells and metastasis or disease-free survival, thus identifying tumor-derived ALPL as a major contributor to the pathogenesis of PCa progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPuD1njWZ-NbVg90H21EOLACvtfcHk0liOjHDraIVJNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFOiu7jO&md5=73aea82569d21ce02ea4fa58feb194d0</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2016.402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2016.402%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%2BR.%26aulast%3DSnaith%26aufirst%3DA.%2BE.%26aulast%3DMarino%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLwin%26aufirst%3DS.%2BT.%26aulast%3DOrriss%26aufirst%3DI.%2BR.%26aulast%3DHamdy%26aufirst%3DF.%2BC.%26aulast%3DEdwards%26aufirst%3DC.%2BM.%26atitle%3DTumour-Derived%2520Alkaline%2520Phosphatase%2520Regulates%2520Tumour%2520Growth%252C%2520Epithelial%2520Plasticity%2520and%2520Disease-Free%2520Survival%2520in%2520Metastatic%2520Prostate%2520Cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26issue%3D2%26spage%3D227%26epage%3D236%26doi%3D10.1038%2Fbjc.2016.402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gangjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risinger, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooberry, S. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Discovery of Water Soluble Microtubule Targeting Agents That Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">8116</span>– <span class="NLM_lpage">8128</span>, <span class="refDoi"> DOI: 10.1021/jm101010n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101010n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlens77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8116-8128&issue=22&author=A.+Gangjeeauthor=Y.+Zhaoauthor=L.+Linauthor=S.+Raghavanauthor=E.+G.+Robertsauthor=A.+L.+Risingerauthor=E.+Hamelauthor=S.+L.+Mooberry&title=Synthesis+and+Discovery+of+Water+Soluble+Microtubule+Targeting+Agents+That+Bind+to+the+Colchicine+Site+on+Tubulin+and+Circumvent+Pgp+Mediated+Resistance&doi=10.1021%2Fjm101010n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance</span></div><div class="casAuthors">Gangjee, Aleem; Zhao, Ying; Lin, Lu; Raghavan, Sudhir; Roberts, Elizabeth G.; Risinger, April L.; Hamel, Ernest; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8116-8128</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two classes of mols. were designed and synthesized based on a 6-CH3 cyclopenta[d]pyrimidine scaffold and a pyrrolo[2,3-d]pyrimidine scaffold.  The pyrrolo[2,3-d]pyrimidines were synthesized by reacting Et 2-cyano-4,4-diethoxybutanoate and acetamidine, which in turn was chlorinated and reacted with the appropriate anilines to afford pyrrolopyrimidines I (R = Me, H).  The cyclopenta[d]pyrimidines were obtained from 3-methyladapic acid, followed by reaction with acetamidine to afford the cyclopenta[d]pyrimidine scaffold.  Chlorination and reaction with appropriate anilines afforded cyclopentapyrimidines, II (R = 4-MeO, 3-MeO, 2-MeO, H).  Pyrimidines I (R = Me)(III) and II (R = 4-MeO)(IV) had potent antiproliferative activities in the nanomolar range.  Cyclopentapyrimidine IV is significantly more potent than pyrrolopyrimidine III.  Mechanistic studies showed that III and IV cause loss of cellular microtubules, inhibit the polymn. of purified tubulin, and inhibit colchicine binding.  Modeling studies show interactions of these compds. within the colchicine site.  The identification of these new inhibitors that can also overcome clin. relevant mechanisms of drug resistance provides new scaffolds for colchicine site agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc5L05H-4Yj7Vg90H21EOLACvtfcHk0liOjHDraIVJNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlens77M&md5=8a0bd50260d069a868762389f24d5399</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm101010n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101010n%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DE.%2BG.%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DSynthesis%2520and%2520Discovery%2520of%2520Water%2520Soluble%2520Microtubule%2520Targeting%2520Agents%2520That%2520Bind%2520to%2520the%2520Colchicine%2520Site%2520on%2520Tubulin%2520and%2520Circumvent%2520Pgp%2520Mediated%2520Resistance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D22%26spage%3D8116%26epage%3D8128%26doi%3D10.1021%2Fjm101010n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocharla, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strecker, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Dihydronaphthalene Analogues Inspired by Combretastatin A-4 and Their Biological Evaluation as Anticancer Agents</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1649</span>– <span class="NLM_lpage">1662</span>, <span class="refDoi"> DOI: 10.1039/C8MD00322J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1039%2FC8MD00322J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=30429970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1649-1662&issue=10&author=C.+J.+Maguireauthor=Z.+Chenauthor=V.+P.+Mocharlaauthor=M.+Sriramauthor=T.+E.+Streckerauthor=E.+Hamelauthor=H.+Zhouauthor=R.+Lopezauthor=Y.+Wangauthor=R.+P.+Masonauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+Dihydronaphthalene+Analogues+Inspired+by+Combretastatin+A-4+and+Their+Biological+Evaluation+as+Anticancer+Agents&doi=10.1039%2FC8MD00322J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents</span></div><div class="casAuthors">Maguire, Casey J.; Chen, Zhi; Mocharla, Vani P.; Sriram, Madhavi; Strecker, Tracy E.; Hamel, Ernest; Zhou, Heling; Lopez, Ramona; Wang, Yifan; Mason, Ralph P.; Chaplin, David J.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1649-1662</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The natural products colchicine and combretastatin A-4 (CA4) have provided inspiration for the discovery and development of a wide array of derivs. and analogs that inhibit tubulin polymn. through a binding interaction at the colchicine site on β-tubulin.  A water-sol. phosphate prodrug salt of CA4 (referred to as CA4P) has demonstrated the ability to selectively damage tumor-assocd. vasculature and ushered in a new class of developmental anticancer agents known as vascular disrupting agents (VDAs).  Through a long-term program of structure activity relationship (SAR) driven inquiry, we discovered that the dihydronaphthalene mol. scaffold provided access to small-mol. inhibitors of tubulin polymn.  In particular, a dihydronaphthalene analog bearing a pendant trimethoxy aryl ring (referred to as KGP03) and a similar aroyl ring (referred to as KGP413) were potent inhibitors of tubulin polymn. (IC50 = 1.0 and 1.2 μM, resp.) and displayed low nM cytotoxicity against human cancer cell lines.  In order to enhance water-soly. for in vivo evaluation, the corresponding phosphate prodrug salts (KGP04 and KGP152, resp.) were synthesized.  In a preliminary in vivo study in a SCID-BALB/c mouse model bearing the human breast tumor MDA-MB-231-luc, a 99% redn. in signal was obsd. with bioluminescence imaging (BLI) 4 h after IP administration of KGP152 (200 mg kg-1) indicating reduced tumor blood flow.  In a sep. study, disruption of tumor-assocd. blood flow in a Fischer rat bearing an A549-luc human lung tumor was obsd. by color Doppler ultrasound following administration of KGP04 (15 mg kg-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIQ1UFKH-j37Vg90H21EOLACvtfcHk0lgnLttxXYCudg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyktbvM&md5=a3d05e0345a50f5bd5ffb68ada1c827d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1039%2FC8MD00322J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00322J%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520Dihydronaphthalene%2520Analogues%2520Inspired%2520by%2520Combretastatin%2520A-4%2520and%2520Their%2520Biological%2520Evaluation%2520as%2520Anticancer%2520Agents%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26issue%3D10%26spage%3D1649%26epage%3D1662%26doi%3D10.1039%2FC8MD00322J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folaron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshadri, M.</span></span> <span> </span><span class="NLM_article-title">Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas</span>. <i>Mol. Imaging Biol. MIB Off. Publ. Acad. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1007/s11307-016-0963-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1007%2Fs11307-016-0963-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=27160251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A280%3ADC%252BC28bnslektA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=860-869&issue=6&author=M.+Folaronauthor=M.+Seshadri&title=Bioluminescence+and+MR+Imaging+of+the+Safety+and+Efficacy+of+Vascular+Disruption+in+Gliomas&doi=10.1007%2Fs11307-016-0963-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas</span></div><div class="casAuthors">Folaron Margaret; Seshadri Mukund; Folaron Margaret; Seshadri Mukund; Seshadri Mukund</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">860-869</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The goal of the present study was to examine the safety and efficacy of the vascular disrupting agent (VDA) EPC2407 (Crolibulin®) in experimental glioma models using bioluminescence imaging (BLI) and magnetic resonance imaging (MRI).  PROCEDURES:  Experimental imaging studies were performed in subcutaneous human U87 glioma xenografts and orthotopic murine gliomas established by intracranial implantation of luciferase-transfected glioma cells (GL261-luc).  Correlative histopathology and long-term survival analysis was also performed.  RESULTS:  Treatment with EPC2407 decreased tumor perfusion and increased necrosis and tumor doubling times in subcutaneous U87 xenografts.  Dynamic BLI and T1-weighted contrast-enhanced MRI showed reduction in blood flow of intracranial GL261-luc gliomas within a few hours of VDA treatment.  T2-weighted MRI did not show any evidence of hemorrhaging or edema in uninvolved brain tissue of EPC2407-treated animals.  A significant increase in median survival (p < 0.05) was observed in the orthotopic GL261-luc model following VDA treatment compared to untreated controls.  CONCLUSIONS:  We demonstrate, for the first time, the biological activity of EPC2407 in experimental gliomas.  Further investigation into the potential of VDAs in combination with chemoradiation therapy against gliomas is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAs75bsyFrrYHWj6b1v8uTfW6udTcc2ebPkfHdi6PMQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bnslektA%253D%253D&md5=784ccbe1f1a742b956f4b6e143d385a2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs11307-016-0963-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-016-0963-8%26sid%3Dliteratum%253Aachs%26aulast%3DFolaron%26aufirst%3DM.%26aulast%3DSeshadri%26aufirst%3DM.%26atitle%3DBioluminescence%2520and%2520MR%2520Imaging%2520of%2520the%2520Safety%2520and%2520Efficacy%2520of%2520Vascular%2520Disruption%2520in%2520Gliomas%26jtitle%3DMol.%2520Imaging%2520Biol.%2520MIB%2520Off.%2520Publ.%2520Acad.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D18%26issue%3D6%26spage%3D860%26epage%3D869%26doi%3D10.1007%2Fs11307-016-0963-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tumati, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, D.</span></span> <span> </span><span class="NLM_article-title">Development of a Locally Advanced Orthotopic Prostate Tumor Model in Rats for Assessment of Combined Modality Therapy</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.3892/ijo.2013.1858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.3892%2Fijo.2013.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=23525451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=1613-1619&issue=5&author=V.+Tumatiauthor=S.+Mathurauthor=K.+Songauthor=J.-T.+Hsiehauthor=D.+Zhaoauthor=M.+Takahashiauthor=T.+Dobinauthor=L.+Gandeeauthor=T.+D.+Solbergauthor=A.+A.+Habibauthor=D.+Saha&title=Development+of+a+Locally+Advanced+Orthotopic+Prostate+Tumor+Model+in+Rats+for+Assessment+of+Combined+Modality+Therapy&doi=10.3892%2Fijo.2013.1858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy</span></div><div class="casAuthors">Tumati, Vasu; Mathur, Sanjeev; Song, Kwang; Hsieh, Jer-Tsong; Zhao, Dawen; Takahashi, Masaya; Dobin, Timothy; Gandee, Leah; Solberg, Timothy D.; Habib, Amyn A.; Saha, Debabrata</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1613-1619</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biol. agents.  For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3-KD).  These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance.  We report that: (i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; (ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; (iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; (iv) precise measurement of the tumor vol. and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, resp.; and (v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor.  This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGm67pbWnVULVg90H21EOLACvtfcHk0litWvCT4BYfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFehsr0%253D&md5=bdc7c4dd6702d0c7ed96180e02371393</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3892%2Fijo.2013.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2013.1858%26sid%3Dliteratum%253Aachs%26aulast%3DTumati%26aufirst%3DV.%26aulast%3DMathur%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DHsieh%26aufirst%3DJ.-T.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DDobin%26aufirst%3DT.%26aulast%3DGandee%26aufirst%3DL.%26aulast%3DSolberg%26aufirst%3DT.%2BD.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DSaha%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520Locally%2520Advanced%2520Orthotopic%2520Prostate%2520Tumor%2520Model%2520in%2520Rats%2520for%2520Assessment%2520of%2520Combined%2520Modality%2520Therapy%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2013%26volume%3D42%26issue%3D5%26spage%3D1613%26epage%3D1619%26doi%3D10.3892%2Fijo.2013.1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span> <span> </span><span class="NLM_article-title">Antivascular Effects of Combretastatin A4 Phosphate in Breast Cancer Xenograft Assessed Using Dynamic Bioluminescence Imaging and Confirmed by MRI</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2445</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.1096/fj.07-103713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1096%2Ffj.07-103713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=18263704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlGntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2445-2451&issue=7&author=D.+Zhaoauthor=E.+Richerauthor=P.+P.+Antichauthor=R.+P.+Mason&title=Antivascular+Effects+of+Combretastatin+A4+Phosphate+in+Breast+Cancer+Xenograft+Assessed+Using+Dynamic+Bioluminescence+Imaging+and+Confirmed+by+MRI&doi=10.1096%2Ffj.07-103713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI</span></div><div class="casAuthors">Zhao, Dawen; Richer, Edmond; Antich, Peter P.; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2445-2451, 10.1096/fj.07-103713</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Bioluminescence imaging (BLI) has found significant use in evaluating long-term cancer therapy in small animals.  We have now tested the feasibility of using BLI to assess acute effects of the vascular disrupting agent combretastatin A4 phosphate (CA4P) on luciferase-expressing MDA-MB-231 human breast tumor cells growing as xenografts in mice.  Following administration of luciferin substrate, there is a rapid increase in light emission reaching a max. after about 6 min, which gradually decreases over the following 20 min.  The kinetics of light emission are highly reproducible; however, following i.p. administration of CA4P (120 mg/kg), the detected light emission was decreased between 50 and 90%, and time to max. was significantly delayed.  Twenty-four hours later, there was some recovery of light emission following further administration of luciferin substrate.  Comparison with dynamic contrast-enhanced MRI based on the paramagnetic contrast agent Omniscan showed comparable changes in the tumors consistent with the previous literature.  Histol. also confirmed shutdown of tumor vascular perfusion.  We believe this finding provides an important novel application for BLI that could have widespread application in screening novel therapeutics expected to cause acute vascular changes in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldcNIzMt3h7Vg90H21EOLACvtfcHk0litWvCT4BYfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlGntLo%253D&md5=70d3c8e8fb0f1e0db2800e8b8411f70e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1096%2Ffj.07-103713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.07-103713%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DRicher%26aufirst%3DE.%26aulast%3DAntich%26aufirst%3DP.%2BP.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DAntivascular%2520Effects%2520of%2520Combretastatin%2520A4%2520Phosphate%2520in%2520Breast%2520Cancer%2520Xenograft%2520Assessed%2520Using%2520Dynamic%2520Bioluminescence%2520Imaging%2520and%2520Confirmed%2520by%2520MRI%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26issue%3D7%26spage%3D2445%26epage%3D2451%26doi%3D10.1096%2Ffj.07-103713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span> <span> </span><span class="NLM_article-title">Tumor Physiologic Response to Combretastatin A4 Phosphate Assessed by MRI</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">872</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2005.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ijrobp.2005.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=15936572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVOnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2005&pages=872-880&issue=3&author=D.+Zhaoauthor=L.+Jiangauthor=E.+W.+Hahnauthor=R.+P.+Mason&title=Tumor+Physiologic+Response+to+Combretastatin+A4+Phosphate+Assessed+by+MRI&doi=10.1016%2Fj.ijrobp.2005.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor physiologic response to combretastatin A4 phosphate assessed by MRI</span></div><div class="casAuthors">Zhao, Dawen; Jiang, Lan; Hahn, Eric W.; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">872-880</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">To evaluate the effect of the vascular targeting agent, combretastatin A4 phosphate, on tumor oxygenation compared with vascular perfusion/permeability. 19F MRI oximetry and dynamic contrast-enhanced (DCE)-MRI were used to monitor tumor oxygenation and perfusion/permeability in syngeneic 13762NF rat breast carcinoma.  A significant drop was found in the mean tumor pO2 (23 to 9 mm Hg, p <0.05) within 90 min after treatment (30 mg/kg of combretastatin A4 phosphate) and a further decrease was obsd. at 2 h (mean 2 mm Hg; p <0.01).  The initial changes in pO2 in the central and peripheral regions were parallel, but by 24 h after treatment, a significant difference was apparent: the pO2 in the periphery had improved significantly, and the center remained hypoxic.  These data are consistent with DCE-MRI, which revealed an ∼70% decrease in perfusion/permeability (initial area under signal-intensity curve) at 2 h (p <0.001).  The initial area under signal-intensity curve recovered fully after 24 h in a thin peripheral region, but not in the tumor center.  The response obsd. by DCE-MRI, indicating vascular shutdown, paralleled the pO2 measurements as expected, but quant. pO2 measurements are potentially important for optimizing the therapeutic combination of vascular targeting agents with radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6XcQDfaGu7Vg90H21EOLACvtfcHk0litWvCT4BYfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVOnsb0%253D&md5=3f621dfdc6de6be00f77586c19847cd6</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2005.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2005.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DHahn%26aufirst%3DE.%2BW.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DTumor%2520Physiologic%2520Response%2520to%2520Combretastatin%2520A4%2520Phosphate%2520Assessed%2520by%2520MRI%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2005%26volume%3D62%26issue%3D3%26spage%3D872%26epage%3D880%26doi%3D10.1016%2Fj.ijrobp.2005.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, R. P.</span></span> <span> </span><span class="NLM_article-title">In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated with Therapeutic Outcome</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2010.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2Fj.ijrobp.2010.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=21345614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=574-581&issue=2&author=D.+Zhaoauthor=C.-H.+Changauthor=J.+G.+Kimauthor=H.+Liuauthor=R.+P.+Mason&title=In+Vivo+Near-Infrared+Spectroscopy+and+Magnetic+Resonance+Imaging+Monitoring+of+Tumor+Response+to+Combretastatin+A-4-Phosphate+Correlated+with+Therapeutic+Outcome&doi=10.1016%2Fj.ijrobp.2010.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome</span></div><div class="casAuthors">Zhao, Dawen; Chang, Cheng-Hui; Kim, Jae G.; Liu, Hanli; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">574-581</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: To develop a combination treatment consisting of combretastatin A-4-phosphate (CA4P) with radiation based on tumor oxygenation status.  Methods and Materials: In vivo near-IR spectroscopy (NIRS) and diffusion-weighted (DW) magnetic resonance imaging (MRI) were applied to noninvasively monitor changes in tumor blood oxygenation and necrosis induced by CA4P (30 mg/kg) in rat mammary 13762NF adenocarcinoma, and the evidence was used to optimize combinations of CA4P and radiation treatment (a single dose of 5 Gy).  Results: NIRS showed decreasing concns. of tumor vascular oxyHb and total Hb during the first 2 h after CA4P treatment, indicating significant redns. in tumor blood oxygenation and perfusion levels (p < 0.001).  Twenty-four hours later, in response to oxygen inhalation, significant recovery was obsd. in tumor vascular and tissue oxygenation according to NIRS and pimonidazole staining results, resp. (p < 0.05).  DW MRI revealed significantly increased water diffusion in tumors measured by apparent diffusion coeff. at 24 h (p < 0.05), suggesting that CA4P-induced central necrosis.  In concordance with the obsd. tumor oxygen dynamics, we found that treatment efficacy depended on the timing of the combined therapy.  The most significant delay in tumor growth was seen in the group of tumors treated with radiation while the rats breathed oxygen 24 h after CA4P administration.  Conclusions: Noninvasive evaluation of tumor oxygen dynamics allowed us to rationally enhance the response of syngeneic rat breast tumors to combined treatment of CA4P with radiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPUFWrpMkdXbVg90H21EOLACvtfcHk0lhoUhyPZ2ZOZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtrk%253D&md5=a8f81fd671121cbc9cbc62d69f8c9db9</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2010.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2010.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DKim%26aufirst%3DJ.%2BG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DIn%2520Vivo%2520Near-Infrared%2520Spectroscopy%2520and%2520Magnetic%2520Resonance%2520Imaging%2520Monitoring%2520of%2520Tumor%2520Response%2520to%2520Combretastatin%2520A-4-Phosphate%2520Correlated%2520with%2520Therapeutic%2520Outcome%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2011%26volume%3D80%26issue%3D2%26spage%3D574%26epage%3D581%26doi%3D10.1016%2Fj.ijrobp.2010.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galbraith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirling, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhani, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustin, G. J. S.</span></span> <span> </span><span class="NLM_article-title">Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">2831</span>– <span class="NLM_lpage">2842</span>, <span class="refDoi"> DOI: 10.1200/JCO.2003.05.187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1200%2FJCO.2003.05.187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12807936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVKjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2831-2842&issue=15&author=S.+M.+Galbraithauthor=R.+J.+Maxwellauthor=M.+A.+Lodgeauthor=G.+M.+Tozerauthor=J.+Wilsonauthor=N.+J.+Taylorauthor=J.+J.+Stirlingauthor=L.+Senaauthor=A.+R.+Padhaniauthor=G.+J.+S.+Rustin&title=Combretastatin+A4+Phosphate+Has+Tumor+Antivascular+Activity+in+Rat+and+Man+as+Demonstrated+by+Dynamic+Magnetic+Resonance+Imaging&doi=10.1200%2FJCO.2003.05.187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging</span></div><div class="casAuthors">Galbraith, Susan M.; Maxwell, Ross J.; Lodge, Martin A.; Tozer, Gillian M.; Wilson, John; Taylor, N. Jane; Stirling, J. James; Sena, Luiza; Padhani, Anwar R.; Rustin, Gordon J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2831-2842</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Combretastatin A4 phosphate (CA4P) is a novel vascular targeting agent.  Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) studies were performed to examine changes in parameters related to blood flow and vascular permeability in tumor and normal tissue after CA4P treatment.  Materials and Methods: Changes in kinetic DCE-MRI parameters (transfer const. [Ktrans] and area under contrast medium-time curve [AUC]) over 24 h after treatment with CA4P were measured in 18 patients in a phase I trial and compared with those obtained in the rat P22 carcinosarcoma model, using the same imaging technique.  Rats were treated with 30 mg/kg of CA4P; patients received escalating doses from 5 to 114 mg/m2.  Results: A similar pattern and time course of change in tumor and normal tissue parameters was seen in rats and humans.  Rat tumor Ktrans was reduced by 64% 6 h after treatment with CA4P (30 mg/kg).  No significant redns. in kidney or muscle parameters were seen.  Significant redns. were seen in tumor Ktrans in six of 16 patients treated at ≥52 mg/m2, with a significant group mean redn. of 37% and 29% at 4 and 24 h, resp., after treatment.  The mean redn. in tumor initial area under the gadolinium-diethylenetriamine pentaacetic acid concn.-time curve (AUC) was 33% and 18%, resp., at these times.  No redn. was seen in muscle Ktrans or in kidney AUC in group anal. of the clin. data.  Conclusion: CA4P acutely reduces Ktrans in human as well as rat tumors at well-tolerated doses, with no significant changes in kidney or muscle, providing proof of principle that this drug has tumor antivascular activity in rats and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoraIEkX52IMrVg90H21EOLACvtfcHk0lhoUhyPZ2ZOZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVKjsb8%253D&md5=e8fd067433d43c93d7b3585b6e77ce2e</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1200%2FJCO.2003.05.187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2003.05.187%26sid%3Dliteratum%253Aachs%26aulast%3DGalbraith%26aufirst%3DS.%2BM.%26aulast%3DMaxwell%26aufirst%3DR.%2BJ.%26aulast%3DLodge%26aufirst%3DM.%2BA.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DN.%2BJ.%26aulast%3DStirling%26aufirst%3DJ.%2BJ.%26aulast%3DSena%26aufirst%3DL.%26aulast%3DPadhani%26aufirst%3DA.%2BR.%26aulast%3DRustin%26aufirst%3DG.%2BJ.%2BS.%26atitle%3DCombretastatin%2520A4%2520Phosphate%2520Has%2520Tumor%2520Antivascular%2520Activity%2520in%2520Rat%2520and%2520Man%2520as%2520Demonstrated%2520by%2520Dynamic%2520Magnetic%2520Resonance%2520Imaging%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26issue%3D15%26spage%3D2831%26epage%3D2842%26doi%3D10.1200%2FJCO.2003.05.187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vichai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirtikara, K.</span></span> <span> </span><span class="NLM_article-title">Sulforhodamine B Colorimetric Assay for Cytotoxicity Screening</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1038%2Fnprot.2006.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=17406391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1112-1116&issue=3&author=V.+Vichaiauthor=K.+Kirtikara&title=Sulforhodamine+B+Colorimetric+Assay+for+Cytotoxicity+Screening&doi=10.1038%2Fnprot.2006.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforhodamine B colorimetric assay for cytotoxicity screening</span></div><div class="casAuthors">Vichai, Vanicha; Kirtikara, Kanyawim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1112-1116</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The sulforhodamine B (SRB) assay is used for cell d. detn., based on the measurement of cellular protein content.  The method described here was optimized for the toxicity screening of compds. to adherent cells in a 96-well format.  After an incubation period, cell monolayers are fixed with 10% (wt/vol) trichloroacetic acid and stained for 30 min, after which the excess dye is removed by washing repeatedly with 1% (vol/vol) acetic acid.  The protein-bound dye is dissolved in 10 mM Tris base soln. for OD detn. at 510 nm using a microplate reader.  The results are linear over a 20-fold range of cell nos. and the sensitivity is comparable to those of fluorometric methods.  The method not only allows a large no. of samples to be tested within a few days, but also requires only simple equipment and inexpensive reagents.  The SRB assay is therefore an efficient and highly cost-effective method for screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGZ8pao808l7Vg90H21EOLACvtfcHk0lhoUhyPZ2ZOZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O&md5=7173035a1f9eb3f02dd7f1a947bca659</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.179%26sid%3Dliteratum%253Aachs%26aulast%3DVichai%26aufirst%3DV.%26aulast%3DKirtikara%26aufirst%3DK.%26atitle%3DSulforhodamine%2520B%2520Colorimetric%2520Assay%2520for%2520Cytotoxicity%2520Screening%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26issue%3D3%26spage%3D1112%26epage%3D1116%26doi%3D10.1038%2Fnprot.2006.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skehan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistica, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronise, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaigro-Wolff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray-Goodrich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M.</span></span> <span> </span><span class="NLM_article-title">Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1093/jnci/83.11.757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1093%2Fjnci%2F83.11.757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=2041050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1991&pages=757-766&issue=11&author=A.+Monksauthor=D.+Scudieroauthor=P.+Skehanauthor=R.+Shoemakerauthor=K.+Paullauthor=D.+Visticaauthor=C.+Hoseauthor=J.+Langleyauthor=P.+Croniseauthor=A.+Vaigro-Wolffauthor=M.+Gray-Goodrichauthor=H.+Campbellauthor=J.+Mayoauthor=M.+Boyd&title=Feasibility+of+a+High-Flux+Anticancer+Drug+Screen+Using+a+Diverse+Panel+of+Cultured+Human+Tumor+Cell+Lines&doi=10.1093%2Fjnci%2F83.11.757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</span></div><div class="casAuthors">Monks, Anne; Scudiero, Dominic; Skehan, Philip; Shoemaker, Robert; Paull, Kenneth; Vistica, David; Hose, Curtis; Langley, John; Cronise, Paul; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">757-66</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The development and implementation of a pilot-scale, in vitro, anticancer drug screen utilizing a panel of 60 human tumor cell lines organized into subpanels representing leukemia, melanoma, and cancers of the lung, colon, kidney, ovary, and central nervous system is described.  The ultimate goal of this disease-oriented screen is to facilitate the discovery of new compds. with potential cell line-specific and/or subpanel-specific antitumor activity.  In the current screening protocol, each cell line is inoculated onto microtiter plates, then preincubated for 24-28 h.  Subsequently, test agents are added in five 10-fold dilns. and the culture is incubated for an addnl. 48 h.  For each test agent, a dose-response profile is generated.  End-point detns. of the cell viability or cell growth are performed by in situ fixation of cells, followed by staining with a protein-binding dye, sulforhodamine B (SRB).  The SRB binds to the basic amino acids of cellular macromols.; the solubilized stain is measured spectrophotometrically to det. relative cell growth or viability in treated and untreated cells.  Following the pilot screening studies, a screening rate of 400 compds. per wk has been consistently achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2v5P80YUP7Vg90H21EOLACvtfcHk0lj11xJvDhX4-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D&md5=cee33642400d34b01d8f962cb16a9386</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F83.11.757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F83.11.757%26sid%3Dliteratum%253Aachs%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DR.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DHose%26aufirst%3DC.%26aulast%3DLangley%26aufirst%3DJ.%26aulast%3DCronise%26aufirst%3DP.%26aulast%3DVaigro-Wolff%26aufirst%3DA.%26aulast%3DGray-Goodrich%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DH.%26aulast%3DMayo%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%26atitle%3DFeasibility%2520of%2520a%2520High-Flux%2520Anticancer%2520Drug%2520Screen%2520Using%2520a%2520Diverse%2520Panel%2520of%2520Cultured%2520Human%2520Tumor%2520Cell%2520Lines%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D1991%26volume%3D83%26issue%3D11%26spage%3D757%26epage%3D766%26doi%3D10.1093%2Fjnci%2F83.11.757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. M.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the Colchicine-Binding Activity of Tubulin by Organic Acids</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>675</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/0304-4165(81)90231-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1016%2F0304-4165%2881%2990231-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADyaL3MXksFKks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=675&publication_year=1981&pages=226-231&issue=2&author=E.+Hamelauthor=C.+M.+Lin&title=Stabilization+of+the+Colchicine-Binding+Activity+of+Tubulin+by+Organic+Acids&doi=10.1016%2F0304-4165%2881%2990231-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the colchicine-binding activity of tubulin by organic acids</span></div><div class="casAuthors">Hamel, Ernest; Lin, Chii M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">675</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-31</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    </div><div class="casAbstract">A no. of carboxylic acids and org. phosphates were highly effective in stabilizing the colchicine-binding activity of calf brain tubulin.  The most active were glutamate, glutarate, β-aminovalerate, glucose 1-phosphate, glucose 6-phosphate, fructose 1,6-diphosphate, creatine phosphate, and 6-phosphogluconate.  Max. effects occurred at high concns.  Combinations of agents were also examd., and the most effective mixt. for stabilizing tubulin found thus far was the combination of 1.0M glutamate, 100 mM glucose 1-phosphate, 1 mM GTP, and 0.5 mg albumin/mL.  No loss of activity occurred over 48 h at 37° when tubulin was present at 100 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7KAW2P8PRbVg90H21EOLACvtfcHk0lj11xJvDhX4-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXksFKks7s%253D&md5=a658ea4b7dc66a11024aeda7a99d3aef</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0304-4165%2881%2990231-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-4165%252881%252990231-2%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26atitle%3DStabilization%2520of%2520the%2520Colchicine-Binding%2520Activity%2520of%2520Tubulin%2520by%2520Organic%2520Acids%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D1981%26volume%3D675%26issue%3D2%26spage%3D226%26epage%3D231%26doi%3D10.1016%2F0304-4165%2881%2990231-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Antimitotic Agents by Quantitative Comparisons of Their Effects on the Polymerization of Purified Tubulin</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1385/CBB:38:1:1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=10.1385%2FCBB%3A38%3A1%3A1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=12663938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=1-22&issue=1&author=E.+Hamel&title=Evaluation+of+Antimitotic+Agents+by+Quantitative+Comparisons+of+Their+Effects+on+the+Polymerization+of+Purified+Tubulin&doi=10.1385%2FCBB%3A38%3A1%3A1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin</span></div><div class="casAuthors">Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Most antimitotic compds. have highly specific interactions with tubulin, the major protein component of microtubules.  It is, therefore, often desirable to characterize interactions of these agents with tubulin.  In particular, quant. comparisons between new and old ("std.") agents, between different classes of agent, and between structural analogs (e.g., for a structure-activity relationship study) are important.  Because antimitotic drugs have a variety of effects on tubulin and bind at multiple distinct sites on the protein, the tubulin assembly reaction is probably the only universally applicable reaction that can be analyzed.  In my lab., we use the assembly of purified tubulin induced by higher concns. of monosodium glutamate as our basic assay system.  This report presents a detailed description of our current routine assay, including the effects of a variety of reaction components on the reaction.  In addn., the variety of effects that reaction components can have on the quant. results obtained with drugs, using the colchicine site drug combretastatin A-4 as a model compd., is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLvDICXLUiYbVg90H21EOLACvtfcHk0lgDnAq__DQgVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D&md5=c37c365cc707e237f43feffca64d706b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1385%2FCBB%3A38%3A1%3A1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FCBB%253A38%253A1%253A1%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520Antimitotic%2520Agents%2520by%2520Quantitative%2520Comparisons%2520of%2520Their%2520Effects%2520on%2520the%2520Polymerization%2520of%2520Purified%2520Tubulin%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2003%26volume%3D38%26issue%3D1%26spage%3D1%26epage%3D22%26doi%3D10.1385%2FCBB%3A38%3A1%3A1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00551">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11175"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00551">10.1021/acs.jmedchem.9b00551</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (as SMILES) and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_001.xlsx">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR,<sup>13</sup>C NMR, <sup>31</sup>P NMR, HRMS, HPLC for final target compounds and intermediates (<sup>1</sup>H NMR, <sup>13</sup>C NMR only) associated with this article and a table of biological data including standard deviations (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_001.xlsx">jm9b00551_si_001.xlsx (11.58 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00551/suppl_file/jm9b00551_si_002.pdf">jm9b00551_si_002.pdf (34.15 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00551&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00551%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00551" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799f0e509092410","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
